0001019687-14-000141.txt : 20140113 0001019687-14-000141.hdr.sgml : 20140113 20140113162242 ACCESSION NUMBER: 0001019687-14-000141 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20131130 FILED AS OF DATE: 20140113 DATE AS OF CHANGE: 20140113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIMULATIONS PLUS INC CENTRAL INDEX KEY: 0001023459 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 954595609 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32046 FILM NUMBER: 14524668 BUSINESS ADDRESS: STREET 1: 42505 10TH STREET WEST STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-7059 BUSINESS PHONE: 661-723-7723 MAIL ADDRESS: STREET 1: 42505 10TH STREET WEST CITY: LANCASTER STATE: CA ZIP: 93534-7059 10-Q 1 simulations_10q-113013.htm QUARTERLY REPORT

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

SQuarterly Report Pursuant to Section 13 or 15(d) of the Security Exchange Act of 1934 for the quarterly period ended November 30, 2013

 

OR

 

£Transmission Report Pursuant to Section 13 or 15(d) of the Security Exchange Act of 1937 for the transition period from ______ to ______

 

Commission file number: 001-32046

 

Simulations Plus, Inc.

(Name of registrant as specified in its charter)

 

California 95-4595609
(State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.)

 

42505 10th Street West

Lancaster, CA 93534-7059

(Address of principal executive offices including zip code)

 

(661) 723-7723

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filings requirements for the past 90 days. Yes S No £

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes S No £

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

£ Large accelerated filer £ Accelerated filer
£ Non-accelerated filer (Do not check if a smaller reporting company) S Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes £ No S

 

The number of shares outstanding of the registrant’s common stock, par value $0.001 per share, as of January 13, 2014 was 16,073,894 and no shares of preferred stock were outstanding.

 

 
 

 

Simulations Plus, Inc.

FORM 10-Q

For the Quarterly Period Ended November 30, 2013

 

Table of Contents

 

PART I.  FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited) Page
     
  Condensed Balance Sheets at November 30, 2013 (unaudited) and August 31, 2013 (audited) 2
     
  Condensed Statements of Operations for the three months ended November 30, 2013 and 2012 (unaudited) 3
     
  Condensed Statements of Cash Flows for the three months ended November 30, 2013 and 2012 (unaudited) 4
     
 

Notes to Condensed Financial Statements (unaudited)

5
     
Item 2. Management’s Discussion and Analysis or Plan of Operations 14
     
  General 14
     
  Results of Operations 20
     
  Liquidity and Capital Resources 22
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 22
     
Item 4. Controls and Procedures 22

 

PART II.  OTHER INFORMATION

 

Item 1.   Legal Proceedings 24
     
Item 1A Risk Factors 24
     
Item 2. Changes in Securities 24
     
Item 3. Defaults upon Senior Securities 24
     
Item 4. Mine Safety Disclosures 24
     
Item 5. Other Information 24
     
Item 6. Exhibits 24
     
Signature   25

 

1
 

 

PART I.   FINANCIAL INFORMATION

Item 1. Financial Statements 

 

SIMULATIONS PLUS, INC.

CONDENSED BALANCE SHEETS

As of

 

 

   (Unaudited)   (Audited) 
   November 30,   August 31, 
ASSETS        
   2013   2013 
Current assets          
Cash and cash equivalents  $10,554,707   $10,179,298 
Prepaid income taxes   64,798    301,573 
Accounts receivable, net of allowance for doubtful accounts of $0   1,866,445    1,910,615 
Contracts receivable   289,040    203,913 
Prepaid expenses and other current assets   173,075    192,173 
Deferred income taxes   188,126    184,258 
Total current assets   13,136,191    12,971,830 
Long-term assets          
Capitalized computer software development costs, net of accumulated amortization of $5,993,404 and $5,801,578   3,072,547    2,891,169 
Property and equipment, net (note 3)   115,927    117,987 
Intellectual property, net of accumulated amortization of $13,125 and $11,250   61,875    63,750 
Other assets   18,445    18,445 
Total assets  $16,404,985   $16,063,181 
           
LIABILITIES AND SHAREHOLDERS' EQUITY          
Current liabilities          
Accounts payable  $235,422   $146,011 
Accrued payroll and other expenses   337,603    311,209 
Accrued bonuses to officer   30,000    60,000 
Other current liabilities   19,859    19,859 
Deferred revenue   168,241    89,227 
Total current liabilities   791,125    626,306 
           
Long-term liabilities          
Deferred income taxes   1,220,435    1,146,389 
Other long-term liabilities   43,028    47,993 
Total liabilities   2,054,588    1,820,688 
           
Commitments and contingencies (note 4)          
           
Shareholders' equity (note 5)          
Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding        
Common stock, $0.001 par value 50,000,000 shares authorized 16,073,894 and 16,030,894 shares issued and outstanding   4,545    4,502 
Additional paid-in capital   4,908,456    4,842,794 
Retained earnings   9,437,396    9,395,197 
Total shareholders' equity   14,350,397    14,242,493 
           
Total liabilities and shareholders' equity  $16,404,985   $16,063,181 

 

The accompanying notes are an integral part of these financial statements.

 

2
 

SIMULATIONS PLUS, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the three months ended

 

 

   (Unaudited) 
   November 30, 
   2013   2012 
         
Net sales  $2,641,000   $2,290,094 
Cost of sales   448,420    386,870 
Gross profit   2,192,580    1,903,224 
Operating expenses          
Selling, general, and administrative   1,071,091    931,060 
Research and development   162,116    180,335 
Total operating expenses   1,233,207    1,111,395 
           
Income from operations   959,373    791,829 
           
Other income (expense)          
Interest income   9,026    13,728 
Miscellaneous income       15,404 
Gain on currency exchange   23,709    74,654 
         
Total other income (expense)   32,735    103,786 
           
Income from operations before provision for income taxes   992,108    895,615 
           
Provision for income taxes   (306,953)   (308,629)
           
Net Income  $685,155   $586,986 
           
Earnings per share          
Basic  $0.04   $0.04 
Diluted  $0.04   $0.04 
           
Weighted-average common shares outstanding          
Basic   16,049,707    15,927,806 
Diluted   16,366,720    16,365,552 

 

 

The accompanying notes are an integral part of these financial statements.

 

3
 

SIMULATIONS PLUS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the three months ended

 

 

   (Unaudited)  
   November 30, 
   2013   2012 
Cash flows from operating activities          
Net income  $685,155   $586,986 
Adjustments to reconcile net income to net cash provided by operating activities          
Depreciation and amortization of property and equipment   11,903    10,690 
Amortization of capitalized computer software development costs   191,829    182,085 
Amortization of Intellectual property   1,875    1,875 
Stock-based compensation   15,360    38,099 
Deferred income taxes   70,178    46,339 
(Increase) decrease in          
Accounts receivable and Contracts receivable   (40,957)   (390,434)
Prepaid income taxes   236,775     
Prepaid expenses and other assets   19,098    (60,930)
Increase (decrease) in          
Accounts payable   89,408    16,598 
Accrued payroll and other expenses   26,394    9,893 
Accrued bonus   (30,000)   (45,000)
Accrued income taxes       (733,233)
Other liabilities   (4,965)    
Deferred revenue   79,014    75,446 
Net cash provided by operating activities   1,351,067    (261,586)
           
Cash flows from investing activities          
Purchases of property and equipment   (9,843)   (1,638)
Capitalized computer software development costs   (373,204)   (262,083)
Net cash provided by (used in) investing activities   (383,047)   (263,721)
           
Cash flows from financing activities          
Payment of Dividends   (642,956)   (796,390)
Proceeds from the exercise of stock options   50,345     
Net cash (used in) financing activities of continuing operations   (592,611)   (796,390)
           
Net increase (decrease) in cash and cash equivalents   375,409    (1,321,697)
Cash and cash equivalents, beginning of year   10,179,298    12,701,075 
Cash and cash equivalents, end of period  $10,554,707   $11,379,378 
           
Supplemental disclosures of cash flow information          
Interest paid  $   $ 
Income taxes paid  $   $1,091,545 

 

The accompanying notes are an integral part of these financial statements.

 

4
 

 

Simulations Plus, Inc.

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

November 30, 2013 and 2012

(Unaudited)

 

Note 1: GENERAL

 

This report on Form 10-Q for the quarter ended November 30, 2013, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. ("we", "our", "us"), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.

 

Note 2: SIGNIFICANT ACCOUNTING POLICIES

 

Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

 

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

 

5
 

 

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

 

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

 

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $191,829 and $182,085 the three months ended November 30, 2013 and 2012, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

6
 

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

 

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at November 30, 2013 for assets and liabilities measured at fair value on a recurring basis:

 

  Level I Level II Level III Total
Cash and cash equivalents $  10,554,707 $           - $           - $  10,554,707
         
Total $  10,554,707 $           - $           - $  10,554,707

 

For certain of our financial instruments, including accounts receivable, accounts payable, accrued payroll and other expenses, accrued bonus to officer, and accrued warranty and service costs, the amounts approximate fair value due to their short maturities.

 

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

 

7
 

 

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

 

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for the fiscal quarter ended November 30, 2013 and 2012 was $1,875 and $1,875 respectfully. Accumulated amortization as of November 30, 2013 was $13,125.

 

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three months ended November 30, 2013 and 2012 were as follows:

 

   11/30/2013   11/30/2012 
Numerator          
Net income attributable to common shareholders
  $685,155   $586,986 
Denominator          
Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13    16,049,707    15,927,806 
Dilutive effect of stock options   317,013    437,746 
Common stock and common stock equivalents used for diluted earning per share   16,366,720    16,365,552 

 

8
 

 

Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $15,360 and $38,099 for the three months ended November 30, 2013 and 2012, respectively, and is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

 

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

 

Note 3: Property and Equipment

 

Property and equipment as of November 30, 2013 consisted of the following:

 

Equipment  $124,042 
Computer equipment   134,398 
Furniture and fixtures   51,465 
Leasehold improvements   23,645 
     Sub total   333,550 
Less: Accumulated depreciation and amortization   (217,623)
     Net Book Value  $115,927 

 

Note 4: COMMITMENTS AND CONTINGENCIES

 

Employment Agreement

On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee’s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded will be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provides Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement. The Company may terminate the agreement upon 30 days written notice if termination is without cause. The Company's only obligation would be to pay its President the greater of a) 12 months salary or b) the remainder of the term of the employment agreement from the date of notice of termination.

 

9
 

 

For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.

 

On August 22, 2013, effective as of September 1, 2013, the CEO’s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company’s net income before taxes of the previous fiscal year not to exceed $60,000. In addition the agreement calls for the granting of ten (10) options to purchase shares of the Company’s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company’s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.

 

Litigation

We are not a party to any litigation at this time and we are not aware of any pending litigation of any kind.

 

Note 5: SHAREHOLDERS’ EQUITY

 

Dividend

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/8/2012 11/13/2012 15,927,806 $0.05 $796,390
12/24/2012 12/28/2012 16,021,309 $0.14 $2,242,983
5/7/2013 5/10/2013 16,030,433 $0.03 $480,913
8/12/2013 8/15/2013 16,030,894 $0.03 $480,926
Total       $4,001,212

 

The Board of Directors also declared cash dividend during the first quarter of fiscal year 2014.

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/08/2013 11/15/2013 16,073,894 $0.04 $642,956
         
Total       642,956

 

10
 

 

Stock Option Plan

In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the "Option Plan") under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.

 

On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance.

 

Qualified Incentive Stock Options (Qualified ISO)

As of November 30, 2013, employees hold Qualified ISO to purchase 592,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to November 30, 2013.

 

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 532,000   $1.82 3.95
Granted 100,000   $5.61  
Exercised (40,000)   $1.12  
Outstanding, November 30,  2013 592,000   $2.51 4.02
Exercisable, November 30, 2013 366,600   $1.59 3.66

 

The fair value of the options, including both ISO and NQSO options, granted during the quarter ended November 30, 2013 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE November 30, 2013: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.

 

Non-Qualified Stock Options (Non-Qualified SO)

As of November 30, 2013, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to November 30, 2013.

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 48,600   $3.47 7.85
Exercised (3,000)   $1.80  
Outstanding, November 30, 2013 45,600   $3.92 7.78
Exercisable, November 30, 2013 25,200   $1.89 6.62

 

11
 

 

The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was 4.28 years at November 30, 2013. The exercise prices for the options outstanding at November 30, 2012 ranged from $1.00 to $6.68, and the information relating to these options is as follows:

 

Exercise Price Awards Outstanding Awards Exercisable
Low High Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price
$1.00 $1.50 313,100 3.87 years $1.06 279,700 3.7 years $1.06
$1.51 $3.00 31,600 6.36 years $2.35 11,600 6.3 years $2.11
$3.01 $4.50 156,900 3.90 years $3.26 88,500   4.0 years $3.18
$4.51 $6.68 136,000 5.16 years $5.49 12,000   3.7 years $5.59
    637,600 4.28 years $2.61 391,800 3.9 years $1.71

 

Note 6: RELATED PARTY TRANSACTIONS

 

As of November 30, 2013, included in bonus expenses to officers was $60,000, of which $15,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $15,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee during the quarter ended November 30, 2013.

 

NOTE 7: CONCENTRATIONS AND UNCERTAINTIES

 

Revenue concentration shows that International sales accounted for 52% and 55% of net sales for the three months ended November 30, 2013 and 2012, respectively. Four customers accounting for 19%, 13%, 11% (a dealer account in Japan representing various customers), and 10% of net sales during the three months ended November 30, 2013, compared with four customers accounting for 22%, 14% (a dealer account in Japan representing various customers), 12%, and 8% of net sales during the three months ended November 30, 2012.

 

Accounts receivable concentration shows that four customers comprised 18%, 18% (a dealer account in Japan representing various customers), 15%, and 7% of accounts receivable at November 30, 2013, and four customers comprised 17% (a dealer account in Japan representing various customers), 16%, 11%, and 7% of accounts receivable at November 30, 2012.

 

We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.

 

The majority of our customers are in the pharmaceutical industry. During the recent economic downturn, we have seen consolidations in the pharmaceutical industry. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.

 

12
 

 

Note 8: Geographic Reporting

 

We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the three months ended November 30, 2013 and 2012 were as follows (in thousands):

 

  North America

Europe

Asia

South America

Total

November 30, 2013 $1,260 $536 $842 $3 $2,641
November 30, 2012 $1,033 $598 $659 $- $2,290

 

Note 9: EMPLOYEE BENEFIT PLAN

 

We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee’s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $26,127 and $20,814 for the three months ended November 30, 2013 and 2012, respectively.

 

Note 10: SUBSEQUENT EVENTS:

On December 6, 2013, the Board of Directors voted to amend the Company’s 2007 Employee Stock Option Plan. The amendment would increase the number of shares issuable under the plan by 1,000,000. The amendment is subject to approval by shareholder vote at the next shareholder meeting scheduled for February 25th, 2014.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13
 

 

Item 2. Management's Discussion and Analysis or Plan of Operations

 

Forward-Looking Statements

 

This document and the documents incorporated in this document by reference contain forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact contained in this document and the materials accompanying this document are forward-looking statements.

 

The forward-looking statements are based on the beliefs of our management, as well as assumptions made by and information currently available to our management. Frequently, but not always, forward-looking statements are identified by the use of the future tense and by words such as “believes,” expects,” “anticipates,” “intends,” “will,” “may,” “could,” “would,” “projects,” “continues,” “estimates” or similar expressions. Forward-looking statements are not guarantees of future performance and actual results could differ materially from those indicated by the forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements.

 

The forward-looking statements contained or incorporated by reference in this document are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements include declarations regarding our plans, intentions, beliefs or current expectations.

 

Among the important factors that could cause actual results to differ materially from those indicated by forward-looking statements are the risks and uncertainties described under “Risk Factors” in our Annual Report and elsewhere in this document and in our other filings with the SEC.

 

Forward-looking statements are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this document are made as of the date of this document and we do not undertake any obligation to update forward-looking statements to reflect new information, subsequent events or otherwise.

 

General

 

BusinesS

 

Simulations Plus, Inc., incorporated in 1996, develops and produces software for use in pharmaceutical research and for education, as well as provides contract research services to the pharmaceutical industry.

 

We currently offer five software products for pharmaceutical research: ADMET Predictor™, MedChem Designer™, MedChem Studio™, DDDPlus™, and GastroPlus™. We call the combination of ADMET Predictor, MedChem Studio, and MedChem Designer our ADMET Design Suite™.

 

14
 

 

ADMET Predictor™

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour on a fast laptop computer. This capability allows chemists to get estimates for a large number of important properties without the need to synthesize and test the molecules. ADMET Predictor has been consistently top-ranked for predictive accuracy in peer-reviewed, independent comparison studies, while generating its results at a very high throughput rate. The current state-of-the-art of this type of software does not enable finding the best molecule in a series, but it does allow identifying molecules that are highly likely to fail as potential drug candidates (the worst molecules, which is usually the majority of a chemical library) before synthesizing and testing them. Thus, millions of “virtual” compounds can be created and screened in a day, compared to potentially months of work to actually synthesize and test a much smaller number of actual compounds.

 

The ADMET Modeler™ subprogram that is integrated into ADMET Predictor enables scientists to use their own experimental data to quickly create high-quality, proprietary predictive models using the same powerful modeling methods we use to build our top-ranked class property predictions. Pharmaceutical companies expend substantial time and money conducting a wide variety of experiments on new molecules each year, resulting in large databases of experimental data. Using this proprietary data to build predictive models can provide a second return on their investment; however, model building has traditionally been a difficult and tedious activity performed by specialists. The automation in ADMET Modeler makes it easy for a scientist to create very powerful models with a minimum of training.

We are now examining a very different application of this modeling engine – building predictive models for missile aerodynamic force coefficients as a function of missile geometry, Mach number, and angle of attack. This problem was identified by the Aerospace Engineering department at Auburn University, and working with them, we have done some preliminary testing of the modeling engine in ADMET Modeler for this type of problem. Results have been very encouraging, and we believe there are government agencies and industrial aerospace companies that will find such a capability to be highly useful.

We released Version 6.5 of ADMET Predictor during last fiscal year. This version extended our metabolism predictions by training on a much larger experimental data set, and for the first time, provided specific metabolism rates for individual atoms within a molecule, rather than only for the molecule as a whole. These improvements are also available via MedChem Designer and MedChem Studio for customers who license ADMET Predictor. Version 6.5 also adds confidence levels to most of our toxicity models so that users have an idea of the reliability of each individual prediction.

We are now finalizing version 7.0, which we expect to release early in calendar 2014. This new version will incorporate a new model for predicting ionization constants (pKa’s) developed in a collaboration with Bayer AG that enabled us to more than double the size of our data set from about 16,000 pKa values to more than 35,000, and to expand the chemical space it covers to include a larger number of molecules more like those of interest to the pharmaceutical industry today. We believe the resulting improvement in pKa prediction puts our already best-in-class model well in front of any competitor. Predicting ionization is critical to predicting most other properties, so all of our models (approximately 144) are being retrained based on this new capability for version 7.0.

MedChem Designer™

MedChem Designer was launched in 2011. It was initially a molecule drawing program, or “sketcher”, but now has capabilities exceeding those of other molecule drawing programs because of its integration with both MedChem Studio and ADMET Predictor. We provide MedChem Designer for free because we believe that in the long run it will help to increase demand for ADMET Predictor and MedChem Studio, and because most other existing molecule drawing programs are also free. Our free version includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures and then see a few key properties very quickly. The chemist also sees that with a paid ADMET Predictor license, the entire 144 predictions would be available.

15
 

We released MedChem Designer 2.5 during FY2013. This new version provides the chemist the specific predicted atom locations for metabolism by each of the enzymes predicted to act upon a molecule.

When coupled with a license for ADMET Predictor, MedChem Designer becomes a de novo design tool for medicinal chemists. With it, they can draw one or more molecular structures, then click on the ADMET Predictor icon and have over 140 properties for each structure calculated in seconds, including our proprietary ADMET Risk™ index. Scientists can also click on an icon to generate the likely metabolites of a molecule and then predict all of their properties from ADMET Predictor, including their ADMET Risk scores. This is important because a metabolite of a molecule can be harmful even though the parent molecule is not.

ADMET Risk provides a single number that tells the chemist how many default threshold values for 24 predicted properties were crossed (or violated) by each structure. The rules can be modified and new rules added by the user to include any desired rule set based on any combination of calculated descriptors, predicted properties, and user inputs. Thus, in a single number, the chemist can instantly compare the effects of different structural changes in many dimensions. As chemists attempt to modify structures to improve one property, they often cause others to become unacceptable. Without ADMET Risk, the chemist would have to separately examine many key properties for each new molecule (and its metabolites) to check whether any became unacceptable as a result of changing the structure.

We are now finalizing the next release of MedChem Designer, which will add the ability to capture the image of a molecular structure with a new snapshot tool, and the program will automatically convert the graphic image into any of several computer-based chemical structure files. Converting from lines and letters on the screen to an exact chemical representation of the molecule (Optical Structure Recognition, or OSR) is a complex task. Although a few OSR programs are in existence, we are not aware of any that can accurately convert as many varieties of images to chemical representation as the OSR tool within the development version of MedChem Designer. Such a capability allows chemists to quickly capture molecular structures from the scientific literature to use in our simulation and modeling software.

MedChem Studio™

Over the past several years, MedChem Studio updates have resulted in a very powerful tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. We released version 3.5 of MedChem Designer during FY2013. The new features are too numerous to list, but include such important items as:

A new licensing module from Flexera called FlexNet™

Improvements to graphics in structure depictions and the Miner 3D module

Faster performance on large data sets

A 64-bit version to deal with much larger data sets

 

16
 

 

While MedChem Designer can be used to refine a small number of molecules, MedChem Studio can be used to create and screen (with ADMET Predictor) a very large number of molecules down to a few promising lead candidates. MedChem Studio has features that enable it to generate very large numbers of new molecular structures using a variety of de novo design methods. Coupled with ADMET Predictor and MedChem Designer, we believe the programs provide an unmatched capability for chemists to search through large libraries of compounds that have undergone high-throughput screening experiments to find the most promising classes (groups of molecules with a large part of their structures the same) and molecules that are active against a particular target. In addition, MedChem Studio can take an interesting (but not acceptable) molecule and, using a variety of design algorithms, very quickly generate many thousands of high quality analogs (similar new molecules) that are predicted (via ADMET Predictor) to be both active against the target as well as acceptable in a variety of ADMET properties.

MedChem Studio version 3.5 was released during FY2013, adding a number of new features, including:

New algorithms for drawing crisper molecular structures

New licensing module from Flexera called FlexNet™

Faster execution speed

64-bit version to allow access to much more memory for very large data sets

User-defined equations to calculate new attributes by combining others

Enhanced Miner3D graphics with expanded assortment of chart types

 

Current development has focused on the OSR tool mentioned above under the MedChem Designer discussion.

 

NCE Project

During late 2012, based on our strong belief in the exceptional capabilities of our ADMET Design Suite (MedChem Studio/MedChem Designer/ADMET Predictor), we initiated a new molecule (NCE, or New Chemical Entity) design project. After considering various targets, we selected the malaria parasite Plasmodium falciparum, both because of the unmet need for a very low-cost cure, and because we believed that external funding opportunities might exist if we were successful in generating high-quality lead compounds using our software. Our goal was to demonstrate how well the ADMET Design Suite worked to generate new lead molecules in a fraction of the time and cost normally required in the pharmaceutical industry. We completed the design process in September 2012 and we announced that we had requested quotations from chemical synthesis companies for the cost and time to make a small set of molecules. Five molecules of our own design and two precursors (almost the final designed structures, but a step away in synthesis) were synthesized and tested for inhibition of the parasite at the University of California at Riverside. We were hoping that at least one would show inhibition of the growth cycle of the parasite.

 

We were excited to learn that every molecule showed activity against the parasite at less than micromolar concentrations, with two showing activity at less than 100 nanomolar concentration (high potency) against the drug-sensitive strain of the parasite. They were then tested against the newer drug-resistant strain of the parasite, and again potency was observed, with two molecules showing nanomolar activity. We believe this exercise – a software company using its own products to design novel molecules and have them synthesized and tested – is unprecedented. New software license sales resulting from presenting our results have already more than recovered our investment.

17
 

During the previous reporting period, we announced that we had completed the design of a number of new molecules for a different target – the cyclo-oxygenase-2 (COX-2) enzyme that is the target for Celebrex®. Celebrex is the only COX-2 inhibitor remaining on the market, after the withdrawal of other approved drugs (such as Vioxx®) due to cardiac toxicity. Our chemical synthesis contractor has been working on developing the synthetic methods to make these new molecules and has now completed synthesizing sufficient material for four of the molecules to allow for testing them for activity. Samples of these new molecules are being sent out to a laboratory to measure activity against both COX-2 and COX-1 enzymes (COX-1 is inhibited by aspirin and other drugs). The reason for also testing against the COX-1 enzyme is that it appears from the scientific research that was conducted after the withdrawal of other COX-2 inhibitors from the market that it is important to inhibit both COX-2 and COX-1 at a certain ratio in order to provide the benefits of COX-2 inhibition without the cardiotoxicity risk that has been associated with inhibiting COX-2 alone. We designed our new molecules based on activity models we built for both COX-2 and COX-1 built from public data, with the goal of providing an acceptable ratio of COX-2 to COX-1 inhibition. This is much more challenging than designing for a single target, as we did for the earlier malaria NCE project.

DDDPlus

DDDPlus simulates in vitro laboratory experiments used to measure the rate of dissolution of the drug and, if desired, the additives (excipients) contained in tablets and capsules under a variety of experimental conditions. This software program is used by formulation scientists in industry and the U.S. Food and Drug Administration (FDA) to (1) understand the physical mechanisms affecting the dissolution rate for various formulations, (2) reduce the number of cut-and-try attempts to design new drug formulations, and (3) to design in vitro dissolution experiments to better mimic in vivo conditions.

GastroPlus

Our flagship product and largest source of revenues is GastroPlus. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals, and is currently in widespread use at pharmaceutical companies, the FDA, the U.S. National Institutes of Health (NIH), and other government agencies in the U.S. and other countries. Because of the widespread use of GastroPlus, we were the only non-European company invited to join the European Innovative Medicines Initiative (IMI) program for Oral Bioavailability Tools (“OrBiTo”). OrBiTo is a collaboration among 27 industry, academic, and government organizations working in the area of oral absorption of pharmaceutical products. Because we are outside of Europe, our participation in this project is at our own expense, while other members are compensated for their work; however, we are a full member with access to all of the data and discussions of all other members. We believe participation in this initiative enables us to benefit from and to contribute to advancing the prediction of human oral absorption from preclinical data, and ensures that we are in front of the audience of member pharmaceutical companies and regulatory agencies.

Version 8.5 of GastroPlus was released during the current reporting period, adding a number of important new capabilities requested by customers as well as improvements we have identified in-house, including:

A new model for precipitation based on classical nucleation theory

Infant physiologies, including for babies born as much as 16 weeks premature

A unique method for using transporter data from preclinical experiments to predict transporter effects in human and other animals

A number of additional expression levels of enzymes and transporters in human and animal physiologies

 

18
 

 

GastroPlus version 9.0 is now in development. This version will add the ability to simulate dermal (through the skin) drug absorption from patches, creams, and ointments. This capability has been in development since May of 2012 through a funded collaboration with a top-5 pharmaceutical company, and is in final testing at this time. A number of other improvements will be included in version 9.0 that will be announced with the release of the product. An interim release (8.6) is planned for the very near future to enable certain customers to take advantage of a new physiological model for minipig, which has become a more frequently used animal species in preclinical development, and to add the ability to simulate more than two drugs for drug-drug interactions.

 

MembranePlus™

MembranePlus is a new product that has been under development for a number of years, but was put on hold for several years due to other priorities. It was revived in the past year and is now nearing commercial release. Like DDDPlus, MembranePlus simulates laboratory experiments, but in this case, the experiments are for measuring permeability of drug-like molecules through various membranes, including several different cell cultures (Caco-2, MDCK) as well as artificially formulated membranes (PAMPA). The value of such a simulation results from the fact that when the permeabilities of the same molecules are measured in different laboratories, results are often strikingly different. These differences are caused by a complex interplay of factors in how the experiment was set up and run. MembranePlus simulates these experiments with their specific experimental details, and this enables the scientist to better interpret how results from specific experimental protocols can be used to predict permeability in human and animals, which is the ultimate goal. MembranePlus is unique and our customers have expressed significant interest in the new capability.

We plan to release version 1.0 of MembranePlus by March 2014.

Contract Research and Consulting Services

Our expertise in oral absorption and pharmacokinetics is evidenced by the fact that our staff members have been speakers or presenters at over 80 scientific meetings worldwide in the past four years. We frequently conduct contracted studies for large customers (including the largest five pharmaceutical companies) who have particularly difficult problems and who recognize our expertise in solving them, as well as for smaller customers who prefer to have studies run by our scientists rather than to license our software and train someone to use it. The demand for our consulting services has been steadily increasing, and we have expanded our studies to meet the increased workload. Long-term collaborations and shorter-term consulting contracts serve both to expand and showcase our technologies, and to build and strengthen customer relationships.

During the first quarter of fiscal year 2014 we continued to work on our 5-year collaboration agreement with the Center for Food Safety and Applied Nutrition (CFSAN) of the FDA. FDA scientists and our scientists are using ADMET Predictor/Modeler to build predictive models for likely toxicities of food additives and contaminants. During the first part of this collaboration, we analyzed FDA databases and worked with FDA scientists to ensure that the FDA data to be used for building new predictive models is as accurate as we can reasonably make it. Both FDA scientists and our scientists are building a series of models to classify new compounds as toxic or nontoxic from FDA datasets. Included early on in this effort was a special modification to ADMET Predictor to allow the user to set a minimum value for specificity or sensitivity when building a model, and this is now a standard part of the program available to all users. Sensitivity refers to how well a model identifies toxic (or any other property) compounds. A model that determined all compounds are toxic would have 100% sensitivity, because all toxic compounds would be labeled as such; however, all nontoxic compounds would also be labeled toxic. Specificity refers to how well a model distinguishes between toxic and nontoxic compounds. Increasing one usually results in decreasing the other. Depending on the purpose of the model, some scientists will prefer to train models that emphasize one statistic over the other.

19
 

 

STRATEGY

 

Our business strategy is to do the things we need to do to promote growth both organically (by expanding our current products and services through in-house efforts) and by acquisition. We believe in the “Built to Last” approach - that the fundamental science and technologies that underlie our business units are the keys both to improving our existing products and to expanding the product line with new products that meet our various customers’ needs. The search for suitable acquisitions continues to be a high priority.

 

With our significant cash reserves, we continue to seek suitable acquisitions. Because we have been unable to identify suitable acquisitions and our cash continues to accumulate, the board of directors declared a $0.05 per share per quarter cash dividend that began in February 2012 and was paid in May, August, and November 2012. The board declared an accelerated cash dividend consisting of the February, 2013 dividend of $0.05 per share per quarter plus $0.03 per share from each of the expected May, August, and November 2013 dividends of $0.05 per share per quarter for a total of $0.14 per share, which was distributed on December 28, 2012, in order to provide our shareholders with the income tax benefits from lower capital gains rates in 2012 over 2013. We declared and paid a $.04 per share dividend in November 2013. A dividend of $0.05 per share per quarter is anticipated going forward; however, there can be no assurances that such dividends will be distributed, or if so , whether the amounts will be more, less, or the same as expected. The Board of Directors must approve each dividend distribution and may decide to increase, decrease, or eliminate dividend distributions at any time.

 

Results of Operations

 

Comparison of Three Months Ended November 30, 2013 and 2012.

 

The following table sets forth our condensed statements of operations (in thousands) and the percentages that such items bear to net sales:

 

   Three Months Ended 
   11/30/13   11/30/12 
Net sales  $2,641    100%  $2,290    100%
Cost of sales   448    17.0    387    16.9 
Gross profit   2,193    83.0    1,903    83.1 
Selling, general and administrative   1,071    40.6    931    40.7 
Research and development   162    6.1    180    7.9 
Total operating expenses   1,233    46.7    1,111    48.5 
Income from continuing operations   959    36.3    792    34.6 
Other income    33    1.2    104    4.5 
Income from continuing operations before taxes   992    37.5    896    39.1 
(Provision for) income taxes   (307)   (11.6)   (309)   (13.5)
Net income  $685    25.9%  $587    25.6%

 

 

20
 

 

Net Sales

Net sales increased $351,000 or 15.3%, to $2,641,000 in the first fiscal quarter of Fiscal Year 2014 (“1QFY14”) from $2,290,000 in the first fiscal quarter of Fiscal Year 2013 (“1QFY13)”. We attribute the increase in revenues due to an approximately $435,000 increase software license revenues. Analytical study revenues were up $53,000. However, we were not involved in any collaboration studies in 1QFY14; therefore, net revenues for studies and collaborations decreased $58,000. In addition, training revenues declined by $26,000 as fewer training session were performed in FQ14.1.

 

Cost of Sales

Cost of sales increased by $61,000, or 15.9%, to $448,000 in 1QFY14 from $387,000 in 1QFY13. As a percentage of revenue, it also increased from 16.9% in 1QFY13 to 17.0%. A significant portion of cost of sales for pharmaceutical software products is the systematic amortization of capitalized software development costs, which is an independent fixed cost rather than a variable cost related to sales. This amortization cost increased approximately $10,000, or 5.4%, in 1QFY14 compared with 1QFY13. Royalty expense, another significant portion of cost of sales, increased approximately $34,000, or 25.5%, in 1QFY14 compared with 1QFY13. We pay a royalty on the core GastroPlus software licenses but not on its optional modules. The majority of the royalty costs increase was related to an increase in Gastro Plus license revenues. We also pay royalties to Accelrys on a portion of the ADMET Predictor Metabolism Module. Salaries related to analytical studies increase 33,000 in 1QFY14 compared with 1QFY13.

 

Gross Profit

Gross profit increased $290,000, or 15.2%, to $2,193,000 in 1QFY14 from $1,903,000 in 1QFY13. We attribute this increase to increased revenue outweighing increased cost of sales.

 

Selling, General and Administrative Expenses

Selling, general, and administrative (SG&A) expenses increased $140,000, or 15.0%, to $1,071,000 in 1QFY14 from $931,000 in 1QFY13.

The major increases in SG&A expense were:

·Commission expense – we incurred commissions to our Japanese and Chinese dealers as they increased their sales. Commissions were up by $29,000.
·Salaries and wages increased by $55,000. In the 1QFY14 greater portion of time was spent on R&D and projects that were capitalized than in 1QFY14.
·Trade shows, marketing labor, and travel costs – We continued to increase our visibility at tradeshows and conferences, increasing spending in these areas by approximately $38,000.

The major decreases in SG&A expense were:

·We incurred $36,000 less in M&A consultant fees in 1QFY14 vs 1QFY13.
·We reduced advertising by $10,000 in 1QFY14 vs 1QFY13.

 

Increases in SG&A expenses outweighed decreases.

 

Research and Development

We incurred approximately $535,000 of research and development costs during 1QFY14. Of this amount, $373,000 was capitalized and $162,000 was expensed. In 1QFY13, we incurred $442,000 of research and development costs, of which $262,000 was capitalized and $180,000 was expensed. The increase of $85,000 or 19.2% in total research and development expenditures from 1QFY13 to 1QFY14 was due and supply costs associated with R&D efforts.

 

21
 

 

Other income (expense)

Net other income in 1QFY14 decreased by $71,000, or 68.5%, to $33,000 in 1QFY14 from $103,000 in 1QFY13. This is due mainly to lower interest income and lower currency exchange gains in 1QFY14 compared with 1QFY13.

 

Provision for Income Taxes

The provision for income taxes was $307,000 for 1QFY14 and $309,000 for 1QFY13. Our tax rate decreased to 31% in 1QFY14 from 34% in 1QFY13, due to higher permanent tax deductions in 1QFY14 for R&D and other credits.

 

Net Income

Net income increased by $98,000, or 16.7%, to $685,000 in 1QFY14 from $587,000 in 1QFY13. We attribute this increase to software license sales outweighing increases in operating expenses.

 

Liquidity and Capital Resources

 

Our principal sources of capital have been cash flows from our operations. We have achieved continuous positive operating cash flow over the last eight fiscal years. We believe that our existing capital and anticipated funds from operations will be sufficient to meet our anticipated cash needs for working capital and capital expenditures for the foreseeable future. Thereafter, if cash generated from operations is insufficient to satisfy our capital requirements, we may open a revolving line of credit with a bank, or we may have to sell additional equity or debt securities or obtain expanded credit facilities. In the event such financing is needed in the future, there can be no assurance that such financing will be available to us, or, if available, that it will be in amounts and on terms acceptable to us. If cash flows from operations became insufficient to continue operations at the current level, and if no additional financing was obtained, then management would restructure the Company in a way to preserve its pharmaceutical business while maintaining expenses within operating cash flows.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Our risk from exposure to financial markets is limited to foreign exchange variances and fluctuations in interest rates. We may be subject to some foreign exchange risks. Most of our business transactions are in U.S. dollars, although we generate significant revenues from customers overseas. The exception is that we have been compensated in Japanese yen by Japanese customers and PRC Yuan (RMB) by Chinese customers. In the future, if foreign currency transactions increase significantly, then we may mitigate this effect through foreign currency forward contracts whose market-to-market gains or losses are recorded in "Other Income or expense" at the time of the transaction. To date, exchange rate exposure has not resulted in a material impact.

 

Item 4. Controls and Procedures

We are responsible for maintaining disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

22
 

 

Based on management’s evaluation (with the participation of our chief executive officer and chief financial officer) of our disclosure controls and procedures as required by Rule 13a-15 under the Exchange Act, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective.

 

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting, as defined in Exchange Act Rule 13a-15(f). Our internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of condensed financial statements for external purposes in accordance with generally accepted accounting principles.

 

No changes were made in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected or are reasonably likely to materially affect, our internal controls over financial reporting.

 

Our management, including our CEO and CFO, does not expect that our disclosure controls or internal controls over financial reporting will prevent all errors or all instances of fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and any design may not succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitation of a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23
 

 

PART II.   OTHER INFORMATION

 

Item 1.     Legal Proceedings

 

The Company is not a party to any legal proceedings and is not aware of any pending legal proceedings of any kind.

 

Item 2.     Changes in Securities

 

None.

 

Item 3.     Defaults Upon Senior Securities

 

None.

 

Item 4.     Mine Safety Disclosures

 

N/A

 

Item 5.     Other Information

 

On December 6, 2013, the Board of Directors voted to amend the Company’s 2007 Employee Stock Option Plan. The amendment would increase the number of shares issuable under the plan by 1,000,000. The amendment is subject to approval by shareholder vote at the next shareholder meeting scheduled for February 25th, 2014.

 

Item 6.     Exhibits

 

EXHIBIT NUMBER DESCRIPTION
   
3.1 Articles of Incorporation of the Company. (4)
3.2 Amended and Restated Bylaws of the Company. (4)
4.1 Articles of Incorporation of the Company. (incorporated by reference to Exhibit 3.1 hereof)
4.2 Bylaws of the Company. (incorporated by reference to Exhibit 3.2 hereof)
4.3 Form of Common Stock Certificate (1)
4.4 Share Exchange Agreement (1)
10.1 The Company’s 1996 Stock Option Plan (the “Option Plan”) and forms of agreements relating thereto (1)
10.2 Exclusive License Software Agreement by and between the Company and Therapeutic Systems Research Laboratories dated June 30, 1997. (2)
10.3 The Company’s 2007 Stock Option Plan. (3)
10.4 Employment Agreement by and between the Company and Walter S. Woltosz, dated as of July 22, 2011. (4) (†)
10.5 Amended lease agreement by and between the Company and Crest Development LLC, dated May 23, 2013. (5)
10.6 Employment Agreement by and between the Company and Walter S. Woltosz, dated as of August 22, 2013. (6) (†)
31.1 Section 302 – Certification of the Principal Executive Officer. (7)
31.2 Section 302 – Certification of the Principal Financial Officer. (7)  
32.1 Section 906 – Certification of the Chief Executive Office and Chief Financial Officer.  (7)
101.INS XBRL Instance Document.
101.SCH XBRL Taxonomy Extension Schema Document.
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB XBRL Taxonomy Extension Label Linkbase Document.
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.

________________

(1)Incorporated by reference to the Company’s Registration Statement on Form SB-2 (Registration No. 333-6680) filed on March 25, 1997.
(2)Incorporated by reference to the Company’s Form 10-KSB for the fiscal year ended August 31, 1997.
(3)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2009.
(4)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2011.
(5)Incorporated by reference to the Company’s Form 10-Q filed July 10, 2013.
(6)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2013.
(7)Filed herewith

 

24
 

 

SIGNATURE

 

In accordance with Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lancaster, State of California, on January 13, 2014.

 

  Simulations Plus, Inc.
   
Date: January 13, 2014 By: /s/ John R. Kneisel
    John R. Kneisel
Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25

EX-31.1 2 simulations_10q-ex3101.htm CERTIFICATION

Exhibit 31.1

RULE 13A-14(A) CERTIFICATION

 

SIMULATIONS PLUS, INC.

a California corporation

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Walter S. Woltosz, certify that:

 

1.I have reviewed this Quarterly Report on Form 10Q of Simulations Plus, Inc., a California corporation;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

 

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: January 13, 2014

 

By: /s/ Walter S. Woltosz

Walter S. Woltosz

Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 3 simulations_10q-ex3102.htm CERTIFICATION

Exhibit 31.2 

RULE 13A-14(A) CERTIFICATION

 

SIMULATIONS PLUS, INC.

a California corporation

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

I, John R. Kneisel, certify that:

 

1.I have reviewed this Quarterly Report on Form 10Q of Simulations Plus, Inc., a California corporation;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

 

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: January 13, 2014

  By: /s/ John R. Kneisel     
  John R. Kneisel
\ Chief Financial Officer
  (Principal Financial Officer)

EX-32 4 simulations_10q-ex3200.htm CERTIFICATIONS

Exhibit 32

 

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of Simulations Plus, Inc., a California corporation (the “Company”), on Form 10-Q for the quarter ended November 30, 2013, as filed with the Securities and Exchange Commission, Walter S. Woltosz, Chief Executive Officer of the Company and John R. Kneisel, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. § 1350, that to his/her knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

/s/ Walter S. Woltosz

Walter S. Woltosz

Chief Executive Officer

(Principal Executive Officer)

January 13, 2014

 

 

/s/ John R. Kneisel

John R. Kneisel

Chief Financial Officer

(Principal Financial Officer)

January 13, 2014

 

(A signed original of this written statement required by Section 906 has been provided to Simulations Plus, Inc. and will be retained by Simulations Plus, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.)

 

EX-101.INS 5 simu-20131130.xml XBRL INSTANCE FILE 0001023459 2012-09-01 2013-08-31 0001023459 2013-08-31 0001023459 2012-08-31 0001023459 us-gaap:NorthAmericaMember 2012-09-01 2012-11-30 0001023459 us-gaap:EuropeMember 2012-09-01 2012-11-30 0001023459 us-gaap:AsiaMember 2012-09-01 2012-11-30 0001023459 us-gaap:SouthAmericaMember 2012-09-01 2012-11-30 0001023459 us-gaap:NorthAmericaMember 2013-09-01 2013-11-30 0001023459 us-gaap:EuropeMember 2013-09-01 2013-11-30 0001023459 us-gaap:AsiaMember 2013-09-01 2013-11-30 0001023459 us-gaap:SouthAmericaMember 2013-09-01 2013-11-30 0001023459 us-gaap:EquipmentMember 2013-09-01 2013-11-30 0001023459 us-gaap:ComputerEquipmentMember 2013-09-01 2013-11-30 0001023459 us-gaap:FurnitureAndFixturesMember 2013-09-01 2013-11-30 0001023459 us-gaap:LeaseholdImprovementsMember 2013-09-01 2013-11-30 0001023459 us-gaap:FairValueInputsLevel1Member 2013-11-30 0001023459 us-gaap:FairValueInputsLevel2Member 2013-11-30 0001023459 us-gaap:FairValueInputsLevel3Member 2013-11-30 0001023459 simu:StockOptionsOneMember 2013-09-01 2013-11-30 0001023459 simu:StockOptionsTwoMember 2013-09-01 2013-11-30 0001023459 simu:StockOptionsThreeMember 2013-09-01 2013-11-30 0001023459 simu:NonQualifiedISOMember 2013-08-31 0001023459 simu:QualifiedISOMember 2013-08-31 0001023459 simu:StockOptionsFourMember 2013-09-01 2013-11-30 0001023459 simu:Customer1Member us-gaap:SalesMember 2013-09-01 2013-11-30 0001023459 simu:Customer1Member us-gaap:SalesMember 2012-09-01 2012-11-30 0001023459 simu:Customer2Member us-gaap:SalesMember 2013-09-01 2013-11-30 0001023459 simu:Customer2Member us-gaap:SalesMember 2012-09-01 2012-11-30 0001023459 simu:Customer3Member us-gaap:SalesMember 2013-09-01 2013-11-30 0001023459 simu:Customer3Member us-gaap:SalesMember 2012-09-01 2012-11-30 0001023459 simu:Customer4Member us-gaap:SalesMember 2013-09-01 2013-11-30 0001023459 simu:Customer4Member us-gaap:SalesMember 2012-09-01 2012-11-30 0001023459 simu:CustomerAMember 2013-11-30 0001023459 simu:CustomerAMember 2012-11-30 0001023459 simu:CustomerBMember 2013-11-30 0001023459 simu:CustomerBMember 2012-11-30 0001023459 simu:CustomerCMember 2013-11-30 0001023459 simu:CustomerCMember 2012-11-30 0001023459 simu:CustomerDMember 2013-11-30 0001023459 simu:CustomerDMember 2012-11-30 0001023459 simu:RecordDate4Member 2012-09-01 2013-08-31 0001023459 simu:RecordDate5Member 2012-09-01 2013-08-31 0001023459 simu:InternationalSalesMember 2012-09-01 2012-11-30 0001023459 simu:InternationalSalesMember 2013-09-01 2013-11-30 0001023459 simu:RecordDate6Member 2012-09-01 2013-08-31 0001023459 2014-01-13 0001023459 simu:RecordDate7Member 2012-09-01 2013-08-31 0001023459 us-gaap:EquipmentMember 2013-11-30 0001023459 us-gaap:ComputerEquipmentMember 2013-11-30 0001023459 us-gaap:FurnitureAndFixturesMember 2013-11-30 0001023459 us-gaap:LeaseholdImprovementsMember 2013-11-30 0001023459 2013-09-01 2013-11-30 0001023459 2013-11-30 0001023459 2012-09-01 2012-11-30 0001023459 2012-11-30 0001023459 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2013-09-01 2013-11-30 0001023459 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2012-09-01 2012-11-30 0001023459 us-gaap:IntellectualPropertyMember 2013-09-01 2013-11-30 0001023459 us-gaap:IntellectualPropertyMember 2013-11-30 0001023459 simu:RecordDate8Member 2013-09-01 2013-11-30 0001023459 simu:QualifiedISOMember 2013-09-01 2013-11-30 0001023459 simu:QualifiedISOMember 2013-11-30 0001023459 simu:NonQualifiedISOMember 2013-09-01 2013-11-30 0001023459 simu:NonQualifiedISOMember 2013-11-30 0001023459 simu:StockOptionsOneMember 2013-11-30 0001023459 simu:StockOptionsTwoMember 2013-11-30 0001023459 simu:StockOptionsThreeMember 2013-11-30 0001023459 simu:StockOptionsFourMember 2013-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 14242493 14350397 685155 586986 16073894 12971830 13136191 184258 188126 192173 173075 203913 289040 1910615 1866445 10179298 12701075 10554707 11379378 16063181 16404985 18445 18445 63750 61875 117987 115927 2891169 3072547 60000 30000 311209 337603 146011 235422 89227 168241 626306 791125 1820688 2054588 1146389 1220435 9395197 9437396 4842794 4908456 4502 4545 0 0 16063181 16404985 0 0 5801578 5993404 11250 13125 13125 0.001 0.001 10000000 10000000 0 0 0 0 0.001 0.001 50000000 50000000 16030894 16073894 16030894 16073894 4001212 796390 2242983 480913 480926 642956 796390 642956 5 years 3 to 7 years 5 to 7 years Shorter of life of asset or lease 10554707 0 0 10554707 10554707 0 0 10554707 124042 134398 51465 23645 333550 15927806 16021309 16030433 16030894 16073894 2012-11-13 2012-12-28 2013-05-10 2013-08-15 2013-11-15 2012-11-08 2012-12-24 2013-05-07 2013-08-12 2013-11-08 48600 532000 637600 592000 45600 313100 31600 156900 136000 100000 391800 366600 25200 279700 11600 88500 12000 3.47 1.82 2.61 2.51 3.92 1.06 2.35 3.26 5.49 1.71 1.59 1.89 1.06 2.11 3.18 5.59 1.50 3.00 4.50 6.68 1.00 1.51 3.01 4.51 P3Y10M13D P6Y4M10D P3Y10M24D P5Y1M28D P4Y3M11D P3Y8M12D P6Y3M18D P4Y P3Y8M12D P3Y10M24D 301573 64798 19859 19859 47993 43028 0.05 0.14 0.03 0.03 .04 SIMULATIONS PLUS INC 0001023459 10-Q 2013-11-30 false --08-31 No No Yes Smaller Reporting Company Q1 2014 2641000 2290094 448420 386870 2192580 1903224 1071091 931060 162116 180335 1233207 1111395 959373 791829 9026 13728 0 15404 23709 74654 32735 103786 306953 308629 0.04 0.04 0.04 0.04 16049707 15927806 16366720 16365552 11903 10690 191829 182085 1875 1875 15360 38099 70178 46339 -40957 -390434 -236775 0 19098 -60930 89408 16598 26394 9893 -30000 -45000 0 -733233 -4965 0 79014 75446 1351067 -261586 9843 1638 373204 262083 -383047 -263721 50345 0 -592611 -796390 375409 -1321697 0 0 0 1091545 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">This report on Form 10-Q for the quarter ended November 30, 2013, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (&#147;SEC&#148;) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. (&#34;we&#34;, &#34;our&#34;, &#34;us&#34;), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><u>Estimates</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management&#146;s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Revenue Recognition</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (&#147;FASB&#148;) Accounting Standard Codification (&#147;ASC&#148;) 985-605, &#147;<i>Software - Revenue Recognition&#148;</i>. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support (&#34;PCS&#34;) obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, &#147;<i>Revenue Recognition &#150; Construction-Type and Production-Type Contracts&#148;</i>. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Cash and Cash Equivalents</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Accounts Receivable</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company&#146;s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Capitalized Computer Software Development Costs</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Software development costs are capitalized in accordance with ASC 985-20, <i>&#147;Costs of Software to Be Sold, Leased, or Marketed&#148;</i>. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer&#153; program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $191,829 and $182,085 the three months ended November 30, 2013 and 2012, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Property and Equipment</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 70%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="width: 35%"><font style="font-size: 8pt">Equipment</font></td> <td style="width: 35%; text-align: right"><font style="font-size: 8pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Computer equipment</font></td> <td style="text-align: right"><font style="font-size: 8pt">3 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 8pt">5 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 8pt">Shorter of life of asset or lease</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Fair Value of Financial Instruments</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 15%; border: Black 1pt solid"><font style="font-size: 8pt"><b>Level&#160;Input:</b></font></td> <td style="vertical-align: top; width: 3%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; width: 82%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt"><b>Input Definition:</b></font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level I</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level II</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level III</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Unobservable inputs that reflect management&#146;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The following table summarizes fair value measurements by level at November 30, 2013 for assets and liabilities measured at fair value on a recurring basis:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 40%; border: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level I</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level II</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level III</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Cash and cash equivalents</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For certain of our financial instruments, including accounts receivable, accounts payable, accrued payroll and other expenses, accrued bonus to officer, and accrued warranty and service costs, the amounts approximate fair value due to their short maturities.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Research and Development Costs</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Income Taxes</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We utilize FASB ASC 740-10, <i>&#147;Income Taxes&#148;</i> which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Intellectual property</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for the fiscal quarter ended November 30, 2013 and 2012 &#62;was $1,875 and $1,875 respectfully. Accumulated amortization as of November 30, 2013 was $13,125.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Earnings per Share</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three months ended November 30, 2013 and 2012 were as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2013</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2012</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Numerator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Net income attributable to common shareholders <br /></font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">685,155</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">586,986</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Denominator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,049,707</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">15,927,806</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Dilutive effect of stock options</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">317,013</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">437,746</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Common stock and common stock equivalents used for diluted earning per share</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,366,720</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,365,552</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Stock-Based Compensation</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, <i>&#147;Compensation-Stock Compensation&#148;, </i>using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value, amortized on a straight-line basis over the options&#146; vesting period. Stock-based compensation was $15,360 and $38,099 for the three months ended November 30, 2013 and 2012, respectively, and is included in the condensed statements of operations as Selling, General and Administration (SG&#38;A), and Research and Development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Recently Issued Accounting Pronouncements </u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In July 2012, the FASB issued ASU 2012-02, &#147;<i>Testing Indefinite-Lived Intangible Assets for Impairment&#148;,</i> which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">In July 2013, the FASB issued ASU 2013-11, <i>Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i>, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&#146;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Estimates</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management&#146;s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Revenue Recognition</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (&#147;FASB&#148;) Accounting Standard Codification (&#147;ASC&#148;) 985-605, &#147;<i>Software - Revenue Recognition&#148;</i>. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support (&#34;PCS&#34;) obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, &#147;<i>Revenue Recognition &#150; Construction-Type and Production-Type Contracts&#148;</i>. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Cash and Cash Equivalents</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Accounts Receivable</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company&#146;s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Capitalized Computer Software Development Costs</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Software development costs are capitalized in accordance with ASC 985-20, <i>&#147;Costs of Software to Be Sold, Leased, or Marketed&#148;</i>. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer&#153; program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $191,829 and $182,085 the three months ended November 30, 2013 and 2012, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Property and Equipment</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 70%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="width: 35%"><font style="font-size: 8pt">Equipment</font></td> <td style="width: 35%; text-align: right"><font style="font-size: 8pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Computer equipment</font></td> <td style="text-align: right"><font style="font-size: 8pt">3 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 8pt">5 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 8pt">Shorter of life of asset or lease</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Fair Value of Financial Instruments</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 15%; border: Black 1pt solid"><font style="font-size: 8pt"><b>Level&#160;Input:</b></font></td> <td style="vertical-align: top; width: 3%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; width: 82%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt"><b>Input Definition:</b></font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level I</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level II</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Level III</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-size: 8pt">Unobservable inputs that reflect management&#146;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The following table summarizes fair value measurements by level at November 30, 2013 for assets and liabilities measured at fair value on a recurring basis:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 40%; border: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level I</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level II</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level III</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Cash and cash equivalents</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For certain of our financial instruments, including accounts receivable, accounts payable, accrued payroll and other expenses, accrued bonus to officer, and accrued warranty and service costs, the amounts approximate fair value due to their short maturities.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Research and Development Costs</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Income Taxes</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We utilize FASB ASC 740-10, <i>&#147;Income Taxes&#148;</i> which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Intellectual property</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for the fiscal quarter ended November 30, 2013 and 2012 was $1,875 and $1,875 respectfully. Accumulated amortization as of November 30, 2013 was $13,125.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Earnings per Share</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three months ended November 30, 2013 and 2012 were as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2013</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2012</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Numerator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Net income attributable to common shareholders <br /></font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">685,155</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">586,986</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Denominator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,049,707</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">15,927,806</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Dilutive effect of stock options</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">317,013</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">437,746</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Common stock and common stock equivalents used for diluted earning per share</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,366,720</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,365,552</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Recently Issued Accounting Pronouncements </u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In July 2012, the FASB issued ASU 2012-02, &#147;<i>Testing Indefinite-Lived Intangible Assets for Impairment&#148;,</i> which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">In July 2013, the FASB issued ASU 2013-11, <i>Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i>, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&#146;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Property and equipment as of November 30, 2013 consisted of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 53%; text-align: justify"><font style="font-size: 8pt">Equipment</font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">124,042</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><font style="font-size: 8pt">Computer equipment</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">134,398</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><font style="font-size: 8pt">Furniture and fixtures</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">51,465</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">Leasehold improvements</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">23,645</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;Sub total</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">333,550</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">Less: Accumulated depreciation and amortization</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(217,623</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;Net Book Value</font></td><td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font-size: 8pt">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">115,927</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 53%; text-align: justify"><font style="font-size: 8pt">Equipment</font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">124,042</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><font style="font-size: 8pt">Computer equipment</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">134,398</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><font style="font-size: 8pt">Furniture and fixtures</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">51,465</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">Leasehold improvements</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">23,645</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;Sub total</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">333,550</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">Less: Accumulated depreciation and amortization</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(217,623</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;Net Book Value</font></td><td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font-size: 8pt">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">115,927</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Dividend</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Distribution Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Shares Outstanding on Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Dividend per Share</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Total Amount</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">11/8/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11/13/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">15,927,806</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.05</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$796,390</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">12/24/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">12/28/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,021,309</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.14</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,242,983</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">5/7/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">5/10/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,030,433</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.03</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$480,913</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">8/12/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">8/15/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,030,894</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.03</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$480,926</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$4,001,212</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The Board of Directors also declared cash dividend during the first quarter of fiscal year 2014.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Distribution Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Shares Outstanding on Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Dividend per Share</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Total Amount</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">11/08/2013</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11/15/2013</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,073,894</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.04</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$642,956</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>642,956</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Stock Option Plan</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the &#34;Option Plan&#34;) under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><u>Qualified Incentive Stock Options (Qualified ISO)</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As of November 30, 2013, employees hold Qualified SO to purchase 592,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to November 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="vertical-align: top; width: 38%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Transactions in FY13</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Options</font></td> <td style="vertical-align: bottom; width: 2%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Weighted-Average Exercise Price</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Per Share</font></p></td> <td style="vertical-align: top; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted-Average Remaining Contractual Life</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, August 31, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">532,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.82</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.95</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Granted</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">100,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.61</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercised</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">(40,000)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.12</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">592,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.51</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">4.02</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercisable, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">366,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$<font style="font-size: 8pt">1.59</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.66</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The fair value of the options, including both ISO and NQSO options, granted during the quarter ended November 30, 2013 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE November 30, 2013: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Non-Qualified Stock Options (Non-Qualified SO)</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As of November 30, 2013, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to November 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="text-align: center; width: 38%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Transactions in FY13</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Options</font></td> <td style="vertical-align: bottom; width: 2%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: center; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Weighted-Average Exercise Price</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Per Share</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted-Average Remaining Contractual Life</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, August 31, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">48,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.47</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">7.85</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercised</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">(3,000)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.80</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">45,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.92</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">7.78</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercisable, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">25,200</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.89</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.62</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in"><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified ISO, was 4.28 years at November 30, 2013. The exercise prices for the options outstanding at November 30, 2012 ranged from $1.00 to $6.68, and the information relating to these options is as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Exercise Price</font></td> <td colspan="3" style="border-top: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Awards Outstanding</font></td> <td colspan="3" style="border-top: Black 1pt solid; border-right: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Awards Exercisable</font></td></tr> <tr> <td style="width: 9%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Low</font></td> <td style="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">High</font></td> <td style="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Quantity</font></td> <td style="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life</font></td> <td style="width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td> <td style="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Quantity</font></td> <td style="width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life</font></td> <td style="width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.00</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.50</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">313,100</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.87 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.06</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">279,700</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.7 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.06</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.51</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.00</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">31,600</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.36 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.35</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11,600</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.3 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.11</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.01</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$4.50</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">156,900</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.90 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.26</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">88,500</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;4.0 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.18</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$4.51</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$6.68</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">136,000</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">5.16 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.49</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">12,000</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;3.7 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.59</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif"><b>637,600</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>4.28 years</b></font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$2.61</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>391,800</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>3.9 years</b></font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$1.71</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="width: 70%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="width: 35%"><font style="font-size: 8pt">Equipment</font></td> <td style="width: 35%; text-align: right"><font style="font-size: 8pt">5 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Computer equipment</font></td> <td style="text-align: right"><font style="font-size: 8pt">3 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 8pt">5 to 7 years</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td><font style="font-size: 8pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 8pt">Shorter of life of asset or lease</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 40%; border: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level I</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level II</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Level III</b></font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><font style="font-size: 8pt">Cash and cash equivalents</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">$&#160;&#160;10,554,707</font></td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2013</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 8pt">11/30/2012</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Numerator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Net income attributable to common shareholders <br /></font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">685,155</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%; text-align: left"><font style="font-size: 8pt">$</font></td><td style="width: 13%; text-align: right"><font style="font-size: 8pt">586,986</font></td><td style="width: 1%; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><font style="font-size: 8pt">Denominator</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,049,707</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">15,927,806</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Dilutive effect of stock options</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">317,013</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">437,746</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 20pt; text-indent: -10pt"><font style="font-size: 8pt">Common stock and common stock equivalents used for diluted earning per share</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,366,720</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="text-align: right"><font style="font-size: 8pt">16,365,552</font></td><td style="text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Distribution Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Shares Outstanding on Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Dividend per Share</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Total Amount</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">11/8/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11/13/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">15,927,806</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.05</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$796,390</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">12/24/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">12/28/2012</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,021,309</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.14</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,242,983</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">5/7/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">5/10/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,030,433</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.03</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$480,913</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">8/12/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">8/15/2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,030,894</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.03</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$480,926</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$4,001,212</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The Board of Directors also declared cash dividend during the first quarter of fiscal year 2014.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Distribution Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Shares Outstanding on Record Date</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Dividend per Share</font></td> <td style="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Total Amount</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">11/08/2013</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11/15/2013</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">16,073,894</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$0.04</font></td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$642,956</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>642,956</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><u>Qualified Incentive Stock Options (Qualified ISO)</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As of November 30, 2013, employees hold Qualified ISO to purchase 592,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to November 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="vertical-align: top; width: 38%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Transactions in FY13</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Options</font></td> <td style="vertical-align: bottom; width: 2%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Weighted-Average Exercise Price</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Per Share</font></p></td> <td style="vertical-align: top; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted-Average Remaining Contractual Life</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, August 31, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">532,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.82</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.95</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Granted</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">100,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.61</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercised</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">(40,000)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.12</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, November 30,&#160;&#160;2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">592,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.51</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">4.02</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercisable, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">366,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$<font style="font-size: 8pt">1.59</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.66</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Non-Qualified Stock Options (Non-Qualified SO)</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As of November 30, 2013, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to November 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="text-align: center; width: 38%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Transactions in FY13</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Number of Options</font></td> <td style="vertical-align: bottom; width: 2%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: center; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Weighted-Average Exercise Price</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Per Share</font></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted-Average Remaining Contractual Life</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, August 31, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">48,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.47</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">7.85</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercised</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">(3,000)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.80</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Outstanding, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">45,600</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.92</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">7.78</font></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Exercisable, November 30, 2013</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">25,200</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.89</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.62</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td colspan="2" style="border-top: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Exercise Price</font></td> <td colspan="3" style="border-top: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Awards Outstanding</font></td> <td colspan="3" style="border-top: Black 1pt solid; border-right: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Awards Exercisable</font></td></tr> <tr> <td style="width: 9%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Low</font></td> <td style="width: 8%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">High</font></td> <td style="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Quantity</font></td> <td style="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life</font></td> <td style="width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td> <td style="width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Quantity</font></td> <td style="width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life</font></td> <td style="width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.00</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.50</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">313,100</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.87 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.06</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">279,700</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.7 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.06</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1.51</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.00</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">31,600</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.36 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.35</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">11,600</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">6.3 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2.11</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.01</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$4.50</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">156,900</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">3.90 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.26</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">88,500</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;4.0 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3.18</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$4.51</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$6.68</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">136,000</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">5.16 years</font></td> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.49</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">12,000</font></td> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;3.7 years</font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$5.59</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif"><b>637,600</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>4.28 years</b></font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$2.61</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>391,800</b></font></td> <td style="border-right: black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>3.9 years</b></font></td> <td nowrap="nowrap" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt"><b>$1.71</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">As of November 30, 2013, included in bonus expenses to officers was $60,000, of which $15,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $15,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee during the quarter ended November 30, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Revenue concentration shows that International sales accounted for 52% and 55% of net sales for the three months ended November 30, 2013 and 2012, respectively. Four customers accounting for 19%, 13%, 11% (a dealer account in Japan representing various customers), and 10% of net sales during the three months ended November 30, 2013, compared with four customers accounting for 22%, 14% (a dealer account in Japan representing various customers), 12%, and 8% of net sales during the three months ended November 30, 2012.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Accounts receivable concentration shows that four customers comprised 18%, 18% (a dealer account in Japan representing various customers), 15%, and 7% of accounts receivable at November 30, 2013, and four customers comprised 17% (a dealer account in Japan representing various customers), 16%, 11%, and 7% of accounts receivable at November 30, 2012.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><b>&#160;</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The majority of our customers are in the pharmaceutical industry. During the recent economic downturn, we have seen consolidations in the pharmaceutical industry. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the three months ended November 30, 2013 and 2012 were as follows (in thousands):</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 25%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">North America</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Europe</font></p></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Asia</font></p></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">South America</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Total</font></p></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">November 30, 2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1,260</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$536</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$842</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,641</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">November 30, 2012</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1,033</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$598</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$659</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,290</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 25%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">North America</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Europe</font></p></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Asia</font></p></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">South America</font></td> <td style="width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt">Total</font></p></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">November 30, 2013</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1,260</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$536</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$842</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$3</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,641</font></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">November 30, 2012</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$1,033</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$598</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$659</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$-</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$2,290</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee&#146;s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $26,127 and $20,814 for the three months ended November 30, 2013 and 2012, respectively.</font></p> 317013 437746 191829 182085 1875 15360 38099 217623 30000 -40000 -3000 5.61 1.12 1.80 P3Y11M12D P7Y10M6D P4Y7D P7Y9M11D P3Y7M28D P6Y7M13D 60000 .19 .22 .13 .14 .11 .12 .10 .08 .55 .52 .18 .17 .18 .16 .15 .11 .07 .07 26127 20814 1033000 598000 659000 0 1260000 536000 842000 3000 2641000 2290000 130781 Black-Scholes option-pricing model .0314 .3895 .0136 P5Y .0625 992108 895615 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Stock-Based Compensation</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, <i>&#147;Compensation-Stock Compensation&#148;, </i>using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value, amortized on a straight-line basis over the options&#146; vesting period. Stock-based compensation was $15,360 and $38,099 for the three months ended November 30, 2013 and 2012, respectively, and is included in the condensed statements of operations as Selling, General and Administration (SG&#38;A), and Research and Development expense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Employment Agreement</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee&#146;s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded will be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provides Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement. The Company may terminate the agreement upon 30 days written notice if termination is without cause. The Company's only obligation would be to pay its President the greater of a) 12 months salary or b) the remainder of the term of the employment agreement from the date of notice of termination.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On August 22, 2013, effective as of September 1, 2013, the CEO&#146;s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company&#146;s net income before taxes of the previous fiscal year not to exceed $60,000. In addition the agreement calls for the granting of ten (10) options to purchase shares of the Company&#146;s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company&#146;s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><u>Litigation</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">We are not a party to any litigation at this time and we are not aware of any pending litigation of any kind.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><font style="font-size: 8pt">On December 6, 2013, the Board of Directors voted to amend the Company&#146;s 2007 Employee Stock Option Plan. The amendment would increase the number of shares issuable under the plan by 1,000,000. The amendment is subject to approval by shareholder vote at the next shareholder meeting scheduled for February 25<sup>th</sup>, 2014.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> EX-101.SCH 6 simu-20131130.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - 1. GENERAL link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 3. PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 4. COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 5. SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 6. RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 7. CONCENTRATIONS AND UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 8. GEOGRAPHIC REPORTING link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 9. EMPLOYEE BENEFIT PLAN link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 10. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 3. PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 5. SHAREHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 8. SEGMENT AND GEOGRAPHIC REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 3. PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 4. COMMITMENTS AND CONTINGENCIES (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Dividends) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 6. RELATED PARTY TRANSACTIONS (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 7. CONCENTRATIONS AND UNCERTAINTIES (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 8. GEOGRAPHIC REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 9. EMPLOYEE BENEFIT PLAN (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 5. SHAREHOLDERS' EQUITY (Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 simu-20131130_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 simu-20131130_def.xml XBRL DEFINITION FILE EX-101.LAB 9 simu-20131130_lab.xml XBRL LABEL FILE Common Stock Equity Components [Axis] Additional Paid-In Capital Retained Earnings / Accumulated Deficit North America StatementGeographical [Axis] Europe Asia South America Simulations Plus LegalEntity [Axis] Words Plus Equipment PropertyPlantAndEquipmentByType [Axis] Computer equipment Furniture and fixtures Leasehold improvements Level I FairValueByFairValueHierarchyLevel [Axis] Level II Level III Customer Relationships FiniteLivedIntangibleAssetsByMajorClass [Axis] Stock Options One AwardType [Axis] Stock Options Two Stock Options Three Under Condition 1 StatementClassOfStock [Axis] Under Condition 2 Under Condition 3 Period 1 ShareRepurchaseProgram [Axis] Period 2 Period 3 Period 4 Period 5 Period 6 Period 7 Period 8 Period 9 Period 10 Period 11 Incentive Stock Option Plan PlanName [Axis] Other Stock Options Minimum [Member] Range [Axis] Maximum [Member] Under Condition 4 Non-Qualified SO Qualified ISO Stock Options Four Customer 1 MajorCustomers [Axis] Net Sales Income Statement Location [Axis] Customer 2 Customer 3 Customer 4 Customer A Customer B Customer C Customer D Record Date 02/21/2012 Record Date 04/27/2012 Record Date 08/07/2012 Record Date 11/08/2012 Record Date 12/24/2012 International Sales Record Date 05/07/2013 Record Date 08/12/2013 Software Development Costs Intellectual Property Record Date 11/08/2013 Record Date 11/08/2013 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Prepaid income taxes Accounts receivable, net of allowance for doubtful accounts of $0 Contracts receivable Prepaid expenses and other current assets Deferred income taxes Total current assets Long-term assets Capitalized computer software development costs, net of accumulated amortization of $5,993,404 and $5,801,578 Property and equipment, net (note 3) Intellectual property, net of accumulated amortization of $13,125 and $11,250 Other assets Total assets LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable Accrued payroll and other expenses Accrued bonuses to officer Other current liabilities Deferred revenue Total current liabilities Long-term liabilities Deferred income taxes Other long-term liabilities Total liabilities Commitments and contingencies (note 4) Shareholders' equity (note 5) Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding Common stock, $0.001 par value 50,000,000 shares authorized 16,073,894 and 16,030,894 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity Total liabilities and shareholders' equity Allowance for doubtful accounts Accumulated amortization of computer software development costs Accumulated amortization on intellectual property Preferred stock par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock par value Common stock shares authorized Common stock shares issued Common stock shares outstanding Income Statement [Abstract] Net sales Cost of sales Gross profit Operating expenses Selling, general, and administrative Research and development Total operating expenses Income from operations Other income (expense) Interest income Miscellaneous income Gain on currency exchange Gain on sale of assets Interest expense Total other income (expense) Income from operations before provision for income taxes Provision for income taxes Net Income Earnings per share - Basic Earnings per share - Diluted Weighted-average common shares outstanding Basic Diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net income Adjustments to reconcile net income to net cash provided by operating activities Depreciation and amortization of property and equipment Amortization of customer relationships Amortization of capitalized computer software development costs Amortization of Intellectual property Excess tax benefits from share-based arrangements Stock-based compensation (Gain)/Loss from sale of assets Deferred income taxes (Increase) decrease in Accounts receivable and Contracts receivable Prepaid income taxes Prepaid expenses and other assets Increase (decrease) in Accounts payable Accrued payroll and other expenses Accrued bonus Accrued income taxes Other liabilities Deferred revenue Net cash provided by operating activities Cash flows from investing activities Purchases of property and equipment Capitalized computer software development costs Net cash provided by (used in) investing activities Cash flows from financing activities Payment of dividends Proceeds from the exercise of stock options Net cash (used in) financing activities of continuing operations Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of period Supplemental disclosures of cash flow information Interest paid Income taxes paid Organization, Consolidation and Presentation of Financial Statements [Abstract] Note 1. GENERAL Accounting Policies [Abstract] Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property, Plant and Equipment [Abstract] Note 3. PROPERTY AND EQUIPMENT Commitments and Contingencies Disclosure [Abstract] Note 4. COMMITMENTS AND CONTINGENCIES Equity [Abstract] Note 5. SHAREHOLDERS' EQUITY Related Party Transactions [Abstract] Note 6. RELATED PARTY TRANSACTIONS Concentrations And Uncertainties Note 7. CONCENTRATIONS AND UNCERTAINTIES Geographic Reporting Note 8. GEOGRAPHIC REPORTING Compensation Related Costs [Abstract] Note 9. EMPLOYEE BENEFIT PLAN Subsequent Events [Abstract] 10. SUBSEQUENT EVENTS Estimates Principles of Consolidation Revenue Recognition Cash and Cash Equivalents Accounts Receivable Capitalized Computer Software Development Costs Property and Equipment Fair Value of Financial Instruments Advertising Research and Development Costs Income Taxes Intellectual property Customer relationships Earnings per Share Stock-Based Compensation Recently Issued Accounting Standards Property and Equipment estimated useful lives Assets and liabilities recorded at fair value Summary of fair value measurements by level Components of basic and diluted earnings per share Property and equipment Details of dividend paid Summary of the stock option transactions Exercise prices for the options outstanding Segment And Geographic Reporting Tables Geographical revenues Statement [Table] Statement [Line Items] Property, Plant and Equipment, Type [Axis] Estimated useful lives Fair Value, Hierarchy [Axis] Cash and cash equivalents Total assets Numerator Net income attributable to common shareholders Denominator Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13 Dilutive effect of stock options Common stock and common stock equivalents used for diluted earnings per share Amortization of intangible assets Accumulated amortization of intellectual property Stock-based compensation Property and equipment, gross Less accumulated depreciation and Amortization Net Book Value Rent expense Royalties expense Bonus paid Class of Stock [Axis] Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount Plan Name [Axis] Number of Options Awards Outstanding, beginning balance Granted Exercised Expired Canceled/Forfeited Awards Outstanding, ending balance Exercisable, end of period Vested and Expected to Vest, end of period Weighted-Average Exercise Price Per Share Outstanding Granted Exercised Canceled/Forfeited Expired Outstanding Exercisable, end of period Vested and Expected to Vest, end of period Weighted-Average Remaining Contractual Life Outstanding, beginning of period Outstanding, end of period Exercisable Vested and Expected to Vest Award Type [Axis] Exercise price low Exercise price high Awards Outstanding Weighted average remaining contractual life - awards outstanding Weighted average exercise price - awards outstanding Awards Exercisable Weighted average remaining contractual life - awards exercisable Weighted average exercise price - awards exercisable Bonuses paid Customer [Axis] Net sales concentration percentage Accounts receivable concentration percentage Geographical [Axis] Revenues Compensation and Retirement Disclosure [Abstract] Contribution by employer in benefit plan Fair value of options granted Assumptions used Pricing model Dividend yield Pre-vest forfeiture rate Expeceted volatility Risk-free interest rate Expected life CONCENTRATIONS AND UNCERTAINTIES Customer 1 Member Customer 2 Member Customer 3 Member Customer 4 Member Customer A Member Customer B Member Customer C Member Customer D Member Customer relationships Denominator Incentive stock option plan Member Increase decrease in operating activities Intellectual property policy text block Non-Qualified ISO Member Numerator heading Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Property and Equipment estimated useful lives Qualified ISO Member Details of dividends paid Custom Element. Stock options 4 Member Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Weighted-average common shares outstanding [Abstract] Weighted average number of shares outstanding basic and diluted at record date Weighted average remaining contractual life abstract Custom Element. Weighted average remaining contractual life outstanding, beginning balance Prepaid income taxes Accounts receivable concentration percentage Pre-vest forfeiture rate Assets, Current Assets Liabilities, Current Deferred Tax Liabilities, Net, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Other Income Income Tax Expense (Benefit) Deferred Income Tax Expense (Benefit) IncreaseDecreasePrepaidIncomeTaxes Increase (Decrease) in Accounts Payable Increase (Decrease) in Employee Related Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Develop Software Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, Fair Value Disclosure Allocated Share-based Compensation Expense Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price EX-101.PRE 10 simu-20131130_pre.xml XBRL PRESENTATION FILE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S*TG?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[ M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\ M(V(T'4\4"_'L)MI< M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?```` M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O M_%[)K?BL"EJL2UI0]@)88@((EL]X>W MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/ M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M: M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+-> M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$# M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B"'XJD MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8ZA/EWA MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`*9%H\)4# M```G"P``#P```'AL+W=O M#57CIZXJ/%ODBA^H\'O^X5)6R8EG"TCSC0_6=E^JOV^_?;G9Y\?*4YR\* M`+)RJ*ZJ:G.M:>5BQ=>L_)EO>`97EGFQ9A4LBV>MW!2<)>6*\VJ=:J:NGVMK M)C*U(5P77V'DRZ58\%&^V*YY5C60@J>L@O3+E=B4ZNW-4J3\H:E(89N-Q]:0 M]UNJ*BDK*Y*(BB=#]0R6^8X?G"BVF[NM2.'JE:5;JG;;%AD42L*7;)M6,93W M08=^F0/3/)?_E*UX$'Q7[H/D4GG[([(DW\F_0FO?VY4%">SJ2W]$4JW@NJ[K M[;D)%\^KZN,DX#7$KSL(]ZF/2E:7]]$1"I.B)*M$]4[=K.F^R&&$LNLN5&:H M2G$MX$?A)H9,'%,F=/;<\A-)H0$D^) M![>=H@`YNC:B'C[.WJ31?#:SPT>9>^[8=6POIK;C^'.,.4>8B^Z-+1J$ MLN#XD=K>B)+?0G<"`"P2X[`(&U/%G,S=NVB<9,-W8]:`>QR48`T]X6\Y5 M%W,&"M@AF?C3$0FC.H_X$4=?H6A#[X:?TY!,88@C&MBRECBTO#;:'(R>EQJA_G+R+HE^U'=]28@Z6%?;FS#9[N,TRX;8^)?8/%?X%@V'L0%L_LB7LZ M(QCV'H0%-'L&GP;!L/<@[*+9,_FS_8F.>,4$YF`5S9[3I[A/%"5G8:EAT0,=WT6;P*7Y<+2PU+#J<3W93ZK&B8!7JM(6=AD6' M&PO=V]R:W-H965T&ULE%C;CJLV%'VOU']`O$^P3;@X2G(T,)KV2*U45;T\,\1)T`0<`3.9 M\_?=9CN`31.1EYF`5Y;7OMM9?_LJ3\ZGJ)M"5AN7+HCKB"J7NZ(Z;-R__WI] MBEVG:;-JEYUD)3;N#]&XW[8__[2^R/J].0K1.L!0-1OWV+;GE>9/Y1BJI% MDEJVZ<]`_A;@TH\].Y-NO703^ MJ)V=V&?E5%(=C"^$.P")EV&KWXT4T.7@4:!8L4$RY/($`^.N4A4H- M\$CVU?V_%+OVN'']6_"**:"DF8)O%!O5YG MHE@]UCB__O\JD2!E1(5`R4MP1?` MW4MCUKY31!3W$$,).&B^$@6&.(\VCGA/B]H0LAQ!`A.1WD,8TH!DOC0%WKA@ M=^^3F)@;)PB)NUBR<$D)L1"I@6"<$+[L.0QID.'SI2FP)LC;F?:/83A-3731AWC?CDJL.6UP6*4AA#T&B41)=P*>#I& M<)^2\$8\^2/*%-A29KDD08A6%C)*0].KJ0&(B>\/#(;+*`R<^3[KT)8T:^=$ M8[0VYON,6`TW-2&44I_?DJP]DXT!N7Q@/N1E9"I@8@XC=G0 M'$W?J?8\7QPV;XL;.-C6=S:.:&(P9V9'Q%+=VH`HF48 MW)+VT"A0!RRK1.W6D&@,2O-9-*I`[;7Q,*#$C^(AW*;;K&F@3D(^U.W]_D:G M8X';8T%C=+YQ1LF04%KD>"[$/`CIK4I]:"Y0[.E&;*TZ3#0&Q3WY).2!!4EM M2!S>K-6'9@.=#H?1$4)7!&+P'!+&`0T&SVC?C1%!'/*;`7YH/-#I?!BU3RT. M,;P[B9#%J""UM)OK1N:QAZ9#AS:G`Q]2&H5IS$UAM]=-8=9>>+Q#[O%&U5L--X*ZKC+@*],,PFIR")Y@@"(;6A`+QPHL7PE+4!Y&*TZEQ M#R1A8`WDO97A_4U;#_[63['P```/__ M`P!02P,$%``&``@````A`'V.LTI=`@``3P4``!D```!X;"]W;W)K&ULE)3;CILP$(;O*_4=+-\O!G+<*&25-$J[4E>JJAZN'3.` M%8R1[1SV[3O&"4V;K93F@F#X_X-"6SK0&>=YM4S=(X'C/%94,#86;N8>BBD`+66NP5-"Y`#-3<8?ZV MDJV]T)2X!Z>XV>W;!Z%5BXBMK*5[[:"4*#%[+AMM^+9&WZ=DR,6%W2UN\$H* MHZTN7(0X%A*]]?S('AF2%O-5^S_'4-5F!!$1.E(T\2NL8$\$J4]).!!>&G[O\H.JU^!E%R1@5(>H;@_QF2C*)A.II,[Z"PD%%G<,T=7\R-/A(<&HQI M6^Y',)DA^>(LY-%[_9=5].@A2T_)Z(02=&&Q/8?%8#*@7#;/J4,(WKE-XN\B6R%_O(ON@^E55X#%V[2KY=#SMN2%R MT`RO-*->\8=!E-QOT(LSBJ[ZL@TFO[DA^Z%-<%__M#]/R[0[$OT+G.>6E_#"32D;2VHH<&L<37"`33@18>%TVTW5 M5CNN_Q0N?@$``/__`P!02P,$%``&``@````A M`$D1G+I_!0``,QD``!D```!X;"]W;W)K&ULG)E9 M;ZLX%,??1YKO@'B_$&,@BY)HF*7;) MJ2S8QOUDM?M]^_-/ZTM9O=9'QAH'+!3UQCTVS7GE^W5Z9'E2>^69%?#+OJSR MI(&/U<&OSQ5+=F)1?O*#V2SV\R0K7+2PJJ;8*/?[+&5/9?J6LZ)!(Q4[)0W$ M7Q^S<]U:R],IYO*D>GT[?TO+_`PF7K)3UGP*HZZ3IZL?AZ*LDI<3Y/U!PB1M M;8L/AOD\2ZNR+O>-!^9\#-3,>>DO?;"T7>\RR("7W:G8?N,^D-5C&+K^=BT* M]&_&+O7@O5,?R\NO5;;[/2L85!OZQ#OP4I:O7/ICQ[^"Q;ZQ^EETX,_*V;%] M\G9J_BHOO['L<&R@W1%DQ!-;[3Z?6)U"1<&,%T3<4EJ>(`!X=?*,CP94)/D0 M?R_9KCEN7!I[T7Q&"H:2HUCZB!UTY#.H4/T70A01C#D,:+W'KF8NZ9%YV' M\HA?#-T$XV[H+6ZX>.."[2[X()IU=M$S:F*1?DSG\:P7*/F%JN.VY-?SY(O4 M`&@4:P&@!EZ[(&DT[S1*##!VPQI/BX$OTF-8=/:Q"*A9BB($7FQI<:RZOYXZ M%ZMN@ZBWBVY1@[6G2[*PU1Y&]/:\^2(U`!HMM;Q1H]0^MO2?[PHCE]SU(O!% M6@R#XF(14(.U)]Z\KY'2^J7J_KI;+M;=]M<3ND7-,/7^TE<\$P#+,//KKH5: M]TVULDO10LR;)6'"R3,H^!=ND5/#2YW&H>X616VI;?ER%DUWC.0:.C890U`D M!YU08AMTHN%MVA4N5FDU-S`C1<.&T]A6`E`-2S`Q#+Y*#T,G#4%1VX-93T-U MZ#34?=%]DW$F;/C6#^%A$X+YF\3:,B;-O%BE9:Y@1TI&C:\!YTZ*L/6!1RU#%W`Z36:_4*L%,+$C1=@#0NP]T(@WL0*VAX0R\8?:-R[3AVA5GM`Y_TMG.R^>9]G M&X";D!>,(:^_O*5S%&':U)O9TKZ)=\$8[_3['2E"SZ%G29D_.$Z?>:%6ZVUR M1XKDS$?QTK;54HUYTX9>K%)C,!^KI$@=^GXPE*&G=_%/K-+#T,$C16WW`\MF M3S7T71]ZH58]F^"1(FS"8A%9>Z`Q;V(/^"HU!!,\%$5*#VP/./0N_HE56A@& M>*2H[0'I>Z1.@8:^+WHP@KRY_I!%430L@.TJO(EZ=.PN3P>/%'67OP4\]";D M";5>8\^VW].;D"?4JN<1\B`7)7DH[+:62S[4J#=MZL4J-0:3/%(T M;#J=]\U19BZ\"X!BE1Y&/]6X[T@1-B'R0LN&'VKLNS[U0JUZ-LDC1;()<.IM MZX$&O8D]&+O?ZY.3R:-(Z4%L82^<02L;X,0P^"JU$M0@CS"]<=L>#,Z?<`KP M[!J/=G-6'=@O['2JG;1\X^?2!,Y'NF^[,_.'0)QZ=S_`D?4Y.;`_DNJ0%;5S M8GM8.O/FP-,*#[WQ0U.>Q<'Q2]G`8;5X>X1_3C`X?IUY(-Z79=-^X,?JW;\[ MMO\#``#__P,`4$L#!!0`!@`(````(0!&8VL=*04```87```9````>&PO=V]R M:W-H965T^UK,,8A:Z8/;9(>[O&Y/CYVO/GR4>3..ZWJC)5; M-_!FKD/+E!VR\K1U__WGY6'I.G63E(7NJU6I#;EBJ1Z?;L\I*RX0(E] MEF?-IRCJ.D6Z_GHJ697L<]#]$41)VM86;XSR1996K&;'QH-R/@[4U+SR5SY4 MVFT.&2C@;7MRZC\'Z*9JY_FXC&O0]H]>Z]]JIS^SZ>Y4=_LQ*"MV&>>(S ML&?LE4._'OA'\+!O//TB9N"ORCG08_*6-W^SZQ\T.YT;F.X8%'%AZ\/G,ZU3 MZ"B4\<*85TI9#@.`WTZ1<6M`1Y(/\?>:'9KSUB5S+U[,2`!P9T_KYB7C)5TG M?:L;5OQ`4"!+89%0%H&_LD@8>5$8+Y8657P26F8,Y,V\Z'\H3?M"G"6_3D"DT'`RSUAM\2.9=761&3-3# MQ!U"$P@0>X$$$>J+A(C M!HG)*EB.$<]U8NXR`JOP_M3RA_2>DTA9!@>`&(N>@S?MI7/P4+IR$3(C9B5Z M'GIS-3"MXWP'Z"VO^X(Y>$@[[#ABD#;P%B.TJRFT'#RD)9V!4"UB+/H&.Y/ MN4#KS0\-DTL0<@?`/,H]*=,"#*R^[C`:VER"D/LANL/-0\A>-T?KNLU8"Q`D M>[ZZT_-)P<9W[B&WD6P2A-QD/A_-U."GLDT\I1O?##<)LC'^I'@+;/)-@MJD M62ICZ':?E'"!&7$W[-[/N'@T6H-)(2?0NN%NF!UCKM4<<,>IGY&L#2LSATZ\R#R[&(W MY$_I2R`T3C829+$$PDG9)]!#^>JX)N6;)SH2J5.?W@.>5=;Q%V*R]:.71(O! MEB-!?>TD&IO\20G(OW48":@F5ZI'D$8?*X?HZ@PU.;ICY6JTO26Q_M MPDGA)]!#VZE)E>28D'WMRARZ\D'^67K?S$%B'#E"!.$6%"U'=Z!P4A`*M.Y\ M,P@E2.[Z!#*P\Z:FGA_B[5TOT#JUN>E+D%0=CZHFD^).H`?4QIXO04@=QI#^ M(ZI_*N^(F7?FEB]!%L8CD_).H(?ZU9:.KI<@C'OB]0))GW08W81)YVB=V?0; M05"[T8R$')D4<@*M$YL[K02UDE>J);KD2?E&;N2;:38$=9)5_.K,@W"SRQ>" M^046Z6X-S+U5@FR\-@BY^_%.;H6;BD_I-03UR4D\UOU)`4?P$*?M+CTK2WH$ MZ?3J2Z\V!7"S.,'O`CVTG9I&UL ME%E=;ZLX$'U?:?\#XOT&L/-%E.2JP>KNE?9*J]5^/%/B)*@A1$";]M_OF#$? M-HU-^I`VY#`^9V8\A\;K[Q_9V7GG19GFEXT;3'S7X97X\;]Y^_G;TO7 M*:OXLH_/^85OW$]>NM^WO_ZRON7%:WGBO'(@PJ7JNJX\KTQ./(O+27[E M%_CDD!=97,';XNB5UX+'^_JF[.P1WY][69Q>7(RP*L;$R`^'-.$L3]XR?JDP M2,'/<07\RU-Z+9MH63(F7!87KV_7;TF>72'$2WI.J\\ZJ.MDR>K'\9(7\X^[FN MP)^%L^>'^.U<_97??N?I\51!N6>@2`A;[3\9+Q/(*(29D)F(E.1G(`"O3I:* MUH",Q!_U[UNZKTX;E\XGLX5/`X`[+[RLGE,1TG62M[+*L_\0%,A0&(3((!38 MR\_)PT&F,@C\;H+,)U,R6RQ'4/%05ITE%E?Q=EWD-P=:#XB7UU@T.Q0FD9C=$*,AH@8AJB#",KP` MK[VPI`WK@816!Z2XK^/K\C9T!5C0;1;:X87^0MTR-95HB%@L6R;(=@BA?@M1 MR$(?C"H>899WY^92$LWF[,-+O`Q;AG(8=,R3?!TQ]/R!! MEP&%.S3)>.X"K'*GE*K4=HB!UU;?3$5$5@0S(13VL&?'LQ=@E3TA4Y7;#C$F M]E8$0\2LKMXT(*3;%PKW^2/PAU&0S_O8LQ0 MF.7F;2INTC5T\>N^W2'&I,&*8(B8U_D/9B%9+/UN&46&>"KH34LS?0'6Z2^T M]D&,B;X5P1`1UO3]B=]56:$>/D)=@'7J^LQ!C(FZ%<$0@9G7QI)"/H!>&9_X M&JW2IU3?N!)DXF^',"-$E2#,;'3O!&A]ZM0?2$"048(5PN12[1:>=SVJ"A#^ M-EX`NJ$JH&M-W+P!@HP"K!`FH[0"%G?F9R`\KB=@W!"J[U*;B9!N/$@A:)]& M(58(DTO)033W24#]L!T8:C%@J;X6\R0*!%K7T)59:D"048,5PN12S30*X%FB M_W.O-,(">Z6QR$'#5'M+'T_B(1\T&^58(4Q&P9*`^Y-PV3V_J!413CA>`OIF M7P*E@^UAM=\HL$*8$:)*$$8X7@+:9E_"\/$HL+IO9(Z!4MY"'/KM&V$25!ICUMAS`):4:4?V=#DX<,NT;K_/69)$%&_G;#EE&P M!M.E'P;W%$!']+O)/%6)0*L**-6[2(*,"C".`<*,4=0FTCS;(@$]5MT(W59# MGR-6(X[L$"8A[8X.NUJK`B`/#]1`H-4:$**/)((@0X(C.X1)2"-@=F^FBJ^Y M^@+&C:3Z+EW(H)FL_AO).`:M3$)Z(VD9=C57B_&01Y.A1Q.B/S5)D(%@9(

V4B-B=V0A1!(@O7OH[VBR@1NL[61]) M$M0*"#M'JA5&$F"J@!&B"M"<>=Q(HNBLJCEHB=Y)4#M,%K0_3*06NT7+,%_+ M5;4(M^P]\5F*@=ZJ:M`W!$50.TRT;HODYU^3JR4R(T3E_Y!!PTG/T-_TD21! MIF^SK18NSI3N__N'"O#,"$]#,EX<><3/Y]))\C=Q'D3@^[3V:GM6]43$H8%V M?1>LX.P"KGOM!W"$=(V/_&=<'--+Z9SY`4+ZDP4X7H&'4/BFRJ_U&?>:]:WSZHC3V"LU'U)DRBF!'JA*]DW)?WQ?7>UHL0ZWE>\TSV4]`4L MO=V\?[<>M7FT+8`CR-#;DK;.#05C5K2@N(WT`#U^J;51W.'2-,P.!G@U!:F. MI7%\S127/0T,A;F$0]>U%+#5XJ"@=X'$0,<=ZK>M'.R)38E+Z!0WCX?A2F@U M(,5>=M*]3*24*%$\-+TV?-^A[^=DP<6)>UJ\HE=2&&UU[2*D8T'H:\\W[(8A MTV9=273@RTX,U"6]2XK[!66;]52?GQ)&>_9.;*O'CT96GV4/6&QLDV_`7NM' M#WVH_!8&LU?1NZD!7PVIH.:'SGW3XR>03>NPVSD:\KZ*ZF4+5F!!D29*<\\D M=(<"\$Z4]).!!>'/TW.4E6M+FEU'^3+.$H23/5BWDYZ2$G&P3JM?`90B3!YY$DR:-%FB]7%["PH&@RN.6.;]9&CP2'!G/:@?L13`ID/CD+.F:O_[** M'CW)G6LJ3AB[@,&[S,FF1$,U+?,KL MP3ZS+[J77<^ M5W?I=#3F#SC7`V_@"S>-["WIH,;0.%KB()MP,L+"Z6&:KKUV.-'3:XL_,,`> MQ1&":ZW=:>'/WOQ+W/P&``#__P,`4$L#!!0`!@`(````(0"0)Y&PO=V]R:W-H965TLH'(F*E;"/ZFH"ZK@M3XZLJH939I&1>YXKALY M!>6EC0JK^AH-D:8\9H\B?BE8J5"D9CE5X%]FO)(?:D5\C5Q!Z^>7ZBX61042 M!YYS]=Z(VE81K[X=2U'30P[C?B,!C3^TFY>!?,'C6DB1JAG(.6AT..:ELW1` M:;M..(Q`QV[5+-W8#V2U)Y[M;-=-0'\Y.\G.LR4S&I`(?6ON)YZH;&/[T2RV,'O>(8/>"`F77L_\ MW@3FR\4%,-*#3^AZ9QHVG9&P7UADH/MS\2]UP\I.$8:WZ!9O&C:]^5[?&S)M M:E[@!OT/`H%Q\X:U^2W6-&Q:(V&_H,B,]XRQ31&&-[UQ=A:4Z8DW#IC42]5:)'3+C/6-L4X3AC<"B>WUN#6VZ&P;7 M0IA<2(*H_RFTP+A_TUUOFYBN*L&5O;L$DZ@WV7)F/[T>GWUK(/S M1K^V(^DAA'N$YT?!(#T$Q@>`[O!4@OMM18_L!ZV/O)16SE)8G]S9'!:C&L\D M^*)$U>RK!Z'@+-$\9G!V9+#INC.`4R'4QXL^]9Q/H]O_````__\#`%!+`P04 M``8`"````"$`SZ:32#P#``!5"@``&0```'AL+W=ORX>94FI0L#0R`272K5SSY-926LB1[RE#8P47-1$ M05-L/=D*2O)N4EUYH>]/O)JP!AN&N;B&@Q<%RVC*LUU-&V5(!*V(`OVR9*T\ MLM79-70U$8^[]B;C=0L4&U8Q]=*18E1G\V_;A@NRJ2#NY^"69$?NKG%&7[-, M<,D+-0(ZSP@]CWGFS3Q@6BYR!A%HVY&@18+O@WDZP]YRT?GSE]&]//E&LN3[ M+X+EWUE#P6Q(DT[`AO-'#?V6ZRZ8[)W-?N@2\%.@G!9D5ZE??/^5LFVI(-MC M"$C'-<]?4BHS,!1H1N%8,V6\`@'P1#73.P,,(<_=>\]R528XFHS&4S\*`(XV M5*H'IBDQRG92\?J?`04'*D,2'D@B4'\8#S],X+$9`?,ZAP3V(CU$:&SH&E3T]%YZ8'>7C3X>2KZD]AP.(K48@."-"(#B-()AY1IL*P_\J:UL93`3HWP<35[7[?*^/AV/ M8G\VL^>G9AR>%R*SO(=?]'KE&FPKCT)G9ZP,YO+*1ON[B'0(8:F??$2]!KOJ M(]NWE<$@8N[8`<>C'[HXQ@,OQ6]KA++C>>0UVM=\ZV@WF\LK&^7<1 MZ1#"4J^+_\FI.+SC-=A5[SIO,`?GXZECZ]H,#P27#B$LZ3-;^G7'C9[DAN`> M-P;S]G%CQH=B&$*8&$P9-P6JIF)+U[2J),KX3I?H$`Z,OK>_/=R'^FAW^E?! M',H)]'O]`%3UEFSI#R*VK)&HH@50^J,I_(["W`M,0_&V*XL;KJ">=Y\E7-\H M%"1_!.""&ULG%==;Z,X%'U?:?\# M\GL#)DE)HR2CAFYW1YJ15JOY>";@)%8!(]MIVG^_UY@`-JF'3!Z2`,>'<\^U M?7U7G]Z*W'LE7%!6KA&>!,@C9\:+1,(E/_BBXB3)ZD%% M[H=!<.\7"2V19ECR,1QLOZ6+IJ2"EU"2)(*W%A*](Q=$7"7T[5 M7FS2JC$(&RW>-DOT:/>!F'`?(WJ]J@'Y2<1>^_)X[L_#>GV1=:$G`; M\J0RL&/L14$_9^H6#/8'HY_K#/S+O8SLDU,N_V/G?P@]'"6D>PX1J<"6V?L3 M$2DX"C23<*Z84I:#`/CV"JJF!CB2O-6_9YK)XQI-[R?S*)AB@'L[(N0S593( M2T]"LN*G!N&&2I.$#4R&2SXNSLP:2!5XHJ45,0+X'X M$IB6T8;Z4:00HB)Y5"QK%"$/@A"0GM?--+I?^:]@:=I@MD,,-A'Q!:$R`?): MC1!X7^-UTR]2%%A)44E0VK;Z!G"WVD+KO4-$M&@AAA)P:+P2!5XC(&]?/(VB MEE>+TYA9#S,W$;$+86@#DO':%-C6UL6LM6D,#F=U0H/)W/9M`)@'QF?6AF(( MA1D_7J@"VT(?6EXM5&-`36NT;:(+86B[OT6;`MO:;!,UIC,16^)C&Q!V+AO* M8'&-=TV!+66+P')-8URNN1"&-E7F>IN(>X$JL*6MM]QT1C6FY]K4%!\/`#-C MY@7=UF((?;A%J`);0A<=KQ:J,2X370A#&X:J--[%&FVI&]C8@'H^6OKC(>*# MZ8?5YCPZQS7:4K?HF+5W#C["1W>WZ39$4-AXNV MBN#.HQH1-S0]1%#98OE9=V#8@IXNC:P>VBL=(%Z]4D<7`1;M* M#%T<(+KSE^GB384$7ZLD'7.38U>A:)+L@ICZK&(RTL4K567HXJ!J6/,AQ@-$ MMV&:*F^J)/A:*>EF>>.BJU(T+KH@ACYHAGYC1=>C?K6B&]!EO483L_(&T5]W MUDZO6K/^)N`>HN/0K9AN50K"#R0F>2Z\E)U4FQ7"D;2]V[:`CZ$Z]5OWM]`: MUGV4WSZ`SJQ*#N1KP@^T%%Y.]D`93")8Z5SW=OI"LJIND'9,0D]6_SU"#TZ@ MJX#3,/+VC,G+A>I9VJY^\S\```#__P,`4$L#!!0`!@`(````(0`%!B\=(P,` M``@*```9````>&PO=V]R:W-H965T6WG M9'7[6E?HA7!!6;-V_(GG(-)D+*?-;NW\^OEP$SM(2-SDN&(-63MO1#BWF\^? M5@?>5)B$3@T(BU4TK9+EU79"6IL9BPEC0P4C!>8PF7?.>*EA. M%[DUIHUC');\&@]6%#0C]RS;UZ21QH23"DO@%R5MQJ@.EL^[AK&\;:"NE_]*`#FM>N`L7 MG#:KG$(%*G;$2;%V[OQEZON.NUGI@'Y3$+I_DWVA!(&]9)K<"6 ML6]5 M"B4JDSOEHKV@"`'+\[()XWCEOD"DV5&3&,W<09W&MQ7I2:%6`O`Z1BB\SQC" M$OX[_!.2FM1'6M@W3(::P%:D0\7\7)<%">%=0H[#*?':`?,NBW#AV;=.C";6 M:0;1M!^6-1QH&FUK`7AAVW115]A$J);:H@/OOJLY$8S5AB8PJ+#0[/]8DIL(",[WLEMIF">&K?-3&:L;S&%%9>BX^P M*;'--LS+:$Q>\;1W-M++T6AV?MA83#X\N:X/3*MMJB#NG;CD*!J+;%1B\_4Z MPOB"0M/]?VI'D7F4]8Z':MO*P0R>CZQA,@W9-*R:\!U)254)E+&]:K8^[-ON M7_,BD*@7`=W*NP'HPRW>D2?,=[01J"(%3/4FX76R:A`^N? M);QQ$>AOW@3$!6/R=*$Z5/<.M_D+``#__P,`4$L#!!0`!@`(````(0!RHZAJ M@P(``.P%```9````>&PO=V]R:W-H965T(.EZ9BMC/`B_Z2:E@:Q[=, M<=G20)B;]S!T64H!]UKL%;0N0`PTW*%_6\O.GFA*O`>GN-GMNQNA58>(K6RD M>^FAE"@Q?ZQ:;?BVP;B?DQ$7)W:_N,(K*8RVNG01XE@P>AWSC,T8DI:+0F($ M/NW$0)G353+?C"A;+OK\_))PL&?/Q-;Z\,G(XHML`9.-9?(%V&J]\]+'PF_A M979U^Z$OP#=#"BCYOG'?]>$SR*IV6.TQ!N3CFA\@2HZH`$F/D`S= M'\_3]T)8,-3'=\\=7RZ,/A#L&7RE[;COP&2.X%-@P<80ZK\BQ1`]9.4I.9U0 M@D%8K,[3,ILE"_:$*15'S?I:\TJQ.2E\)=#>X!$#/_?X]Z2?K'BQM^*+X+VM MPP:R!V_II;/-M6(R'2073C!#YTY\MC)LIK<=^4NH.S.0S5Y96`?-Z$PS'AST M86S>4EQX1,C_>_27)J,AO/@ M+TQ7Z#X%IH(--(TE0N_]Y*3('7:'H5ZEOI"O]M,:%DYW?<]OM<,QZQ]K_*H"-DHQ@``!@```!X;"]W;W)K&: MP7B,8HP%3"9Y^ZVFVFZJL1V]^JKJ_;P]KG*^9[ MU:%L-_7A9>W_\_>G=XGO]4-QV!3[]E"M_1]5[[]_^O67Q[>V^]KOJFKP(,*A M7_N[83@^!$%?[JJFZ%?ML3K`.]NV:XH!7G8O07_LJF(S7M3L`\%8%#1%??`Q MPD.W)$:[W=9E];$M7YOJ,&"0KMH7`^CO=_6Q/T5KRB7AFJ+[^GI\5[;-$4(\ MU_MZ^#$&];VF?/C\TZ# M-(!(3X^;&NY`I]WKJNW:_\`?'KOVS8/6`^']L="-S!\@\N6T0#XT^T'#XR5PQSW4\MN32!^#;Y#^TB#9 M!802^9R0[(P$(.NL#=*U7)N&H3B^=]8F^3GL*#]#1$V0D!+Y+8)(@\]9+DW# M:Q]B6VF"?G"&2#+FE+,P5#&+*9)3A,>I2),S0L3!'2X7IV%'G#R'Q;PA$HWB M(A5//G9\/Y^^+QD/8QN`Z(*!F>K2HRAAH&_WG+[(T:<X1I MV!%FPV))$3'"))<13QVCR0DBTI@GURR.0_\O3]M(.R8W,V`=<>W#3)[=QBVI M"7,9(>/`G?6@VR[ZZ'A/+(W2V5JWU[< M?!Q=?NK'RJE@9AA391ZF8J8.HYP(<$5+4''.KM`Y5&!(M[V%SY>&&85!" MQ)/9[%)`QJ%U'RI1._CR_*'?D_Q9U\(AXV!:A`N]:&1S]'HI[GDYW666&N3R>N#5N(E2> MLSA^TG7SC:$=;P_6,S#!87"GCB#F= MF5."<\&NF\9Y-8P9 M"A@(!\AO`%2:LS%N]YO`AX'IO$X\RDA#YC2OB7#-.C=1D$A2,?%JJDU;]F(O M$9JF:0MM'QMMR.`GQ["AA.LD)@H2D8@DL_-$Q3EKXB>)P_4P]9'0&<-,('/+ M1VXB5)XV].6Y0_N?UE7:]6ARAXRIJQ!,R5GR"`).(A/;EU3>76M"/[J[I75\ M(C,,RE.2"6>:-RM,N MO]C[).Z$Z01'[MXP#,I+E8QEZDX&160:\M3V+Y6G?7ZY/-P*1)XMBRDK,L8] MP)?A8,)^.$ZNI(Q00EUS0#C?)0*76V_R%JL$:HCKWUS;G;YN[R)S3 MY44#``!2"P``&````'AL+W=OOM:5]T*XH*Q9^6@4^AYI,I;39K?R__Q^N)G[GI"XR7'%&K+RWXCP M;]>?/RWWC#^)DA#I@4,C5GXI9;L(`I&5I,9BQ%K2P$C!>(TEW/)=(%I.<*XG MU54P#L-94&/:^,9AP2_Q8$5!,W+/LN>:--*8<%)A"?RBI*UX=ZNS2^QJS)^> MVYN,U2U8;&E%Y9LV];TZ6SSN&L;QMH*X7]$$9^_>^N;,OJ899X(5<@1V@0$] MCSD)D@"3@;/:#KL!/[N6DP,^5_,7VWPC=E1+*/86(5&"+_.V> MB`PR"C:C\50Y9:P"`/CV:JJ6!F0$O^KKGN:R7/G1;#2-PPB!W-L2(1^HLO2] M[%E(5O\S(M19&9-Q9P+7S@2-KS:).A.X'DTFXVD\OP`E,&'I+-UCB==+SO8> M+#T`%RU6"QDMP%FE)X(D]Z<'\J+FW*E)>BJH!=3T93V;+(,7*$/62=)SR=A6 M;,X547B0!(!W8(2T7<^H)D$LOG=DG![L=1BID4Q.)(YB,Z2P$.$YIXC#Z5/B ME0_>1[29@V8D8A@N5Y\+`0X>VY'E%-GB\R9XU#L/'[%IX,QMON*!* M[&`E]F-3(TETYM"7F\@>WGPX;$'%UT`IL0T5'V,UN3(24TX4FH\#-BBQX-2. M>=))AC.FQ`XK3: M`7*63-II/EQ2'X_;8,X.,%PW9+KV:>^*G1:0=IJN2_0OJV&-#:B:\,4+"YF6 M;0$Z+2#M--VZGX5Q-$^<(#:N)@I/-3;@510K8>L)1#,V0FS.1N9&LU?OZEDDXR^B?)9Q="6SZX0C$ M!6/R_4:=N@ZGX?5_````__\#`%!+`P04``8`"````"$`E:PC\GTP```PF@`` M%````'AL+W-H87)E9%-T&ULY)W=;AM9MM_O`^0="H;[6$9$6=2' M+?=T>T!+LELSMJ06Y>XT@ER4R)+$;I+%814MJY&+N<@;Y"I``@SR*/,H\R3Y M_=?>NZI8593D[M-&@.#,F;'(_;GV^OBOC[WYS9\_3<;1QV2>C=+IMX^Z&YN/ MHF0Z2(>CZ=6WCSZ? M/YO$H^FC:)`NICGS=C>W'T6+Z>AOBV3??;2SN?/HU3?9Z-4W^:N#=+"8)-,\ M8AW1X30?Y;?1T=1-P+J_>9:_^N:9FKKFV]'[=)I?9S0=)L/ZM\?IQXUH>W,] MVMKL;M>__$L\W8BZV_;E3OW+8AF]!RWC2;V_7_E90XQA\BGZ:W);;_=DYPF\U&JDQA&!W'>Z-SCK(9V7F_&\55]E">7 M\3AK]-E?S.=L)GHSR@9LZ*[61S[2B1MSQ-&/R7C<^66: MWDRC?A)G\.XP.LJR13+_<[W;D^.T_E%UI!_2\6*:Q_-;UC9NZ5ZT?9)%9\DL MG>?(3M3/XWR117Y;S3E_2K+ZI'[M-DNT#UVOTGGS0/N3>,PR*E/MIY-9/&VT M],/Q[22%"'DZ^&4]ZE_'\R2+3A:Y"34KK:^B8`M_$OZLWR""C14_^;YQ!O7N M=I#MG9&_AHCMGQP?'![W#P^BU[UWO>/]PZC_W>'A>3]:^]`_B!X_K:^VM[A" MF+OMPAQX*LZR)&\L?C_.KDVA#/2/Y&^+T<=XG$R;#4_GR2P>#:,1>G&21'G\ MJ7EVO8%ILBR:)X.$@2[&R7HT3?(HO8PXK_0FG@Z2"(T5#=/%17ZY&$=QZ$*3 MQYOUC>VCP>;Q(*^.6&\3%I9\0N-F'*O48YI?PQT#+T[M6S](+A/$[>XMG:IG?P(;1,/F8C-.9:8I! MFN592;(!"G\Q1@:&43R12/T:YVAZD?/Q[OK+E]OKV`?;+W_N;7;7=U_L-8&!IUCG$=HJT42=3?7,?'Z_RAS MNCU>Y-?IW$1NFH8/1S)]R)*.?;7N][9BU5R[=\W5?;Z^^6)[?>^E$TO]"JZV5Z=H.$!HDH_`,T]7V2_!A,04()KMS6B*F1BQ]=,T,RI$_Z5W M(:@XR/]K?!#6S]03%8OO"I,]R^ZK77[@MM:WK78`E'USWOGA^\/CT%3)V^BD]/#,^]D MK,!654=IJTZV(P>&2OY=S:G'P*`,:-40T'ULOBQZZY=OYVF6R01?CO+ZY"?8 M=?``,'N5]>ICQ?E^/4)'TW:\;A(=#R>CJ?E>^>ACP_R<)1FJ9.!`806;U&=W MVD+0X.XU>!)=SM-)Y%NGTP81A#B`Y+F'E_7)WN,/L9=XFJ2+;$6;M^C!"'#D M3/#@%JH,KF/,4WTPOW*#(1[-KGD*-DQ/^^JCBP00F^A^B-^].?ESIVYB#C MCZTX4#1TIU&G3&_X\R+S$`8LAY^28FO&B7DIX0!3^\L<(CMAPB?1Q6W@WCMG M/DAFC#ER,%TXHX[;&;`%CC>664/[WO@_U(.X;[A6?%_O9+YRYR+.V#T\(>?* MME5OMP:W$M?*DJ>X,NY?$+_>JL4U-&7T.SV\=E$!R5E^ MRO_?O^CZ1B\=K+M[H_%M0(%#1'M(`*UA*="D@R09>FV`$D?/)_/!*$O,B,I! M0%(%GAM=BUV5.VE;E<9QKLU"Y[+::'DU8\P?K07F%WD<;TC^C4GN"*L8F=H: MKF-DKD9387HMZ!:C7#^E._I".6,6"U'6^_47L]G8\#8@>XAI':?90@$Q;5QA M(*E;=K$RM%Q8:SDG]=%1!T6`R+R7>H/N1O3V\!C<]:[^SP'+>?@'W,()IJ M/?3X1_--0-%:P]J__OZ_^H?[__K[_WZJ/19[Z.ZYX.%&U,N,^9/)S`6>,'Q: M,YW(3."N1SWB4`,LYI[8A2B^`E0:NM_YS^O65"$]VZ!8UPL8FR34ZIP\%SRX M3--\RH%DT37(`YHE1BUD7EI&$L&T./["64,LZ8^)=@T$R`]B$$*-6,YNC]4$*J9K^M`18MT!GYFQ^R_/[(`'7]ET>EXD:T+NVU$:X]NDD?KT:-T M,=?_++)'3QUMPH0V#6L9+X900!N*2V2RKIUF('23_2E[8::I$DEB%>%;?;'4 M84K`-G.TWSL^CWK[^RR_9)P0$Z=/MPV4W3=Q:*-7^=# M"Y6;RE"7A47:*OS;QNB>/3],Q;:6>W$ZG4S4G&/:B$YM%M&J=7U>CK)H$D_Q M!,P4F8`XDO%_NOO_]/J(EM,YYT`EHEGN&(/::2Z+`U_G>0TE'Z MD6V6YRBA^$Q,OVZASL+T670R`!WOUR^/CW8I['!#YLX<[1'X8H'+DC57QOE' M[<0:_%KL22;26098HTAB0/(R^5)\JNQVGBB<)UW38.S2?/?*I6/)2;//A]'K M5/\M@_6FUW]M%JNMV3Y9>AV,V2"U[O6=>7NYM]MYOKF['O&9VQM[TG].^:_1 M,]+DOXJDWS[:>\0?@W3LE.*$]'Y7G\S?8&Y7\40* MT`:PYL]LW/Q5/^1U.A#7&+Q*9+;16,L?LPYX-JP$EV&X0#J]P$4&$[BWFN(Y!.6"L.W M)?]OC"G`".&M.(L^B8>D`+>?VA1.(6CZR]&G9.BX=N5172L(\.O\"^Q'?@>;19E0%CAM+5'I_O]1V"9B_'HRGC`+7J$_2PD]D^: MW4&)0NN8Q-(W$(/&2L^ARD2,C(J$"$6/IB'GPP>.OTUS)FS(PQ-6SM9%$$@, M>?1]MB!V%I:7)?./2(9;$_)OCJZG,#!M^'3B6NB#";P!'M(F@MP" M9*4Y^*:0++<#MTL6C>B'H\A@H=1AN'@LV'L;S;R_.BQ&%%U)P\1E6@.'=G[% M^3I/.\QFJ3VEU4_$FRX0.H5> M0WOMBC.]QLLQY!Y_C$=C&\B%1M*?!$JH2%N>.VEP5 MO].+%42VT-]\X=SAY>/LF\`%7;=\6@:&I[=1QCK89)`:\SCRVQEF8RQT35;( M"@&(!4()COT&H;4PJ[PO)P[2!B`CW)'JWTB.N1)"_BP+KP/68`>"4GBJSLO8 M=^Y0V`U-;5W1I:F2DJG1<;"-C@SI]:H#F#`>&YE&:)I2Z-2DL,VRR<[4>/UE MJDMD*H9D5]41O9(U#FZ`@[:$[5N701C?KDP3]J"FJ&,^JA>F*+Z: M)UX+&7PMUQQ<`>)(DDJ*5^DPB:FEXKI"%8:YI3M9D8R1"-@3"YX@"ZQEAT"""_'"_DRQOW'!&15)6 M^EWPI>&B@G^+8\1E76!`PI`+R:T=*!81@)GCE7322_``T0ERRBR%P[U.@1+# MA`"UJ9O%C(]QV1TC!.2@@56E(/E,IE<,1*<63`IZC$"-G>W=+PTCZ M/RP,EL_!;VRWHRI%8Y=3A^F*S_;]1K,OB3#/70;%>.RW'!H\,`'1<7CB#LH8 M),7([UPZ9D*9K)UA!9EZL38\JG;H6HXT*LI;\#"3*^.\1-'+06(F*2@)PZ@C M4D,`3-*J(V\8%;^EU.("2Q"\3ILWM](O--'/H>NVBE MQJQ$%M&#((LE*S;G2PIK*B=_Y?TY58R&>L%E+]14$L&(\2T.J/:E!"63!IL2 M7<0DA0'8Z^P#UT!ACC$?XLTG%[D%H>8>%!5=2%'AWMS@/5S#<1E==:8.BLF# M+P>G3,S%0*2ZG($A%B*5%/C$J*MUU5P8HTL1Z+6X!):8P``^@`N*H/M\A62Q MAXWHZ%+'4TJ#82P-7X9K.+O@G#$)46218QD:6/^1=+5T7)"H(652F.M`ADY& M?$[P7GC'&Z1(V=!TPF=6F3BZ>02G-CTK4W<`H" MP"K96S#1GEK2WS'?$DGR46#"ED2T&WQ2S68)3%D!9>'>'J`X0P&EBBEJ>1]9 M-M7H?YW-`!K?/IK)>LT_)H]*5[U2YN#DW,Q$-4"SPE(HQK!%$7W#I__CX@M$ M,VR3.O>"!!SL:V+TU-.M1^^4B^5_.=?W\?P75.OP2]J$XJS*4%7`YDTR6XHK MPU.%$\3GR!5Z>)1=AS1@G@RNIX1FKDRP+]G:R(H_73DKBESI*W3/B$+*2C## MPT>S#H5G(O2448'3JFW//W]V+3@XWPIP9IFM6M,(V0!]0D2#HZHR4P'QF@3Q M(=A"19O]^GDQO+*AEZ*=+N\#,RO0;J)-F:_2([(X,1E9SFR..WK**Q-".X?#23)L$W1>TG^(BJ2/((#1415"$5B$%[C$>7 MH.*:5BTVK<]!_4,K?B[G5DJFX!VF*]HWB22](N,Y)^E+,2\)'+Q8^7%61,6_ MA?.894A2"-+X:M].B%NZH(T:Z`2#E5-O"V5)OQ>3(U@7Y()*'HW=P4S8[S,,V974HW!7^U,O?E1:>[ZT:W^6;N4XU+B(<51^^3X3XWJ**#1+&2 M9/ZO__Y_1`<%K1Q/R4*Z?""2ABH7'E:"5(Z!.,\YU\XPLD^*\@4C#?/AL#[% M5-7.I]A(\TQ[M&R?RZ`H%6)(>M%W<] MMA2!-)&%S#[C++#*Y]WO:#!KS\"#$3Y MJHJ2>)F5O8,X+8I.%AYK3,*:<(0BH["+Q;C<0D=S+C2@XH78T$J6.Q2N\U&+ M`6'E6XF?(SO(XM;RODA@H5`+]5U>=#NMEE0))]L-ASJ07&HE4&JMS-!K<`N& MLPXI!WD1Z#BP6G']`O>25BOJNC9@UCN^MCE@81X;(1#6E[H\S\#W9K@89E"NQH"C\09D5LZCOJVKL*O@&!CH6E1NT`=D#L5 MZ[-3P]SLM[)__.-+,#=ZW3Q%#1K;45:.!]8Z.ZJ2U?HXF%'Q8"8:P\]\6 M9.8-6DA32=&I&,W%*(W[3+55#\,3F&'[5^+:64&U_8J`,@K(]]1P'. MTR*^9\?LC;8KB/G,O30V\V%:68]G'ELJ:3E=-*MG\2]DD`*`$3?>:%]^23/* ML`R6RL3<6/(>1I08@@4',B`K=OO0(SF'6&7422X);+J8,#T2`S^4PE8Y73*> MA%%,>IBGJ*P*U6$.EK1+LA_%TH^5P0T#8G9\P8]!OP9C6S5[G:T?*X3/I:C= MW9WU%YLO6K]6D^7_Z]3;O8%Q!MZKD%8#I961"-1C4%B*I'H7HRW"@=2'Z("_ MF&>?W',5KVQC9;Q2,_[J'=^@UQG31L"/4-#9>81%CD-Q`$O)%&4H%(;,TT]6 MO%,]08^HX!@T%P5\))7+`%=#>Y\!.(O(]X$.V]_<;`D\Y*^66K>@RWO-$%5H M)`!7>VA`;I]H1U:Z2<2D4"?C+/4G#/<' MAZGBHNDXI"=D2A0H&Y$:N%%TUN_9*7NGR(0L*?*DG7K!-RF12XM5\4>>6MS" MS(JW8U6RI9=\[9G0+J:JK*'I@!VYRI?S9F7WZE@0(-ARK<09WU!N$BD/\&)G MLX,0?>'H3G7U7RQPTQX@\T=9U(5)K0HL$_"WY`LZ`6.>6.Z4:R_.P+B#K=K& M8'^J%GIXI2BT$VX>J4EDY1IPG M(-%IX(KEF/H'JV`U;[!,'/D-B!7)L3&$>!/F]3M564C806/%K,=OQCQF[<#5 MD;D-723YC0I;13CU=0)"(P\B)`)52NEOIXG*';KBX-(M,F21Q(B8INS@;]JP M%C*@ULJ*+C77..;*C`84B18$@K#V(@_TXG-7)>KP$5A9T`Z\/J7D22 MX@11QJ'D+_YD]M&1;\.@K?-=B1FX&_^.G!4-95%I%75PZ"I:15$KDX0T2V4T M&8IOM1KO%E87<:%C$9S![(=_NT/GA-!LGK*^P/7#;6U+H5L?V4SG_QR%QI M)DES0V3QP/3<`ZUM]4G?3QVP67H`$VYNQIUIL)?A507HNW:LF M]Y31&_45*8G^[2K_TPT&[C%QEQ>[]KG_)^>HJ*=JBJG8(?=0..I+T1/ZLKDF M%'.#VDL%C3,ZK-ZRZ^,D-AQ,3(63R>+.=>5&'I07V*G6[Q;V9.NY[,F&N[/7 MVEGFV@(OYAW9'1B=AE=-99$-`D'#XIJ>O]@=/*J;^I4^RG=T40%:5'LAEA]] MU0X1#'<[\+Y59<2-QUQ(8`&"HX.V]HHC$MJRQ)A MZTK$7TVRRJL\GX\H%S,MWE711# M!U0[OU*LZV/W-4;GM7$Q\U!ZDIG-6VZW&FU6^[`NX?20G>"$EK9E4*1("1L" M6JE@7G3WOC!@;<>-EJ,LJ=(QE3!S>(V$$1(,!5==D&URZNF4VI M#FR4(N8:PM];I%Z`Q^C<]1\'."CF-HYS$RXMR]FRW?7MYYO.0F[OK6^^?%E` MFL]2.,O)">=G.Y4M+5W`;T`[2EU[K\+O:MA3@;SB]0%?.VC+ZU4>'R"^L=9_ M^V_Q9/:G'O>C)*,%:M$?5?_:8PEOKI=0?3L/G@$NISGN[I%[]`60$&[1G,XI M#FT+[ZF@:_65!7Y>PT=&8$?=6H]?_8-]T-@%F7_9VP;EG"SUU9['. MI/,.G3B,@);4$EM)4\\%F:30CO"U1W/%'B5P;J/03O_1+8@_1-[:C\,[%=35 MLW)SD;,JLB]J[2]FB@N9@E+2264` M2Y<1"$GF-)VP"O7PX-:Y@96KNY2^,-RE4AA]W4 M.OF7DF%L$O3$H*U@U+XQJO$5(N?BY4!-<>;E:`Z(#Z`:(E568J\[VA`77,W` MMRXG&5+M-:42P%>\ZDX;!;/CPKJR[D4UW%=*>HL,PDLK:FPJDK3MXG$MDK3= MX:FP+QEF.:I$B**U?JUKLC)170>+,2$C3Y,*Y&`<[S&UR0Y>8\E M^M'JF7"I\NB$`Z,/7/I.Y1'[RF3"%:KS0[%%7!,UV*S>:F!1KCC2G_M6CK;4 M(SJT*S5?1EQ?R1E7P`X&,92.+.!XZ"U4G$MX;*:;-ZI,%I>+X;P77271HDHB M.=87GD2NY`M/'S>S()$2:IC191(5G@6]K8'$QIQT5["WU&&YL`>%X8,'6A[3 M5P(2DCXM*'CZ%0^"DR9?Y^J;R>P5X0HI&CI5IF5CG+_" M5K.EG*E/J?1T]"H2W??=]?_L68R413I<((8--N,'/J:.1O;T*))%C?1,F6'I M+RXP;;P#6=_B.X)@7R\%,>ZL-JAW7]OJOEA_OM7PEQIO&95+D<9ZG::_N#QT M?<`="K%.WK\_.G>O9.EX>+Y'M[`/C]NN8./,+#T+N&_U>-24VF7L@^)]B?M. MZW/G/00CI*Y"MQ=B8/6]$$QS0`ZD5H(Y5CQ3Z2R*GBR%F7CBF501E2/6HFJJ ML)5IL#3PL_WK47*)EB8U9RG?$_-M_\`AXF`"[0`S16(.AAB26#9688%+ MSCKED)_L,1JS0!J]6DW',83D&9]?8E[7=C>?%B]M7=JV4:'.759OH[?N[J@, M+]-NAKJ(0TWG&I%0GKM\*@+)NOH0H;M])XNG(/^=9T?5K1@C)MU)5G1A]YVZ M%#/K$4WOB):>*7)B#42\@B3N](,PJ5I+S13ITX(K#5V![_8F2<);3),O"8B M5/PT(J[L+RL$V<)>/;6&(05!?&*I@2"A,`B7T:%@(6@_DA!@]3^FXSS-?G6Y MTGNU5L!_"B3H/1]AOM)3,=W5HE6#:G-Z%6A?^D_.:I9#^'>I_08/3TSIM))3 M2^"]4`I!G4\50TYYF,^N>ZOC!OJM2TCY_;09%`1Z,7UVGI6XB/(DF4DFFQ&M/B M1][/)7H=K74EW3,E6NU"3:$Z,B4EZJK,5CVHACPUKND/IRGN4A1FMRHDD$NJ MXK>[]<=:BP(AW:E2C$)=K3F%4FZDB'559:L@R5/-*4/LM*@(+14!(HO'$G#1 MI3@Z;!GCAMB9KPT2?+5DIE.K'L)I;T%$C<[1FCXJ0]6>IDPA8^7KP'PFAS,! M-CN>XBJQA8\SPA,R)RKUEZ^$'7"?.(Q>G4__+C>(*T$D<78;U$KQC;DT>8ZU M@OFU5;I5.5*"6+Q)Q?-0M:>?>)X)Y5E`U?">D_9_^.F:2Q,Y;UEMO&RHHG!':<#'W#IR"T28*Q]4H#9JV^&C)%/!5IN<^E'$,1! M=X[MMB@)I)B4!=<'MUHTU=CEBHUZ^?*Y,U`M)^W#;PYP:S6F+4+2U>K*B$6Z[ET&\@"N,K=3-X\J MG_!FR<*@A@N^$&^PVZ;(A.$ZL_%>*?'9DF(ODI@*57&1S=E*Q::%!LS@O+<: M-=;RTJVJ=<%2M"$9&UBOJ1%=W:7=]#/-R71NX2)$94-2#ER)<$Z*+:*L8M"G MQME?:!T[2^LH`B;\XLZ778<556@M&Q'E\A!L[MZ/0,ZKQ"$8O)*K=$@!/F`# MZ\QA"1L].&!5`C:,8Z3?=Y`\6Q\.\IQC7L'4`>+"$NRH%";]LI%J$60AU:8A MFR?5_8,=Z?#"T6"U]$$([.(JX;-O-$R+[/U!-[U46&K?@B"#QH36$U+G!$6V3CB MA6_MV3T2UOD]$CCXD-16]`#8^GJ-R$7]]3KJ7!A_01.5]FEQCAG MYNEIYPI6*<`M@/F.VV/U,4_*WXE8#_&<5;^T\U9UR,T7ML.B&R^E+HW=./?Z M2OPP0@24<8%[S9"'`ZBWEMB6:>B`-E/G3E3KM2]PL:(C.$GR=?P]_R@:A6.O M5&L`Q.]Z`E4@5MDZ99.(O.24;K'`%WL\NMJZ('"SGRV2[[?45;*^C-G+1/YK M[O+\TND/D`=Y0K8KKDBZXG^R_-Q@*:ZJE&B*#.$BO%HH./_F^\,F(;]6]L.@ M7'0[2KBFA&C14&Z&YL/Z>%3J$8)%QXVMWP]7<-,3OF39"* M/C#?Y,0=>4PA9J2L/G/DY"HFU-PKC7,1'>H"0?J$'`MG#ED0))5W- MR+IJ@A("*2U!+%)25!Y$(4]+Q\.G[`(^W]G8VO,%E1"A(.4).NB*;2#6K=H+4I3?UC[[CWG/],^B/VCL\!V_LW(0G?:4XCL_ZQWW>_OV:X[U4<[\:2*(6T"K/H;:A2L>8IRWRX/D62.H1__-48L#5)\-PJY7\8S8%L/&U6 M1'E9F,(SP<8+<1?:FABWF:7JP6.!.^=Z8G[.??=2]* M"9_>ESQ;CY:CU](X85NZO4_\:Z<]?W8N8X7"FH?@.):Z-8[ME.^;GRR41A`# M,_[O'4`/P8!0B@T`+[-:0N,JZ@'7E#<*/#T>D:9MO9(-QY9"H0$5HO`?$^,`G]EI(V\_H'>N5[-\P3WC! M#%M:SH4,^*$BQ/#"TC%U!)0#=]]"?[J;NN_NE]%:S'!.E9()L&M4(+REWB& M*"^)ME[$5.:P&-97,OI,:[F#RID_9!-Z!)XLM0*,!F4O[US[UI:6O?/[EMW5 M($(&>S7B?][2MQHHM>K52B:I;514<`^]=/>T1];V>XZF*QBN/;ZP M/?JS75I9"Y@B1J$^JY?&:+]K58+^<-UO6%J3V@3N7:U5$5`6#9=?\R#FOB!2 M3%F-LV,H6/\0G-KRM**%+[3G@7^_@Z=A1T/=MCE!ALI:+M2Z/7K@WE`G>;+\ MPFWUH78Q<'@1"4/D+W8BX_8JL5WE=%1FC60$B<5>B(^VJ1" M^^@B%^<+#S')M,M;=DE?'FFZP2$QW[*X(AS.`@-2O)C%3LJE&DFUIVSTJ_DZ M+AVQ8N'H)SV;[^I'69%5BBF%(!(7R[)3"E>JW$/5Z%KY!`TML:??A3EY>]8[ M_>YH'P!Y>G*FHJ.Z`7R;Z#&@&36+)"NX.JS89[V-6;`'CH>XJ/1/CU24RX:: M5^4\:&'0R%*]B74P]FHT;*/R[MRF,>-=P)>4EOX_O3=R4^'A]%K M?MKGS=$YO]G>.ZY/M2_=XJ_*<'A$2+!N=G/^OA3>0V?@,.U'!ZCCH+)E9[.[ M]M>GEOTQ"\\YJ\S5ECNYJ99#HET M&,)5-.@="P5]W)O8L!(]JR M[#$PBHX[2J'4E^>4,K)R>L^(3WM&`V`SW>.LY/]'\PH3],>GY/7#U M;^+-Y.R9,%AJ.*J!NJ-7UP,QKJJPGE&%/>]UOZ4@_EBB,RE0[PEK]#TF6":=<179<^_+T/HNEY#SF8NM^OX`%V M`GR\F3W+]=,6?\BMD%>Y#]=4EO''3&1L$?+!S%;Y\83/^N6?:"W\H%`C4[.4 MO_K_^HJV146^Y/5LZA,01V(GS6M=?7\QII%&^LQC/U>*)6L<^FGK,W.5N`[% MBL4[;4T]I]>##(%6LC*MKP?5NTII?=YEX_H(VZN*[;GZ\H"]%O7P]7%7U-6L M'/6@6?QBD9KZN'U[:JDHD7(55R[LK1\T*/**]7Z]STZ@*DZ/VOU_,H.Z,CNH M:*TL7WW[16@:?SD\6R8[U9(PJ'<%*OWVYCM,'PE:?:BG;K$WRF"`9. MZ1`W=/<_#*ZHW&LF<]P0SL,BNGJ7%#Y9\1+BDVUQP8H`/9WN^/*SGR?\;93H MO-&5XA^LN/%]^:)<]C1:^]`_B!XW"/(;I^&*D'Z!A,L.!+[ZJO%:.0-ZR1Z@ ML)RC10JJ'TAI`&0X*_]*H"!F[7Z]77-T4.9W\LNQW@`3^%ZY6D)0[6^$`,F5 MB[WW699^>,6Z>BNY]=4OZM_T=HJ%.87X&3YUH5ZVJ,=2]]3GSA0,7RK*14,ZU+\8-+ MD?O;?W6R5/*[UE2B@=_!;<5ZRY!T[81\;6'9+.E:ZJ9ZQ\K"ZU\MY>;K7[9M MIKQVN6(_E7-%?N"B/C+H=SA=3?0('==".FOIRED2'J:DH]V?%COF@= MJ$+R^AS%:EZ$Q5"2T+:8>A%)8R!O-BDO#R,];QWH26CX,K2#$&TS/O%9:@QR MH--V:\/?PM`.1[B*!6'?E0P>F)!'DESMV1VU(AUWOPWX65:*-.@4CJIX\&;% M]AL3)Z&^PG!=])#)&F,\9/%^'E&EL?B"=XM#WMII/9/&S*M6?\=LU6`,E2/3 MQG(.ERG",W/U!==:*+=1;U)(0,FXW+!H9TBV=M2KU$WQC+H]]DF>\&D+. M./IO]OY#Z[A%JZT'M=I^4*N=![7JU5=\?PKV`;M]71^UV.'^RF\.ZM^L2,M$ M:_?!V*,I1:3N&FRV3HR5DT3CXN'.;_@A$"Y@V2WD-M1FOXW8./95.84J-ZUR MKY8R&7)^SHC!HF1A%ZXH9P->L%B0N%D5S,Y?*05GS[(IFT>TUR<$>*>&/_WC M&0H>UZFWTN;=CYS-A73WXP`I(2K@2RGK\_"(T"+4RN)2-S":D)B"SE9L6^_\ MY/[ZW'J7@,U=T6W]V],5E;?U=H?ZU7G]XA$1<[)+5G];;W/67H-;;V9#:215 M@Y9?/LNR_-7_%0```/__`P!02P,$%``&``@````A`-FQOG^3#@``%Y\```T` M``!X;"]S='EL97,N>&UL[%W[;]O($?Z]0/\'06F+'E";>E"VY+-\B!6S#9"F MAXN+%N@5!251-B]\J"25V%?T?^\,G[/B:TDMM=*A,>YL4=J9;[YY[,Z2(F^_ M>[&MWA?#\TW7F?>'EX-^SW!6[MITGN;]OSYJ%]-^SP]T9ZU;KF/,^Z^&W__N M[M>_NO6#5\OX]&P800]$./Z\_QP$VQM%\5?/AJW[E^[6<."=C>O9>@`OO2?% MWWJ&OO9QD&TIH\'@2K%UT^E'$F[L%8\06_<^[[87*]?>ZH&Y-"TS>`UE]7OV MZN;]D^-Z^M("J"]#55\ELL,7.?&VN?)],[[];Q_U>]%)B_<-8#XW;]W;O#M;Z)?;_[PYLW@ M7]]\^X\?C/4_?_Q]_KT?O^DKB1HB$WQ0+?-R4"D6WHXD*[$%=[<;UR&&J$`3 MLG7SV7&_.AJ^!\$`YN''[F[]GWM?=`N.#!'>RK5`E\&^\(BCVT;TB85N MF4O/Q(]M=-NT7J/#(SP0!D;\.=L$-^%!)=)P7#U+1)/8-$48C$UC/$)MLL$D M'0]6VZ3_5&`3HVM2K^L0_AA=H175=@G3E8^+'(>'Z$I]1?1X3\MY7].@A@P' M`Z25.JPC9;/%`/0=3=G5Y&B6C;6Q=BW4,B86\WY#A6--))4U"K6WU^^.1J=X M9676Q67X6!F`"2>611-2MR*_KS7\.4:<''E"Z\9CH52FZ(>IE]7&1],V_-Y' MXVOO!]?6'2263FKAIPOGY/PT>:CD'?&\>.DTKL1+I^DH7CJLQX.WEOGD1*LG M?[>%!?K*,["/8*$:_%L(XS2N^ZHHD*F\ M7F!BESBXO)[-9M/AU70ZG:GCH:J&)"_CB#:=M?%B8.,HC*8\@@D@F(VGLZL1 M`!FHTU#541&,`<#U9#*=#&"Z[`U]*]2A!(\BI!(,FKX2I58*["7JCD7"4( M)'F5()#D56&+S[@"SZ1[E2"0Y%6"X-A>C=NJA_`?EN'\RDS8^CC6A8MX+=S8 M::(K[!JA3UVZWAIZXO1,C`H]8G3L[M8R-@&8X)E/S_@[<+=HD!L$<(KG[G9M MZD^NHUOPIY*,2'Y7C(238'"^:]X/GLW59U#&[+%$W$0JNM*05CT5NPGU6AU< MJY/15=2P"5)M&VMS9^>M2W47QB70B-S6&TXX=%(E<3AD^WP*>B%V'^>(T-6A MISD'0$PD(<$Y0H2-V9XWKXUD!)^-9`"GC60$KXV0.D7)E3"Y=G=P_G7?P9HV M'0RB[45>/=4""?""B"D&0<;D^:P=4L!H[9BFMD)]R>7&_0A_PM5Q@:4U(_)V MU@PHL+)F!*^-;-PDWF6$IUL76)X+D.SQS7R<%T:B>*_:Q84(SV]$9SB*DK1V M3)[NVB$%9M:.X;4UH9S;YA/#SXV[(#%J2/. M7AJ>%EZ"&:H(C^)9W.S5?=A*9Z_#$\^V$9ZZZD=BOO?/(?HA^L8"TD$GKCY.$0_G!HIU`^\2-4/P<6M7V0\X,6P<5"#"VA0 M5^$1B0`VP!,$X`09"/#BW9@#"$\9"&!C,4$``9HA`#@547%('@Q)-8,8R%2" M_JY40HU)K&14=FAE6?D%_156:DSY/8AF4F\AT#.:X44%@(-4EI58626&N!TR M+:,`7E10H,&L*V;*&Y;5?&F$D*(+&#)&H`Q4,2(N*DG-!9T9@&I&[@6N0TA0 M8"F2#0'@2(%`'#&4-/\.*09),S"-!DE3,(7`S,%'S`GJ"6:&E(0!\$C)BFR= M,&1FC"/20"#(JI`D&D:R2B3%(*M&9JX8R2J1!(*L"DD](:M$4@RR:B1QA:P2 M22``(U(J)/6$K!)),H=01GA,T4Z:7Q^](Z?FL'-T][SZYG M_@Q=)GYO>@4'#*^/W[,/S!4]\M73MX_&"_2BT:41+YN##*S!E.F'DQO]7A/E MPODY``N'IVN(J+4\[.IK=^;W(H/=W:Z-D%H0N+LC&P-R'6,0'@*"4@0S5S9- M,$M*QT!=!3-F73%L7+_CJ)KLHIWKVL)V@*>ZAD:Y"T\8TTFY^:1(B=QOFTZ(R`Z@B2426^_" M!,7=VRHB[^--X]J8;)*Q-`A!?]:"P?UOQ*"A[*4I?$#:E/,G"G%;_MCZ@KO0 M5>YD"PRWF M_)=VWVW+%:-%SP;L@E`,%NJZTV.*HHO[ MX[9Q-68*I7CRTK[IE`">$A;J2\Y(@]D@V<9D)IC7B?,;R\ M+'E5FJD4\Z'Q!\9DK;O,^"MCM1J@9%:'X/.B6``B,U;Q0VR/S(.:NZ^GT9`L M(YID&&`MW%7*!4-I/#;1)GRCMXERFJZ,BW*VLGE9:CGEOE6I%4['P8@ZY>C` M:B7$9VT#AIVJ\TG-A@R[Z&J5S"*GHSQ(*;;I[5[8^8'NF_+[ND7COV"P(+C;ZCV16G,--G05P MB]9R>[XZ,Z/(-1=T9C]OH\C%++\UE,01U$7.M]GCI9%!#D8#"%1-[+6IG_\\Y[+3@] MD=1R15F6KNR"N*9.GT2ZLHAS@7XFZ5ICQ0FF:PWB$^.=%AW\.UX6U97)$[.B M)&O9E4N7+5/;Z8A%V&6/)`9A3>'C7B[32IVTG6(0=NEE06N_XSF]$\!=QD`G M@+L,"3%!VR6E8A#FU@_LS'L"B0]9=1*;"^6MLZBO[+4JGG2BIWTHLUP9Y2`> M=Z)GTQ_NCZSD[IL!@;@IZJ<9._+]M$P[ZN_'P>4U\V+; MUEP5$$`9_Y8_5V;4D-8J,UI!I$4(0"W3TR@U"+G?M<]>0N1K7J,8,W$NY"%]XQ$^Z129XXQ#YO*+VC9L_1;7B`[6CPV]Y%[^T* M8S!=(F#J+W>F!4_6QO/,>+?3%=SES;7OHX/Q[2FK9*4E`J=U*@M(;RHK71B, M8*N;RH(E9E-9J<_'8"V1!0]C:BPK_<[+&.]/G/&EPM9A4USI;N.8Y7["R;U: MY$=,-X(+3>;!165E?L1:F=F()C>5E?D1'$=E@ MH+(@W)K*2OVHLMQ/.+F_*O0C&ZMXVUT>7%16YDHC9D?6>XGG-SO5U0VXD><$1])R7P'?Q&.<%7& MPU$D)?,:&^5CSBB/I&3^8N-;Y8SO2$KF*9!'+%+A#7Z+4A^-67953G;O]76R M'&$#!N<9'A@+W5KM+!V?A)<(PB_E$8.PZ>"2]&RL/O<6\)3`5!";#SB-\@AZ M>-E:NJ,'KO?:PSM)I^)8IT\XQ?W1=5..6`DC>,D#Z$^&OC:=IQ[P$JW\V!C& MNP@W$9/F`DL//E>FB1@8':%AXP^?`-)$#(R.Q+!%%==//&+>.]M=ZB&VEN+4 MS2/B@^E\-M9LY+`,CP`DCZ2/QB[P]#3^V)0:<1+S$9\MF-' M>)1D0B)VGR1W<`W-`_PONX#0B*.($-QNYQ'R:`;PD/K8FVP.(RPN$2[?\_#_?7LW&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z' M'FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7 M,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPX MVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:" M8LT`;Q)__/QY.1`R M:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX M15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DW MQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2( MGIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q M7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9 M>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y" MG$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY M&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8G MB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<) M:G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*]) M`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^ M@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI M9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"V MENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%] M4-]@QK.04#E$4/&-W(MO7K-&.1+**:JA?E;Q5'5N=3:&K MJ7S8MU>9J%N@V/**ZV=+BE&=K;[L&B'IM@+?3V1&LX[;GKRBKWDFA1*%]H#. M=X6^]ISXB0],FW7.P8&)'4E6I/B&K&X)P?YF;0/ZS=E!#7XC58K#)\GSK[QA MD#:LDUF!K1`/!OHE-Y?@8?_5T_=V!;Y+E+."[BO]0QP^,[XK-2QW#(Z,L57^ M?,=4!HD"C1?&ABD3%10`GZCFIC4@$?IDOP\\UV6*H[D7+X*(`!QMF=+WW%!B ME.V5%O4?![*.>I+PA02^.Y+("Y?_9_%=1=;@'=5TLY;B@*!K0%.UU/0@ M60%SY\S5T7L]9Q4\&I(;PY+B!4;@0L'Z/&ZB9+;V'R'3[`5SZS#PV6-(C_"A MFKXD*&-8TMLA=\H&;)1-Z*:46W=A*!.^+1-=(F/`L&J#XL,PZ'F=LL/,!IBX M1YP8!,AT@P:<8G#5QQ8E1UZG[#!+&SR)@L7R3++0;-.%#?C4T-.V&$F M6)Y?HFS`8\N+D;+##)6C9-EC3N*&MISNVH#'VDG/ZUP[#`EGKM,]$B7#8_'Q MZDS+F7DP>-G^W=D&?%K)+!BWG,-TE5W),UU7R`NI*(5X4#]PXFQ#;)+KE)`KR\Y_&QCWVR_OQ>%MX; MKV4NJHC044`\7J4BRZM]1+Y]??FT()Y4K,I8(2H>D0\NR>?-K[^LSZ)^E0?. ME0<.E8S(0:GCRO=E>N`EDR-QY!4\V8FZ9`HNZ[TOCS5G6?-26?AA$,S\DN45 MT0ZK>HB'V.WRE#^+]%3R2FF3FA=,`;\\Y$=Y<2O3(78EJU]/QT^I*(]@LZ2NB,^)MUDZ!_5)L^P\O M>*IX!C-'/)R1K1"O^.H7N!5`$-D(,(C\_Q+F*<0H?A?&_'T)^=),VU^UE_$= M.Q7J;W'^G>?[@X)(4T@#9F.5?3QSF<(T0*Q1.$775!1@`9]>F>-Z@C2R=TV7 M9^H0D?%L-)T'8PIR;\NE>LG1DGCI22I1_J=%M+72)F%K`M]G_3Q\W&3P0"`+PT%0#$O"&.^D<]5D6C$Q%%-;D?Q(89&!R7`R%$<$1MW- MQ,R.&VN%23:W%4E?<66WR&#]#2=#L4VVL./&6F&2+6U%TE?<(9L]0H9BFXRZ M"UQ+3#3JKO"^Y`X;%-+PK*'887.6>*PETZ8P)W06.&E-]'.3_0X8GIB#-P44 M.V#7RM(UH"5F8.J42=*7W&%;/L*&8H?M:JO9M,1BS_95?$MA]*IQ+AQCHB%Z4[O#XG-+E_8/@="IHN2& MYAX?C-/D&[@.\2U['89.F<94:\P\7AF:@DI:R:S9AF`7FH\7RZN-72\/G1O8 MMKE\3O"XU9A\H5O.-S17&YOOH=,#>M\>7Z^.^X=#V*OCOL;ETZVO;N1*7N]Y MPHM">JDX82M+(?7=W:XW;YOF[@%TN4>VYW^R>I]7TBOX#EX-1MA+UKI/UA=* M')LV<2L4]+?-SP/\">+0=@4C$.^$4)<+;.JZOU6;[P```/__`P!02P,$%``& M``@````A`-7/Z78+`P``:`@``!D```!X;"]W;W)K&ULC%9=;YLP%'V?M/]@^;T!0_B*0JHF5;=*JS1-^WAVP`2K@)'M-.V_WS5. M*)`URTL2FW./SSWW8,MPT)>PR&*@F?L7F3[FC7:DDA640WZ5D<0']>3R"43^9LA8.Y'T?P#9>:BF\R1__MG@L8*?3)]0RSFY)\?AI$W:5`8_(;F M'1($P7NGV"K;R6XG7\WDCFU852F4B;V9VAY4I]_M+Y0[SPR1R?X:+IIN+#O] M`QCT+=VQ)RIWO%&H8@50NK,(VD?:J\(NM&B[>;L5&D9\][.$&YW!D')G`"Z$ MT*>%&8']?X357P```/__`P!02P,$%``&``@````A`-#?^?S0`@``,`@``!D` M``!X;"]W;W)K&ULE)5?;]HP%,7?)^T[6'YO')-" M6T2HZ*INE39IFO;GV3A.8C6.(]N4]MOO.@8W&6.#%R#A^/SNL6]N%K3B7O.-$JT+)D8TS$']MI:=W;LI?HJ=8N9ITUUPK3JP6,M&NM?>%"/% MYX]5JPU;-Y#[A5XROO?N+P[LE>1&6UVZ!.Q(*/0P\PVY(>"T7!02$OAM1T:4 M.5[1^1U-,5DN^@WZ*<76#GXC6^OM1R.+S[(5L-MP3OX$UEH_>>ECX6_!8G*P M^J$_@:\&%:)DF\9]T]M/0E:U@^.>0B(?;%Z\W@O+84?!)IE,O1/7#10`GTA) MWQJP(^RE_][*PM4YSF;)]"K-*,C16ECW(+TE1GQCG5:_@HCNK(+)9&<"WSN3 MREQFE"_(,6\EWFKN@@<^H>5,0J":6!&4,2_K[WN[)7NS)?J]]*7?A MQA`SB86,,-DY&"_.,7B_%3^=1=]`#IK+@68:%2,R2$X/Z,5C,C1+]`WDH!F2 M,YI%S8@-;78ZVXO';#J]CKZ!'31#]I'4LW/(7CPF'Z8.FB$YHY>QNE%JZ,S3 M4WOQF$UG:?0-J8-FR#Z2VD_^P?/U[V;VXC'Y,'70#,D9/<*&J7`ZVXO';#K[ ML\^"9L@^0H89?`:Z5X_9A[EWHB$\HV^/8#CN,+C#@%/"5.*#:!J+N-[XH4QA M,L6[\86QFO0C/_X!\[ICE?C"3"5;BQI1PM(TN8)&-V'BAPNGNWY\KK6#2=W_ MK.'-+&`(I0F(2ZW=_L*_4^*[?OD;``#__P,`4$L#!!0`!@`(````(0!)A:0D M;`(``,<%```9````>&PO=V]R:W-H965T#?'R%C:5[13/2_Q,S?X?O7^W?*H M],ZTG%L$#+TI<6OM4!!B6,LE-8D:>`]_:J4EM;#4#3&#YK3RAV1'\C2=$DE% MCP-#H6_A4'4M&']0;"]Y;P.)YAVUX-^T8C!G-LENH9-4[_;#'5-R`(JMZ(1] M]J08258\-;W2=-M!W*=L3-F9VR^NZ*5@6AE5VP3H2#!Z'?."+`@PK9:5@`A< MVI'F=8G76;&98+):^OS\%/QH+KZ1:=7QHQ;59]%S2#:4R15@J]3.09\JMP6' MR=7I1U^`KQI5O*;[SGY3QT]<-*V%:D\@(!=743T_<,,@H4"3Y-X&4QT8@">2 MPG4&)(2>_/LH*MN6>#1-QOED-L\`C[;V.5_!50F7,56?(7%GC_ M89G,TM$-)"0X\@$^4$M72ZV.")H&),U`70MF!1"_'1&8<-BU`Y=XAA%X-5"% MPRJ?SI;D`*EC+YA-P,`S8K*(("`:E4'M=F4'=LHN'\[*)FQ!31=1.(@'4`W2$-374K[?ITN MDG^V[+G`[IQW$?/\L@,C$^N9S]+H*P02ZX1]XUQG$U-X-10Z=$G?C MO*YS5\R_]\?%V@\0B3]@C@;:\"]4-Z(WJ.,U4*;)#(SI,(EA8=7@NWFK+`R0 M_VSAPN30+*D+O%;*GA<@3.(5O/H-``#__P,`4$L#!!0`!@`(````(0!949:G M9PX``$-'```9````>&PO=V]R:W-H965T+_9G"Y@A,?CU>3^='I:SF;']?UF MMSI.]T^;1VBYVQ]VJQ/\>O@^.SX=-JM;U6GW,,N2I)KM5MO'B1YA>7C+&/N[ MN^UZT^[7/W>;QY,>Y+!Y6)W@_(_WVZ>C'6VW?LMPN]7AQ\^G+^O][@F&^+9] MV)[^5(-.+G;KY?C]<7]8?7L`O_](B]7:CJU^8YS M/:MG,-+UY>T6/)!AOSAL[JXF7]/E6&63V?6E"M!_MYO?Q^#_%\?[_>_^L+W] M^_9Q`]&&/,D,?-OO?TC3\58BZ#QCO87*P#\/%[>;N]7/A]._]K^'S?;[_0G2 M78)'TK'E[9_MYKB&B,(PTZR4(ZWW#W`"\._%;BM+`R*R^D-]_M[>GNZO)ED] MS19E6E9@?_%M3SM=__35JD92X^2F5'@TXZ23XNLG"]2.$<97/\.E[EO,D?^UD*],1 M/GW'>9K4^2OG.C<=X=-TK-[F)%RFZE3ATQ_Q+:=:FX[P:3IF+V=DI@M#U5F[ M.JVN+P_[WQ=P\4+FCT\K.16D2QC-%IB.KRNYYRH.2DT.\E6.VUL;KA-BBT::R'K6`[;4M!1("CH*1@H&`,P@R"X2$!U?T(D MY"@R$M:'&PN"T!"WK87MTE+042`HZ"D8*!@#@-R&2_,3W):C7$W@7U\`68+] MO-$V!5Q>SJC$)HTS<;%@I&-$,-(S,C`RA@1%!*:<3XB('`4N*J@VYVV6D8J_ MT48OAL29N)`PTC$B&.D9&1@90X)"`G-I&)+X\F,G`VFL/+=G?*-)`?-+$(N, MY-X9V6XM(QTC@I&>D8&1,23(42C.MSLJC;&CFA0PGP>.YL119^0<9:1C1##2 M,S(P,H8$.0IS=>BHGO>GM:78V#_-0'_K6L- M(RTC'2."D9Z1@9$Q),A9*8?9(O=.9^48V%E-,ISL@B1;&Y5P:D%%D&FOC1I5 M>*0N:C3'1B)JM'!&*"IP.9X=%3D&CHHFY4*I@")EK06HM26:15DJ5Y0F159XTJ991,TR)!/V108>WGRC[+BJQ> M^!D*QT9*I7.O&[D"DA(QR-5(D9"3;*R%+9(B(==5:RQLE51)GA2Y]T--4)TU M&BK3&V[%6I3ACJ.A$&5*:HD2;/4BQ#LH51"@8>191!VOG8=3+5N M0JX8*16LA,8J6!Q;CCJ.!$<]1P-'(T+8/RF`WNZ?EDO(/Z.@PE1E&9F;&GFK M`JY]Y#)#';<2'/4<#1R-"&&7I10*7/Z0XDFUGD*1""66J5"&6M,QB$3'D>"H MYVC@:$0(NRU%T=EN:V6%W-;H%?63:JM7Y$_*A4:Y7_.:5".80>TRV!HT5[=#U574&93[>5X@*W3V MV6?(.#4(EG$&O;(D&:MP2>*HXT@8--?Y>RD]&=%B+Z](RIIXHG48S$#!XEI0 MX64Z!O-4RU''D>"HYVC@:$0(YY1(KE=RW&\$]&SMK5PU M"B]#@U#ZLYRE7W=$Z6>H\V/9 MB`F.>HX&CD:$<"S>I<$RKL$,"IQI.&HYZC@2'/4<#1R-"&'_I!(*6O= MA%+JI%18WE[1FO)V5C99K7QH@V59QY'@J.=HX&A$"+M,--@K+G.QE3%EU7#4 MHX&C M$2'LLE0@;Z]BK5=0%6M$)B:B8QJI,W')MAQU'`F.>HX&CD:$L,M2O@0N?V@G MD6D-A"*A$9JO&&I-Q\"JXTAPU',T<#0BA-S.B<1ZN;B5-58@!LV]H&L,JD&; M!/7N%:J:PEIOY8K;C@4S6="1;@9L1U@;`BN_2\7^O4MA@9Z5!1GFSZ!Y[F1M M8U#M76XYZFQ'F-R"T_1[%A4%83LJU8S/G`BE#Q4DZ&SFD$9S'#YRJ[4Q'6OO M=LM19]#V"$FK37Q&>LLTC<9T^F"R`AA#?0] MQGQ:^S+`SDMM<>[DF&N!@BXNC1;H&F';%]-QH>]AINI&N'OX8283,Y"O@<[V MTIOQE(#G;7:UJD+L:D5R3I#2YL=*Y_J+N_%-WC4F8:X-L MKE-9(OZ'.6_,(_..%!UG.Z^5"W)>(Y)KJH)R8Z5S#8^)P`7JO#$)D@F.8.">O=N70V$I81!6!07?LI5&6F\E=5%+4<=1X*CGJ.! MHQ$A'(UWJ:>"JR>'@JQ'6!MA782)".LC;(BP$3/L)]%:+U=WP4650?AEF,)? M2R:UNB-8^=0RU/FQK)7@J.=HX&A$"+M,U-@K+G/956A$JIF(]<9;66=:CCJ. M!$<]1P-'(T+8Y<^0<`67<`8%F[>&HY:CCB/!4<_1P-&($'9;:J-@07\ETUI) MA2NWO%<)NZ+:J_S&(J1:RR>\,4J\DN;=*A=5F^K4=V?@;5L$(&&S@V7>N.X4;)=@S688M@$0S&HKK$6JF.V$>I6,[V M4E%JCA+R6:N1M*HC$/)RD&.JXE3!(;Z?PV4N1P68D:`RVO<6 M7PV"E9-!1"+3O8.U,HDN>:*M19!HBVRB:Q)"80ULHN<^'"C1)=%*'TJT&H3X MKE45233='IB.9H^)COKPAJ'D$LL@(K%\_6E5 MZ:U\3)PVLZCC5H*CGJ.!HQ$A'(W/D%@EEU@.^;<+F@AK(ZR+,!%A?80-$39B MAMTG4NMC*4CEVOCS(([TXZAKB69'3IGYJ=&X9@?KG<,#T=N+PW. MS`\W.J:&PW'[#`E7<@EG40+KDIM68'+$4V/CS+!39'UIGS$C4W'WC)G7!V9N M-:>;X(,2#=T_,QHYZ/",&3GH^(R9/RA.B]1]Y^HV^9H84=86)7JE)L73T.8I M\:)U!OH][#S-X:8PSFEG;&#I"C-/59P;R=XVI>^D]\Y"'RN;UW-ZK"%^+#)/ MCVXDK23@#WR?"[N4EF>'7>O34"[#FVLJ$S;LTY)%'ENP"\`VV[@SA=698Y"P MDXE*N#/18<^F.4EQ[RSTH5)X3YYD>(@>JB)6HQM(1SV;IMYI7.R?(=1++M0M M,E'/X6XS+M6&6!2\WLVHB0E&6=4T&IT9!`>>/?-PA[)R-W@;7$U+O;/0QUHL M2GJH(7XH,JF.;B`=^'R:^@L"!1Y>ACR_W-4@6#A;9`(/8:6!)Q:@;_TIJFBT MSL)$/H7+M"#>2CGPY+^#._Z MX\C#TG/V1`.OJ=+YW:)$/036*C7"6L?T]K3*Y^PJ[YP-S#U^":_(?"&##^;G:>7+:,W@KV[D`Z1T&OR1#P[PN_9%\)T#+)(6 MA9'DK'5=O5T782+"^@@;(DQ^)8(^O>#1OOZ.`_VWY[O-X?NFV3P\'"_6^Y_R M^PO@P<+UIXN.ED,+/!R*]"F2I7Q.$FN!;XN`1PNQ%C@WN`$?:.XRUE-"B-D;4GZR"%I4NUC*'%G5#E[9`EV@/Z!"U3^&\X&]2 M(N>5PGG!GV[$6N`@\-<-D98,H@DO#T=:RG(I-SB\I846N5?A+;!;@;J)M0KEBVOA;+K_&RA&A%@R7/-'(`>)EJ*5_&X<[!"U1+ M^4X.;Q'0(M_#X2UPWW[9P%UFW@+WZI=MM`5NQB]%M.6F`._A<0L?[::0;BH_ M9ZZ^X"M,GE;?-_]8';YO'X\7#YL[F"(2]?[/07\)BO[EM'^"A1R^QV1_@N\N M4?^]AR^KVS=?G^RO\"A9^[K;Z[_#P``__\#`%!+`P04``8`"``` M`"$`VIMGR_,"``#5"```&````'AL+W=OY;:7!"T;;1JEK=1*5=7+LQ<,6`&,;&\V^?O.8);`+MG0 M%P3#\3ES9@:;]>US69`GKK20542]F4L)KV*9B"J+Z.]?#U?7E&C#JH05LN(1 M?>&:WFX^?E@?I'K4.>>&`$.E(YH;4X>.H^.)-*53(#CRIS=*TX M2YI%9>'XKKMT2B8J:AE"-85#IJF(^;V,]R6OC"51O&`&\M>YJ/61K8RGT)5, M/>[KJUB6-5#L1"',2T-*21F'7[-**K8KP/>S-V?QD;MY.*,O1:RDEJF9`9UC M$SWW?./<.,"T62<"' B>)I1+=>>.<%U-FLFP+]$?R@>_=$Y_+P68GDFZ@X M5!OZA!W82?F(T*\)AF"Q<[;ZH>G`#T42GK)]87[*PQ@=KP0B,=S@200NT5P1%>4@(R& M`CYM?,]=.T]@.FXQ=Q8#UP[C=0@'1#ME4)NNC&!4QJI@*GS=@8#CY+1-Q]"P@-SP@?-A[ MNVAW>&U]W!Y/X_-P:P\UIWL#ATK-,OZ=J4Q4FA0\!4ZWF6]ECR7[8&0-M8>C M11HX3IK;''X?..R_+GI/I33'!U!VNA^2S3\```#__P,`4$L#!!0`!@`(```` M(0"^Z35KLP0``#@0```8````>&PO=V]R:W-H965T&ULK%=; MC^(V%'ZOU/\0Y7W)/4`$K+@D[4JM5%7;]CD$`]$D,8K#,//O>QQ?\(4=L>V^ M3"8?QU_.Y\\^QUY\?FL;YQ7UI,;=T@TFONN@KL*'NCLMW;^^%I]FKD.&LCN4 M#>[0TGU'Q/V\^OFGQ0WW+^2,T.``0T>6[GD8+IGGD>J,VI),\`5U\,L1]VTY MP&M_\LBE1^5A'-0V7NC[J=>6=>P&*?=W4P_M(ZCIME7TY=;@O]PWH?@OBLA+`:;4XU*"`3KO3H^/270=9$<2NMUJ,$_1WC6Y$ M^=\A9WS[I:\/O]4=@MD&GZ@#>XQ?:.B7`X5@L&>-+D8'_NB=`SJ6UV;X$]]^ M1?7I/(#="2BBPK+#^PZ1"F84:"9A0IDJW$`"\-=I:[HT8$;*M_%YJP_#>>E& MZ229^E$`XD:&H*:7K5%/E%/`4^;QY(QX;'9'LW;E4*X6/;XY ML`-@_LBEI/LIR(!7N,3F5/KV+=O`+TJRIBQ+=^HZX`B!M?:Z"OU@X;W"^JAX MS,:.,2*V(H(N!DJ[,X'U52!J8'4T5/=HHM?;CA4*#=54,B>9J>LG,4,6"XK$WLR+*$=88:5G-.1(R M"5$R'..1%S(0GBU"A@A3I$ M4Q!`"54EL(XWH9U\.-?5RP:#^5!B'K@3P83Q?D=)=&DC+U1>^/!]]:3&VMCR M*-4?#B6A7(BY@.@'H95&:6S*$SRCJ[H^VA*?7F6TF)I"&*29%/I&`EL^4'5) M0(I-'(J93U$4)8GA=J&-TI70QJ@H^6].L>X*7Q&U:A,P2',J],WRP*,TI]A` MS2D.07.0KH?^5%_1A>""F56B[IM.ETV[Z/^6S5JQ)IMW9[4JAOY<3W4;L"C- M5P8E=(>(XUU@U44^,$E950F2>6A-`^<>%XBNF3;7#S1_Q9=O;4HXQ\M=R5JT M)IIW;:55P:6'+GFE>^UL*+ENZ#V3IL]L/.U"WJ#^A+6H:XE3X2F\V<\A, MHO+6M1XWNH%OZ&V,+E$3#S,X'S[`HPQ.6S:^CK,UY&G_L(DS.,$\P),,C@D/ M\#2#]OP`#X"(?<&3N<*][5*>T.]E?ZH[XC3H".K]L:;V[.;'7@9NXQX/<&,; M'3W##1U!4_(GL+R.&`_B!3[MR3O_ZE\```#__P,`4$L#!!0`!@`(````(0!W M8`P9@Q$``+)E```8````>&PO=V]R:W-H965T&ULK)U;;QLY M$H7?%]C_8/A];.O6DHTD@UC-*W:!Q6(OSXJMQ$)LRY"4RI=OO=K[\_/9[]MM[M-]OG]^>CBZOSL_7SW?9^\_SE_?F_ M_Z5_69R?[0^KY_O5X_9Y_?[\C_7^_-;R\O]W'/[I&S\^>[F[-<) M])_-^ON^^O^S_5Z3VG2=PA7XM-U^#:'N/B"J?`FU=7<%_K$[ MNU]_7GU[//QS^]VN-U\>#G2Y9S2B,+";^S_:]?Z.%*5F+L:ST-+=]I$Z0/\] M>]J$U"!%5K^_/Q_3!V_N#P_OSR?-Q6Q^-1E1^-FG]?Z@-Z')\[.[;_O#]NF_ M,6B4FHJ-3%(C]#,U,EY<3,>S^:)KY96:TU23?K[]XZFCW1CH9VID-/JQCV]2 M3?J9:TXNYJ.KZ\F<&GNEW_-4D7[FBJ3@*Q5HOG5]I)^IPOABO)B-9DW0^96* MUZDB_SE94R*+L?:U6'UX=UN^_V,)BY=]OW+*BP# MHYO02LZNV-\^W_Y?NE&>A58^AF;>GY-6E$E[FB._?1A-)N\N?Z.\ODLQMP,Q M/&*9(T(2AV9;"90$6@(C@97`2>`K<$FR]-J0DC]#F]!,T":/ZC:#(M98")$C MUAK)[0;4843E]O0$M$#318\GJS?7V@ M(9H/-)(I&87J(B_$1>Z#LAHM$`5$`S%`+!`'Q->$C9TZS<;^]N0/+7%=(A') M?RUTZ8-Z78`H(!J(`6*!.""^)DR78+J8,*\G11?.1Y]0G?^(6D0*D49D$%E$ M#I%GB(\Y.*YZ(H1DF#7A_N74E3!LE"(;$N+I,+T2Z5"B^GQ`I!!I1`:11>00 M>8:X1,&+U1(=28MHW:B]/)K;441"AI&4H8_*%=M2,2.%2",RB"PBA\@SQ&4( M=NL$&:([8S(DPT8+4UDTI])PC_JH/.86D4*D$1E$%I%#Y!GB,@0_=8(,T7XQ M&9(CJS;)$:`6D4*D$1E$%I%#Y!GB8PX^JAYS6"3&XXLWK!&A);%F1B0FA[AC M789C%JI8K:PM(H5((S*(+"*'R#/$%0J.JE;HR!H1#1C+BMJ3=;?\]M]Q"CZ-*9';]WJQ4+(%"*-R""RB!PBSQ"387R:F>S"^<*8D%@8 MY0UVB>IE0*00:40&D47D$'F&N`S27[X^`\;H(1.JIO@248M((=*(#"*+R"'R M#/$QGV88QV@8$^*WEU-YAE"BRJ5/'K+[$J3;111&:40&D47D$'F&N`S2,+Y] M?QBCF4Q(S`YY!UZBBD3@+Q5&:40&D47D$'F&N$2GF7J*(06$Z%41J10601.42>(:Z0])='M@[TD&.P M@DM$+2*%2",RB"PBA\@SQ,<00>8;8 MF"?23+X]+;JFN-%,2*P6\ERF1.4<:!$I1!J10601.42>(2[1:49S@D8SH7HK M1=0B4H@T(H/((G*(/$-\S*<9S0D:S83$I9>'+R6J7/ID-,L<4ABE$1E$%I%# MY!GB,DBC^?J*,$$SF1"[]&`36XQ2B#0B@\@B:8 M)NB8,F)*-?)^(D=_,=OI:9Q MXZ]OI1+B)J*1NV>)*I<^MD45,U(8I1$91!:10^09XC*$;?L$&>(NSV2(2,P` MN9-,^Z@\YA:10J01&406D4/D&>(R!`M0RQ!N,D>S[J&XP\/F[NOM-H#!YX\G M]*!QM]I]#$]"BO.ZA-C$B%$5:C%*(=*(#"*+R"'R#'$II+=XFQ1H.<+3DD$= MVN3+OMT4,Y%VC!15)D>;*H8O6JJ*Q1;P[DL7TAT73,/W]2=<2/0F(;^I]^&; MCZH3Q76DWJ>H<3^UVUR1%LU2<5[\`^^]M"NA]].3\Q!=3%BE0O>9BYD7?Y*Z MGZ+B+W!TS[[GBLQIS(O38-VGK1^GT?,T.F1SUGT4]>SXHNG!NYA*H!+A&UB!0BC<@@LH@<(L\0'_-IIK!!4Y@0 M/RA8E#N`N""4J'Z)0Z00:40&D47D$'F&N`S2)[YYF`AK&)AE&^E%N(Q;R6*5$Y8O:(E*( M-"*#R")RB#Q#3(:Y-(QO=@U=2]Q+)B0FA[S1*E&]0H@4(HW((+*('"+/$%?H M-'LY1WN94#TY$+6(%"*-R""RB!PBSQ`?L_22KT^..1K&A(1K*/>R<5TL4>72 M)\-8OEY0&*41&406D4/D&>(R2,,8)L?;MHXYFLF$Q.P0AP++$E4D`A>J,$HC M,H@L(H?(,\0E.LU?SM%?)L1F1W*.Y1RRQ2B%2",RB"PBA\@SQ,S30=C:?"X+H2D=OQN9WNT[A0I]G-.=K-A,*#5M4>*P]E2E3N5)M1T4UE M5+)*9U2B3$9-+Y3-J$2YC$I;/J,NBLL0K%Y];'5D-8W.L#Z;FD<4GF$J,ES+ M`XH410\5%1F2RZ1-J:HH[MM5KCCN,JH)+R,3-D;GD'+D:S(J'VO7C7(Z* M'S=;--<+X0E\#ND^CHMYFE>=HU=-B.?4M;RA+5%%S-@6/7.7D_K'%3JF8SJ;(+678Y*K<^NQ_/%%21/78\EST*ZW=>E MZL*YI4TH/+9432AYOY>B*,5RIK09E;10N:UI-^TFH_G52&BNL9;)J+1M,RIM M.][V=#*?3Z5,K!:725K>'TZN!;K?A$1RB?5EF:+JY,JH)(G**"?7I&GF8[$, MZAQ4ZIF,JN3*J$2YC$KKL]E,K`L^!W7UN&JGF>8%FN:$:BN$J$6D$&E$!I%% MY!!YAOB8I4,^,J'0!2^2F:4Y6TTHD:O+$E4F5%\Q(X51&I%!9!$Y1)XA+H-T MP6^_45B@0TZ(WRA00>8;XF(--J\<O=EO5P_/N[/[K;?PNN[Z5SBP[L>QW>+WRX:>KEXYPBA9$XEG3&$D@65 M=`.%DNO\JG)9,I_`H(2:HTVU8'6%M0:[25# M)3,JZ8X:9&L-C92^XQBHT]!(Z9N`H1(:*1V.#Y3,KV@\G5^4GS.G%[G3T>E0 M'1HIG28.E#14A[ZZ'RJA.O25]5`)J4-?[`Z5D#KT7>=0":E#7_\-E5"&T)=D M`R4SZAL]?CI40GVC)S*'2JAO](#B4`EI34_P#)60UO3DRD!)0UK3\QT#)5/J M&_UVT%`)]8U^86:HA/I&]V=#):0;_:;%4`GI%H_+Y-6>DF[T+/Y`G0GU+3X" M)^M,J&_Q23@HH;[1>,T)K=$WC0Z%00M>4W@PPT-J$KBD].S=0,J(Z]&JJ@9(QU:%? M(A@J(:WI640JT]LWL4X[G]V$\V8LH\#_6V4-?VU@JOPJRZ? MM]M#_@=U]++_:RL?_B<`````__\#`%!+`P04``8`"````"$`VC=WZ6("``"* M!0``&````'AL+W=OBOG^NS3Y18QX>:]WJ`BCZ"I5?+CQ\6>VWN;0?@ M"#(,MJ*=X-"VSHP%>AT.J9WF:GC/%Y4`C0VE. MX=!-(P7<:+%5,+A(8J#G#OW;3H[VP*;$*72*F_OM>":T&I%B(WOI'@,I)4J4 MM^V@#=_TF/LAFW%QX`Z+-_1*"J.M;ER"="P:?9OYDETR9%HN:HD)?-F)@::B MJZR\GE.V7(3Z_):PMT?OQ'9Z_\7(^IL<`(N-;?(-V&A][Z&WM=_"P^S-Z75H MP'=#:FCXMG<_]/XKR+9SV.TY!O*YROKQ!JS`@B)-D@<;0O=H`)]$23\96!#^ M4-$6GI(2L;5.JS\1E`53D2M8N^&.+Q=&[PFV M&]%VY'YXLA*)W_>")CQVY<$5O:`$92S6;[?,\LL%VV%H\82YCAA\/F,F!$/1 M21G53E?V8*^,]0U6KN/&L4S^ODSQ4L87??;/HA^"^D-8WN,013KQ1P<1,SO" MS"?$BZ`(.3VH!V,OCH-E13811^D(.D$:@QY+^_!Y6OCQ^D^G_<%@8RKXTPY. M_7-CB]$S]+TE0F_]7._JZ_U9N0IW@$T?\"J, MO(4[;EHY6-)#@Y1I'T&,9ZHQU>@O#:X3\/<(#3!,&-UNZP\-=U M^HLN_P(``/__`P!02P,$%``&``@````A`$85"4\M!@``.!D``!@```!X;"]W M;W)K=QP_?JY/SK6C: MLCYO7;YFKE.<\WI7G@];]^^_/J\BUVF[[+S+3O6YV+H_BM;]\/3S3X^O=?.U M/19%YT"$<[MUCUUW>=ALVOQ85%F[KB_%&:[LZZ;*.GC9'#;MI2FR77]3==H( MQH)-E95G%R,\-$MBU/M]F1>?ZORE*LX=!FF*4]8!?WLL+^TU6I4O"5=ES=>7 MRRJOJPN$>"Y/9?>C#^HZ5?[PY7"NF^SY!.O^SKTLO\;N7TS"5V7>U&V][]80 M;H.@TS7'FW@#D9X>=R6L0*7=:8K]UOW('U+INYNGQSY!_Y3%:VO\[K3'^O67 MIMS]5IX+R#;4257@N:Z_*NF7G7H+;MY,[O[<5^"/QMD5^^SEU/U9O_Y:E(=C M!^7V845J80^['Y^*-H>,0IBUZ#'R^@0`\-.I2M4:D)'L>___:[GKCEM7!FL_ M9)*#W'DNVNYSJ4*Z3O[2=G7U+XJX@AJ""!U$`KV^+I8&V2!0O[Y/69<]/3;U MJP--`Q_97C+5@OP!`E\7AAC#4M]:*="I(!]5E*T;N@XLHH7R?'OBC#UNOD%* M:]N7FN=50WV=F30WS,'FH`8UB%C3BG((S! ME%'"F)CO-763G47/8D1-@)N"Q\Q:0TJNLR`>MPWA@[UEY_!]/G63S6=E*$&- MYHMY)&*Z@)0((L&B,0(A5%YG3)+YS"FQ339V#U87-9HL"L>/[2^G;UXF5/$] M5$IL4X4T'0EJ-)4O@[%>B&5>EQ&+QW02+@[-M3Q=O9J221M,:Y`L9-R884A& M!%X@Y5MH:@XOKB3'J4W'W#@^L91:-+=39R4T=6I>&WQJGKR_%SA.>3KRQ@QH M3A1A#E<>BWTKRZD.HQ4R9IX<=SS%5)/;P)S?$!SGO(DGK5&1:`U^MI!!.-D3 M6N'UTV;L3,JEQO9R+ASR)A?G8V2=-A0A&,RXV*I_RDW!*F"Q'$-0.#6PE\/A M>#?A/'N*J,F["9`A[X!CQ%LRSBG7I.O<&S>BGAYNP7@8S'3M([ MUA3$43PV!"6SS.$=LANNP.WG$FY._95D\(_.P90J/-]44+J[C('?<`9N/YEH MD=WF.FFF,:Q"*86QD2C97>;`;[@#'RNB=X(Y_E=>'-BNI:/8Z(1+W.4-O9IZ M@V\5*]$:W`1AS+C=:53@>\8VHFB6-RR;O0(]PMRGW$9(M$@/$>ES%E@;)B62 ME0@X/'4.;4DYX;.6SQ&AU-;#)K19O9E2`0_D.`DIFQK6Q@Q>6&,<\;3&5@$307Q`AE*P22<2B0C@@7-< M".6TO&(AY]0S.!\SH7-I>L)*1I+9PSM57]P'7X%>E*$8ARCEO,LX!,Y\J/C0 M9IS;SRE:!*D:1%:[IK,2RG>7?8@;]B$F\X;81^")V+?:-=5Q=+N&,=C?&(7R M60:RL,XWC,2HD*ZSZ14^D]XDBRB8']>6C2SDNV$GPC8Z0>S$CV'DC4W6+R&E MDKD\JF?D^_=U?Q>U%R[&'8EYU"(LI@Q]>'(>YC)B$L6*2\&#>)P.I-[R?WE, M?Y?-:0V71(NTQ\!WI%@8CWN:%,U*:P1\DV+&4EN@V9E,)JO$2+ MKJ2^[X5LS)@5-)-6EA(MLK>P3B%&L"]2)LMGWF&ZX2_"]A]9_@,``/__`P!02P,$%``&``@````A`%])VI"[ M`@``U0@``!D```!X;"]W;W)K&ULE%9=;YLP%'V? MM/^`_%[`"0E-%%(UJKI5VJ1IVL>S8TRP@C&RG:;]][NV"2UAR\@+X.3XG'O. M-3:KNQ=1!<],:2[K#.$P1@&KJR837\4T@EB(&AVD6Z48SD;I*HHDD< MSR-!>(T\PU*-X9!%P2E[D/0@6&T\B6(5,5"_+GFC3VR"CJ$31.T/S0V5H@&* M+:^X>76D*!!T^;2KI2+;"GR_X(30$[<;#.@%ITIJ69@0Z")?Z-#S(EI$P+1> MY1P/E!D]0M%ZY@'YQ=M3OG@-=RN,GQ?,OO&:0-O3)=F`KY=Y" MGW+[$TR.!K,?70>^J2!G!3E4YKL\?F9\5QIH]PP<66/+_/6!:0J)`DTXF5DF M*BLH`*Z!X'9I0"+DQ=V//#=EAJ;S<);&4PSP8,NT>>26$@7TH(T4OST(MU2> M9-*2P+TEP9.Q))$OR/E[((:L5TH>`U@T(*D;8I<@7@*Q-9;\TQ@XLG/N[20W M%=`:NO&\GN)T%3U#@K3%;(:828>(0+RK`%3?5_#W2$_*%IPAN+XIO]&ZXC8> MDURA;<5TZ2SI!7]I#Y".7D&F4+[BOC^>),VF/@VN4R MZQ`]S]#;\6E;<%]Y>IZVAXSQ/+]&V8+[RH.T/62,VQ;<5QZD[2&)6V%Q5U2OP8MK)"VX+SF(V4,N2F+83\?;=.B^ M*$ZGG1F?<`L:$3$^V\$N9^S0??%!R"WFLN6K=BTXFOZ;,PA==0^6/)#XQLW`:]E0:.$_=8PN<#@]T[#@%<2&E. M`WOP=1\DZS\```#__P,`4$L#!!0`!@`(````(0"T-N!3VP(```@(```9```` M>&PO=V]R:W-H965T?U<5^1):"-5 MD]+0"R@1#5>9;(J4_OIY=_6)$F-9D[%*-2*E+\+0Z]7'#\N=TH^F%,(28&A, M2DMKV\3W#2]%S8RG6M'`FUSIFEEXU(5O6BU8UAVJ*S\*@KE?,]E0QY#H2SA4 MGDLN;A7?UJ*QCD2+BEGP;TK9F@-;S2^AJYE^W+977-4M4&QD)>U+1TI)S9/[ MHE&:;2K(^SF<,G[@[AY.Z&O)M3(JMQ[0^<[H:@WH$W+<'K"!(@/GAQ#[_(]D^`.2=;(DM*8$M`W4-FG512'2_\)JL'WF!N' M@=\>\XKPP4UO"6P,+;U=GH,R@E$9RX56;EQ@*!/U1D8RD_^103#4>V`^BE]Y MG;+#3`>8V=O*`+D\001#V$D[T`72,"A#Z:[=T=1[=PH/9<9SG8N^ MSOL(W(*^GU$\[7V-2CT?JY[O*(+'4ON(NUW#28&!.\YF$7CQ/[/!;%WLS`UWE^/#3FWT?&J&PO=V]R:W-H965T<^^75Q8,:R#T8*_58TR++*8%1Z$:.74U__K@^65!B'1\;/N@1 M:OH(EEZL/WY8[;6YLSV`(\@PVIKVSDT58U;TH+C-]`0C_FFU4=SATG3,3@9X M$PZI@95Y?LX4ER.-#)4YAD.WK11PI<5.P>@BB8&!._1O>SG99S8ECJ%3W-SM MIA.AU8046SE(]QA(*5&BNNE&;?AVP+@?BC,NGKG#XA6]DL)HJUN7(1V+1E_' MO&1+ADSK52,Q`I]V8J"MZ::H+F>4K5.W\#![=?HZ%.";(0VT?#>X[WK_!637.ZSV#`/R<57-XQ58@0E% MFJP,-H0>T``^B9*^,S`A_"&\][)Q?4U/S[-R,2MFYX@G6[#N6GI.2L3..JU^ M1U3A7266\HD%WW]99O/\M'B?A$5'(<`K[OAZ9?2>8-.@I)VX;\&B0N*W(T(3 M'KOQX)K.*4&O%JMPORX7\Q6[Q]2))\QEQ.`S88J$8"B:E%'M>&4/]LH^'][* M9=PXE"G?ECG]'QD/QN(`A9?EI!P.3>PJ!::#3S`,E@B] M\R-18I^DW32MF]*7\M_]LVH3QH>E'SA%$^_@EIM.CI8,T")EGLW1F(ES&!=. M3Z&7M]KA^(3/'J]+P%;),P2W6KOG!0JS=`&O_P```/__`P!02P,$%``&``@` M```A`/VVYA?%`P``*PP``!D```!X;"]W;W)K&UL MK%9=CZ,V%'VOU/^`>%\^S&=0DE6^2%=JI:K:;9\9<((U@!%V)C/_OM<82&Q2 M=4:S+W$X/C[<*)5(2_]:*F4>?)MW-#N^RI`M^OKI_EHW;_,).O M2=Y11D_<`CE;!CKWO+`7-BBMEP4!!R+M1H=/*W/C)L?(M-?+/C]_$WQE=_\- M5M+KL2/%[Z3!D&S8)K$!3Y0^"^JW0D"PV)ZM3OL-^+,S"GS*+A7_BUY_P^1< M M"W3C"3.>$B%I&OF%<5K_(TGN("5%T"`"XR`26SX*HO@C(MX@`N,@XL);WQF! M/RR&<5@<6)'K++SH_2Z`V:<"QD'#M^(@\,/X`R+A(`+CZ,+Y<"31(`+C(!): MKN^$_[\EMMS>OEKV&<_6RXY>#3B!D$K69N(\NPG(CF4B-W4JG/^J&R@8(;(1 M*BL3UD-),*CUE[7G+);V"Q1H/G"V(XA;.\-RM)/FU9:/26 MQT"W(Q)/=;R34'!_@E&LE?+^(=I(1HI[@HE`KI;TR'WBWZ/OE!V4Z]K6$I\JT MENBC,HE"_W:;*IF!+?UT9H2&FID!01KX>TD(XQD9AQ/F]\K\\%"2^Q! MF0X#[3Y*Y70$;=%T0E&L91?:*Q'V$`)"B]OFR`S)YDE^#FO_*!TQ9V#OHERJ%+Z_^6T)1C^+PZ M%I!/E/+Q0;Q@:O/7_P(``/__`P!02P,$%``&``@````A`,FT6TT.#0``CCX` M`!D```!X;"]W;W)K&ULK%O9;N,Z$GT?8/[!\'O; MVFT922YB[<`=8#"8Y=GM.(G1<1S8[D[?OY\BBXNJ2EF=?KB^.3PLJ1:2AY1T M\YR_)]_U]_FX]'QM'J\63WL'S>7 MX[\VQ_$?5W__V\7S_O#C>+_9G$9@X?%X.;X_G9X6T^EQ?;_9K8Z3_=/F$5IN M]X?=Z@1_'NZFQZ?#9G6C.^T>IE$09-/=:OLX1@N+PWML[&]OM^M-N5__W&T> M3VCDL'E8G>#^C_?;IZ.UMEN_Q]QN=?CQ\^G;>K][`A/?MP_;TU_:Z'BT6R^Z MN\?]8?7]`?S^'2:KM;6M_Q#F=]OU87_C[W_'QWO]\_-87OSY_9Q`]&&/*D,?-_O M?RAJ=Z,@Z#P5O6N=@7\>1C>;V]7/A]._]L_M9GMW?X)TI^"1Y.:XA MHF!F$J7*TGK_`#<`_QWMMJHT("*KW_KW>7MSNK\,G+7A+"4GI(S" M,M0P469+#E0V[O>(E(`M.?BT44L?FA<"3;K11()9!:((U` M6H%T?80X"L79=Q2GPXE:+T[WV_6/Y1X<@)0.!""&:0\G0V6#^H\(^&]=*P12 M"J022"V01B"M0+H^0IR%^?IL9Y4-ZBPB$4TV*_P"22G\]"J"S0;E("FC0Z@: M),THJ1XDS1V)1`5N_.RH*!LT*HBD<[TX)F$4\<7/$')'8(Z62,@"30C3/)K- M`\:I#"?4G&`2L(C6ICW2[;,\BW,_29,@@!0X.PC*!@T"(ID:*K^N(`@9RU-A M"(DES%B42D-(-2',@BB,@]SE48^_RG`RS0DF81*0?\QD;>@S38^B),KG?FHB M00EA>W!V5+01&A8#N>)(`G:/A678ZDCX2E(:ABV/+(#%)O9^8&0LR=4'(]26 M@`62S(,\]!0:"R6CA'#\X$RI5D=6(@9R-9+D?IAJ)PK+L$62\FB5EN&J)`[F M.9N!*DNR9<+U:FT)6!@J%I$?;C062EN='0L4:'!5NT@L0X0R&+5NE@QG_B9, M/)`51:YC:3KVH$I"M35OBBH(PBCTVI1ZJ,12S\.!]0]V=W8!#%%:$5>,VNHM M@8;56Q5+"542JB742*B54$<@ZI]2/N_W#W42\<](IWZJHHC-3$7H6#;'I80J M"=42:B342J@C$'59::">RY^2.NJH@P_@OK8R%2J@TG3L);^24"VA1D*MA#H" M4;>5&CK;;914I``0>D/VA,AZ0_<,L]BXKX99;$6MAUE^3J7!43KI[."@V"+! M,?K+JI]TSIPI0L.P"UR:^W5'%U%I&'Z!F\4#DSJ:R=P"QV;]VEK!!2Z#Q3[U MMT)CH;32V;%`P45B@5#LY_DB1`AF4#\M(#33IX\Z`)5AQ7Z>KPV$+'KW2M6< M??RT]$=-BKZ](FDU%EX%@!NIY MDG#AY5DN-1*J)%1+J)%0*Z&.0"2GT:#DLB?#[SZKTV9T++SC,=\I+`WKU:,) MS_'!044'W2Q4258MH49"K80Z`M'@,`WV1CU(L07%JI:R!&805]D15]"%9UG_ M2@E5$JHEU$BHE5!'(.KRAT19)$69@<@0B/F>LO`L[[)02ZPW:$6/=87A!3_Y@H>\,_J;XBA&;Z M21^*3@/EWN520I7M"/U[M^GED;95VXYZ@:9WK@3'N>MLA*JEO\X::$;#QXYS M"L/*O=NEA"IKRS^4J"U+3]/4(24\SG8(U0MQ"*%9;P.HM+(JRMRM%:6$*@/- MO1*J"8O>O5(99]\]2A5R]PC-R6!)_-F9*3G#0G&9QO`LGE'*R%!\QBH+X7E& M.)G[/;BI/M,'CS/B2>[+@#@?,TGTJ*K!]^E9-JV5 M@?2#?OL*4Q2SJJE]Q[YY/UL3_Y*OD&/:"-4G!LHAX3T?O2;$,6U9?IDI)519 M",+6L\578LO2MJB/2J#THI:`4F$&[RHZ849]5YKC M[,RA<"&9,_*&;A:X>DX,"P7DMUCJ1\OHZ4<+H7Z$C9+S#%62:1_8*B1,%WVN M3*5+50-8/8`U M`U@[@'44HR%2JN?L>0"E$YD'+$3'!LMDH8[;5=C@703K?>DPTC5EA5,YFA\U MM<.\N<9AU!S;:[>.YLUU#M/F:-R^0K0ID:J]=\XO+12`>G!U!..&EEOA:-0I M-O64+]#8**U>H+'RK5^@,7G5O$!C%VU?H+&+=B_0_$5I6I0`/+N<446251YXQ^`!PS3;N8O&M M#(6%G4U4M3.$88\F,4MQXQAXJ1#>3F09;@E5 MM7$,O-9\GO)+M<.78I-JYPQAX.-)Z`<$#?Q7;!Q2N7&PD`^K"+SI9!@@??PM MZFB4SH:)?`QER"JL,AP6>39V:F<)(Y].$C8H&L*`:QT&`K:+)Z)45XY#MFA9VR^J!W-GH?S MTF\<`R\6Y^&4+:"3%TJ.#K1`PR`> MQ@OUYN9`CS"!%GU:RZZ_#%-HT4]->$L4+-0K-M+:=10NKF$S(EO@71CHH]_7 M$M8B:-'B4+3`7<->8,@:W#4\ZA]H268+)8AE"TCBA=*VL@74+<1SJ`6^?+T> MO#-P9M@7N*V!*RS!D2$_KA.P/Q3()?@WZ![D9"B\\";"0CW)ELZ5T*(>:,N6 M&EK40VS9`D>`$,2A^X)COX4Z`Y-]X%P/PCO4LHS!&7@0(?LL8W`'CNZ'6J"2 MX8![J`62!>?`T#)U]0)?`S^M[C;_6!WNMH_'T&PO=V]R:W-H965TT(/7:="W'-'"=DT-1G];F MMW^2#PO3H&U6'[*2U'AMOF%J?MS\^L:X-8"AIFOSW+:7T+9I?L95 M1BURP37,'$E392T\-B>;7AJ<';I%56DCQPGL*BMJDS.$S>]PD..QR'%$\FN% MZY:3-+C,6O"?GHL+%6Q5_CMT5=8\7R\?A^=;TL%]S=@T9?%7E#*#FV%M#9W%%=\])>VL"T61T*4,#";C3XN#:W;IBZ MCFEO5EV`OA?X1D?_#7HFM[0I#I^+&D.T(4\L`T^$/#/33P<&P6);6YUT&?C: M&`=\S*YE^S>Y_86+T[F%=/N@B`D+#V\1ICE$%&@LY#.FG)3@`/P:5<%*`R*2 MO7;CK3BTY[4Y0\7 MS/H%,(JWNA9:^*X?@)>/7@6\G;\P]BO=P'(]YU?K@+5;!Z-8-[OK?*`MZ!?" M*%QU+`_Y\X7["U?G_4H8Q2OG#U?:/#==JJ.LS3:KAMP,V#\0?7K)V&YT0V`3 M.>9>#UG_6=(AVXQDRUC6)JR'?%*HU)<-FB]6]@M45][;['0;5[;8"PM62HPV M4H%8!1(52$>`#1('G5`_[Z"3L3"=PL.=`$;"%5'"0BR)5"!6@40%TA$@B8(: M?P=1C`7VII2\I:QBQVT\J-0AP[YLLA],!J4:$FM(HB'I&)'4PKY\![6,!8H= MZF10@A:.K&7'C1[*'4P&N1H2:TBB(>D8D>1".QG+G>ZZ8@,RXTZ5\&;'$0\. MXY%.=<<-1F)9I"&QAB0:DHX12004S%@$;R\6Z__MN7]V][XKM5B:7GA*P!-I6@ET*DVBP+OO-2DRRW>( M#..0(],CR.DC@SS%O3VW".8\,LY,F8^D>7^I!#:6I@-?.1\2/CV'.^:H7I7H MIA('0LM[\QV5)C9QV`#C?X;>>C@N_8S9[YKN(HA+O`!#X+ MX=C4\:T7;L%1?6+GA7#P3.!^"+U\`@]"Z(H3N.N(;Q![\!6^`2[9"7_)FE-1 M4Z/$1U`/-W]H^@W_BN`/+;E`WN!+@+1P^^_^GN%K#T,[=RPP/A+2B@=XM3U\ M/V[^!0``__\#`%!+`P04``8`"````"$`RQJW**5_8J(_7G]^V_+&^Z?R`4A:@%# M2U;VA=(N=5U27E!3$`=WJ(5?3KAO"@JO_=DE78^*(Q_4U&[@>8G;%%5K"X:T M?X0#GTY5B?:XO#:HI8*D1W5!8?[D4G5D8&O*1^B:HG^Z=I]*W'1`<:CJBKYR M4MMJRO3+N<5]<:A!]XL?%>7`S5\F]$U5]IC@$W6`SA43G6I>N`L7F-;+8P4* MV+);/3JM[(V?YGY@N^LE7Z#O%;H1Y7^+7/#MC[XZ?JU:!*L-/C$'#A@_L=`O M1P;!8'GQ=8]("2L*-$X0,Z82 MUS`!^&LU%4L-6)'BA3]OU9%>5G:8./',"WT(MPZ(T+QBE+957@G%S0\1Y$LJ M01)($G@.))$3S&,_3C[`$DD6>$H6WYG'<93,9X]/!2*Y'GA*DIGC1]Y'YI%( M"GB.\WAP15RQNMRL?4&+];+'-PLJ`-:/=`6K)S\%WL$EL::C;S^S#?QB)!O& MLK)GM@6.$,BUYW7H^4OW&?*CE#';:8P1L1LB6#(PVKT)9":0*X`+BD998/@O MD,58F*QA0ML!>-,9Z"IW0\0P9&\"F0GD"J!I"*<:0BC#^P4T.,$&0:DH3@2> M,<>MB(G`[M&NV)`QAHPZ)D@V07(5T:1`Y?P".Q@+Y"EX/LX[G(@30>^*&T-& M<1,DFR"YBFCBH*)5<>_[PX*YAN';6X%$L':C*FA/AA\B*$S&5-Q+1*TY?V%4 M5":Y(UZ2?A!YD9$+^4@#\]%4078\KHH%ZZH$$BXT57-#E0B*^$8B*EXBHHNS M'I!))!`2PBA<&"RY.D:3`&OSN`06K$L0B&Y,XAD21)!JC$3>ND8FB80+L1\E M1K7EZA!-`3L,3;JSPW8=>JG*IRV&E(%RN)-R(:R7Z,V,0Q6YGILMF6^W]SDO5PPU()&9XN]*GN9)1J MJH1B5A3#Z6/:"8>H1/01/UX$DV40DPIY>NB:V1;]CN9ON/M9'2II#*?MB6@! M1?.QK^]DE`+MIU`VA=AAGM&+@6+ZXG`NSGL-ZL]HA^J:6"6^LH/W#)9B1,=+ MP8;7MX%OV66!S='$@Q2.+W?P,(7#P!3?1.D&YCG]81NEL,'>P7WX@ACACM^& M:T)7G-%?17^N6F+5Z`1J/%YYO;AHB!&PO=V]R:W-H965T__7WYZ>+W[:O^\?=RX?+YMWUY<7VY7[W\/CR^ M[IYV+]L/EW]L]Y=__?B___/^^^[UU_V7[?9P02V\[#]7>WOOVR? M[_;O=E^W+U3R:??Z?'>@?[Y^OMI_?=W>/0R5GI^N)M?7[=7SW>/+96CA]O5' MVMA]^O1XO^UV]]^>MR^'T,CK]NGN0/W??WG\ND^M/=__2'//=Z^_?OOZE_O= M\U=JXI?'I\?#'T.CEQ?/][?V\\ON]>Z7)QKW[\WL[CZU/?P#FG]^O'_=[7>? M#N^HN:O041SSS=7-%;7T\?W#(XW`RW[QNOWTX7+5W+J;Z\NKC^\'@?[UN/V^ M+_[_8O]E]UV_/C[\[?%E2VK3>?)GX)?=[EMI_N MOCT=_G_WW6P?/W\YT.F>TXC\P&X?_NBV^WM2E)IY-YG[ENYW3]0!^N_%\Z-/ M#5+D[O^E95OYL,E:469M* M`B6!EL!(8"5P!6!"T*S_&4+X9FCU*9*DFB@&@@!H@%XDK" MQDY)S<;NU]HI78VHPHG+K6^)ZQ+(C"X^A2X+GC:;,6C4!4@/1`'10`P0"\25 MA.E"EPW0Q3N<$T7QS<#,67()UB'HZ,P90T:5@/1`%!`-Q`"Q0%Q)F$K>SY=7 MZN,SQT?S#`E$S!PASV8,&L<.I`>B@&@@!H@%XDK"QD[3G8W]_)GC6^*Z!")F MS@U/F\T8-.H"I`>B@&@@!H@%XDK"=/&.C0ES/"F&<#[ZB&CX:60;1!VB'I%" MI!$91!:18XB/V=NUQ-6CMDO$I/)NS/6"-^26#,# M$I-C*K-BC,I9`:CW/H>:+]9?A4@C,H@L(L<05\C;L5*A-]:(X-Y85I2&;KA? MWS2`.D0](H5((S*(+"+'$!^S-U?EF,_W$4WP:4R/:-WX8B%N<#>Q8G'".T0] M(H5((S*(+"+'$)?(>S`ID<^B$\UX$[PD$&E$ M!I%%Y!AB,DQ.KH],DQ6;#0>#E],$HATH@,(HO(,<0%.\VJ3M"J1L1O;&=" MJDV.RC)$]WJ35Q&,4H@T(H/((G(,<1F\7RQ7D?.O3)-@/2]?X[* M$J&-Q2B%2",RB"PBQQ"7R-M+*=$Y4RO85'%E$C?\ZTDTLV1HQD59+LDY)@LV M5DNHQRB%2",RB"PBQQ`7S%O+4K#C5R9__RR,;D1B:@FI-CDJC;E#U"-2B#0B M@\@B<@QQ&;PG+64X^U9@$MPMFUFCXH1 M*40:D4%D$3F&V)BGTL:>?QT>FN(6-R*1%G([*4>-:8&H1Z00:40&D47D&.(2 M28M[/"VFHY--HUE'5"R'&T0=HAZ10J01&406D6.(C_DTESI%EQJ1./5RSRA' M);$Z1#TBA4@C,H@L(L<0EZ'F4L^P8-/1HI973;%3LHY11^]ND$&E$ M!I%%Y!CB,ISF1*?H1",2TT<:\AR590AM%6M-CU$*D49D$%E$CB$N@W2B;V0# MVLWI:#?3`#>(.D0](H5((S*(+"+'$!_S:=YRBMXR(9H(Q0R0^T(IBDYW$95W M`7BGI/E[XT2@P9M&1.>C.)R\HTY1-*@B*M\_\4YY9_3C=FL:C%1IMQ)B2K7R M9B1%,:7:[$U9IV;2#QU7:@CGGBK&/440>28[)@Z$`P2B'2B`PBB\@QQ`7S_N''5Y59 ML!OEJA(1WP224FUR5)8AM$45$^HQ2B'2B`PBB\@QQ&7P-N`$&8)K8#($)*:/ MO`S-QJ@TY@Y1CT@ATH@,(HO(,<1E\/ZAE,'?WC;SX1'$PY?'^U_7.P^J3WM/ MZ;'N\+"WGP]BIS"BPF9M$'6(>D0*D49D$%E$CB$NA30FYTF!?F46$3F$?-%O MLQ.)EYL8E2='%ROZ#Y>*BME3\.Y+"S-L5,S\`PXGG$@T-CZ_Z=SZ#VR*3F3+ M$GL?HR;CU.Y215K[(^`5@(2S#)D`!!UB'I$"I%&9!!91(XA+H5T M1F==`.9HF"*BC?64`IN$:-W)BV,K5M6N&B47K[X>)=8(58_*=H5+X5W+?Y\5 MP?NPK`B(K6?3O*C&Y2P$^1WG+,Y"7#"[>34J7QV'MOH?BE+UJ'Q$+LY/\4QS M]$P1T:YSSI,013NP"74I*J,>D6*(=_^G^)PY^IR(_.9G<=IRAL63&RJ^=7*K M47!R?R1*I7[]63IQ=:2-.KZ_,4?#%!%;^$)4@3J,ZA$I1!J10601.8;XF+W[ MD;/]K&=CY\%'L1D?D+A*BI5N$RLRA<:**?5[C%*(-"*#R")R##&%VIJ_.^-S MCJ&=P>$54V29/?$P1=8QRM^JC!-)VHH64I1"I!$91!:18X@+)EWJ\0M4BW8T(C&SA%2;')4&V"'J$2E$&I%! M9!$YAK@,WOV5UZPW9`AFL;PPM0&)Z2-L\R9'91G&B@GU&*40:40&D47D&.(R M2"_ZA@QH.MN`BL5@@ZA#U"-2B#0B@\@B<@SQ,7O75Y[Z8:?KO*]-!P/)TB(@ MD19YXR2XV':,2CG0(>H1*40:D4%D$3F&N$32Q89;V=-7U='>EJNJ\"+K-MK; MHWYEC,F"`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`L M6UTJH;_0@>U*N43"@/Z#T5E9(IG6UZGK)60GT+CY/*7D^I;^&I M4E&RFI*B5:WI^_=4I]KK*2D:]H-%:^LI*4I?@*[UC10-NQJRSHQZ35]\Q#JK M"B$4EM";STB=6IWUA$9*[]FJU:'Q5%M;36:WJZHZ]!HHJE/-G0F-E%XZ M5#L.C91>ME,KH?4M[,=+#2:4!^&!<5G24&OT1LM*:PVU1B]RQ))50ZLE?8T( M2^B%BU2GFF\-Y1N]WJ]29T+Y5FUMM;A=53NPII[5.K:FHUN'KJA0].; MH"N=:B@!@JT"P2@!Z)W`M3J4`/2:W%H)G69ZF6RMA$XS[4I@2;>8W_J/2["$ M/@NY]9]V8`G]5-"JWC,Z2"5^[7.YQOW,K/`5Y7$U5?P*6(E?T^!J_5Q3S@WM M7(WBTB\*?;W[O/W[W>OGQY?]Q=/V$UF&ULE%3+CMHP%-U7ZC]8WD],PJM$A!%3-.U(':FJ^E@;YR:Q)HXCVPSP][V. M(0.%5G23Q,[Q.??L1E#IL4\E^C`IYT8*#*ZC-.'"66+>9>?GQ*V]N2;V$IO/QF9?Y$-8+*Q M3+X`:ZU?//0I]UMXF%VRMQ5&4VFT7@Z&,8()VNP[E%Z2DK$QCJM M?@50?*`*),F!!-\'DN'D5A(6`NK\K;CCB[G16X(]@Y*VY;X#XQ2)KQM")QZ[ M].",3BG!6"T6X761S.(Y>\7,B0/F(6#PV6/>$`Q%>V54NUW9@[VR3ZT/Y2%L MG,HD?2!G,L/_D?'@C.*S#SZ9O?$&Y8`9G6#&UY412!Y]+A1V4\H/8-4H8 MQ]"N"DP)'Z&N+1%ZXT.:FE(TE M-11(.8BF:-B$^0X+IUL,$V=4.YS+[K/":QBP!P<^H876[KCP@?<7^^(W```` M__\#`%!+`P04``8`"````"$`*37&$Z4&``#P&@``&0```'AL+W=O'\OKT]+\^Z_DT\PTVBZ['K-+?2V6YK>B-3^O?OUE\5HWS^VY*#H#%*[M MTCQWW6T^G;;YN:BR=E+?BBO\>S.2],-)GYHN3;0C<>B[9*2 M2)I&_M)V=?4O(]$9]2(N%X$K%W'LNT4\+@)7+A).;,\*[H@#(J:3@2N7F$U" MVXK<\/US";@&7+F&;4T\QP]G]S@"VXM&`E=4FH/!"9I1F:!N1& M"UG_9>5$X6+Z!3(UYYRUSK%E1HP,DI9$=J,"6Q5(5&"G`GL52%7@,`"F8$OO M#>R!G^$-D2'>X*S6"`S,4HQ`!@[9J,!6!1(5V*G`7@52%3@,`,D(V,<_PP@B M`^?)($ELUY-GOF8<#W9;GTF^3(E[2N^.AFPU)-&0G8;L-235D,,0D4R"<^IG MF$1D8#-"3O8&.-%,MF#-2&^ZU%-ZES1DJR&)ANPT9*\AJ88VP]D>V).@LN`)(XC*2#(M#L"(FPY((X,$];VE?6* M.6EX/MI^U$3,^GH6(P3!#!9/\7(SR@I%SE''M^,LD0B4E8RSQ#$@6T'J^S"!?RA? MR(FL)#:'G.%9[:J)S4DNK(Y[6,GW[BB[0\JP[@X^N[V_NV?EG"16;X9K*35E;3/6FZ>EX&"B M;'1HJT.)#NUT:*]#J0X=)$@VC'0.NF%WEA;RO*T>%1RB#^\\=QCDB`>##1_H M^?0)RK,#2TL2-@@8Z%_"![E>#^UT:*]*.YYRIJ:"@=('U*%WDXTB'+D46NYT_"Z*9D$(]D,V\K]&T]4Z30W). M15I%9@.!A1/>X$"1!UN$1!XD"`G6#B&AM4=(L%*$A-8!H9&<(CW=,*=(N^*X MY'7=6$<[W&6L&Y3*&(.4]%*V?FPSEI1>'!*IND466UPXG+PHM$1;P3LS;=P. MQPVS26.ER.+J?N2$,TM+GN$X*7D3\1<]8P>1`2 M"[Y%+8]N.]<.+5OQ/-%'[1`:)!-"0CN5M3TW##W5)FF4;!/LWQ]++M+E*D6- M0TIR*>=+S%G#Y$)HD%P(87*Y01`ZRC&8($F,VR$T2"Z$!"M%2*C[OJ^<"^2U M/)FA1\XZ[O`/3>IFF'2&@S4-G)@>!$\1:3;UNP24,2;?OOS;JN3O3D M,;QOGCS?EVK9ZR;Y!.=5:VI$LAPE8$0KE=G5Z&FS2J]1X@,WDC>M@1H-X-&2 M75Y4PE+1.GAPK047%/@DDHRGPM9H'X*E&'NQ!\U]%ALFAMO6:1[BT>VPY>*= M[P`7>7Z%-00N>>#X`$SM3$034HH9:3]<,P*DP-"`!A,\)AG!W]T`3OL_+XS) M65.K,-@XTZ1[SI;B&,[MWJNYV'5=UI6C1O0G^&5]_SB.FBISV)4`Q`[[:;@/ MZ[C*K0)Y,[#^S36)]_L*_\XJ*48[*ASP`#*)[]&CW2EY+F_O-BO$BIPLTIRD MI-P4A!8+6I2O%3ZUIOML!NI)X-_$$X"-WC__G'T!``#__P,`4$L#!!0`!@`( M````(0"IV*O%#`,``&T)```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``! M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````)Q676^;,!1]G[3_$/'> MDJ]V746H*#@-4@(,G$YYLESB-%8)(.Q&[7[]KJ%)2>=F:MZ,?S6*UXRKPB?=ZP M7)K];O?29"^2Y4NV/"OW`8TFXO56GAIT6:1*G[C'KR4(MBVG+#.>4@F[M&<\ MK0I1K&0'O:0LL\SVH@7J$I8^5UR^VEW+;']:24HSYD)@>T4SP2SS?<*:,*I, MBRBOA&UMY?66I;*H.H+_`=OZ1N>!"J;DC(PMK3C-)ED)7]NZB> MQ)HQ*2P3`,UD/6QCVV,^M`?#&@&C0Z2*T"B!A4.-F,N,B7`5T4IJ)`^&;\"?^R[3H")X[KA7$L9D"A6$O&".(%'T*^Y'RGM6O"0N.%LYN-F*%%7I(83<$YCT2.DH-C)T@<%_MAH"_2#Y7= M!:W@KP+5&YC#3(P=/]#FN`+[PKO8B2:^"^FB,%;JM="?!,VB:;A`B-R"Y6,? MDPC^&RVVUP7C;Q,P#]00=*]JKP4>+U#O!$Y?R_FLJ@33APR.CGU7J$.@:2EM MH1K\P5&P)UR1!-VI/Z'V_:.OVAS'MS\X@=,-?JT^C;EKPYH-W-)^U+ M`EI55&HI>L\:`M^V*0?WVH>;;,KS)S$O<>%1R797]>&DE:SA&EG");9;?Y^P M)G!+5YD*XJYI_LB6.\R_"^IA<=^\GNS>\+P[Z,*;H35GF>_O)/LO````__\# M`%!+`0(M`!0`!@`(````(0`:,QE5V@$``#$6```3```````````````````` M``!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U```` M3`(```L`````````````````$P0``%]R96QS+RYR96QS4$L!`BT`%``&``@` M```A`/Y[WY32`0``'!4``!H`````````````````.0<``'AL+U]R96QS+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$9C:QTI!0``!A<` M`!D`````````````````2!L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)`GESDS`P``T@H``!D````````````` M````9"D``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A``4&+QTC`P``"`H``!D`````````````````>C0``'AL+W=O M&PO=V]R:W-H965TS3 MY44#``!2"P``&`````````````````"?0```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)6L(_)],```,)H``!0````````````` M````&D0``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A`-FQ MOG^3#@``%Y\```T`````````````````R70``'AL+W-T>6QE&PO M=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0"T;?PK#@,``.$(```9 M`````````````````$R*``!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`%301.V^`P``FPT``!@`````````````````D8T``'AL M+W=O&UL4$L!`BT`%``&``@````A`-#?^?S0`@``,`@``!D````````````````` MQY0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`-J;9\OS`@``U0@``!@`````````````````#ZD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`,/CQ3%K`@``Q04``!D`````````````````V=$``'AL+W=O&UL4$L!`BT`%``&``@````A`(IW&!,[!``` MA`X``!D`````````````````O.4``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.?!IR9W`@``'08``!D````````` M````````JP$!`'AL+W=O&PO=V]R:W-H M965T&UL4$L%!@`````K`"L`GPL``-\1`0`````` ` end ZIP 12 0001019687-14-000141-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-14-000141-xbrl.zip M4$L#!!0````(`-N"+42]62>K(V\``/H1!0`1`!P`1#1(D13J)3SFRG:,:Q];8SIS-4XHA(9LS%*GAQ;;FUR]`W2")%X"$[LQ4 M31P31'_=^-!H7-CX^,_W@2>]HC!R`__3B7P*3B3DVX'C^L^?3KX]MBX?.]WN MB?3/B__\#PG_^?A?K99TXR+/.9>N`KO5]?O!!^G.&J!SZ0OR46C%0?A!^MWR M$O*;X,;U4"AU@L'00S'"#\:2SB5XJMM2J\50[>_(=X+PVT-W5NU+'`_/S\[> MWMY._>#5>@O"/Z-3.V"K[C%(0AO-ZHK<0>)9,<84_9#!7_^C7,DR!#(\?>]C M/:ZL&)=1@*SB!T`F3Y4GN7T.M'-%9I076W$2S>2!=S#Y,W[]X_O/T'//R?\E MW!1^=/X>N9].*!7?X&D0/I\I`,AG__?U]M%^00.KY?I1;/DV.IF^Y;G^GUGO MR:9IGJ5/IT572A+A4QGPC#S^:47SF@G`@O(K2/!3)YZ]0!?6SL8/%XJZF47U M<5%W6M1!2^4B9)\^!Z]G^`$N+\,6D%M0GA8/43\7LGZ>X+NE&@*G*[2+]Q MB>D+2=1ZMJSA[(6^%?U,"T\>9(#!3\+`0U'F.^F3C)?\P/>3038N)P[/XM$0 MG>%"+5P*A:X]>Z_\I<47,`;RZVQTZ9,,=*3;S%Z@^A#NAH.T..E%)]/N02AU M'J7$?4!]*67C^4O:1N3=UO2%T_?(.9D\)I+3Q]ASG$AGTZK&W<4._!B]QY+K M?#JY"8,!KD!I`1-CC(,Q6(.`G;PT>PWYL1N/9K^=_=YUR).^BUU5BA(M6'#* MM$[WUY,+W'%EH$!5,S^>+;\\%W>6*6\B;8BM'SBK*'`W"F/B<2[FZDQKFC]; M>0V[Q^E+$[WGXIV%5Z:_7P`P_>7$I/EVOHSN^WMKV[&3BC.,-'TBU$C*OAM) M6:>1,GJLTI*Q>P$_)D[TQUT0QB^7J9^ROJ+!3Q1NS9;S_HF>!X@RPNR1@\&\ M#SW7=N,Q5LEQ<9?O;G1R,2VRJO3'L\SZ M:6QGV>"VY8(F#;D>%\1`G.LD#(;H:"A#J]N0A931QS*[%,;#:5&J[Q&GBF(8LS&1IXIB&*$Q$:>*8ACC5 MAJ._$G=(+'$8K.F1T2:,1SW/\N-+WYFI]WGT-!JBI;%I4?>&/+SD(=M_28S" M8R91C@T:,O&2Z28)?3=.0H0M?N.^DY^B(^13OAD:2O%2ZA99$7H)/*<[&(;! M:QI.'".G"NS0D"I[+W3)-UENF)[SZ/K8V4>WZ!5Y\F$0::;:Y]'LQW]A.59H MOXQ219?\4[XI-LVEA;W?!5*L9>^7A11*0XHE4S2D\&!#BB53'"HI"F(2.XGB M8/#C,0[L/^^'Z9FJ>_]`UH$OWZS0F8<=Y.C7>::B3;11@RY/;\%QT&6F:$.7 M.G1Y"=&1^!=*U88R!6<[?]P%_F^)Y9%&O MUA]!.-4SHBBTI'LY=WBD=GT;USW;N;X-[/3CF:5=Z[F5&^:RGM=LF-LP=S\/ MC"XQ5SEBYC*O"!\L<_?9YS;,/6;F[K//A4?,7.8-EX-E[C[[W(:YQ\S\S,W3V?NW30:(FMET?"S,L=V.59_VFR')?4-/*F&EG9 MX)'!I4;^?"2-_'GKC;S%GMPT\A'TY,Z1-')GZXV\Q9[<-/(1].2K(VGDJZTW M\A9[FLM:4 MMTQV;;#9,Q8ZERSPRVXPM[B_N)>V;;#>_'%6>M[\=O5AH_3'^\(EGB@G2$ MZ031H8RB;$>@6:W1+);R7_/4$&W?B+9[;I_!HY']#<]#=IQ8WC1T/B)FY:O? M^"R6B61#GQVAS_:GCZO[$L9A,(%]7\)H7$Y)UL;KAQ9.-'D_*U M<0G%+J%AR`$ZANRF;FX?.,ZV;JX..**V;O+^'U5[-RF_][NU$]\=-_6WQZN5 M%AP@*TI"=.%&@:K([7-<9EK9]-&B"%);3OV/+U:(HEP1$WNEA2K+P/AZ.7(< M]Q539]6VY-V[9(!"*PXR4@QQV&`98U:ME-`KY`<#UR\36VZ79;E9%4^?+UB! MP:`]+*:DR8;X1_8&FR_#X8Y%SNJ@,"*'>N*1-*'G`^HO7RIQ(I$JT@>$I9*# M;'=@>=&G$W!R(:L*_L^$'\_RZZXJ?;S!7BP=:@":;1[I=R@>KT??!E&T(+C@ M.$\1"-W09$V;0U@0P"T]Z_Q&D73-T$U#+Y'N(/?\.G5ZG6`P"/S42N.N>I_$ MQ(DYKO^,9F[!EPUQ&$8JC3A*&V#M7 M9J-BMF6#..C,:BO(9.`@E*$NFS*CS"O41_B!\V2]C\OA!JNKM:$JFC&77R"B M-AH&>QB&K.B5T/1"-+1.8>-B@W%.1C/IX&,S3 MAJ"M5<-S:=M!XL?1`[*1^VK]]-!GU_.0C"BT[CN[#7A@\ MA]:@LN44[%EERG+5I*]3AW)K*X8)5+!^'01T8E,&NJP50#+N&.%X0A[__1JT,JF`G+;5$S*XS&)$X9181J) MVGCN1'?TS6)D:F&@:6H;M+=G1P:,,FR;L%VWK6N.(3K0H6RL#/$\4AA4U56@ MFH96)H4:(.X"WZX=.]!]/+/N&@!8W`P_@*Z/@\AG%WN@641Q_6Y["8DKOP2! M\X9]>E6#Z+"M40,&BRAQ\!@F&[)!.Y4J\'*_ZL`O5Z81]LA&FXYJ\F74Q\/B M-C13J8BG8PW=V/+)M>E*RAH5P)"++NDG[L2(Q(D"5FPF'H@H>`JJ" MPA%!F"#G>C#T@A%"GY&/^F[M29P.\)^%L*-`B`A(+':J`6E:[`%Y5HR<6]?Z MZ7IN[**ZAH*RK`"*4:6"!"%CL!=LZP#60#:--7O6B`2:=6-K50>RO!K)+M9> M!P/#3`1JJJ+P8IA.GA_0*_*3NG8P3(5VBMF5UX'`$N08BBKS8A#79W1%AX!: MG2BGHKA>T<8C@*)5E%T]P%.`;AB94KG%,=`<:*K&*(Y:&:)*"8AI<7^'AKE* MLCQ!8H`QD%]1@`JUZL`>4&RY/AYYK-#'$5Z$G4@R2%*?BJLB>V%5;69"4Y/I MA?1R4:+`E=O-5&$;FGH=<)>.XXX33_4LU^GZDT"GJKE40U7:9+&[I/Y:,,H- MHYK`4#6=&P:U,%]K)4;5`#6D+==:32J#UAH]8RR3V@LGG:R^NH">4*S46EEP MN<9\@BE70K[R$K?7M[(,4B9)#+(J2R>\R"X]+WBS?!O=!.%5D/R,^XFWNN!9 M,_B@IQ`\\M8`EHMSM<`63"DIMWTY",+8_3O]+JBJ>34#R-KB4B&OZ'6!9]C' M-4V(22P2_(V+Q:%;]Q4YR^M$@BU/XEJ*+_R"UP6=:?N6CLEW##K+QX$;U6YQ M^.E9X7V8?M/EI"-1#W.4;/0S\ZB75)%8LT@S@:QCB5=)O%+ M$!('P&;/O),98/PG#^*R,!'0ELVW06C=*$IJ6JP$SUA"72R,)A*&I>2@CRCC M%!SQJ81*C)D*4%'SATVY,P:1PE!6=V3U4`IU8=J*GRB05!L4(^7$@A+@MO#\ M#`*#7I7(D5(+#*MKGYT'K`M&E.-B,`^;FQ#KN1@,5>13K5&::.^^?Y4>+O:= MTE.E3`L[V!,H,K6VDR%'')2,.UJ*U]%U:(+-8],8L"F*JI@&W#PXG0&<:H"% M$WWKQ9:;6[L,(GUZ5!Q$[F/=N"&UM2#A/>*]/KYSI1X1;:R\(QG748PKQJ'& MMPCU$X_,5IG!3Z?+*VF:-6F$K#!B.!&2)7ZCV'-334,I#J3V_BA2E"E9VS-= M"K/\/N(@#S>8%/0ES^TC\K=%%E6D()0\\J(@#;.//MY8;IA&Y5=N9'L!^02( M945I]EK7QW2+;DD2.)EE28GQU&@&K(WKHS#H`_9!$;A'BFR*/>-URZVS/Q?& MVO%RLGM[0#G9NU:@ZVK=7,?^)5S^TH_QA M0OJCC4UC+@A'"C?F9%77MH>Z*/`H/F^HJYN'77(J%&H:X,649@+X-W*?7\C6 MU"L*K6=TEQ#][_LKRR.?K0XO%\&B-B+2)O"8<<-C?(L4)18+>O M_.IB1_[ZE2)#<@[Y<)1?74PI6E-4(=Q_Y1E6:TK75??)!A67/DH7<47;8.HL M9^LHDP/CI,P5LCU<(RX_^HHU)&'T=SRAKN[I9EFTZ55"#LD;!:TM@E9:BK'[ MH'4*-'ZJM62PJZ#S[T:<%J(_5]X>=K[\R=-":\1^WY_*%=TM00G#/!NV#G.2>':FG,H!HZ?7A`..2MVJ2*032H@$.T".-! M`)U\-'FHZA>D("_GA7G`O"A.Q%SN1+3#YTQVXN)2TT`9RD=EFWFB7P;;'!=M MZ+RX#,MYNGE4UJ&RR)8;!^K[Y8R_X()QU/5[:5+6U07L2E>J,)YL%V>F#"U$ M&^KZ'86V&Z6)O>I',]"4#9$&6$&W3?7K,`/JNE#?NY.&J1C-*)IR\*:I&,TH M;;-]5+;AB&9DL=',[IN&)YHQ#.VHC,,5S(B=6*[=-E2PM+3%-!&->J%K%WVO M5.J9"[X/@J=TJK`-Z;*#)JQJ/_G44([;?AP?HRFGNMP8BRW2+#2CUIB1/2XM M]'YFTWO9P]A"/TAG8&LL61+T%O9N.IM88\G2&+FP?RL-*SE"Z@)3:J>JN?>F MI(+YM08Z\FE;X`C-B'KWC%4WT)%/-8&0.!CH'94GN0$=N MG*2P0$?/[E7V1[0P'+) M-0N=8'PS9F)YY*),18AGO.C![S+X*L.K);MM5I?]-N?<45[T]._J5QDTUA3C M-B?T5-3&H$*\Z$5/^RY_58S&G(PI"B]ZZG?X598/RV#Y2QUY$&1AHXWQ558$ M6K."*OMMS<7!!G-39&<^/FLN##;J]\:48H:9II_SF',M<8X`B_5"-+1< M]1L0(;D5B,YZ3-7)+X\E<7![,N^C"@&=FX8="I4)?IX,87+WPC1!B:`/G7O[QZEWNVW1ZE[U_EXEE?MJM@. M(J.OU_4=]/XK&C'+!0#(0($J\?.YM='BK@([(='!TVC(KIT,6K^-ZZ=?SZIV M_%'LM<^3[&V><@:"12D+M='B+O%3AY2X\:QG9C%]S!0TEK!0`5WS9%"\<2/; M\D@^&UY=6N->.1:35]LJ`?Z-/.]7/WCS'Y$5!3YRTBM96-/YG%SD6?42B;DM?T1#6*@ZJR.,FWQ,X!O\.W9E?Y,7 M.\%*3?GB",/XA.&?U2QQLYJRG+T;DX+D-E^2>^Z[WZ20. M$W0BG=66DAGYE4EYM#P43:Z[OT.LFU/%N7YU55[\D'%11@4(O'>4*(H)`'V) M40F$3A#%]_TO0>"D]_.B\-6U4?08>*R#=G'`3>[G7KB8*T]:/5R\5H*&;K0K MX4HS/O3"H,^\G5G<7+*I:`:%A*J?4S2O#6030(7."5@@^A&/*+@/?D$^PI$% M-M&E,W#]-*:)W5=T_4Y6)9A'R>+,[VT9F/3>+9-H<8!YS6A"&>B@+MX'%&&? M:Y,T>E1"0BYMQC/&>%QB]H(0NP#Z:[4<037P\S2=]?R4(% MZZ(4@S/E5095:J0U@II<<+!!6TTDU@"V)GOE`..Z,H+?CGE'IG6@F@L77G'A M$*Y$LCPJUJ MM"F$N:)J8>*W6R5,9*?(\FV$?339.L7,_;<5IBEO\8O3=='[L.-9[D#,.HL& MZ=4S+OG"P?,O(P/3%`3^"O41GB`Y:XS_VT!NT]=Z%$L4`)#7GJH.H5D9("X6 MDDL:K]#X[ZY_:=M!@LW_@&SDOI+S;R+,V%*!J;47)BVE\Q@XC71@8 MWW4K9KP'IE'4^"Q`UJ<.-YMU8$*P?GVF76)RWY&(EC!,%12VQ)),(2"Y@P9= M*Z8+-\CKP=`+1@@](,_",PSJL*68_79H%OJV?/&BH7-O&QHF7!?RE.OKM3Q^ MOG#0@1O$6K3@]B>JMFXM<(\)$T2/#@*=2B'T7,F"07,;O0VA`@O)7P-ZVF"3 M(V*B.:^:]`7DS+*%@JX0M:P!\'1\G9PK$C(Y,8%(^;JDKP,AL\A)4.8SN^J\H$N\)6M"`0"WW!!GBQ0*OX`E@ M6Y%%`,>OV`@Y$4%"?ZTZS?`BY,"K!J!*Q0BE,H6`K!$3<`/,L?^-ZUN^O6#_ M\;GM!/]NXJ9QM4*XK)EX>"BG!".D]2O('R";>%X+UJ4@J8H1=NIY6Y/Z-SB5C&,^*G)'?S_XQ3'_Z M;QE._E<3R`>)Z-NR/&R?F.*)?MWM[';7M<[O'M3SL$6A2:%A*C1Y7I7W\SF;ERY6OE@UOJK5?Q+6#&.J9ZY]1QX6O][!L^B0-A<%F> MS=[]F,RP+P2C*JHP1#A>_-_6?/'Z_S*[@]-N[:]@D-EQ^%43.Q.5LR/PI^\IO8U<<7M\T_C^#+K6`5PEM MS&F9*AZ')5%,3O!.?3_R_`B@GUEW'"C)B88VQNUM@@2OPD`%)8DRVV=P.<%F M`;DMUV6VWBRXHN2S$+RWH@;#72(H?(%86'K_L$7@`$`+EX=-]@W`=5"6.?,4 MI+!=+0$!O#?VK-AVX!FOV5_'H?[X4M!4`DE0(7CPQ<2-;5Q[((2EC_GAQ4"A MT"&;&%89:`#0>#]"`$2.W2C, M<*LBW8+4(-#SJ[B('K3R(T-BX@JJUSD`F^/9(-ZP/D:\Q@?U'?FXK?B/!9_@ MRJEW36-`%+='!21C&<^&UP6NMB%G3*6P9 MN5E1S2@Y.J>S.X3"HH-0@[E)T->`BREF:=!3N2PO(MD8;GLGDDV\4DC=!&"E M:/JOX:K%PJ4M+G4M`I&BI]P4379%/8B4E('51/5J._#\@$UARWSIS$:"%EXKZ?TW6 MN"IB[#MR*4']M^)3P@6E@C#&0!)H5@0V%^6&R&3Z6^SK%7&/I%>.+-,*CR6: MB=U@VJ\5V.R-C_]-68WOKV[>I,Q&82#FW'CMV[05HQ6K\^HF8W6.AKU&O]53 ME@Y>@61Q$'D=G6VPO"743Z%5HSM`!*A[%H%OQY,H331&9CYBCT;SC`O9//5= MU[^7R=:VDTBR.<>E?LDX]8R9D#UB)9W60"XZM-O;+T$&N&"P@+DTLT)AM\XM M&\1GYR6^(B5R$82I\X/;0A!T7\)+71<$IA"^2_P=(!_C"2."!G0;Z'](5@-9)@7.H)_)H$(!)J01$J_#V,)S,-CZX+&*[@NB""X);V#%TC)T2?9GW"DL" M92!`:V1N![95X,O]8>$&7RB^GDH_WJ)-*OT?]1IE&*5$,,"*-AU(:'?99-^Y M<,%LR=59L(2EEJ*)(`/(9C^.)&;2!<+V`>"V&7(7+I4+G-K?8'U*KQ_?-*:J MGA7HP0B*G#Q$##:&-P+40$2Q0VV*EX&`<%`"&F(SDXPCGQ'S0`"RA8LPX$*G M:'H')BU=`'O78L`IBQFI'WD%WD><%,/*^V"5J>LE06:6H`-)4^O.5H5EEU;8["3" M\IF*'&1OR5`6NEKM"`Z.E@NX#AT"?T+M!$&RD2(!-KC'45@@T\B!%=LDHIT_ M]]6V$7\#14(!QK<91A%HW858GZ)K`(B)J(6,+"FLX%+IO).`3@@$VH0:?0HK M00ADI)I+Y'+0U%8;DB[1VB#,*%.I&4@IT`?U6'AI^JE2I1&AJR.]*R+'?U,N MI\'NA9W!,<:"D18?>(TW*'HHA1*S;@,NI3J9?LDZ*[D>AV3F^.`]+T#PS*T) M!UDQ08=TQ;`*2:QIWL@X4SY95O+54!%.XU+2;??H768JEV&D.RM/9Q%#$#4D` M)/8PGJ5CMHYWYZ,\T$RDWH]2Q!)O119 MBS7VQ=DR&E?4IT>JC-1UMU3WQ$!5"54H;7LG(&Z$!?XOQ8+W:8&B_9XPBL$* M3,N7.%1Z&A3H!&.WM[SA3QL8G!%UEBA59CYX639?<%%*&R_@:^!VZ:>D'N[( MB!_W;N%!MI'G)8/;RL!/;71ZAEB7=7`N-/`1!M@HM[2V'(VK"4=+C6!19"8GV2'O=^&'H2/MQH": M4L+52QW%$Z:$'X'&`47S;XQ>RJ`:4JM3YBG`]QAYE+X->2M@2L$=V`^=)82I MA<5APVV8$$&KA1\(KE1Z1%4";^]!&X'C"7PFS5[E*B5Q>?AF@JA.89^$M*VT MDX>&SLRYG0%+N@X@3QJ0R^.UE$-+HL4/'``8&!XX5QW?TMM`MX(WX$4S"4%` MOH!T!>G5/"%LS<6'Y6)5W\228LBJ\.YW5"V6N_R;)]''6[+K=0AQ;+FHV^#- M,P>^"LC$'ULV*(4Q!3X`'N'QZULFX+XZT;T?1#/0&:&4R"+6$%*Z@[IR(3)? MA7HGRY]@F%M_H3I)CH_DEEJ)@,IOI3>;/CB*,`:E#D_(`E3EL0J=)OLPQ8V8 MJ#:*)9`^4V%NI9A4J!>CNAZ]-NOZTC,<-&_0)%`JTHYY.F35"!=\@M$`]'JE M^$0JFC@1%(N"&I9,C+FUI/`.X-=D5SD(HGER#[(! M-!I`.DW<*4D\U.]6A"D:RM:?6I@;4DN%0^LV?11(4*G&$\FY0ZI))<->LI71 M>#A&VQD/,]IMPRFK>+$4+Y69P/Z3;"1WG"&O74-]A%W MATV!O=^MX"^.1]6Y)K!>@LP)\N;C6-A80)U0V/]D%X(.'[M..-.Y+'PR\WS7 MOR4I.`5`'"F+R'<-*:M(I-.F#X[2P7,TB'6,$CW9$+1RO?D.E)ZWLF;:'MNZ M;G1\)`\T,,DA#&F]<7'0A<*V1XG&27/V%E:2J1C:T-..SK]C^Y:NRV0]B&T! M7L>"LC!`;?"`4M70-0G0Y)N"<^0'*B4!0!4A>(SINSA2E@Y(C,V8HFZ)G(FS ML%1JQS0&(Y*#TXT]5M5IL:&UKIUH)]>9\C4EGARQP/>&.!9T=J%1%&Z@*)`++(0"%UE"'V_(AS%Z539GN'*3V8\%-!+)2G=%0\(Y9:G$:XV5# M':#@R57(I,C&EMG8KJSAHDTG`AG)(;'F;1$`3_.WLB;5ZK,7N+6`5?@/+'8! MJ_!.Q`[12G/QQ.UV1G:5#(*K*5-K;)0]HJ1#*C^Q[.:DP4C6#!IF3[R!WKD0 MW^*S/7X/D+/?N7T]XW,P'/`4CPGA]&RPD`P0ZV%IF*0<2^=8!+/L1_A MA+Z@-.&4@S>Q@@!3.-/9-NA7X8X9\^1=M5UV:*=(507C'M?Q/K'C*N+[K&'` M=5$UXZX8+"\L=L1J+_EZ(9!#ZFT#YY=F$ MCBZ?J;??.W8T^YD-6C^]9L71'..Z!PTZZEJ$`+GZ]"R!#@$+U&M@9>B\7!$D M\A?P%&OR%QCD,2AKN-\/?F;![?A%NS,TY/]>)H_#L@%ZI+T">:?W4U&R9O=? MAJJ17>A-V54-D`.+OEQ:.QM?31^#AY'O^PQA82!YXC;#.LTG)^X.?-T!^88KU34>RA3$41K!F.I4KG3YZ*3#0AF=MO!"A7MC402(,@2;#$=AB*"'ZV/<"AU+VPD7?FBY*J&;"EAT M>9$JD4&G51?[UU;N8:W<]U@#^2_+53ENTU3EQ`=*[9A7Z8#[2K3B)#9+2K]D MED]B[E+E)]8SJ9,KS%`1577LC3AU8SKC_+VY52OG6A#*6DZH`U^O0:Y_)+6W^6=!C)S? MC\1'I?!=6:EA^Z@XEUYL6EV-REL4`72X7V3!3V5KJT<^D!OD[RZ?KM]=E&YB M;RCP/I3DC0JR\TFXD9A0:,'8$]T4N&UHB/X3^Y$X`IO(.BJL*A2Y]9;0Q6BI MIUI^T@D[-4(0QPFA*KF0"I%TJ`WJ+\?2.X5;=+X<7;/T(5G:8#ZE/D4SR]O` MSFF'A-:"?3"2NC9_C/5`.C6"&L)HU]11T?]H%M#I&]B>@:_3RLDPE,=IU.7$ M2@3]Z?="M05]O2\.M"_^\%(LG?)8!%,"UP=\BEEY&QI@C/',3*>J^YC-9T6* MR1=6(!(ZJ$J+>E[$(FT0]YJJ>\C9/T(Y:#@>M#$.'/^YM)C`MW1]A#BJ(58( MXSGFM_R-"C[QFU,K$:)?*AQA6*ZU)F+B"#_7,5=/677*\?1(.>VRDQ-E3CQA M#S?CMY[VJ*?`,4ZWM=G+S9)4'F`=6V*N>]_']V-+HI9UZK..RS[N?'51?I(X M/PFDOV'-6QVOR#VM575D"!WEJZ[4/CV>65MNL9_G-1@P6T:OUS4&K4&ET3C> MIT9-EPND2P&VKWKTZE',N7H:NZ;+ M(2V9HZ;876@N%C;E4"64_E37^"5=LYTD#\M(:BKS6@88R9<+,5#2T+U(914B MN9KBZ$NUP$ZN&?M>+%M%^EB1[TRP@9%L[DQ7W(N![\MLFSW1RX9"^+('M[58 M!/X/<1:0"NS*2B>1]!1BJ/TB=VW?H#M%)\RH"J[)5_&N8Y!3V[.G"`0]BO[;;(/$;/SQQ`_9XG%6>R(FV\E#M9M/I7[\?.Z\%"]/B@)G?4?T#6$-,N39//GQI, MR1NW+B@^TEX4LY08#5.JRJ[[SD5+W;\YH_[H"!!VPQAT6PTSOQM&!LV<1A>2 ME_7P!Y'GG726@ZUDRPFS++)^;#HV5`D7:G@*@28K;?$VW*?41'8B&O+(TDO9 M@E=-X5E-.,^=4X%O@B<&'!Y>IY\?",X_/-$TV@E5_SXIU>72B]D1C.9&Z%I% MV1=3K?W:.L,J2A80A>G(2S170_P\YM$]ETU.\%XA6_6L$*U:TGPF>S0X:6M, MC!PA`TS9.A'C%G`UOK;!/94CCH7>GD530_!]KG4O1Q@`<\61'RP%8XF9(V)Z MB&J\(;M(JXE"@)G8-R2[4SA1?T(%C!Z1I*A`('UB"<\=UM*,&59@AA)3W[1#MR.@U373+P`B%5`A-0;^=#Z+>+4LRN6O<@6 MLOBX*LKNL\?>\W$08S^&]E"W>&A3"\0QYO"!J13+J4/^TG+1!U*-@D5"WSLO M=#FPG[96<6ZV-88+G@^Z!FM5@O[A\CV\VI>A/`$ ML2C:;$F1%GNJV7Y>!?5*(PQE`NO!8DZ(%J\<^4=/WS#V3[>UD)U>^^W7]V`; M/S>-X:`GNV701]GT`D>6+:G%FZXX/FT(S&-J%-?NHVG< M9&]H0@5/$4+='*IN+E3-93MRGHS4B$F[->RKY<_GL'OH1JS`5;-$9!78/4>R,[:,V:6+2U];%DI;`=YR\;W"C<;R>3ZX@B`Z$+&9H-I0 MW=Y,:$7BTOLOOZ8OG>&XF@&9C8>OIRZN%/$5Q;EHQJ.(L&\[:\LAV&LF,=(! M>C,E%@]RG)B\_[BO6L$9J`Z+X_WRK+VZ,DU/B^.>ZC_GZ MLUB<]H&H@Z?-CW7DKHH_C]ICY!..@4)MN)U@1V./''EU>)H?H,W'0UYT#(3J M!3FK!3G$KMZ9,B=MBG[_IUR+*%'P(D>FW=+2S,'6$?!5`VV0HIA_XE%Z1"XE M`4=1X(SC:(O]3S"/`_8JWX_*6QJ)5[MPGZT'UUS\M+^4?UX*)[/SD)9>_6'/ M,'N]U1OVC=&P?V8+=V:FQ]O$%:]U785T7;T@9[8@)S$^ M3F!P?,\/%VJ`UL*&J6!;^IBMHT)9V"OL3[-+H2OXL,-C?_)<;?:-5G>T*Z&R M%C.G6Y">,6H/C&&KH"5Q_F*F3+W`"23.6QE%9URD)6">7*0&J)+(65!/QYI/ MMS?7-0=&X8!H+36.O!K=SL`8="]&9)R#97(MS0Z4#:(2FK[0`(D?4I71(I<5 MS]=6CM^2T[>:BW<9(YU^WQBT6^?`R/6"B`7I&;U>P;.5TTJ6U;*>JIT[/WY. MS`W*L,8;3(8@J+!7/_=",6D*H:Y`9DP&9H1&C8\3*5^1+R6U-.N8&)$C9Y;F MSE;4>3,#<[@II3S]U@:1D64`T5GF1L*N](ADGOK?,K>KY(U,M.]]+YO?AP&@3?L+.%3@(6G`]=,889`>Z2?:"$*5'Q(2H*D1._!+X'GU7;_ZK(K0\>^^\8 MD"+6UCN"9(],#+NZ^8-^;;2`]Q/1HZ71-[D5/WBV:,/,&Q]A;]CP161YMPX> MV%V)/'.T2C_,%R`)T@T243IIP223^:VYV(>JO^%M[`C1"-M+`F0V6D.2J\Y\ MX0+&(I],`H.SG1-X7(+'2>"1>>])EU-VZ_OVO>.Z(@5?P]C$M^E\9R`!&W,\ MEPREWX["4DSA\V*Y=7$J1.#,4P\AJ"C[#2Z=2^M<9AR+W&4:6$M&.M;YP..F M-&&8+R(AA4"`:2#H)7"7Z^#8>5O(1A1!"U0F4815!3@/''\A"L)/NBF^KN8) M0'#+;&RQ;H)N*O M%DB/DV`-EQY,1G2VRHA.PS13=DJZX(V]^.8OG`G6Q[W\&80E%;7HH92P`?_P M4G5,<`M[`^IPZD3@A>/@(F;_-`1(^Y2 MJRZKJW!RC;O44GNQLLQA3*)=5(:AR8M58!&0-M,K5\X8"7'&B#*OLM)V@^P4 M4O,MZ.E5H=G)2&95.H9F-@E$/Y1U<4WV#@3K?I.]AZF,FT4!5_Y])=G[V&5":36 MJ-$R(U^"U^BTGOWZ4*E3QKXZ8Z6@K#]-P*H8=I]QEK%R0D2Q8%X)K^Q?037R M.$L5=;LL@(3=N[""?.?42@S?10!"Q5FX<->M\&!P`TVP^"%QA_Y`.TR`<1,1 M'^*.F`/"$ZN)Z@#>A`_+A5%71*?FK..4(.NO9!ZFQ`34T5QZV*(9O2SZG*G" M%0F$$D*ZQ-5(%T`::HRZ\+14+Q#5[V#S.ZD_`;U2E+#D=P.7!:T9E9&BI]S0 M6#.&%8-ZUM>$!+0H<14"6D@N#0ZXP8F$R'LD"<]8.ZL*2P(B56ENI._%6PK/ M6U;=3NYT4:TZUU(^O.Z8DGY^*M>/REYWB\*L4%L5>5\%7E\3E$A*+K6,/)D4 MK%(I7>+H$O58BGQ5$7K?4]7PDJL)EVP@3C$NL`3M:U%YKKZ=I^;ZY87EM(1* M.?\WRK]ZX^-_7R1N,C6'T([NR]6H@;[QFL)P$QGN2>Z_NKE.W3>G.-2OP3K",?< M2(L1&R))BCDF(C1U\K?"3A(*JXU`\DM>(XBDC3U9:U?:&$%OS.G:C4:A4>L M1O*.2ZT2S53G'""4F`6-OY.-K$"63:2$JT/*1;::2@V4YJGIT`DJ*C)ZWOOU M;'SN'7!>`6>`/D]O$HSE>K<^U:>FAK_2RL2+V\"R4[U8/``/KH%OY^(*_&(. M#W.%):2$CP&?YBHF/TGQI)X5CJGODK$%5]S/?!F+<0-NVQMY$7(N;5#I$ZC7* MC$J)8&R7!A8@2&BLE?_.13,I5<^?!4L/&5(T$60`V8PM"`1FLLT&QM#GEFO( M7;ADMD^QJ]3^!EM5=LO`-XGZU17H`]'I9QT1@XWAC0#U3*8*`HD08F(%=PR:R+9E/B@38X!Z#+IC!@'ZZ MV"81[?RYK[:-^!LH$@HPOLUBT7AO*<7Z-*!^.)&H7+X6/H_""BXEV*2`3@B$ M!U,BO)#NZ@=@$KD<-,S5AJ1+M#8(,\I4:@92"O1!/19>FGZJ5&E$Z.I([XK( M\=^4@XJ=2P@<*O*D1G#`:[Q!`7`IE)(6)B)4E%IG)==Q3A,J`O"U%R!XYM:$ MQV+`7[AB6(4DUC1O9%PO<5A*C?2$[1+*,"%P`UD)@4-!=F5F58?SM,">"!"^9C/_'E8.))!PP&DW^_0O-<-)L=,SB:&( M&Y)P2>RY*O=3!"KO?)0'FHG4^U&*6.*MR(+KKQ`QBE5;-6NCKC^L9JBC>I^" M5ZA#@YYR&*1/[S/74!]6J!HOR>,8K`"T_(E M2?8`!8J'V-8M;_C3!H9R7$[@J.P.FR^XJ&J@*=[`[2J;(7FXHQJD>;?P(-O( M\Y(Q;P7\U$9'QN!SW-4<'U5YM3U8AVN?.ON2(=;XMER(QI]?A#35WUTKB9GO MWG[SUT4NT^009Q2[2`)4G@,?)-DZ*)S);L9?\(QBQ2V6TIJ<87(`N M-/`1!M@HM[2V'(VK"==G-HK,Y"0[Y/TN_#!TI-V(_6+`)!GCG6J6()D2V$<> M%G+2NY5A216(WF&S;_!>@5FE[:S\K4P&%8V"FF+_ M']J;VE-$:VGFW,Z`KUT'D"N0P6AE]U(W-Q=[T=MFP'13264*TJFP#/ MF($QEW_S)!9Z2UZ&#FC*8V-X\\R!KP)R.,:6#2IJ+-+_`AE_T+>(E(%[/\`3 M;QY*_2`B'W04KZ]<6$N9LP3&!ODA!,/<^@N56W+T)??F2CQ6?BM]Z_2A5X1, MG=>77Z/39!^FN*,31:M[I^EC0:4F5>"9LBWHM5E'G)[AB#;?AE;8LL.^NJR! M>9P8FT`?7!KC#)06%H=/1&H+$4KW:I.GF6)1=&;$W%I2L`GP:[*K'`316+H/ M,(<`S\.FB7,GB4=M(.'7^4)Y'E/+<3>[_XEX*20IUD_'A.F9RAE%$27/]=2) M0*U]RVA??3ZJ$]CIC%0?KU1VNL!-SBEO*K^=)@ND3HE,(NCT#T MFV"'ON'PIPL[]R.U2*3XY>\T+1LHG&OIZR7('*MO/J,6:4.A<'/(_%7MGF7C M_RVS$&1.DNV$N"D<+TZ?CZ7/"-))6>2PAZ#_:V?[8!.Y,VNF+<:MZT:G9/+< M!C,_PI#6&Q<'/44L_T]469JSM["2S$_1IJCVY_X=V[=T72851&P+645`^D@. MN$$/+$"C=`H^H!^H/`TJ#L"3!CRZP+Q$<8YM;,84E988*;_2__\VP$1"=2AN M:'5N)VK/=:9\S3K(#-^8@3\H-JI^/RKOZQW$6I4:(",#)Z3"DWV&A>C55)8] MS3+`,V9QRI$(DS%7\ST$B\1!3G3VO)F]*ILRW6-;[<>"FRA;142'8')Q&N-E M0YT3R<(@;V.?[^0L7/.VB/.G^5N9J6KUV0O<6C099\+Q?`L332DA%':"BP>+ MMS,RV&2LGPZGD!"K;)0]B15M>1.3<4X:C&3-H&'V9/ZJ[!.,W^*S/7X/D+/? MN7T]XW,P'/"PD@UD<:F+(-^1<)-7:&,PB5-6!FT!Y+FS7 M2)0%+$`,1B]76J-O5YLB+T,<1#\W1Z8Q;(]DU_-AVV@->T7:^F;3KJB@Z M+D8FJ+$55E[W=H#A#GO22[M>F>G"H2F:LY;(I5H(',J#Q8*7]`I(&N_,',S3 MPVA98;Q;#:K!?,24W^H$DWB.]2UBS(F-)\TISY&2Y%5+;)E4A`X;[I@Q3]ZU MV2Y+QS7W<)Q6O:\OBVS$L1(\Z3X?K,K*W%=%U:W)-]:KX86L8<(6! MG@%$>7J6V$F&"%M:J:D3-HZ2F3ARZH27'4/1!$6SY>=L#A(=H.@ZH():&&VP M:>PRS/P+GT`3]W33]M6F[@3*+\]DAVGU=MF-<5"F;[L>?;K>"3YI7$*`'7.^ MLH2\TRO[^/`"77@ZYP1.O)'4J&;?RXT@>>`?%0*WY65&K:/BG/IQ:;5U:B\%4UN0)\6 M6?!3V>WJD0_D!OF[:*6Y)]W$WE#@?2C)&Q5DYY-P(S&AT(*Q9]F(&Y>3JA&B M_\1^)([V)K(,#HM"16F$)9LO!9FQY90Y()K/T3%)J"IFI$(D'8J=Y'*LQE.X M6.?+T35+'Y*EC517L`WLG'9N:"W8!R,I2_3'6,ZE4SZH%8QV-V"/:!A./U>J+:@K_?%@?;%'UZ*I5,>BV!*X/J`3S&- M<4.WDS&>!>I*`Q_3'ZU(,?G""D2B"A7948.36.19XEY392LY^T!]0QB#)"GK"'N]>XW\,<&Q4X$NJV-GNYIYT&NT*NW@G]V)*H M99WZK..RCSM?792?),Y/`NEO6+)8QRMR3WY5!1^-/<4\W)6JL\-]:M1TN4"Z%&#[JD>O'L6<>SQ-5D-<0WSTV63G;=$\ MA%*)`5B!9:TMF:>GL6NZ'-*2.6JZWH76T6`[%%4:ZD]U[6+2(MU)\K",I%8T MK\>"D7PI9SX8NI6LK*XD5U,=,5]]3J M5Q;9ZGZ&HA41A?!EPW5KL0C\'^(L(!78E15<(NDIQ$315&>6W7F"A?+]-O5! MN/+L5$7/.X'\6:4(%HBJG"\;XR6RKWC2\HS`JFQ3A#5,?I.=(D.:"."%3BB.B/>KHFZR#Q&SW-!7A]IA;O]@?(H%0%!Q MI9B0<\^3`CY9X#=>2@$BQDFH]V-W_V`A>K%0:T1JYR!+LDDXI,GG3PT]0O"@`QG^B;]:,NO3O>KD\/@:K*_O[.1-'F4BDN*3SH>P:6T^Y208<,K2AG-1E5$BBJ.SS1UH-!1(!&IR M/!$MFF3-K&P1?<>%0%G-SL^=NB)G1`4<'KXY5_],5JPJ-MWZ0%6I/^32R_E< M-`5%%W;*OJUJ[=?6&591LH#H*("\1%-BQ,]C'MUSV9V&1I&1%->3;[022_.9 M;*[AI,U-,4"'+$QES$6,6\#5^-H&]U+#7[EGT0P<&EYFW0'2\%8 M8H*.F(63FEHF^Y32A"[`3.P;TA(IG*C_J-P#J%_5G)_,F+,F%3#(`E;5KDO> MFZA40_3N\NC\Y,C9[5_D^IQ81^TGX31*R*COSLL?=\',38?Z,]3,:3 M4E/.,>8V@BT7R]%;_M)RT3=4_:]%HN,[+W0Y<*TVIT$F??4G8.!&Z%XB`G_Z MP5^R\@6[=<,%SP<]H]5J8;\8.55!C4$1'C(6GILM*0EC3\V0R*M27VE\HFQT MM>_DE$$Y)96>OFLXM!PW;0P'/=D4A3[*WB;3V,7>)E>IHOQLD3U)Y?Q&*>+! M'<-L]PJHXA.QB)(<127"J@'^S@IP!$+XA0(H0ZN90M?RATCC; MD;.5I/9->O)A\S5_/H>]1S=B:;2:JR-+ZNXY2@UN-RQL$W-+`UC&HH@Y?6>J MT5^3O75<>O4.R/2`5U_.G>&K2RKND0VB=$L;FV,G*\^*T)X(==G(9ED^]@=WUIXQLVSI58A9P.3RJQ&H M&]XK@@=()N=.538"67Q/-7D6!-'AEU1F[]\ MPI%HJ`VW$^QH[)$CKPY/\P/T7WG(BXZ!4+T@9[4@A]C5._,/I4W1[_^4:Q$E M"EXD'+5;6IHYV(<#OFJ@#5(4\T\\2@^7IHSJ*`J<<1QML?\)YG'`7N7[47E+ M(_%J%VZ`]N`"EI_VE_+/2^%D=A[2:ZT_[!EFKU?NC0_`K>R>JA=NP[MZP[XQ M&O;/;.'.S/1XF[CBM:ZKD*ZK%^3,%N0DQL<)#([O^>%"#=!:V#`5;$L?Z754 M*`L;K_UI=BET!1]V>.Q/GJO-OM'JCG9EI]9BYG0+TC-&[8$Q;!6T),Y?S)0I MOCB!Q'DKH^B,BQ0(S/Z+U#!A$CD+:K99\^GVKL?FP"@<$*VEQI%7H]L9&(/N MQ8B,<[!,KJ79@;)!E)73%QH@\4.JS%QDZ.+YVLKQ6W+Z5G/Q+F.DT^\;@W;K M'!BY7A"Q(#VCURMXMG):R;):(W7^Y\Y)SN".3)[5Q!\`7$XKA9N^!+X''V4# MQ0^E)(DO&4P"9C=803Q9"9[YP M`6.1GR*!P4G%"3PNP>,D\,B<5V1/JQA;*;19V..9QPB<4GX M`>@1B-%O7FRYL@X'9R+/4P\AJ"B;!BZ=2VTOTQY%`B5-226ECS4*\+@IC;7E MBTBDUH![)S)J\`5PA^O(8(=E"[\#,Y06.,XYBC`C&J=;XR]$0?A)=RS7E0A! M&*F42R16"AK*X:%'C#F\YTX^RJ'A`S9-]!+C][!T$#"5B;7*+_)8MGHR*76H M:QL>1_S!I0>3$9VM,@+U0ZIL)UVLPUY\\Q?.!&M[7OX,PI(2\O4D1-B`?WBI M&@RXA;WA'NS?"*QZ'./-\(SQLYAI`=ODHQ^*;7B-@^=@/]T#=QMPV8W,]L,G MX$54!&?1G]/$D2 MXA8I3$1F-&$3I[&A:A")C1A*SCQLM*FQP?$>8H1>"A.=MXBU'7@!(4)5*0*1 M]`TL/0-YI;)"%CVD*C94T9$L@TCG)XH)(FP*RA]GC23CUQ$O<9,?.F*666K5 M964(CBAQE[IEZ&)EF<.81+NH:L'44ZQ@B8"TF4:F<@!$B`,@U!#HK+3=(#N% MU'P+>EH)S22Q.RV95=D+IKN20/1#6=/39&!A`0);Q"IFBMZ)>A<91$9!/XD, MS,:TO*6AIIZJ9RBN2%-+2LD,JKLK1LJ:@*+Q0$_-U.P@'%VOAIE MVS#!M1H$D3HK2XVQNDMPD>X(^Q239PF4M0%^NW-I2\WV2P)&IPA52PA[JTD# M)[!?WEOK](NU4$6[:[2Z!>,4E4J_V"<86B+(671J8AT1(S;K=(W.:'B. MX;!'.)LKBE#)<9,UJ^$E/=/H]@LF`IX_ISWL2&>/FI*2LSLSL)RTE"5K#!6J MD#@FOY:!HQ0_MSM&OUN0GR^X2.,`XK1\"[V;>,RBK1TD:YF+EW0Z':/7.XOC MQXH*W3#\.5.P;V//#ASC207[7K:"OY;&CR:-7[3-@=%O'ZJBL0P-7IZY&%[? M`>UF;R^>*_@)(^)O?#])01-SA/=:F7U!/<#VH%422B#NS6 M@=TZL/O$0PEU8/=0XK0.[-:!W7,5NG5@MQK2N`[LUH'=.K!;!W;/.+"[,9Q[ M@S6ULJD87ATM/_D1/]^DYO-*W'5E?=M;;-_,/9L@K$#E&G8S?N-C[8.ZHZ%Y=A,-LK.I&,S MVF&7FI2=CM6OQO)78J:EVA;K,8KK,?ZBT?K(7Q0(P[<1*O&N'"M)R6@YZ['7 M[**(SC8"D%^FJ5^NP^Q7CGW5-9AOP?PMJ577<6D`]IMG4^X[NO(DY`!Q+#I" M.JEN"$^=*)_6VE;=B'Y5GU/]JGPZ/P_4(&.RBS)VXE'9M79N=2<=O=$:VRN#UO M-5N;(^?516LPZAN=T=9PZX.%U\X8Z`5(K/:K=O=2MS7@=K'BN&^TVJ;1:8TN M#S<066;W`M%J&^UNVQ@-MP;.:XNKE/SJO1IL'YMS%,1/P2Z]5^:.B4"510V% M5Z=E=#L7B!O:6Y>(5G?8,D;;N['6]M9N.@Y?H55RD;L:4.M=*&I28`U'>YHE MYXS;10NL]M:&Q;6M56Y,'UPR3J*(2,!Q_MG?&3+/`8_#:NQJ[!Y+K.D]^+QK MM%JFT9;!C>T;,4?6K:9]N-4Y>S['-`++#?T-N03I(3*[FJEV+ZOQ:9TE4&<) MU%D"=9;`V9*KSA*HLP0>(TN@-7Q`I.2<#SDP3>`A4:"SQJUOM`:=_:-`YXP; M1H$N$:T^GKCUCAL%>@)AZXJYU'7`H*JX731;'GKA:M.K#F%?S.:HL:LN=ON% ML-.VV:7$KRL2R<9+J&Z/ZB'9YV3Z#)92$K@5*.O[X"5SSP@:QY>M?,LMF8Q%>"H+_AV#18!@H2''1R6;@86/>H,A! MH)\@\&TS\TY&Z M[.;SRZHH\*O,:#."1XTW,QB?+UQ_R0$*:L668'CS&876(@9%B#*\-VIOTZD@ M"_D/'DR<$"^+S7[)L$@]@"]SQ(Y"?;A8UR)#&T6? M&M*=!YVPNT.1WCB!RNW$%-+-N>69#OU,FP!F_(<#TA.%7D^$DUJ MK"N`M3A;?%(H7]I";SU+?MBQ\05+RU16K9$D3,:W\!36,46`H-*,5JYDO4.1 MF$HC_#3E2;FD.K,Y+-M2Y8PT1BE<.\W1UKD#963FSCS!"Q:4OXDXZM/9)*8\ M,ZDRPK4LW"T+Z=#@:P]%8.RVVQMG;I;FY+[FI*8Q5-+ M38S?]/M&OY::%<0Z6>;G1<(MS5[93LA5E9J=9K]4/?-1*V6.D1GV^$F3F`4_ MM9R`W=$T/83'GU+JM"\RG#"Y?^+&U$T%F&&&6;>4>/WIG_!!7Z2R1U,=H%3O M)^[9\,.:9&9.R#C`.J<\>RMBSTWX:3`TFP1%%C`F@`HU6.S>6KD=7VG#'W@I M0;__ MY[MU5'Y..F`M'>Y2MGJG:79_,M@BX(T[@!-OGG(QWCN04/:;[1Y`FEFG\"[M%)VD+F9A+5V8O,%>Q2\M1)+("S"JS.YG1! M*#=F7I4&Y;*K[9I.8^_VT%`IGL4NML!*)GM_0)GL_69_:+`ZC;UB:>SKPN+0 M6>RO6;Z1]^C)FW7.>'4R?>N<\3//&=\B1\Z)B\Y4%-5YY$]-*-6IY'4@JL:Z MQKI.H'^,0^[ZY*9.)5\_&AS6QS:5Q+K<87>GV1U45W26PG70'-:9Y'6RY%[) MDITZ5[*:6)>NJWFHRJN*-*S-R#IM\C2&9*\V)"N)=5E#*^.UJS4T5J@C]4FJ6,UE9^GDJ/\U,0Z;"2;:<&,#6L-D7J9:7TJDC`S>6;P MK4&)D=UF>R@R_T028Y23!44-D%?[A6**8RKY,P-9SE/:U&`46^!F^XN*K"S9 MGI=`<#QX]-RB%KP!QSQ'3,WT5Y(ZG9!9HI+3;!4@TZAL2%7(%_D:X4YE$+ZZMP([ MR<5*><`'0GI'4L-VFCQ.2L,*35*V;CG788M5(#?9Z-'GXG[T[TL:-"J/\Q*2 M5_X+'KX?^N9%9,F!HO52?=55M#EP6G&=YOC&=Z_GU@+7YY)OY=-?,4Y4YCRI4-V!2/ MRAT"RT,9\66Q[)6-/9YC#'H[TH1O@7*ACMDQS-*QV&)>R48F.$WM\G"@H1>A MF.-R]JEVZ.:*[*.LU>-OV/9@9`PNDT6/PJ$%I=09,G"MES=JK,*->JJKESLE MK(\GH)?W2":I@,SK-SO]RU/+[69G<\;MA:IE\W(Y],EIY7;3W*Q@:JV\45\] M`:WGECO-]I/SEH=#HW>)')J7E-1M'H5ISUI5 M=YKFGCFY3UA5=Y^$`XU97[6J5JJZT]^CB74%!&&O:5Z@!PT/*)LK7'E5;>[3 M9KT"')JGJI]BK+NWK5/P.:CJ.*0C7&>CHXEA3 MY5A2\G$X7>&*Q0(YLK$4VGMN@I/B^;RM!I@]PHJ>P797=.B,3&/X1'B[TQP= ME[7/N2@LX7RS.2C"^3DVP5$+Q0Y=?V(F6 MG_R(OW7"B>N'<<"_`11O7+CFU__]OW"M_Q$Z\_CG+X&_`,MG>>79>--BSKWH MG>HQ_T?(I['[T;GCX3>DB7X$E7;!'U_Y])=G[P-_CN55C=:HT3(CGSZ;9J/3 M>O8K,52A,B`KMUVSS*$'BW`(VWEC/7I!&*_]^2*F\0I[4FK_6#W6[0U.0*(B'%80YO=QX(GA"UB4 M.'5^X.>RG9@?P$\GHMA#F>HCMT).??N=^2+`8D_@JY.1Z6;FT\`0?ZHK9*TP MY!'S`^8B9/LIKG^\>H!P5_I!*9;WEA/\"R>27"%DX>\`%G"2_=G[Y'L!G\0! MCC]Y8X5.>$S]L))4WSJ]1B@@[;NM;?5RC]`L_%2=G!^`FK+8/O([[FHT/NQM MJU<7Y2>)\Y-`^IL?6>Y^WLA1C=0CAK6*TNC:"F<:.K14)O`%67AWEKN'*GZT MQ7Z>%X,W6T:OUS4&K;*-4,\+C>-]:M1TN4"Z%&#[H]K^)PG;/X(Y]WB:K(:X MAOC@?5ZK9=$\:*Z8-@`KL*RU)?/T-'9-ET-:,NE(W`/":*N1N)O)C-NQRS]/ MWUD!MJ@(O_"`1H#A?9,KSW[KN''$[8.Q:;9FF62Y05S0:EQXF MMSLB*\_=$Q M$*H7Y*P6Y!"[>F+7Q43%= M5R_(F2W(28R/$Q@PKQ8SIUN0GC%J#XSA]@9V51(S9'FP"@<$*VEQI%7H]L9&(/NQ8B, M<[!,KJ79@;)!9.G1%QH@\4,J:X_%(K9Q6LN0=.>]Y7IPI$$R>\=:Y>N$XIS%2=D83YTHG]:"03:K3T[Y9\U6H,1^&.CK#;8G MHQ\%\9-T'7YE[LBSKRQJ*+PZ+:/;N4#N/6.&P5Z`F'KBKG4=<"@JKA=-%L>H<:^ M-KWJ$/9E;(X:N^IBMU\(.VV;74K\>O?`OD)E=9M;OZKZ/6[C/#3NA1;&OVCZ MWV=1K'\UB>"9T?(!76`?0LDR;!#CAW_&0/6IPVWVP4-ICOT("!\F$:(%?I&Z M[.;S2Z)HG,\TYQ0POZ(BP4\X6$S%Y3HM@TH)#<;G"]=?]A[0 M\'B+8,\UY]3LQ^%!SB8TO0^WDH&RQ\6&;]@:9E*'#*2G)#X M%I[".J8($%2:T8LD3\[='M;]=3:S+R=!VL_=4;,QN ML[6UA7QM7>YK76)B3[X@?6)12IP9$(3+-7MO]C5:5FI]DO M5<5UU/S@8R2+/5TPR^YT5R8.?_*]ALZ9%>R>R1MF+S)7L$M)&\9&(CCZT;$Y MF],%='64ZD["DLXDE%HLY[AEDHJ[/=01Q7.*"8K5O.+^@/**^\W^T&!U4G'% MDHK7A<6A M;YVZME?J6J?.7*LFUJ6K'!ZJ\JHB#6LS\K&2V)Z:(=FK#-XJVY9^_4D!XIJ;30J&TZ+\W>=1KA3&82O[JW` M3M)A4D[(@9#><:Z\G2:/H5+I+R!_X M+WCX?NB;%Y&H],_8\B+0>WO28'0)-%`Y),G1G<@EV2>'9#NY.A=-KET)5O6N M*DB#[B70H-Y5)]U56Z-'!2>8W&\,*7G^?6`M?GDF_ETU\Q3E3F/*E?69BP=& M#H'EH8SXLECVRH9_SC$,N!UIPK=`Q4;'[!AFZ7!8,:]D(Q.W+VJ7;HYGK$HZS5XV_8]F!D#"Z318_"H06EU!DR<*V7-VJLPFTJJJN7 M.R6LCR>@E_5$*YN]OC&Z1*'7:8Y:EZ>6.\WVD_.6AT.C=XD4LML\"M.> MM:KN-,T]TR*?L*KN/@D'&MLAU:I:J>I.?X\6KA40A+VF>8$>-#R@;+IFY56U MN4^3X0IP:)ZJ?HJQ[MZV/IGGH*K/09X_.%?]$*@^]C:IE?94WSNF(%QGH*.+ M8TV58TG)Q^%TA6NWV1[FR,92:.^Y"4Z*Y_.VFNCS""MZ!MM=T:$S,HWA$^'M M3G-T7-8^Y[J]VD6E(%/$UV2GYL]_(9^M2:3((;GB(<$?`%,P[T(DTTMCW&`>(Z+SOX3 MP[+SP%T2(-8<+-`(GRCN6UA+JJR"=V,KZ&L_6/@!W`<4F00\LH*EP?[E(%4< MBWWWW<@/_S:8A3<&D6H@#8^?ZV[2H06/@\_?80N'_R\^^,:9QZZ5M*+]XL*+ M`7US-.K#LSQ;XU4:)[8%'S\.V!=X@&/#(UY=SQP^Q0S321PY=Z+FZ;.@ML&^ M6RX\3N&71F_FA+AP7<;G"]=?SN%1S+H-.*=/W["I-B`=L.<=N58+RZ&UO>&+ M2-3HBG7')7O_)WYF"QY,_0#8;R+`$)`#Q%DPC.T8,`V][*"-/+%8!,!V0,`E MK<4D)5:H4[<319PS.PZ0I'B%I"3!P3WDR\(]MQ.)5D*^*-$4`D_\?.U[F#D< M"-ZX\D#4`4*1Y<"2\["620>$[BN_XUZ,')$B.8$5SOQ[X+Z9%;$/F,7MT4^6 M2QN9Q`SN,&`,X%G6:_]$&[;7^PEWA\1G^2*)@!GN#S0&`&4BV?(:B)\"' MM@%;/%QPK$?E[K))X+Q'II\`'U M@;H,-]Y_6PN0%1G9<6<%C@];3#_VI1`[9FL%"[$Q"(ZBR!BTR4!CV^S>B68` MY3;XVVT$O5L8=`(E#WP3'X0X#'-1*+H6[4=JJ"^_=#R4;/!`QSN$VWU.&^Y* M+"MJL0EW[L@,1*`R&Y"E-M\*XR!7!=A`C)E#Y)GAP]C=[`E^(1@&Q#/6.H0X MP"&'PY'/-H,W*`V9($0:NK[8T>)5IEH"XS#': M)*$_C>Y!RL&/-CP8S4)A=H!]-`.O"DPQ,C8BAVP37,;)#)T26#]KX=@@WMEG MX"#Q#N0%X(K8C9"38A<,%C`<`6P'3!K+BY2Q.IV"P8VCQU/X%'$IP`@?6L[`*8SCH7M`[!XW!5Z"G_%2_D/N`1!40\X M=U92#ND*3VWP2L\)=#24Y]:_P:&-Q-+"!E]1E,1;I+<6X`#/K0F/*8BN.:[) MWB:Z#84"O)&#./7GSH39_KT7Q0&`?\_9S`(6##E'F]>CB(&P,/-?0/`D+[ER MP?&.;V?Z09X?B8=9WC+-I``#<@VR%S[7CP#60)A99,W#2[FPX6\#_QY,`]I< M,S#3Q_0TR=Q-J@UTX"Y;*8@$9.)3Q`W(B:AOIY#<2P0UB%X'[)()>#$>`:%! M(]:W`BQ+#-FM+TT3;`.PV=(O8ZZO=1+AM^@L?>7@6>)V>\RHPV48\R"K+1?H MAORDEE6(;)_=4/]P1?CRYZ.3^$@:NE0GFDQ_F>(X%.Y$L^7$,?=@ M,0M6NW>0EAQ'/S&[J#$>GT`*SI+29]A[L'!5)XA&_K%FR+R+`S`M-VW@FJ#E M^P*%3@Y75I6<#Z'$C1_7&_;P`^K07B[`8#F':J43;ZKMM'O'K>D<&=/ MY\L5Q)>X"4RCU;G$C=`;G;@FXS2E)ELRFZN+5>,"<6H;[=%F`R='$"<99^<5 M1$OEO^V.!V]N1BWS&$(,$K_[0>D*[K6*85YY]D??N_WHW''[*@QY%+Y9IJ.: M5Q@0S;:]/EX3ZCKT5X?^ZM!?'?JK'D'KT%\=^JM#?Y?D<5ZB9U:'_JJ$51WZ MJPI.=>BO#OW5H;\Z]%NC(V6J,+EW"*@O"KOTP"G_C'@\L M]Q%S/<\M=Q-G@F#6++,(G&[+?/%_7C(LZZ5L2\MU&8=G.QAL%&6'','`Q,I[ MO/LO_$\TF6'F+A)39;F'C/\'YXM$/D4=54&F>H2,P77[K^%"5U1=,9M/>0#+ M(V:+8JHSW,U_3#BW65<\@A*;U4,R)85-!MA,`&S+#7WQ3+R=(+0PJW[J`/HS M*UB%5-0"9&&/?%EUX(2"%J*T$^"`1SYO]PVS/1#%HNV6,32[ARDYVQ6L+LK5 MJ[OARHLH@T)T,Y78*Y791E+N= MP:#;/S;*\P%VM4?;5HC0@LOW/_)I_W,C:VQ`&*N/;T69"YZ7$-O] M3FR=POZ/F[=IU$%LFB-SV!ZE$-\*X\,QREF=0V,T;+>&O=-AM&V-L$3614$' M@O8+QIV#:%D(A<'^",A4?SN_7<0[T3Z@O*S(@;+7Z;=28!9Z\>'`W;[/U\'M M#%NCT8/!G4QB:D_`[;=8JCAQZ&KX['+\`*R;7BZUYJBA(OCMW7]BAY@Y@]!5 M^'E:D.9M<]!OIT7S@>!9.T*U7-##//QNW7(T]V3W@/`ZVR+@P3S4:<'_I>S/ M`J]=`Q5[G7P(PQA(0!5?((0=7RQKF)YDK%J@V$5WL:AV^9]_PN9UI@ZW/]Q\ M7MN\&_1)H[N"6&D@3X[F)]_;"]/.H1'-W8]78'9ZM]1'`YR-Y)HO%G79H+FT M\LF_P951^,$3;U;CX^34N$P?G$,R`O#VEPTDZC7[9HI"I\/OX*153S\GZII- MLWU`ZI9"L5($WK7!M])XV'IL&E-1:6H(MYZ6F1J6B;,R'\YVOW[I_&F:OYOM MM[*4M8]/$1NPQZ;V:_T>^F^<2HGAIZ_PA"R2[X_;99!\ M$Z/W@>IFY_RI?BP_K9]U9XKX99G^#U^=\"]0]?@%H&.67!5U\&"*]4@"1MC# M:LV.^1('?,V":9JC=)AV,V@/12,OP'5`--KMTZ!18#7:#UF-SMFLQH/0Z)[- M:G0>@H9Y-JOQ(#3.9V]T'X)&ZVQ6XR%HM(:/CD:F0V49V'N]1^>D_6$ON0O6 MFS5E+VQOB56O\LM5418?YC6)6GGO@P#-Q^PSWX$*''=IW./'FS M?">26X)#^%7MOMD>)/*Z\+L/"G39D]1V:Y@V?/<&6N68EU1 M,5[<>22WXT0N%6K_@++;"YW)ORPWYEO,ANW)09W68%CFU'M?``]&B?>6$]`3 MK\(PGHNW_LZCF6__43R9XMFOE/W=N)G,?.RO[]-S&@O@;,QJG?LV=P]`E.VP M'I4DF!B%C8C?.GD5&7>6]8C!&G4-WM%WIM/8J'DKSS[`_GISAVGD](OONM,EFCXGU5JH M.\B\M4%D9!E`Y(7#UT92,D>/B$,U5@+,.5<[([+.2:4>M=D@H7$NS,0TE1!LV>`%RI*J3I# MHS4:82E5J:%7&\JI1(V:$V:&'(HQ,CCH"<$!DS\2&84T@4!,@R$6$!,,;K@+ M.-\:3!98T1.O;.`+'.7WE(;>"R8S^2-68J.F*NRN] M]I!C.260LW19U_X;>7\A=.$F&^@G0%@%QB-,M\P9,DNQS8+/L'`,IAH@!MSOBH>PJ MO@60Q01'&E3)LR1-7H(S(QU;3OC#PDO/PS)2E!\X5,X*EKA7GW=:-.(2I0P- M`Q8;STJ/LY1#.%%^J_I-EJTIE2/WWJW7I(IAA/0Z@_EZHF;Z=9&H9X6WPB.X M!;M]"ML*0,7?!9(HC'`^3VHP*-ZC1VR..;/0OJ-Q?:Z+?R>*1TSC7#*U3%IN M7NO1F?)Y;WQX!O[Q%L@]B?P`^".!P1Q`+8T>8A@$UC`NT0&IGDB+8<7 M`;^C,6YK."8K1W6WBU7LK!D)CZAB`B^H"74*GX!**][W$]SX79V*4P"-D+;`?1:KU40PE!$_AS MH#^'V^!RZP<.(-JZCBQ>J%I@"S;C#S#CYWB=V1;\H&P&K0]Q]10A-6D$I11= MY]:2B45&Y9NY$%X'J'5:S+:6(;L/<)D]9%I'3F=UIOI69`70;K@I_3@"/1^# M8DF_Z/\!L#S8]?X8A(94N6J\&5(:P,AL9FD6<`M'K.',NY>`IM*]8B^(:5D! M&[^4Z)\'KW$>?562*WGO:7IJ7":`V MS5#<(E.40++2,F]%I.X]'9A`2"8$YX\GKE?_4$I?:5VI\,7:?,ST:<@T""]THC]]K=2WF3Y/DS%%=RH54K.;9B;Y84??$9P`= MR5^A)!;B4!UTPD\O5W15&M)-@E[>H309P9*6]%G30(X[;[(/`)-M.[1+LK(: M[G23D63D3Z'?0Z(,_`(3]8Y4#VG%IC79JA&61F(BE%R857)"G6W39F1W90P[ M*_!V*3D"Y(6@=$;+1?>`YS+1JR^$UGM94.V]Q/>B,2DSTMF"RLIT7Q`DDUQ4 M`0+88R^39\(V^`O0),>4#"^BG.3:M`XATK,7^)47$R?#EY+,TLJR^TQ7)!_N(VSRVTI%MG#T8B!F@HKN/0L<>D_;&/C:U?B(_0^L&`$0 MJG6/OI,FZ:*]!_>`J,;=D;Y7_O(7&'J%.M24"#JL16_C<0C2`>Y^=X>/.'UT M`OX_S1>[5>Q;/A$;LI]6GN21J=&RVBMC=[X,.%IS%,4;A4%KD+A/PL\1D1]J M123=+GR"4,)DTX,RP*Y8PI]8E8+"=0C#F+RN6$8.0:AB9R/0TZ16A+K+/AM8 M)HS'_Y:ME*P%:FO4SDOQX)GOXJ,0+:5B/%BES(]SSO7L^%#V_Q+6PGL^#F+T MY]L]I'48$R]%,^(K^1<1M7M\H7:,R0*;F!FX_A^O?HP#U_D9_PM__O]02P,$ M%`````@`VX(M1&8^:L&3#@``&*L``!4`'`!S:6UU+3(P,3,Q,3,P7V-A;"YX M;6Q55`D``RY9U%(N6=12=7@+``$$)0X```0Y`0``U5WK<^(X$O]^5?<_^+)U M=7L?"(_,8R<[K+8O/_WY9^L83HB$FP9>+]F7KPD"!2SP<++Y0$GN.3`'VY",C%O__UU[\8\.?SWQH-HX^1[UT;/>(V!L&<_&R,G"6Z-FY1 M@*@3$?JS\8OCK]DGI(]]1(TN6:Y\%"'XQ6;B:^/J\H-K-!H*;']!@4?H_62P M9?L81:OK9O/Y^?DR($_.,Z&_AY7W?:BO-%3K0.M_.U7EK) MGPWY9Q\'OU^SOQZ<$!D`3A!>OX3XR\6.EL]7EX0NFIU6J]W\[]UPZCZBI=/` M`0/)11-21-?^].E3,_YM.C0W\N6!^ND<5\U4G"UG^"T6C-^1),3782S> MD+BQ616F,;@CV$^-=%B#?=1H=QI7[3>.SPP\?40H"F4BBJDJ%F[L4+#.(XJPZ_B' M25K(XO1BLY6)&)2A/;=7+'2Q@=3O`CP'-P'UJGKDC4LU&`Q)CYV,9+:K!R7DPD_I@2\*'IE M@>7[&J\86#)1130G],#E$D>Q[\`\X%',#%`S*)A2@?1TX#]"V'@DO@@%(]_`SC1P,4*G@ MJT)]PO!"%M19/6)W@E:$,F>2AQHNR47H!L+:'$=C2&4RL00D)XR& M#R'ZO@9\K">V`N5QKWC\F%:;?J9\^"?2I5]7I7F'36QY905!G=% MRTKH3B<@6B2[@H*(HRBK.HLS>W$/04CWP\8A)E$VN7851JD$UL>$J4S MI.?8*BB;N@R/"O-+ZJD]_(1A"^T=D&JX+,X@MKV*A]KK*.[D*E3*A_"J11'F MR"^(NCAD.?&4:A5SKGPSJ+PTE!F<:7M88DV78E/EAE$Q:LHIJ]P^*AM6A;;" M1:J>/^6D(C%=QW<3>8;P\QX%>HD@MB(OY<-$/;[]#Q\S-LFSFK;1,%*JW?]" MV#`V+(P]'E5*+^GN[\G=`6&WG5_X?]<>]:S1U.H9-^;0''4M8_K5LF;3]%E* M*K%/W#TI??8PA]!]E!,AXR MWOR0?/R;&88@?G=-Z4ZI[SL/R(^G_2T9EQG6K$]@UCUGA0G\PSSYR?'C4B7J M@D._0IB("WF^(HKD605W?,BDKD$HK*0O%^U6*YW)H>Z>[^0?IB4CFB&K91FC M!@;'2.GGE"Q%%D^L2PY19A<9D.+">$9X\1B!_+4BF13PX02Y"&2'E#]"D=P3 MA51JN'5JQDU%\S<`UPWV?>3U"1V28#%#=,EV"Q2*HM"FL.V!!+X,RP"IQD\- MXBOM("YC+>W`'U.T(3LD\>H;=*:Q44=4NIM.E[./6 MZ2IJ:X=6VKIF;8UHMW\MQ$I,I4OUQ@U9]>+Z:]93 MO27$>X;*DX^7&K4NQ1H'MS(FT`Z_G8IR1`)75J=QANM2H7$0$BJI'21#[#Q@ M'[/VN+1N+AJKP3Y][+RR;:=R0R4[OOZ"AP\"9[-=K+)VSI4^-4B>)Y7Q-072 M^FLA9=R4#:$=A.!Q=(V\S/,?A3ZZA*[^\JC,HE,P@7;(I2V""7I"P5H>'GGC MZR^(E)$2JZP=0G&E4"8H<@GJ+XF4,9(HK1U(.Z(J54::U1,<%-X0`#NMSAVI M5?8/HOW;`95>Z\I;O*+#.5#(H1K$I&EOO M$X7-VHCEDAR(*!Q0?U!6!D=B=+:@31AYSX#V&@F[RS`OG,=G\M#'M0` MV,6"O*E"6_]&3ADZ=5-HA^).\C<#KTQRE5/6GZU4M>-O-\H!5VM!7D9#P4"A MHI^;63V'\//9C_467X6Q=\;W2O&,K_'C'K-_GNF4LN2:C#U5WG%5F<[,F75G MC4`-NV_88VMBS@;VJ,Z#R[>4A.&8DKDH_N\-JG,SX?@H3-IOPH?GN8'UQ[8" M0V<7>;%VVN6@+@DC>\X>!\J/RG)LY#H7P-2HN4.R MB5/!(CET*>@P%@RM*[Z#Z92O6V]XH)&G@IX/J/2J(*`JCC2A; M*_,%YQ)HL$3RAL^?"A1IJUW@&I&`["\1::H1D&BPWJ4(2376#J,^H2!'L'D\ M[.[>`W#KX("%M!LTAS$SYX6/6BDF]?>6Y3@>8!7MD$VCA73-Y0;6WT)6CX7R M]55S/F4.$S*/0:$=Q*T%>RY[24=$4_\A(#DXR$O, M*SH+RE--*VJY3@6^IYLKC5"DLE/+#*LU4S`Q()H` M$.R>-N_F]1Z4'03;:&Q"'?DD.6E:AL>;CW2U!(F2$&7W>84K4;=$U$,KBEP< M&P3^[Z/8Q(%G+MD59'_LW5!5=*Y6A5J+J'@MS"#:01A?1GGC@)[IL801"5#R&F%Z0F&G@PC[#ND&ZQB>]5^F<[03'&]2 M[;QD$(9K=A#/GL=G"$&E7]F5I;#[`3]/5;)IUW>PZ):YDFS4?.&CSKYPD.&T M@[^>+O!/.@/[!IO$Z4MZI1MF4D(U/#_IC*>B<;0#%>2E"')-#VW^'03YRRZ% MK5`%:N66A\;XEK'3"4'.W_[-/LFAEES.MW6^PNX:HU0A5(1+SQ:5JI*Z/C#- M^UDB?1I@2M[:>B@_12?0NK5UG"W?4*A.KDHZ)$YO214!U[KGI6RA-X`M_SJE M,C"+N"@BKG4'[!"[O0'PXW!T&@^0LE)T`ZW[9@=;\`WX0G(UUT[US;&R%GL#F&>N=RN#=8Y4$6.M^V3* M%M(.6X[J@^`)A4>>A"GD4>?Q4>U#`]MS]`(P,V> M5"MM,OUZ%7_JD+Q/F#Y\5D$Y1Z+M69I#0.481#\,.3KW<>`$[I[.FV^/7<-G M^:LGE".7,E\-W-J>Y[YLEN_0>X.UC4\E8>6X=X%A]'-L4-U%R`O[8)KXV6GR M%;7)E](BP341"J3:!JLC$58UFG;55O&W)XX1Q<3+UI"BPV-EN-2_S`_1.G^8 MMVR%KNGK,]490U0!'&&,*GOIU1FC;(31ZP6,Y/*2K71[;UI\8-]'C$/7)^&: M(OBA?6G<6B-K8@ZKO>%KRD"EK_9\BA^'\T&HUMC;`\'W8$UK5:O=%-3 MN)_9T^*GK!97E\9XPBXGFWTSS%'/L/YS/QBS=UVJOFMMN<3Q"4QV\&[CV`L4 M\,W_*2OXNTNC:]_=#6:;%W.8[%T[-KHUJM[B^2\'+Q2[W3 MF3D`GZG:6VX1^ZK:U2-V)VC%3AOOW*>Q)_I55O2?6&2T;R?F^.N@"RB,[0ES M\6K%S7P]"6N5%(O[+BONITO#NAL/[6^69=Q`1.\/9L9X:(ZJ#NL/(?J^9KH5*:6>@,^D0#Z3B<3/I6%./CN7\&C!#`[&+PBQ M`CTZN;P,@79JW<9V9R@4!=USZ:2T<'KL6FL_;"B7?IU<6B^YG)(9@3"=TW`" MS]C.JI59^@ZF\3WZ=[#S`G67W+S0R94+A]DEGM*(YS1V)]7*+.DEZ+!!C==] ML45R56+%QJ:3*WNDNB66 M\+H-=<9ZB0ZYXH(;$[(J)"U\]M>#$R+XY/]02P,$%`````@`VX(M1)ZLK^/P M$@``URD!`!4`'`!S:6UU+3(P,3,Q,3,P7V1E9BYX;6Q55`D``RY9U%(N6=12 M=7@+``$$)0X```0Y`0``[5U;G=(C9)4^78 M'MOIV7YR$2PG;&/D`9S+_/J5,#A@$!(V(#E-/W1LK,OY+KH=?1*__>=U:4K/ MP'8,:'T^:=6;)Q*P=#@WK,?/)_>3FCSIJNJ)Y+B:-==,:('/)Q8\^<^___XW M"?W[[1^UFG1C`'-^)?6@7E.M!?Q5&FA+<"7=`@O8F@OM7Z6OFKG&3^"-80); MZL+ER@0N0#]L*KZ2.O5S7:K5&(K]"JPYM._'ZK;8)]==734:+R\O=0L^:R_0 M_N[4=E:3=; MI^B'9@O_VIZV+JZ:9U?M%F-]KN:NG6U]S=>F_V^3_3?3L+Y?X?\>-`=(R#B6 M<_7J&)]/0E*^=.K0?FRTF\U6X[]W_8G^!)9:S;"PD71P$N3"I23E:UU>7C:\ M7X.DL92O#[89U-%I!'"V):-?Y^XV0SCQ66/S8SBID5)T"+1C7#F>)'VH>Q9@ M0"014^!OM2!9#3^JM=JU3JO^ZLQ/`CMYRK:A"<9@(>&_R*VVM89<`7G3LH%_ M;R!SKI?`/`'@.C2(Z;D*!C?2;*2=)^`:NF;NAS2Q MB/QAXT8,L"F=X6*XPKT<3L@,.3U[L7"[FO-T8\*7_=#&@&H.HL6RFY@1_9$'F1^X8[ MEC_7Q@H;BP8U+4^.'KA<&J[G.Z@>Y%%8#6AZP:!*AJSY&?\)=1M/T)RCV0A6 MAOM&-30Q1VZ@Q@`]`G/4H[EO4UNS'$UGZF5H^?+L7G1D'K_W0D:Z1]]M5S.0 MJ5CLRY([Q^X%/MK:ZLG0QV`%;>Q,]*Z&F"4W6`HJ`;X!<(VZM87ACM!01H.5 MDB7'WO#!`7^ND7V49]P"Z?U>FF4]MGBI)?#9R$OM$,VUOG MWP'-6=N;272^4J=6P4EL1;,M]-@9`=MK1/E*3"J]9&$'FHWG+L\Y21/90$OH^1Y##;&($F`/5U[2X=KU2%^& MF?(^97$1!#OR*[!UP\%C8IYB)9=<^&*0N6DP%U#2\C!#F\Y43)$+1L9>DYZS MR.4CLV)9\A;82-G'3WK6-)B:K0=(DQ*'ZR;L)01;&G@3X4KU2;#0UJ:[MU,&V:.8T6/#,G!W MU$=?([C!JXNF5F`>(,<%'K[[AQ[C8OQ=W994DX)?)% MNND/_RA6A-T-Q`C6<]Q$#492T)=67;I5!DBW_4)!9=PWC&"^V,7?P-JW6BW@[4&[4K#Z:2W.T.[P=3=7`KC89]M:LJQ>HZE9*+"/%I5XA. M71J-L5=/OTGRH"4\>1?GKJGWPH%2]VGC$!N[4(^KTMC MI8\ZD)XTDK&73,?R8")W2^D$678N(_#;N_`OL)^@D6@P]?MMSU7NT9/Q5%:1 MPQ3L*FF;FQ'DG5WDGW"7.+P=RZ,O:A?98#0<8_DNVLNZI-R- M^L-OBB)=HY[\1IU*(S0'*+@[)VR'1K">Q0:;)NZYKR>H\2&_D)2ON`L18-Q) M'7]:L3$ST_B#IF!^Z<7.OO;:)XW(>=@X*_V\*;M8*1FV52,RL0^[Y>"G[KE& MT,<&7\(P5A+V#'NP83':L=$8];`3Y=;3.K9!4F];DDCY;G7/_,1):1L"0)^&]S!2 M8/OI=B&_^Z!L!^!]OH:1%-N01%F;3A3/G:KHXX4^P6Q:3,!HS MKI&X,=O-#VW-62M!OKP,&I#E>_:TA5K<$YQD]`Y?HV_AWOG[2B0#[R2:]"-! M;XQ7_,FAV8N<9Y8T`@AM,HHLQ)&.K]7Z0'.\9;FZ7-GP>;/Q0S-;2J994B(1:B:V4;$?->-5N3GC+H4KK9B9BIGYL,S,MIE=OVT_?C&`C7`_ MO?7!,S#3R1G6_&+S,]FT(-IJ(K&KC,M!6]YG+(8/;9/14@0S9U&4+NDPE9^)$_NS71`DV399*\$X\!+J]C_W:?*FA MH@S8/@*B*`%V9Q\3=OA21469L",^:X3C@G$4)?J#E]C/FAF1_7V5F4+5LA8A M/.F031(QNU79<4!&`Q*S"&^P=.3$)GZ4C.)S6XQR"O: ML$V`3.,T*-GX4%8LZF?E8*7;W8N.$?"`)]DL#.^'-<[*]<# M*QOHQH9I!_C]J%BU5H2M(\J9PH+E5(/P/I"KH"1O.1>S=0]`B@>DY1+>JE3P M)$M=<.,\,[V%)$)^QJ[2H]TF&HDR*_=B-O(;2B(BQ6[-(][1%BNPXG4K7O?# M\KI;[%U3-VDM*RX>7I:L94I$+2KX> M9A"1J=7#C58,?QI_#P]^,AL#'97<0YA/B70`3AA+Q^D(9(J/0PK:O+LFJD;/ MZQI=CSJK2LR(99:I2SQF5>LZ7$\ZJU/,BF5^J4B\8E7K!E[7-JM2+(HE9 MJE(_,2K53\?K`%U6I8;A$CDXOM.][8ISI+WA:2R&/5P$(KS=H2$=G]W\!K04 M]CM#(<*'G&65A617OI/&)"EZ0#?FEM%D.E\OV2I5#1%:E?D?H?EM3?O$-[28O*CJ02F[I/ MDD@TMC[`2`W"W4G'*7HZ2:/)2A>;J9)C* M%<43\GK[1+(C0QK4DA:>`V@QZS0Q+;=P5*I>R7!S)S9SFN`D'FZ4;5NS'L'F MJ,%[$G_6+;]H]CP^>QU#T[R!-OXQ9:)42'VS"\'7*P6*+28)F*/`&W:E%)?: M5,7-FPIWDL*<,J0X,2>KA\IZBQ*ZCFJ-@&W`.26JNX#**I\\3'5B,JT>P:@Z MSAK,>VL;WY'HP=[PR-Z/OEC**UI?&DX:[YJ]K!_&I_;3C)C4[J'*4UY7AKTA M*8-64EQ'EE#9#^-T!:F.@>$^0J]$ZEP`[[Q>"5Z94%GEE8>ICAAAZ8\' MF*A$2JZKRR$,41_+'BZ/VQZ_`P5$$UAQ?/J6CCU.('Y7HIJP(*N\M0)\D MI_YTU$X=4OE.6$TP'1_9A@ZP.18ELHN,6'XDYC&+2M*VCS^^LW+WT`_0_^[A M;5P\/]W=!6<]G4QT6D$NGQ^(RNW+5S?1]3E3JX>J(9"4M_=GPE$U`"X:)[8! MP;EBFB82Z!Y.K2`CDJH=<-(YL24(SD_3^X08'<]M/,B$I&H)G'1.;`D?AA/G MLP)F!%#Y?;FJ)KK[1Z?<^;2"PW!5C4,("Q#;S+Z,/MM)WS'`MD(ZQ'?DV9KW MZJB^L0#R@^-])81B9RSEA_:Q??5%#%/+^4Q#>)^+@(O@!0PY2[?\@=J&V:4C MVDD`OO=AU_.TQT M[0IW`7!CL,WV! MS/;9IN5U2SH/`T6%SCT4F,5$*"5[(PJEYG7O.A MF->%1SS,M",U<402<3J])_78AR_`WGPRED;**^6*K'76XM5E'W:4*4_ICVGI MMJ?<]ZL5!U_;J?4'\[5$Z8G#CX"^=B3W=AVI5QTL,LF5!(BY/F`[@AR(D]M^ M:Z%@CL0=>2B%Y+#''1I]-(>#C\,QRU($R1GYOG,ZQ]CM\N^N^?`.1A"9Y$H" MW-!Q0#V@%H13##0;GP=\3HX+ZC1WXX+.Z])8Z-Y/'TFS0=RX.)W)VJ MP\%$^GE;W"\A2?.7!O4!.L#=@/=$E*5GXA!NE:!NR(ADU3!FXEY/05J5F;0J;R/VCDBM$=#D]5%!BKUF4NQU@)$3M;678B.@B8K- M.X(SJ+W+I-AN@/&8I@(1T$3%%C49Z#$IMA=@/*;90`0T4;&<@R152T=8WQD@ M7!/69"H_DII);**$05[1XKT(D&G+'`5-C$UL6W1XQLDHT-Y_L(#1+H@?8(4L(:TG+- M6I>";_/2T9=%CI&!)`5W>C.BE"P":YX-.L.DH>0=\5L`'VUM]63H8[""MFM8 MC_[=%LG;QNW=;>-/=>E6&=Z.Y=$7M2N-E=%P/%4'M]LK,JJ-XFJC^,-N%&^Q MOS51%[U MY&9)D=<[`S2#>)*7P$9P:>%I>ET!0VPQD`"YF'ZBL;;@B7R7@)PNGXG;3 M0T8KQ#"3>7Z^-V0Y!K4IO*?A=H%#1NWO(":.+9QG`'#-W!W%TW*[I2&C+0C( MB4,$7YN,P3.PUB!EAARD$#^7&O+%4NU%_^$U1I&MEH-RH4VG4EP>E!;G'[_BDB'#*?(GGK@2^=?!_^&0. M>O)_4$L#!!0````(`-N"+42BM.LC]CT``""N`P`5`!P`&UL550)``,N6=12+EG44G5X"P`!!"4.```$.0$``.U]^V_D.)+F M[P?<_\"KW<-T`W:57:[JU\[L(FVGJQ/KLCVVJ^<:@T-#EI@VIY52MJ1T.>>O M/Y)ZI"0^E0\RTG,+[+3+CJ`^,CX&@Z_@G__K91:C9YSE)$W^\N;X[=$;A),P MC4CR^)'Z(+@ M./H)G:?AX229IO^!KH(9_@E]P@G.@B+-_@/]$L0+]IOT@L0X0V?I;![C`M,_ ME!_^"9V\_2Y$AX<6Q?Z"DRC-OMQ.FF*?BF+^T[MW7[]^?9NDS\'7-/L]?QNF M=L7=I8LLQ$U9.9DMXJ"@F/+?CH_^^-_OSX^/3XZ.3]Z^3&D]SH."RKP_.OY` M_W!TS/[Z_O[X^Y^./O[T_MCR>T50+/+F>TI_CDGR^T_L?QZ"'"-J MG"3_Z24G?WG3JN77D[=I]OCN_='1\;O_\_GR+GS"L^"0),Q((7Y3:[%29'K' M/_[XXSO^UUI4D'QYR.+Z&R?O:CA-R?2O1"/?0I*3GW(.[S(->;-:?`8I)=B_ M#FNQ0_:KP^/WAR?';U_RZ$W=^+P%LS3&MWB*>#5_*I9SREMJ6TJ[-]7OGC(\ ME8.)L^P=TW^7X$=J\(A]Z$?VH>/OV(?^K?KU9?"`XS>(25(V*NOU8Z>L2NF= M:[`W."-I-$[60]W7]@2?]IVLV*`";7WG5;A/BR!>"WQ;TSGL*[Q>BZ_TW+BW=TNS"CMDO+^E/'>#XI:"C$8YJZ*PLC8/CG^)^MRJ[*3T-.^7&S%FF MF;1%>)'3('_@Y2[RP\<@F-/RCT_>X;C(Z]\69K< M%6GX^V<\>\#-1W@-__)&(_>NCYIIC+(:>I"%AOI7$N_"E`X.\^(P+ENZ5)]F MZ4S[^:J!4HW0;_%#4U[9DO23"N`=L0SG/`X89,@V>E/K5`VJ>228-BDA=>G42V,:FGT#HW"<,'GX_37YWA*0E+`X-15FA5/HQF=582! MED\R09=<4@-M\TB4`L,A);0^?[@@JB1AL*09M3_A]#$+YD\466P31XGR7F(H M%6QI_-07!L,@$\(^D:3RH&*G\2)+YUCK=[HB+MDC`]?:;W^Y6.U(W\4(^>]$)NK"\&2BSO%K* MN^6-T`3+KV01$]ZFB\AQ^/8Q?7X785)Z!_I#WRG07_UVB1^#>)P4I%A*@DJI MA`LR:*`Q%DC^[-W\:DQ]N[>DMA02*KK]W](L,G1X0<195U>`:SIY[^_>[:L! MU39L-J(/]_M23B-^.<1.T-\5\4X(/2[92CJ7@D&)&S81 MR8KE#059C)*H@7>ZO*??UBPP6&FZI,Z`JK3I9*$&AF+V6/NT,VB"6I)@NTR+ M`F=V[DHI[7B+60>YM]$L$P7#,3T^R:8SET88EE^[6&0)*189IER_("_L)_UF MC4[!)9/,P-MD4DN#X9,18I]2C0(*D@A-*Q48M+K$08Z?TCB:S.99^LR7=O6\ MTFJX))8%]#:S-.)@J&7&*$ZY*@U$6BHPN'41D(R?Y)TDU*7FE_@9Q\=ZGZ73 M<.JTS-`[7DLM#H9;9HPBMZ@(F@`CT^FR^?%G@C/:FD]+CE03VMLJ>Z&8586D M;--JPB.>#5QA[#0J@XKT99WL_6"7]QZ*RWL_S.6]WP.7]][&Y4'S>2W\)X/9 M=`*%32?#V'2R!VPZL6(3$#J=+?(BG>'L%E>;,T]DKH_UM1I.ER/,T#M+$FIQ M,'0R8Q26)BH-U%&!P:T+0J>X^)(\XVB2%!0U>8CQ*,]QD9\N/P?_2+.S.,AU MY^0'E>#4E0VO6L>UV:N#X>9PS$+<9E?";K<)^)_$R83M#=Z0`= MT-7I`)F4=\X8H8E'"*DLJH01E8;AP49?@RPR;!'U9)P>'I/!ZYP?:PMX9X4. ME7"*K)9QYPWNOZ9VWJ`EZ,4;"$"EWJ"1\FYW(S2]-Z#2+JQ/)2U'@XZH'P:( M8.4<6,D!9($`SL`#)K\C)GQ)(IR=I4EY,4L;%RA%G3'!`+9A@D(.!A/TX/I, MX-*H$4?',.*#YN8##UROIYRP-O=51'DO]U54L*7W5?K"WGEDBU!Y7Z4MO]LX MH\MV;:2A%/7D7]31AD+..R\LP)G\RWLW/-#''!IA7US0Q!U*29!\,,8>?4:< M[(@19:(=;<0AB#BSO@)<8_/>WV%86@Y*."O(I<`$$D]!AF_QG#;"4Y#CFXQ= MI)SI(@F-@M-0P@B\$TLHI;U3QQJB$$U(%78;3I3DU881@HACIZ$.&WI_]VYY M#2B%T]A5=%"!T$<%$B'7IM5$`8($*/,:1_W*P+L=["]HO4SV;.N)$"95X"E,/#W.S7P MF#P^R:]7J80<&U@"L&?@E@0D`XNP%`;^8:<&OB+FY9.VC&/SBO!ZUET)0#*N M@$IAVQ]W.QLR^^9[;YY9`->?!T'TRGU0JI6QH]TZY=AFV.U*N7;+$HA]OQS# M''DEN%1FWG@%5&'F"6WBI*"!>VO/GUW,5IOI3HI)!?R^E@%R_O*40=0-$Z^].!T_T!8`PP,9*L$/E#);\P-69ZGTFVIJ64\G MJ32;;"I![QRP06K-/GK(HC)E.!HM9H)"T!D-M$`;#DBE8!!` M!TU\8B`Y;(31W?6.C&]G>:]FM[`Y5(-;6WMEZG^A=ODK2RX4=C;N7 MB\$PO1:;_K8.$]\1!^H[[_*\47(19U97@&O,W?L[##O+02ES#0`Y-%M>&:]` MZ=((R`3=QOHJH-V`OR_EG1Q&:&+HWQ8$-1^\"V)#=LR.A--#U"*TSJGIU9_! M,$+$),1^N$!<"H;Y)TE(.=E<_:I?U]9X#:V&2WI80&_312,.ACYFC)*]**J! M&A54Z^QV&Z+V9?*$;7(1Y[&&)"6;[._>K:\!I8PU=G76OOZ`/'>:7,2Y8279 MT61_AV58??ZSQK"[.F-??^"#V;`?O!GV@\&P'R`:]H.=87>UQ%=_8&0V[,B; M84<&PXX@&G9D9]C1C@U[:C;LJ3?#GAH,>PK1L*=VACW=L6'/S(8]\V;8,X-A MSR`:]LS.L&<[-NRYV;#GW@Q[;C#L.43#GML9]GQ'AKW%89I%YW2.I5E00*&@56PQ%?=F1QB@NCH_;OWQVR)8U>3H!4HS?Q6(N3!W*HYKB`! MS=SZ>6['W!_>O?_>C;DULUZ)D`=SJV:^@@0T<^MGOQUS__#NR)&Y-7-AB9`' MJ='#;=VFD0O"H((!G;AKT1+?SG:8L?=_9]/[O_/8 M^[\S]O[O()EZ.YOX=I[N^'A'+,WV_! MW%LZZY!.BZ\!?XVR_O&#]D-KG[`.,'FP#C!X\!Q@]&R_\`I+]I M87DU]WD:+MCX0,>:<5*08CE)IFDV*T]E/>1%%H2%K#)V>LY(,:0:#4]LE&!0 M9P#2/IMJ541U4:F,6MK;C`AR'+Y]3)_?19B4P0#]H1\#T%_]5J*XQ8^$(4\* MEE2@5VNUF`M*F4`R!JEDO!/&`*S/CXH2*UG$A/W1XHQR-0OB21+AE__&2V7E M!#FWQ%#`[#*C)P2(&G)D"FY4PHA+(RKN@QVU'[NGQ4JJU?VS*R[(0-44:/\- MA.4E@)2#!9/Q:>4JFU7"PR5-77IRKNTNA=DG0$<(%!-DR)24J/*&46D>FOI@ MQX@"B1B8BSAXE-2K]W=7;)#"JEG0^2,(Z\L0"<\PUC*("?FP]=DBRQA&DH=! M_"L.,K4S4(NZ8H`);$T&E1P(7AC`B6?2N#@JY1%3\.H3/%\(BQ@6\F[#20/L;EBI$`9!(AN$PJ)B7D],`\0T#W]GJJC61:7R M?_DCU2]IO$B*(%M>D!AG_7N#&CFW)%+`[)*G)P2(-')D.K(T&HBK>&1(Y0QO M\3S-"I(\LNN*"S515.*.Y[!:T+VIK%06$'NT`)4D^E..&@U4JJ"J)(]LXFP^ MH^/H8YJI5T!Z4FZY(X78I4Q'!!!39+@4*Q]<%-6R_@AQLWB(27@1IT%_,5XA MXY8,$GA=*K0$`!%!1*6@02F(N*3',2:=S=*$9]OA;\_EUXLB+X(DHKY+[1:U M2H['&XL*]$8=C08@(EG`5"VMX!*I512]OG&EPYL:L?V0JEX8Q&UO5: MG!)N?SU.$`3!)!,ZY;I<-?^NEN>XBG_6L-4`.\ZT)/TP1H`JYTLC!I`M?6PF MKO"UFJTS98-CBW5RE^OI!4F")"2T!Z0YT1Q"&*;J]+#B@,ITSBE:Z'GGWAI@ MQ72!=2:?=(H:951KH[_7^D#RAXWR'!>Y@89](9>$DP-L4ZLK`89$4EC"3L3= MW?C^#A(5JO4!*T8(LNZ)H8`K\J,G"(PF" M/`M)'1&GKR=)P'5>3VK]'0Q9)*"$UY-*$43*?(8% M$X5!AU$8I@M*SEL<8DK4AQA?X:)RI"J7K%5Q.L99@.\,=1IY,'2R`"F$294* MRAJ=`Y1@'F0'<9Q^I6$V1M,T0U&Z>"BFBQ@%M0H5^?>-'WW<%1=/21SCZ"+- M+M/D\1YGL[,TX1%`?IW=9.EC%LQ43FS=POSR=TB%]Q M7LH?Q@L!3D#.\1135"P\*:ME'-^U&BX99P&]33B-.!B^F3$*R[>5!L38L3TW MMYF_>UP!,:Y\.*5(D19!?&F[[*%@QCTK!*3/J:A-331@M4PF[IXN:M`BQFL&&X6*VB(."Z@4S=ESO MG^4;$&SJ^O'@QQ]/#CX!A&/WG#T?'!Q^__P$&@^LD">SU;'Y_]X\%X554 M\U>OXC;@-X/O!OQJ>3#,M0`I!ORE"F<8KN5+>GZ3I`5&)]_"H-LD*2AP0N>[ M37`Y?@GC!3M,]"E-HZ]T4JUH%SM5Q_E6K"O3R[QBU`-#QP%@M=E8YA5'[9SF M\;$T MS#3MU5TR9FBEVIRRU07C;08"%F:JD]'IY')R/QG?H='5.;K[>70[_OGZ\GQ\ M>_I_L)EBR72V[ M??J^L(\=3CE@V0YF5Q(,A[3PE/OQ\U(:!GG&LWF<+C&^Q7Q:(/8*1=4M]%Q2 MRKH:;789E<`0S1:IA'/9@D[V*.7H-^+6KF2]40F#A17.NIJG.,%38MQ%,B@Y M=FD6%>BY-HT&&.99P531[B%-%FPSO$A1.IV2$&USNHY@A58!C#^R0:D^ M8@&.9*U#:=*:&;RR6LW384%M)10G!J4Z4)X,&(AWCXX0]@-$NVT_`'0S`]?% MZ5!W`8>PJHS68[ANK549LQ_W-BX:1D&P894VG@+'!99JAQ0S?HLSB=@-$9(\ MXB14@[WFP;O+/`=7I?`G?M:O6%;L^@B$73=9%W1TC.9!AIZ9'CH^.C@ZXO^/\C+76[`HGM*, M'XA.TOJ7A"4\CLK]F]WD@MML&*URW6D35PABK@=,&)@F M2JI]U%'M^+N#H^]/#G[XL3PSS_YYX"$B"HW&0)93@^6AU M9OH<3TE(5`&;C:)+AME7I$TVLQ88WEE#%9]3+!41KC1A,$\,3*TC6-]3`KNI M`*QE"R4^^>I%+ID%P."-Z?"L>=E&H0;IN+-A14RJ`XMOEFB-:V<\!(/+QE&= M6N@BS:&U(`F+%V'=1"Y*=/.@6#OII+S*WX M8M2Z/*>:LZU1$)!KZ(:*6EY-5Y0"AM)K0Y><=E3>JK2XT@Z#]QCVO$\0D=U#AL'T[NKM39!=9SP!><27 MUFZH%V"QE=72KUK9WXJZJ4+J17:5)ACF#H)K6(I?K8M"9&7Y[,NH69ZU:A!1 MR1\+5150LZ^O`91U"IC&C1]AQ1TN[?CCFD,H5ROXIEL7N(EJI31HFG4@VE*L MW*B!2R_U&V766KZ)IGBES%(%-.7,[Y2I>`=N5["U:SHPRK/2]+1[/22^LU`# M0T9[K+IM;VAAG?`.H#&FTVIXXIQ--*<1A\@QRSBNPRV@,9Q0*VT`IY3VRBUU MZ*80A?K/TV^:06LG2I_+@%SIY)B/.[-%8'1FH%MZ.8 M"7AW#%-)@Z&/$:(X?N4\72T@-GW*TCR_R=*I\OAG1\(E7R30V@1I_1G6>2@1 M6)\'7(+M'E(1XGN,L8'?,JK>!3(\`:^2=WDLVP>Y<2U8)@W$H)H3"I>1: M'EC6LSL2_4#?J(SZ)0`@Z"W.,>TA=FKM^>K8TMZ7AITW-Z`L(#?O?R@ M40!#/AN4XI6'4H=3K74$#0;/!(=NZ_@]#Z-6PR>LJ$L%3W[L/`4ZXJ'-E)1UJGI/LH%686TX]>5 M=)![#RK)1,'028]/]FP2DZZH!(-`5VF2=IVN/O+6R+LDD1%VFT9*83!$,B'L M4^DSR4,ZP0L2G"YR4'RZ2#-,'I/RDE:XO,^")*>NE0[.GP*2L`']%$^IS'WP MHFB+024XO=0QO&J=VQSVZF!X.1RSL+Q*Y=A=C;`J@L;XX1,5`$)7!B]G]<#Y M=<*WH*ZGVG>]=`I.%^2-P#OK\TII,%0S0E0QBVW@\'<'`3T65@_U^K%4D/(1 MAFG&S9Z(&ZK\6%(EP8_\$1*+Z$L_5#915Q6XPR!(:R)BGJIXF_P99GK`U@X$ M8(KE)L#3N7*G4K/2U!9P_")S#UCO_>7JKV"&$P&2W0(2>N#Q#-L/?B8YNV?* MT@C`RUY=HJ=A5^7\JB=SE)Y2(>W^8)L2LGBP31"%-P#I8$H>\P9-J2M<&!>Z M>S).9_PR>)U9?EL`UM`D@R8[V38!-)&O$Y[5]V).@YR$BOHI9)V^S:>#VWF/ M3R8(9MC2H>LSII9%5:)@F=3% M9\6E2F53-N5DMN`<.3X^.>(,8;_Y[6^8/#ZQ)"#/-/AZQ-45A/[M`\6NV5HE MN!E5C[%I#W3OCUL?<9V%=R&%0EL(R&_%+)D"OE_0J?;68/>#L>BI46S=V M#BS#I3=K M`;?P3M=V1OIMI2BN;H!=3\^"_.DB3K^:#L_H5=RF+3:#[R8P5LN#(9D%2.'\ M<7.-+YTBIH2X%KA+?73:S=#QQ9D(1Z?++SE+6=>7$ M-U2:3Z$B15G],90TO9#]GOTK9!YQ7GT1/2P'NT27+P[/:4T(W^VC/\>8_<#N M5IF3#MNINGUYV+XRW=>'S7I@*#\`K/C\\$JUO/_6RYQ=)PWF?V0/'`"ZK]2N MW_6TGT59Y1\,2DX=OE4%.JY;JP&&D58P!7?:3]I.G2MUH1EUK'%Y]N")S($X M25W6^LT>)0#Y$L$&SP]`=)C#\!IYNBIM?QX:6,4N%VEF05F-O)\060%;'N?V MA,$0T8301+T)W/S^]>8\CNJ4,U=I@F?S.%UB7&>?:1V7OP]>]$>T-BG0Z?KF MQA7OK'ZN71H8DF]OC`/H6"+&.7*/CL#$:/ M8!DIV;M+UU.>1I"VP]\XR"*GG;]NA^OL+`[(3!6]#BS#Z>G%=:K7.=,XI``P M[%X'M;@50#4KWK((`M.NP'J"IS72K=V<<;1Z:G\>U0)KWS;?,)UOWS&ERLD` MO$US7N6"'W;HV:CE=J7&J@K=11JMBE,7\8RSAS3'.O+9P157:*HT__#.0].* M9)@ZK7-<_G>2\!LFJX74\C6K)&J]N7F%+7+,;E:JXR/[VVB"WM'^38J$,S!N MI1Z".ZZ+_9;.K,N?:,^`VA_$MSFM&TNFZI?9ZLKHZ2OJ`>:H$JSDV3TNR+9] M*DF^1GZ6)IR_[3_LZ'QP'_U-ANT>;D@#[RP'P502O<]IQ M]UG>/=[.W,K2;4JW_FVZLD+1F_/45D3I/Z5:WADW&*KD]G(9'7Y3QXG?[D&@ M>!,LUXH2&ST8(6*O&G;Q8:4$;=IN"U@9(,Y+,:C4&U8OR'=FHU9-XBN M"+^$-%=.STVU/GR:&K%+&)LM<,0(2[\:M\9C6&EG%2L+6R"RL1P`:TN;4MI0 MB/>1?U/D*E8_I,D"+($KD*U9X1J1@*H$[S&!OFK&Z$"N#IBH)LPJBN[#5)]W MPC+=8;&VBY7I`W"MZFI9N%11&3!#]8CE^9WCE1Q4CY):.B M&GH2]I3@QZ=RP,K]SZP4@T$]^ZMRBN884@#,2Y`R5MIK@TL_-0RW[-[='MWQ M4=1WDCSC?!MW>K4%`:"S144M:*TI!4I<`CMPTUJZN_XW"/Q8D MPS?5P>@;6J&"O6I17V-2M-F0`IRF&!U`;3$! MO]&VJFGUI%A]+<78,H*\'V(J8,MYV!.&2SLY4-%#[N$](/OQ8>,!!NK(O]F( MOQ>!K!JW52#[S2+GJU/?`A[U%36_($F0A%L(:;4%`2"V144M"*XI!7I(:X9N M"FFG=0G@R%T/12QM&:MT$BG3W\LD?<0"$JBR**`E!G7\%R$*\64IR:++J!8% M0IPL#3&.\@MJ(W[+Z'K.;]*/7W`6DER9:]A"S_'C"G;5Z+VYH%<"X]%LD4H2 MYG.]TGT53QCA2H-1,6]?-CE&39$%_=]T\/;'Q>"`O%.;@K6N` M]09R68E[$;T.JXLRHEU%L;*!GF=R:$H%]V(N:Y=1$K'_L-6.YR!F0],-SD@: M];=6%*T[K`BWJ4>&5ZZ;?\1>'Q;CUT"N2/DG.>Q:TIXM<_$?\.H#GBX6RVL[ MHIT^RY:TU_T2Q/+=3BM%Q\D:Y]Q(=T60%<,MK((NG:+(+'B`'O`C21+NJZ9H MB8/L=1KUQ(-1QXEV8C`,^`"38G;@ML5\?&H:!N<[$51]G%!Z_BEA@H]*2\O M_G4A2E_Z*T4`<4*&2_&&)#_1"H@:U]ECD%1YU.A4,D]C$@55UM0;VE+,Y96Y M*ZNY9Q`WZ?I-^P=;*MOI@[;;;([.4[C;*!@,Y;=9&^&(;:OL`]0IG0>+[?+9 M^-M\`:T^`>[IB(T:[+P).*CT'7E,R)2$[+Q'>:^.QMDWM+R0X/P>OQ2GM!J_ M[\)N:\'8F\Z[02-OK9^O@>%UN(3U*RZL`:4%1L=OT:?QU?AV=`FC]XO5,+W@ MH%%PFF36"+R3958I#8:E1HB*N\ML<:G6`#>X;#0D0'3DZ[O?/7.:F[NZ]V_1 MW9?/GT>WOZ+K"W0W^70UN9BCL[/K+U?WDZA.ZN;ZC#YZT:M-2QGKQ%-[?7-^/;^U_1Z.H7QU#X.X[-%D M4KZXQ#9@^';](T[8N-$*IO4.=6`93O?!UZE>9TMM2`%@R+L.:F%7;55&DX:Q M*06MB@'GBZTJ;_+&0PL!1VJM1QY6PG[1VLHK?WB+SJX_?Y[<,T]\QQWSV34/ M7=[_ M"H.G53ZIFX!&T:W':$QKEF8UEZRTK42;C"8=,!RT!-JG7J6&N!YJ*X+SE:H: MVGO+025`8*:EQQR@#IZO`[WF=V_1[?AR=#\^1S?RBKH]@FGCUDP?R+A+9ZS-S231YT7TXH[HY4%Z(9*&ED8]#$#[%-F MI8$:%1AQVAU^9,LZ#:H!LUD;3:?S6/NJ=&:P9C7OM!N.5>JT?F#':JX_W8YN M?IZBM"6MUP+#/$JAD M/Z-10_44EBN"F[6J:O@))S@+8HN]"TMU")Q45@*!D?O%@\Y_F-!AX'QL\49?K6XVXMJ>M#=FVER M63`<,P`4[Y[5XJB4!^?V^A4RAGYJ>9^DTH=Y*F&PM#+YJN,C=G3P]&[\UR]T M&HK&O[`=51B$^I+CZ^DX+\B,.F!5LI.^D$OJR`&V^=*5`$,2*2QA_[3^.PPV M=&X3\,.Q2W,DI5-Q&SV9P7CN*1F4P##/%JFX]$_M-1A$/(^"Z+5J[7"&^!E'17-8JGKDI"#JM,FI)4B&$(. M0:M\GO-V:\^T;VM(SC%MSZ?S5<)P?GRT3"A>YR"W':;7*LOMT+U!=;O#^1H% M@:'R)NAUB>CK$E!=!&I]H5Q0AD%[Y0T6.Z;;JX.XBV3!9UM=,!0>"%AUA:Y[ M=PX&.2\"DO&L;JU[_),D+[+%;!4"*9K%4M/55PP*C7Y&`PT4&P2S]EY M.K6XET1_%KY-)0N&7P:`BAR`]]MXU5IQO)-EGXQC'!:+(&["4`ZNT)TDME)S M=MQS0"6:8Y\6.MYI,Q"H++-HK=D\WK>K4^F+O*!HK_+654"Y+$_IC MB%N+/78N=7@Q;I^06J^2W4>CAI4!ALEK`A?GN8SQ\1)-\GQ!J=S*=WE7T+EO MD&W^@)\BQ*R#W_8">7WT+/J2X^DBOJ1=,;]G.Y+:H'/=DIR%H9M5M0E,URO& M.V4WQVZW0X)P71Y:\`)1S$J$X9'OPB<<+6*V`E\OQH_R'/.,2)"`Q?WSM M,P[8?:SH.J$]V==A=+9>8ZRJ?Y4F6;<%#%UJK9*\[&`.KZIT M/].^&#"=8'WLXEV;V2S(EFRCY!X04?$@>/'P-+\C!1K55D^)@PJ"@SQ-\,ONVB;)ISDE/\/K`3N]*.R#(3; M*S@YG!4:EJU[5O';/WO72SD#- M.L[FFK;PFUFE2<$[?8:@[#/G'!/?F] M'#B2KU^PGT%]TX:0C^_KENJ=^UNOBB;D+9XPREDY*.4%H:*5JV]/.@S[;3Y: M%$]IQDY]?TDB&A&MVH:OZY\NQR\X"TF.;S(2XEO:')MWJ"U\&%2'VUI##NJ0 M&W]U?SKLMJHJ;+16&FC.5'(T33/>L\L^34?"19&SE7W#D`,@H'0]>RM_]!/XYV5PTG=[#;_AI`Q[JC*JJS+P8Q MRJIO`NF5]0N:O"*J!NL)N7T<0`:P^P)`6P(.RV2PQ#,@E1#Z.Q>#DH^IAG5) M$CRA/ZI2Z,@$O;!#`"IE2",%CR5]:!JF,%'$9;5T\;'.>+J\I\TT>B%2.UBH MP8G*U@$]Z"G#`\3TT=]9"4#ZO;*NLG,60]M+7@:(Y7%=]:P(+"L`C(]9![4J MHY?]P1@7.]:GR^;'GPG.V'6KY27;6U5Y(#M->$YH(&[U#=P#U*B!\CSR?#A- M75=YIA4--$#??S8C3;7,&8TDRM#8.A2X,L%1R'[`T!(VYJY)U>#3?! M[EP*5PF#&=5,"/NDND\+.OL.N-:.]GVO%C/J6ZFT[CT,B9"SG5TEP&;!5)#P M;F\M+"%]=BWG*3*YPD5Y1?,DG9'$U-VD8LXZG`9DT^4D,C`ZG1J8>$:B MD?34\?Z&R>,3G9Z,*,F#1TS]P`/.JIVS_'JU8<6/M.*'92Y^/?[`@SCZPPF0P"TI M"#^+2.>N=^Q8+S^'/GX)XT6$([8)4*9X*Z_T"4U[5^T)K=L92WBARW6.R^]2T\Q8P<*_EDQ?)+0.C\2&O&5 MTBA:S#1WN4)*$E)@OG7=K\LH#!>S!7^8J(U> MNEHZN!1XAMV@#I(TQ[4\"D3#;S^SSI:BGI@77ODLX1A9E/]JEP[M'-`5EG)! M)P\O=+1"*UL;/TW3W\OM=A@^[Q+3X9]6X)9B#V)]P*>0=>F-M'#;=)(*@AE! M=>C$)$HL^4PI`H,SE/PAQA$_&GV;+H.8+7J5[[O@2-UA=#J.XS(S_)YK4BN` MX90-2H%;M1PL@MT%<9!15'\+'C$[:W\]G9(09WE[:J-H!3M5I^>0!U2F\FFQZI2@4AA>C&*&*JQ',T&V M9,5%01T";-W+7[(#!>>T;NR2#DL3=1XL/[.]1G),N-]QY=+/JX=5AC+I[*SR"G:K;U]_M*]-]!=ZLYYVY M:X`5/7"=DLGF48!=+C@$2Y[>L95=2KK,((HYGE1HEQF7P'BHG59/'?I`4DV)!S;'C3B;]TCYU,DU3;;.323[S:CJ9NFYB&AQJSQA'[RH5 M?7\#S!I/,VFW*[[E7'J<:`^-[ZZ2-G-I7&[:O:J)=!7PL?W[G2YF2;ZS3XY; MV4S;C8UZ'WE]'5!51<4\A,GQ?L<6D4N`KZ/;_8)S=GP@B=BY]I`]$):R7[GJ MC?:?WZ=..K11M]EW;;_]^KKTP)KW>WJI7J;VK0I@B;#8KU]ESV]%%+U#1]V7 M1M(XGKK:U[4&LD_>8/V&WE%8;8GBUC&YNS2J_,0 M?JWV*GV!1P?PRO>M+:K>[_4M[3WIU_F@;<1=].UM(@#5O[??M(/Z^/8^#^T4 MI?NJP]XRW[0YZAI[[>8#0>Q53U^K@;?:V0'7]?9W:[_LI`U.;2/:D?'3[ MP3#VJN.OV_3?;F-TC/R`Y`.)G^!\(8Z_\P)J-O.408!"& M5^<'UJO_&J>@_O^:TB8+*Z_[!(=5U?=_5:B6SP+"+O- M>98F_$&Q11!?DBG6O>`VN`A?&8EL*Z?*/F32]WZP8@/0QB,133FH51!B)>V( MF>U,`(HZR*IOI>:,@0,JT;#.0@<&T^R!:B9)[1OD$(.JA_Z(P7^;CQ;%4YJ1 M?^+H2Q+AK'4%DF6$R3N^_Y:-,*TJ5P.*14>]Q]GLO6X\@X#.>9@%H=**>,L_ M-.^N`69[:#T0U`G=MEJO%:,"]#V;H-M;W[.Y27;F>]:']CI]S\;MH5E,@NQL MQ*GQP[:FQJH6.QYD3S\`_;LQT?Z(`['H]-,F#!R=?;M:SZ]]0:JBRA M'0%X:4+E\*37O1$3VX-$H6L.E)?I5YR5/Y$94;W`M]M/^E_SWV[CF5?TM_,] M6!YTMY54G19%=4--[..F?O>Z^S<\HK:>B< M3S3ZV?_S7"ZS[)P`9\\VZF9.K@/(HV\P/5`?3MO."MZ.D>S3U'F#IM[F''D- M&+#ZNY>ZJW:S45#M9F?-;G;8VLV.R12C0Q24WB.U\Q[[,>)`/4'\*D^S'B`/UQL6K')W6ND)E'0E9\M+=J*9[5K[7R')1E^."#FR[`X!^\W[H&_?8 MZROWGX-_I-G9(B_2&<6LVO`4I>#M>FHP"K?Q*RE0&Y]GS%ALO&.$N27Y[S?4 ME=!?4'>C"A3U*FX?G36#[SXVJY8'TY,M0`KO_^$"Y4%,^W385F8'.2O-'=U- MT&#M+[A:R#N[C6`#N[F&H!/V3AI;A,)T.`S9>[@Y#7M#3)Y9Y+`6=W89ZA9! MP:.L3SA]S(+Y$PF#6#54*(7AC1AFJ$+BMI8@J,'C%C_C9(%5+P*N_NQR4.B# M:M.D_IOW?JL`U+=\_6<8YN[,@I+H%A*US/"4)CDYQ0G\HV*$,OF9$ M'A9\UGZZ',_F<;I4O@DQ0-\EA0=7JTU@:V4P]!V*6"3O2AH]+!&NQ!&A_RP+ M17.J`8.S6]R4F[!Z)SD)?PGBA8/DYOWO^3_\ML5FV]%65'EKDK[+WEHWQ)5>_[KVKK^UM+Q6;;&<] M<_6IU]D;A?KU>R#;:V3;V[,TPO$K['[U-;YS\DPB3">T0;'UZ-;^NWO;)77- MN+/.*?OHZ^RFFIKV.VPM@I8$Q[O*>[:3RJVRETLZH;O/.MM/<%FC;2**/BKWCP_"6-:3$Q*9:NA\_^E_=^`)4WYX:K_RK^[M[U7UXP[Z[NR MC[[.GJNIJ;#W344/IU06D4H8VN"[SD%VG3O;R>T,BP_NQ24,ZX;;RET+X]=@ M=<]=5E$ZGK+A-#;D/'9R>H^M0G^A_\Z*@+H)@O-[_%*S^:7-U/QG=> MS%<=@S[^C/M7'F5_!V8.*3CE2>]C5,KY;.?WAG9^#[F=W]NU\WL`[7QB:.<3 MR.U\8M?.)P#:^8.AG3]`;N&=CZ#W,YG=NU\!J"=SPWM?`ZYG<_MVOD<0#O?XKB<%#R1>7Z3 MQB1<:N8^%DHP+6*!6&FFK*WKPU;G.$EG)&&K4,K'E20RL"RA!BCL6*\D?;3V MA$^5R3/NY5Q4."2]."P;6&'MFZ-10CG3J@[0\E/M'OT7197A(,?GN/SO)+F> M8[:^D3R.0HJ6L(4-F;',6N!L9@U98CJN@Z)*F5U+2&MU%#3Z?BQ8X#C&/$/* M3<90%#45X<-N:O.A;NOX[ MR';N@0/;RO<&/M]#9G,?'-Q6?LJPWC^W)$"VM``/;EM_3?4M7?\=9#OWP$%L MY6H!DKVE^<>"S!F0<5Z065!@=EUXNH@OZ40@OVSR)T3KXA"NRV-9#FB!*&8E^C"\Q4(O]%5>ZR5>*,N[=^$3CA8QOI[6EW?S MFX!$ZFYE4H!E#TNTXK9P$9`X9SE\HEK/1_;IL@[T?ZI3`3?Q0K4B+)4"9@P- M1(#C4'OE6K.>(Q<#UO(ZC/VFOVMMO>=>#W:V8:O7'Z12<-M_#]8BVG!U,PN% M'-RVWXM91@>P7J0E;Y'(0>Z_>'[G]Z+2V?I;%:_T-U*0ZH\AC-,'9:MUL*N>GSJL'Y\ M*N3%H)R7TWY\TS+!MR-#E^]`7D^%^IX&.0E'271.X@43+VYQF&;1N2RYTA;* M!$V)#2ID?*0LX66SR;Z$*@^L?+YD%I5?0$'!WB"AWT"1(;N#(P+)7A*\)%-I M_O]U]$$3PQ+\)J\I!E517DQ->:9;]NG]'9BII.``#KTM?Z+BD]#R%CJPK&$/ M>)/.TO*=!^@!/Y(D*=TH+3'TXBW[MQIN,LR6FO&2!`\L M5R?!.L**4H":5P.NW]0M4=_\/<=33+\?T4"GA>J**JK-8-(!9!1KJ.(IAE(1 M44W4L=<5+NC_-"7X[S"&G@+(&C)4FK[A[2G:-/S]*8TCG.7LJ%>QE+6P*`6H MH37@I"<6*M$_H5(8C8KRM3P>01D`LI4U5$U/:8XEZI-= M[]!(G[(TSV^R=$JD0T;KSX":7H9*>(Z9R:!2R%/;-HDDV&PDR>4>7Q`"U,YJ M;/W6;B11+>J[S>%RM(EX^ MG7@WV%"DJGQA:E5_[JZ7!*W>DKD)EFPRJ7!\>B5`7

JS+'VS>U[K#:/TR7&/",GC@SK34/T09O3`K:E9>N24%44\K^R)5:W=OVW+/6` M_*%[HQ)H>ZJP6AJQ&1HK?4^&N\+%69`_W60INU`7G2[9R[_&5)K#M0&9<@W0 M0E8Z7"!6!JH+00]+]`TKAYKV6[2:\8Y\)=BL*UMM0^?WZ2C\8T$RW.2@I!4J MVC>89?:UUP9DWS5`"_OM51%LA;HJ!-6E'"!>SD'WPK9W\YY3-Q*G\[MT6GP- M,JF_50J#-)X*H\Y6E0ZJE6`YU4G"SG"LZU0EVH#LM@;H@4ZU*6,H(,T0=$A[5@"T?1F>'9:,M_:)5#AV)>$I+$V*#L MW!P`/"=Y&*?Y0CY`6RN#M[`.\P#SLF(0+P>M"O)U'B_F[\#B2'X,5+.?9*<) MR*8#`0OG_6IUQ/4/^9.AJ%V"YWVI41@N>-(3')WC>89#PE'1GV/,C_0FT6B6 M9@7Y)__]H"G3MLJ&1(=M5TERNK[^`&I_X0`UW^`.HOV5`Y@3LK7/B%<9&7ZA M,2Z.6*O53^BFO_`-7YR%)&?KN.6=2QGU7'T;$#6=5UDXY*;R<"T,+%9MRU4X M$`=R@"HH!Z@$4]*X?AR93FK9KP]0"](!*D%!I7AN:/1/5++()TD9O/5NCE;U MQ#<9":6CJVY*]Q,-6PDM$!ZBYSUB!JBG/EMZ(\TN*6VOX MNA;^"#\(P6OB_'H5WRGM&TC_`LQ?76WSQ_V!&%X3^]>M^D[YWP+U+]`#:!A' MJG5'C]Y_$(;7U`/6K?J.1X`&U"OH`1O/K[;>'W:*:)]ZAYN&@#$A'MY[VK^Z MI#_17]>_HO_#<-'?_#]02P,$%`````@`VX(M1,=.UP)*)@``Y7\"`!4`'`!S M:6UU+3(P,3,Q,3,P7W!R92YX;6Q55`D``RY9U%(N6=12=7@+``$$)0X```0Y M`0``[5W==^(XLG^_Y]S_P;?WW'-G'Y)NDO[>G;N'`,EPE@`+9.;V4Q_'".(= M8S.RG83YZZ]D;&)L2RH9&\EI]F&GFU;)JOI5Z:.J5/K[/YY7CO&(L&][[L]O M6N?OWAC(M;RY[2Y_?G,W/6M/._W^&\,/3'=N.IZ+?G[C>F_^\;__^1\&^=_? M_^OLS+BVD3/_:G0]ZZSO+KR_&4-SA;X:-\A%V`P\_#?C5],)Z2_>M>T@;'2\ MU=I!`2+_L/WP5^/R_*-EG)T!NOT5N7,/WTWZNVX?@F#]]>W;IZ>G<]=[-)\\ M_+M_;GFP[J9>B"VTZ\NW5Z%C!F1,_O?6NS_^^Z+;:EV^:UV>/R\('UTS(&TN MWK7>DW]XUZ+_>C%K??KZ[L/7BQ;P>X$9A/[N>^^>W\7_VY+_W;'=W[_2_[LW M?600<%S_Z[-O__PFQ>73Y;F'EV\OWKUKO?V_V\'4>D`K\\QV*4@6>I-0T5Z* MZ%I?OGQY&_UKTC37\OD>.\DW+M\FP]GU3/[5YK1/C<2WO_K1\`:>%8D5\!F# MV8+^[2QI=D9_.FM=G%VVSI_]^9M$^)$$L>>@"5H8]+]$5W9?3>%+5&3UEO[[ M6X)1N$)NT';G/3>P@PT%#*^B9H2'J,,'C!8_OZ'DY+NM2ZH5]*M_@=`&FS6* M:(G6OS'>EA]HQW/GR/71_,ITJ("G#P@%OFB(?*J:!S,I^\WN%V3/_AVO&>RHTV1UW98+=+@!#V3+/* M/C\-5RL3;T:+J;UT[051'V*GEN6%Q%#=Y=AS;,M&0IG)]5+9X,?8(UH4;.C$ M\D=HKRE8HJ'R:"K4P-7*#B+=(=\A&D7%0/8,`%$"2*L#_X%,&P^>,R=;#"J, M8",$FDE1V:`FB/R$YF1&"S8S;+J^:8%F&1%=E=.+1>")9R\"TAWY.PY,FT`% MP1="7>'TXBVQN7ZPK0E:>Y@JDWBJ89)4-JP>Z<';('1%IK6%'8S)4B8:%H>D MPMGPWD=_A`2?WB.U0/&\5]S^R--SM=-T;=,U[/,S\]ZIBI7]OFI==V##%E/6 M.+D#)2N@JVZ`:!F?"@IF'.!8X5T<68N[B$SICG]69HM2W1<4,7UMVC@ZO-\B MTP_Q=A-=+=?<3RABNV=BE_SLCQ&.C*A:CEF]'YG9H8GIWN6Q(NYRW=4Z2<>R M+#-+9TB/<50`BUJFCQK7ET13N_:C38[0\Q)+#;.+(PQ[M(Z:CL(@\N0"=LIE M^E+""%7D9X0MVZ=K8I5L%?=<^V$0;!K@#HYT/)2P::ENZCPP`F=-,66=QT>P M8"&T-1HI?/T4D_*&N<;()_H3#6A`?M@C0<\!F5S1/.F(CO5P_S_YF783!VM: MQIF14*7_2.8-8]N%D>XC'GPR?,>S]D;LT-B(AT5"H[]\YXVU?>\3F[)V.V3' MO$=.U/UW2@LC?5MFL+%THVB-CZSSI??X=H[LMW3\]`\1(V?O6G&LYB_DI^_; M,4S0TJ:?=@,:'RL8.6E:W#([T+12M+%E>)AH%T$LZ=/$UIXJY,-+<8NWZRC@ M<&8]V,Y.BQ;86\F*,A:;)V`D+5TRA*-#T(FF8J=/C.;YGVC#PR#7%`A"2S\4 M&%RK@"'A8T:Z+9;^?@N@T"]T$GH1CRIE34Z:MDR%7*H0=R?$E,5KV[=,YQLR,5?QV:V! M('S0"001[^H6WM^0X_S3]9[<*3)]ST7SON^'"/,68"8)$)F/.B$#DH(Z>'[U MG)!($&^BK#6?!TNN*1".3_K!P>!:X?9T:[^[<_YAX<,@V!2'S1#XE"CM4!,`[O'=NZ=CRSZ-2_&_5>,_"933_I M%["K<&+R5BO/G0:>]7ODSRKRB!=.3UPZ*#HZ'JD!`E%YYMMN`;=GH&OR&V,1 MX32'@J/ET9O)OGI,Z+8.J/6@/.SUC^DNO-YN6\H.GE6MA^O<14*%_MC3- M]5;#D!/XR2]958M__KX;WFAQ;;N$(9M8@N?;`K=Y3`ZC/MAVRK/7]GV"CIB1 M;#M5/G0IN>X;$(.3ZF>R0]&(]^Q04'+-E;G6^1(N@H'!JAYHT.L--'.$_(>& M&A]-!]%!(17AB6=0!QCM#;M^8T+I4R7WX)9"#\ZXK4E>TX MB.SU\:RO:G+$A0";HR,M,#]WCNZ#VOZ8:= M3.RCX`'AK12$5?#Z2Z:($(1W2:WPX/,I5RB93%&4K@!.!> M#YCVF`+NVQ5&%\I,>T4:\F=O(HH ME`4H2H/)YEL/H^J8:YNHB?TGFM/Z'V&`\-1;!$]$&F0>X)V_^'3JHAE0\6$YA$'Z0LC7,3X5.KB&^7P@LA`#[3Z1(KNTB9[V-WRVGNVG)"& M7VX\;_Y$=K9LUZ@(@Y="3D8D>**8VKR]=FQZCXA,UE$L>N^>B7A3".\!BG3-G@XPTK*R MT-7FXP`(O-BI M6,RY'N@D-P7C.Z1Y'ME``4BAF-7F#)'&#"P//>`C*H9#-,_<]P3XK`1T4.!J M@"4N*@GZ!&YH7C-8K6'PE.;DT,: M'C[G>J`C8SF'&$UMS@MI5$#VTO1SFHS'7D`&1;@VM\6K.+-]@S>2#=IH: M(F@BA<-Q#)=(&6_6:UD4`?61"P*D/"(HLL=PGL!#I-`RT:HMK8Q[N0*'\D7- M.20">)KB.!XG4T`T8$&:=V%C*!ZU>4.DG<,CB-ZGV;D5?`F]%&S_M=?;7TRWIVO8[ MCN,]40RO/=SUPOM@$3KY"T#B&*I<-PV^8UU&7GJLNYPLZ]26H;VBY93^W"OT M*Y6!SNQ+]>7M`U`O+SH]H"?\V@$:V(]HGLW^E8:^3%^J;X(?`'UYT>D!_;[W M@RRK(QQ)8QX=OK./BXB<0&QZU3=<#X!83D0ZPKHM+=4.@P>3O4E MU\I@9(E$7_BB&I^2T"4TJN^\5@S;OBCTA8Q?W8[#8)GR=K5%."H&K^8*=Y7X MV>7701"Q\HN7A^QQX=+1#D[X^L5P<:;*E3Z:%-/VH_6J/X>;%B[^Q[IG=V.FO/>K>]X6QJ MC*Z-T;@W:<_ZHZ'*ZI5]ES"+=L,5NV*9!"I#8::#_#B]G%L_(-=0L0=5(/UL M_*N835TF.9],!?3B>Q2T0?C1MI`_]1SNDL2F4>WFE(-&S+T>*-U@S_?'V%OP MXOM[C53['.5P*."OZ;'A>+EQEW$5,D`M7@Z)ZLJ5=?#JJ;(<6C5#^22 MX3ID`FC/5[8;O<1'WYV,!\]9EH#TJHM;BN'P2O&E$Y83(E(R!EK%MDN66L>+ M*O(((120J7;KRR('DH(>@.58DY@7U3OJ98%AZ=J(TQ"`YZ#&/]MT`$7$&V^'N..5Y`A@$ MRMWWLC`)6-<#GZ'G>OLSAG!3PB%1[J.7Q4C(OAXH77L8V4MWF[EF;6;8='W" M%)'JC6F[=(Z_0@O29F8^ MITU^"N2RWORI<(@"B%,DTTQY22KI'7X1FTV?$)/;I$GNUY7IVQ8;0T9SY36, M9+'DLJW'C)D=8M=VPH"70,4D4%YRZ%!T,JP?B@]-I8FDWB)'ETCF])?OOY%3 MWP.]Y/%(1KM$<190-@&(XR2DOSR<2R8[2':FK9U0W[B+A:9P929]]O7:\)T9BY`=@ M8F2G/?W%N!Z,?M/D6>\=6U(7U0NHU)XAZ(#(\?71)D!?;>Y\>A-SMSJUK:5%H_GT9\,RKS%KK^9KJM-#*]*1.,/10MRXBX%AV!`WYLX,BC%Q@G0(8 MM>JTTEI1S)9FAHM3#P5(CVRTR)9?X,P<`CK5Z:A'!!TF0CW@YE59.;@J31FK MK^^1LN,I@*10]="$%_E<>QB&/8=$=:KL,W#P:>BZ*GRM* M+B&E\FMFYK,P+GA(GZK+9QQ10PX7O1XJ1.]+TSILHT5T'Y?P\9N)R;`#GVA^ MPL<(=QS37G&V"I+=J$[5/J*BE!*P'KJA*-^MML2"(Z(NE2G7T+2$Y(T:Z=03 M(:'R!/*C'B=!4FS^0S^$08S(@ME%V_\28='\MQ>);8L!NND',HG$014)#NM8 M>2[\,9>C:E#08X'*,Y.O(2NC-T74RM/KJT),I`=LT=64#Y(=PABC=?1@0CP1 M%M[DI)000N6Y]17#!N7[M6PN\N*+N4W6RWB9)`*,Y"K:EY;M3_F%@&.9OXQX MCS0A%*YOP#F!0:O\CL`1I@6NV'1?N..'[2J/O61GA/8:SPK) M(^P3%!4*!SU$*=>+\JLHQ](:L2A?HP)%LJQ&BX1=056I-O_FL50)*%2-%QT< MHO0&NMSRP^I$^56J(RY$?$'JJ@&1..)G9@Z9#8JZ`*=(-1U]@1!UQ3XYZL05 M-64PSY%"L:ZS7.51L&8(K?D[!GA"(3>7%MR'\NN956;:2DJNZ9&$:'BP&3NF&]#J7N37 MJ$HB&VN9/I1?^3T`,*\TUZ_%??W"NU$IS+324YE?7?AX959](YCP6U!:`=0-=')2R$I'3TVK4E!Z+%IXWTIS`9X=Z>:[E66BS^$@Q>\Z>.=]M*U%[9%8U/;_%JR]H])?Q;90LR( MMET1-GZO29:E1J*XMEJENIDMD:\(5CTFJFFX6IEX,UIP!U\\CWW*SF,7Y\;T M[O:V/?E&:RQ.^S?#_G6_TQ[.C':G,[H;SOK#&V,\&O0[_9[*PHMY!@$USC@T M*K?7!TXE#9D`Q(AE-]8-M,4D::$P7V'/\CYG+>_RW!A/Z&OOLV]&>]@U>O^Z MZX]IM5.%5L;,P1`;&X!4;2RF>'0OD``L3ZX7Q?8'QC(?CI$6E1[&2`LNV]L+ M\]1C$\4&ELAEKX9?LC;Y_MSHC&YO^[-MU6%JEIU1M`;VAHH70`YSJ1V-T$PE MNU'IJH2,%&"TLOTH-MM2.&=]EJ5$IX<11R6T'CR'"-FG4T^P*;3=UKNL[7X@ M.]E?VI/>+Z-!MS>9_D^TH,Z^*339[?#%-IEMIW)O2N/O>](?>@&2LC>)+A2; M6C$^V5VIK$3T,*/XVMW8)"MYJN!<\4+8:F6-Z>.Y,>D-VK->UQBWZ0YU-FD/ MI^W.K#\:JEP%66R)C4Q,J=#L6(.3,CRI3A2;'A3'C#&6D),>YDC68(MT%Z>H MD$7YCOP=!Z;M!JS=:>LB:Y2?Z.YTV"%;TTD[,L1H@WI'?IG,VGVR32VY0644 MWN"/6?`B$Y2XRDHA_&_R+$@\8@U,1T:L^]8CQ9Y.9G.#O"4VUP^V-4%K6F\W M]>#-GJU<9FWE,XW/C&XF[?$O_0Y9R\:C"3W&56D?!8,3&`670N6N#RWI86$W M*+G]'H18I#RT,-.DF(+<7E(ZKHIMI/W63OY#T;=>S[CJ M#7O7_9DQ'K2':CT=M,I4Q&.\X'<\'Q*P%%.J]6<4#BZ..\,\&<`>U/LP0`CF MW192$M+#]J;AO8_^"$F/O4?J<2DVO`^Y!()W-/)V->W]ZXYLZ(S>K]3CJ/)E MLPP;D"PO%H72W+7]04$6,#:)ZO?)!)CD,M,$O.MB,)#X-3>.W@II5\'*G8]&BYX?V"LR:7/NN&3;J7Y73CI&7YDP$3\;T*:" M1Z7Z03=I@"!"T`.NN%8.+>Q-ID$IS`"DRI]>DP4.+`X]T&/<+P);'8Q<^5MJ MTN8G(Q8]D)QA<_Y2T3A7[GP[=C:20'+ECZ+)(BDE%CV0G!"1DC$\Q$5$HEP7 M-_'H`>FU:>/H;ETJ MB;OO$D;#U2[?DC43_;)TQ&[CRP30H)E3\=)HL> M4!1ZX):L"V3*2"T-\1,0(OL#$:M_T:OL6@F0B1X@[J[<@:V.3:'^12Q9N$3< MU_9D28`B$?D#T`$=!)>J,?K#7 M@&4H2IL`D2I_5TH.$1EYZ#&-]4SL$N9H`9U'24GV(Z*'$^&FOE1GRA]WDK\(5UYF>H`^1$\IIK'GDC]: M*'5``9NO?$_*GWF2AKNLM)H4S9U1GR$CEGO8G63CIVW?/WPDE['W*;JAF@0P MYW<^6H3.@,PE6X1$NZ&RG34GSGL(ESI-P5/K`B%A:'GXGTNQ'I2JK/&Q;`/ M$)D>F+^H<_:004=M4:^7[81D%I2?'R0[;%SD^T#1Z;&9*UKY>%LW>%$+';9I M/UYUBT,"GQIMWRHO9:&I^>7OOO.,+U>]@G$#7@?3.^I5>,9)Z&6&WCTV0*L0 MBLX\8C+5YL&_QP[C0<]=2+$G+/U(0%S'=R._(2G?M^J]":QN065";(A2T%_] M=A@\>-C^DYS3R=2+4TQ&SM*K3?*HQ!C;%IJ8[K(2I:G@VZK3QJI1JLI`T&1! MWEX$)5N'@DNDG+7Y(E>=YC-9FWLWT4Z8[HN+[B8?MDZ__DO*.]V+4\6C!V-Z M!%/LFDX2THP<+YZ[I`ZZ^?88?K5Y8=47!.O58:-=,:=#B@0@T9]\D?.G<*BMGJ@4:Q++`12P]^%.=2B MP'2?7&UFY-OM9YOWKNUG^B=?A!6/1G4TNCQ<8DGH@=B`/L9(PQ_]U1I[C]L4 M.!%D7"+5GMKRF`%DH0=H3!:+,J9*;#N*NU&]N+$/*-"=!D\\3?2$[')?XJR7 M2&&+72&YPJ;E7"'1)XWHFT;ZHR=/R,D31"7FUV?_S%1IA>!=T, MZ$50OC,$2M\@M*`LZ>$2*5R=\N,6.4'V7'%/] MB,66\.C'(U*]W2REOBPDV5+1XT11--"+,O!=Z.)IJ0N^BZ;`=UD&ODM=/"]U MP7>I(WS%%=QVPW\YMW$\GO`N5$^LX'.\M%A2:!*F%@AC-!]L1<4<>C3N1X3O M/1]%;=76[8G2-Z20YY"HGH/!2`O9;J)W)GLGI=@QDWM%HZ1C)OF:03YG1-_[ MX7TRC/2\8;@BJP=I+4C**VBG>NJ4NU/+9%2/56^(@FVMH('G<\[QF6;*YC2^ M1+/E!0I84[DZ,4RABUQO9;L`8RALJ3K4(V<.'&;U,(C?D+U\"-"\30`WEX@H M&]FIQFG?_HCL8`/3G<>W62VVP4AVHZQ*K@@3[Q"NU)M<10LI4>\YO<1J/Z(I MO3NP?;7E$#X:RYU72O["*%G`Y5*DRMYXSX MWG/..J1G#79'RLJX5C)OB`14\[M,\G2RZ[[2"S92 MY[#=$`0[G$,[U2%@V:RP<152/\65M8Q4:AQ7WA[,7@9(OT0%R`TF>_#%5J#LJNBZ*14ETH3HR!=+/ M['0H*R$]#A=%5:1%2/)H5#_(4P8ZL0STP(H<3G%@_QD?7``$=*J?XP2'D$#\-]\A=&V[=H"BN]Y9)LF^.8P.@N2TFY(&)P.@1%^-B2F6 M%U3SE:3M1)W'_HUV!)!`WOV)]*(B@XZY6.:S1[D.?Y@7D$[Q/^B#)J=@WRG8)T2AXYB^ M/UI$#]GP0WP>ERBZ%U16\VP8.E7-L90P,F!$3G&I2:R&20= M=\GPWC.=S;1A03OE&V2F:J3O7S,9/'3;*Q3H!Z!`/^@2M)05Z(K&:SJKOG/'[. MNZB$S)X+_;.T"SWNV4AU?7*FGYSI)V>ZIH[;@7;.=)K[,S17HBLR>ZT:)/G] M@>OA)4_&)+S?DFFGA]B+%(8A]'J=X?\*3<=>V&C>GXZXGIRBAJH/D,4ZD#YJ ML-FKZ8`X]%RP2!EM56\FQ5+E,JG'GK[X^GD;8]-=HNV=L97Z; M.?$>;\ZG=KZ/(ZB3LFG5$_6-6M(;>JX#U7I3.XU MPK8W)_:$`_4)^X>*YX8T#/R^.XZ8$MS\J>5CRCV=3=)F#ER:S*S46]CW_1#- MNR&F]4BWUA)YA*-_C#GI/2-LV3[/G5JF+^7.U:-J4VEA:Z(L!PJK][RV\=;O MF)A$?9-7X<=4[_`;-7EQX'H=^DC$MT#1?>TCZ&/AQY3?O6V2/G+@>AWZJ/*8 M\OU"?8)0H[2Q4(*5'%5ZK@8WBP]?/*(M#/5MUZW+!9]2?H>Y29K,A.JDQZ[_ M*_)I!HP[I[=1+?+'F4=_.J)ZPT>@[+V:)FJ]++`G8]@#*)-*EIQ8Q]BV$`5O M<42_/7@L8$_L:_+J2R+UZK;2//Z5JR=<)YL0'I!5-24Z_X,%%'PI%W5-QE+E M(*`&TX0(1,T&4SWVS7\XX&"A)7)1;3.2XX":31-"+8K-II0&G"RGR(&KR':D M1P*UGB9$CA1;3TDM.-E/44!.V=HC.1*H_30ATJ5\]2FE!3^`_;P2GX!$**[5 MA%A<([P"I^@=(R2DQE3``X`:2A-"?6H-11+SDYE`8DAJK.?0<4&-J@F11+5& M58V&J+4U6$6.":*7EHC`::E9>ITW-)V!O>`5ZBXH22'N!9Q__GIULY3]<(O=4 MXCJ]P.CO:S$UBA3WL0T`1#I#>'4A6")U&"!4-ZL/1U6@F[H)\]6:0&K!U],$ M#AD@U`2J#RUI:@*'HZVS">2W.O=5[7Y9&IROUF#9)\9N1X%M,I'@%_8<>?0,ESU?$T/'2C4W\KB[3S^ZZD)EJX!,'(1 MMX85HZWVQ68.4.ZT1XTKJIJ\G.EOSIX\,#RIMMI73ZD!GIRHC@$/:0FWG[W6 MVI_LE>V9Q# M9+U?5;Z('G9-L%KAOT(UNUNO%:A9[JO*-P-*U(PA?)W5K!DE7#18%Q5<;V;> MTE>M10?XT-DI(I6%"6L>C/+"5E*:J`8JC73U!\BJUZ"\E6;%'UZ7'C:BX%1] M";/'TBU(?1S56G3`=*Y5:D*=.0A?]-!$-5!II*NG2SJOJNY2^<1^A:DM$T1^ MHNS@8#,CG/K$9&B+H8GI1=/'X@R6RW?9#):/Y\:D-VC/>EUCW)[,OAFS27LX M;7=F_=%P:ORTZTYEE@J+5W'>BIA2X5PR6BR(6F$_K;5L5HI;JW9'0:')F"R/ M=3WLBRQ#%J(KT98==WY'_HX#LD8%-A)962MK99_.CJ%+ODTIB5X<5:*7((E>2DJTMOA8*8E>'E6B[T$2?2\IT=JB.Z4D^OZH M$FV#)-J67:+T6*,83-8LTBN02*]D15J;CZ642*^.*M(.2*0=69'JM=QWCBK2 M+DBD75F1ZK7>=W7,CNV[%AG;RQF>?HE*D7M6YA+I<4(#'9JY?*2\R?KA(SI! M"\CTP`B@>S#`*CI25^3ZXQZZ$_4L<=2N;8$`Z5C6ZU?](;L:\>_%,JA'>8PP M_<%<(DXF!)]*M2\$'!V&,%_74L[^=%'N9[0P[R,;U/I\;-[W1S:0]_J7?,2:]\6@RZP]O=O4? MRD7R&.I4,%I!H3XNA0ZAH&;%Y(0BY0>#3N$X17M:C<-QNZ&]Z)7I\$\:')(F M8I+G0H\8W10ML\,3EFU@DVB&#$O;LB"Q&=+B7#$D$_!#>X4P&9GH>%'45ODF M5J1CV=`IDU\]#AJ]$'MK]A7^N-E^*^5[6DD,BGC40_IMWQ9:0;J-ZC.VK.3S M_.DA]ZD7@F>AHK:J([6R.+#YU0./"7I$;H@X6ZB7%LI7`*@;(\N4'@?HWFKM M>!N$KI"+%G:PK8[!38V]S!ZAOYP;O=OQ8/2MUS.N>L/>=7]FC`?MH2;YL'M7 M"MSY!`4VC@![84*<'2O5B4++Z1(0731/H1G=QK'OPPCWJTV,-V>"D^@":'MU MF5X)9#,V*2TN/8PV7Q558+/OP65/M3#9)A8UK>[V<)]JH.O;UJ^F$Q[G"G?V MDZH755B1U;I%KL=FJ#2;UZ:-(W[:OA^NULDUF%L4/'ASS_&6``L[RL=5'R#K MU39Y&%ZAWFVYO?-?5KF:=2W]0>7'Y".J3HU*F\?P%2IJ4C^_:S_:<[(MFY#3 MW9%4MOC3RGT+KT-Y>;C6572SCO&_O./-T,RH@N4QOJPZF5Z!8AY-MJ]^>OW5 MHX=:AVR[%$RPV8^KOL3PRJ;88FQ?H3+3S*AKC%!T40_YP1%5N?C30$76[U5F MO129AZM&:ERFBA//;NNJJP7XIO)";FH5MU8DI5S6\;_0_Z-?)+_\/U!+`P04 M````"`#;@BU$PG-BG*4+``#.<```$0`<`'-I;74M,C`Q,S$Q,S`N>'-D550) M``,N6=12+EG44G5X"P`!!"4.```$.0$``.U=6W/B.!9^WJW:_^"E:FM['[CG MTLDD,^6`DZ:6`(-)]W2_3"FV`%5LF9;M!/[]'OD"QK(50ZE;2G/F+G$H=>59JU143`U')/0V77E0:^J>J?7JRB__?JWORKP M[^KOU:IR2[!E7BI=QZCVZ-3Y11D@&U\J=YABACR'_:)\1I;/6YQ;8F&F=!Q[ M86$/`R$W)KA M%!.G.SXS\%J62VS?0AY@7>0!3ZO1/`%"H\FI MK4GS_+)Q>MEJ%AS/0Y[OKL=K+!O1OV+=[XEKK#M?H-FI<[XN<8< MVT@!SU/WNI*PYDN[YK!9O=5H-.M_W/?U@*\2,EXN+4*?LMB;%Q<7]8`:LPJ< MRT=FQ:+;=4Y^1"Y>2P8JD?`3ZGJ(&EO\IK?ND&0^K8?$+5:2R7H6LI*8U7>K M,X06:]XIS3T#)Z$0=2GT[6UW38W5OMSR"W04R\.L"XYF`*'6\@"%JX6V+!8$9`0U_ MN>*A<\DM.P'\"O\`B2%7/*?784;Y'*M*38UZQ%OQZ<7L@*VB$/.Z(N7@PP*( M8&`33PDE`;IH$D,24.+NR8^(FDHH2TD(NZJGQ22$^RXVA_37X/."81?$!)WZ MT!!UC%AR.AG(,B+U"_?90,GL$C7$!M_7!1V'FIB"U!MD\8FLSS'VW-#X.32Y MV5M@:YY8<63WSG#0U0:ZUE5NU+XZZ&B*_DG3)OK1X$FCCA`#'>?8(X!<9OUM M1KDKV@5=H7S8DOJO@W?-VFCN<#I<\,J),Z;\147ZF/+<7V&X4NSIMQI`PCJ_J%:4?=M&['5<*J3&85BS$!0UAB& MXT,M0FUWKO;M"[[774P411.YWA MPV#2&]PIHV&_U^EI!QOL(^9`,O=6O.+\[I,%SPZA4S(IB.>:@[5W!W'MHD7I&ZP*R1T'N"8;J:"C$%N_(NT\4]JD.3O M[WN3,+=S^T/2YU&O#0XYY/4YE']SQS(QZLH"XGM4HLW&VF+GT+&^:2. MM4_#?E<;Z_\,XGWR]5`-/<;0A$VHMKW5A"'J(B-16>92Y49OIHU^5E/&6A]* MF*XR4GFBF8S5@:YV#KV<-$"=J$J'3/(`WYF'".233:J1\LC=T$J[X9QG&]AD M#291)1\DG`=H&4_4'J2=PTTX=]B9,;28$V.,%P[C&3TN+D6"W.SMM-D_\D)S M>#=61Y]Z'9@(H^&89_A#-;5F+RQGA?$-E.U3XHTL%)VL91'DICY)F_JBIFCW MH_[PJZ8I-U#O!RNB8MLC/;93!7;5#6%C>U.FRKE0SS,P1ZR%?/&!#U:N_DO MZB'WWH]MB94/X2`'Z[NL'7#24Q*ZW"_%]\D'[P-Q4[8U5_*HJ3EK"9ALI6U^Z"2<"G1%:5>_1/H;6BBV%39[G5_+.^ M-Y`C]ZZP:]]Q)8J&AH[QX.&#[7CX8P04\MPM(BSX!<\]1MP1=K)N_W%!\A@0 MC@SVBX%@[/!W2$IR]&,(%/*$6;!Z[N-]08;<\<*AQ9Z.CX=58%PE M&/CH>TATG2M8F,%X2NN29F)B:N?M!D5'N'^'( M)'=K*$@^ND>P^G`1L`Y]C_]NVEP_^-BIA]QAPEG*JPZ+AE`28QQ=5\`1?!5: M8F80EV^Z=W=DJK_(FS$/ULUYS]I3Z]OK;%*GM84S'.FS^>/* M]MIS>J'\*,8L=Y)P%%/@R?W159E/\;>*=0E=[A#A7"3GF?ZQ4L]XB)^:(E(. MN1N$4XJ\Y_W'R9!5-Z3/&B0,*L%-QDM^/^ZZ M`EY8\*(K;)LS/`W:_&I\<>U/4*VVM*V8A8N6W&0,O)BV1C1P+`(Q0Y`BW+0$ M(<$A!:Q`]1A\+,`C'N\^2@RC\'$@8];?0F4+/>ZJ,G3!UD_4M<_EOZF2$'V[ M*ID*V)^D:F['B2I;G0UM+ZY&QI]3]\?O0+%H2Q0 MJ'`757;/.+PAW7>,0)2D"_]6C?M5>5.UV:JVF[6E:VZ0[@)B8X;=0,3]]@`1 M2'.Q49LYS^!4LG4M.`=%9A_^H;KI7'1\Z4UKV?B9'>O8\MRXY0?1B+>D]X<3 MR-H#3X$+XD4B)=ES$';DH7+!0Z5Y]H-@]@/R&HKHDGE0V?!D]:>^*8I&EN_> M8_L1LTH`$VJ?'"*Q+'X*<5WQF,^3"W_9P"4D'>*8DR`WFGZXMZLH8:X,+^A? MFHX->[R>AVW.!KKYCR[D))^SWC''7UQ70ED$6&2HOSC,S,`K-K\[4MUSC*?X M"(GBE'USB*5"/7EQ\E$GB>5"#0NRQ-K;Y'='_D!A>\%OQ0:KLA`G^>22(1=B M)9]<-N1BO,@8WAW]*!A+B!2QN21(A<@0F\N"5(R$+$))T-XZ/LL"N]5>%JSD M.=.P6^TEP:J391;49'-9D.)G3#.Q;A%*@E8CL[F7A7:;4!*T`Y*=8+?:2X)U MDAT%DQ+&@)47LBG*N^/M!<^I(#TE:D=^%+^-_56N=]=CZ,TQ2]:_VPKDD]\= M^781)JYV$OJ[8Q\X]/?X!6X]?;@-/(_X[JCS(9<3;S)NQ?C(I;X[[H[O>HZ- M67,;L-A<&J2M;*2M\B%M9R-MEP_I23;2D_(A5;.1JN5#>I.-]*9\2#O92#OE M0]K-1MHM#](Q-AQF\M<+IS)J%J%$:%MY:$N45S>@VGEH2Y1;-Z!.\M"6*+]N M0)WFH3TM#]H>]3"CP1#(TI&%4UL)"?W=L6\,>I9GZ;,RHCW/0WM>1K0?\]!^ M+`]:V>NI59#)D.'%"A3C1=&G6*?==0PY0`JAL[=X1(KY@1HVU6?,T`SS&S\. M#7[,MO53]I2RN_8JG=H]:C",7-S%X?]'#"\0,:$9RI4)6O)[_NM3F]K1L57.82^=,^>_$ MT[%;E/M_3,T)7GHWEF,\%=,SR;YOGO5B&6^@7,:OR=..D[*4SEN\PK$L;'@^ MLN)[K<&5XY67]E0QUC)X*=[/!1=G>%C-R2)\M=9*C+]BO&50*^O>L0:B;'X[ MZ,'%4]_JD^?H)52"HGOW+H/J_"_-F+Z%A]/UO0 MTLDC@U"ZE-'%U+$)S8*?22J=`CN]56-]FR&MZX]**9U94M4RA"+L;T"]=+U\ M@UQB0!;I$LOG[-YF4Y13>.\I:E^#!*.\O4'&F._7`#5_PP#W'*R#?3(5`F/G M;J6+A(2'\M"O'[868MU3H;CUK:O2,7&?1ICQ!G!0*[,4%7E>52+\F?]ZE\07 MC44HX2V2%H]JF"_8Y'\L#U,WW+)#6J&S@/5FM6$9H56PR7]!S%R_$TIU7=\. MGQUJRP74<=B\==@4`QJ&QXG9^]\9:O=U>$][7M7#7YW#Q_\`4$L!`AX#%``` M``@`VX(M1+U9)ZLC;P``^A$%`!$`&````````0```*2!`````'-I;74M,C`Q M,S$Q,S`N>&UL550%``,N6=12=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` MVX(M1&8^:L&3#@``&*L``!4`&````````0```*2!;F\``'-I;74M,C`Q,S$Q M,S!?8V%L+GAM;%54!0`#+EG44G5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`-N"+42>K*_C\!(``-`L``00E#@``!#D!``!02P$"'@,4```` M"`#;@BU$HK3K(_8]```@K@,`%0`8```````!````I(&/D0``&UL550%``,N6=12=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`VX(M1,=.UP)*)@``Y7\"`!4`&````````0```*2!U,\``'-I;74M,C`Q M,S$Q,S!?<')E+GAM;%54!0`#+EG44G5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`-N"+43" XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. EMPLOYEE BENEFIT PLAN (Narrative) (USD $)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Compensation and Retirement Disclosure [Abstract]    
Contribution by employer in benefit plan $ 26,127 $ 20,814

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT (Details) (USD $)
Nov. 30, 2013
Aug. 31, 2013
Property and equipment, gross $ 333,550  
Less accumulated depreciation and Amortization (217,623)  
Net Book Value 115,927 117,987
Equipment
   
Property and equipment, gross 124,042  
Computer equipment
   
Property and equipment, gross 134,398  
Furniture and fixtures
   
Property and equipment, gross 51,465  
Leasehold improvements
   
Property and equipment, gross $ 23,645  
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMITMENTS AND CONTINGENCIES
3 Months Ended
Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Note 4. COMMITMENTS AND CONTINGENCIES

Employment Agreement

On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee’s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded will be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provides Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement. The Company may terminate the agreement upon 30 days written notice if termination is without cause. The Company's only obligation would be to pay its President the greater of a) 12 months salary or b) the remainder of the term of the employment agreement from the date of notice of termination.

 

For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.

 

On August 22, 2013, effective as of September 1, 2013, the CEO’s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company’s net income before taxes of the previous fiscal year not to exceed $60,000. In addition the agreement calls for the granting of ten (10) options to purchase shares of the Company’s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company’s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.

 

Litigation

We are not a party to any litigation at this time and we are not aware of any pending litigation of any kind.

EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C=?0T].0T5.5%)!5$E/3E-?04Y$7U5.0T525$%)3CPO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/CA?1T5/1U)!4$A)0U]215!/ M4E1)3D<\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C$P7U-50E-%455%3E1?159%3E13/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C)?4U5-34%265]/1E]324=.249)0T%.5%]!0T-/53(\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/C-?4%)/4$525%E?04Y$7T5154E0 M345.5%]$971A:3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C1?0T]-34E4345.5%-?04Y$7T-/3E1)3D=%3D-)13$\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/CA?1T5/1U)!4$A)0U]215!/4E1)3D=?1&5T86EL M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C5?4TA!4D5(3TQ$15)37T5154E465].87)R M871I=CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T'1087)T7V)E,#!F8F$R7S,T93A?-#@U.5]A M8S5B7V8V-S,U9F4S-30S9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]# M.B]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)U-)355, M051)3TY3(%!,55,@24Y#/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)V9A;'-E/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)RTM,#@M,S$\2!A(%9O;'5N=&%R>2!&:6QE2=S M(%)E<&]R=&EN9R!3=&%T=7,@0W5R'0^)SQS<&%N/CPO'0^)U$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'!E;G-E2P@;F5T(&]F(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!O9B`D,3,L,3(U M(&%N9"`D,3$L,C4P/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV M,2PX-S4\'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D(#$V+#`W,RPX M.30@86YD(#$V+#`S,"PX.30@3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPOF%T:6]N(&]N(&EN M=&5L;&5C='5A;"!P3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY M.3(L,3`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ,2PY,#,\'0^)SQS<&%N/CPO6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y+#@T,RD\F5D(&-O;7!U=&5R('-O9G1W87)E(&1E=F5L;W!M96YT(&-O M'0^)SQS<&%N/CPO6UE;G0@;V8@9&EV:61E;F1S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-#(L.34V*3QS<&%N/CPO&5R8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PS-#4\65A&5S('!A:60\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X M-3E?86,U8E]F-C'0O:'1M M;#L@8VAA6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M2=S M(&%N;G5A;"!R97!O&-H86YG92!#;VUM:7-S:6]N("@F(S$T-SM314,F(S$T.#LI(&]N M($YO=F5M8F5R(#$X+"`R,#$S+@T*07,@8V]N=&5M<&QA=&5D(&)Y('1H92!3 M14,@=6YD97(@07)T:6-L92`X(&]F(%)E9W5L871I;VX@4RU8+"!T:&4@86-C M;VUP86YY:6YG(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N9"!F;V]T;F]T97,@ M:&%V92!B965N(&-O;F1E;G-E9`T*86YD('1H97)E9F]R92!D;R!N;W0@8V]N M=&%I;B!A;&P@9&ES8VQO'!E8W1E9"!F;W(@=&AE(&9U;&P@>65A7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAAF4Z M(#AP="<^/'4^17-T:6UA=&5S/"]U/CPO9F]N=#X\+W`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`[ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP M="<^1V5N97)A;&QY+"!W90T*96YT97(@:6YT;R!O;F4M>65AF4@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@65A6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!O M=F5R('1H96ER('1EF4@8V]N=')A M8W0@7!E($-O;G1R M86-TF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/'`@F4Z(#AP="<^/'4^0V%S:"!A;F0@ M0V%S:`T*17%U:79A;&5N=',\+W4^/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^1F]R('!U6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^5V4@86YA;'EZ92!T M:&4-"F%G92!O9B!C=7-T;VUE2!O9B!I=',@8W5S=&]M97)S(&1E=&5R:6]R871E9"P@ M=VAE=&AE2!B92!M861E+B!!8V-O=6YT6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F5D#0I#;VUP=71E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF5D(&EN(&%C8V]R9&%N8V4@=VET:"!!4T,@.3@U+3(P+"`\:3XF(S$T M-SM#;W-TF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP M="<^5&AE(&5S=&%B;&ES:&UE;G0-"F]F('1E8VAN;VQO9VEC86P@9F5AF5D('-O9G1W87)E(&1E=F5L;W!M96YT(&-O M2!M86YA9V5M M96YT('=I=&@@F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^06UOF%T:6]N#0IO9B!C87!I=&%L:7IE9"!S;V9T=V%R92!D979E;&]P;65N="!C M;W-T2UP65A2!O9B!T:&5M#0IA="!T M:&ES('!O:6YT*2X@06UOF%T:6]N(&]F('-O9G1W87)E(&1E=F5L;W!M M96YT(&-O'!E8W0@9G5T=7)E(&%M;W)T:7IA M=&EO;B!E>'!E;G-E('1O('9AF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^ M5V4@=&5S="!C87!I=&%L:7IE9`T*8V]M<'5T97(@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ MF%T:6]N+B!$97!R96-I871I;VX@86YD M(&%M;W)T:7IA=&EO;B!AF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@6QE/3-$)W=I9'1H M.B`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`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V9O;G0MF4Z(#AP="<^)"8C,38P.R8C,38P.S$P+#4U-"PW,#<\+V9O M;G0^/"]T9#X-"B`@("`\=&0@F4Z M(#AP="<^)"8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.RT\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@F4Z(#AP="<^)"8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.RT\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)"8C,38P.R8C,38P.S$P+#4U M-"PW,#<\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`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`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`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^/'4^16%R;FEN9W,@<&5R#0I3:&%R93PO M=3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M2!T:&4@=V5I9VAT960M879E&-E<'0@=&AA="!T:&4@9&5N;VUI;F%T M;W(@:7,@:6YCF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QP861D:6YG M/3-$,"!C96QL6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E MF4Z(#AP="<^3G5M97)A=&]R/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE M/3-$)V9O;G0MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/"]T6QE/3-$)W=I M9'1H.B`V-B4[('1E>'0M86QI9VXZ(&IUF4Z(#AP="<^3F5T(&EN8V]M90T*("`@(&%T=')I8G5T86)L92!T;R!C M;VUM;VX@6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,3,E M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H M.B`R)2<^/&9O;G0@'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-3@V M+#DX-CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP M="<^1&5N;VUI;F%T;W(\+V9O;G0^/"]T9#X\=&0^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V9O;G0M6QE/3-$)W9E3L@<&%D9&EN9RUL969T.B`R,'!T.R!T97AT+6EN9&5N M=#H@+3$P<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M M:6YD96YT.B`M,3!P="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,S$W+#`Q,SPO9F]N=#X\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D/CQF;VYT M('-T>6QE/3-$)V9O;G0M'0M:6YD96YT.B`M,3!P="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,38L,S8U+#4U M,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^0V]M<&5NF5D(&]N(&$@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M&ES=',\+VD^+"!W:&EC:"!E;&EM:6YA=&5S(&1I M=F5R2!I;B!PF5D('1A>"!B96YE9FET('=H96X@82!N970@;W!E6%B;&4@=&AA="!W M;W5L9"!R97-U;'0@9G)O;2!D:7-A;&QO=V%N8V4@;V8@82!T87@@<&]S:71I M;VXN($%352`R,#$S+3$Q(&%F9F5C=',@;VYL>2!T:&4-"G!R97-E;G1A=&EO M;B!O9B!S=6-H(&%M;W5N=',@:6X@86X@96YT:71Y)B,Q-#8[2!A9&]P=&EO;B!I2P@;V8@=&AE(&%D;W!T:6]N#0IO9B!!4U4@,C`Q,RTQ,2!O;B!O=7(@8F%L M86YC92!S:&5E="X\+V9O;G0^/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPOF4Z(#AP="<^4')O<&5R='D@86YD#0IE<75I<&UE;G0@ M87,@;V8@3F]V96UB97(@,S`L(#(P,3,@8V]NF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$)W=I9'1H.B`U M,R4[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F="<^/&9O;G0@F4Z(#AP="<^0V]M<'5T97(@97%U:7!M96YT M/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M'1U6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^,S,S+#4U,#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*#(Q M-RPV,C,\+V9O;G0^/"]T9#X\=&0@6QE/3-$)W9E M6QE/3-$ M)V9O;G0M6QE/3-$ M)W!A9&1I;F'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$ M)V9O;G0M6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N M/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#AP="<^3VX@2G5L>2`R,BP@ M,C`Q,BP-"G1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!E;7!L;WEM96YT M(&%G'!I2P@;W(@)#,P+#`P,"!P97(@>65A65A&EM=6T@ M;V8@,3(P+#`P,"!O<'1I;VYS(&]V97(@=&AE('1E0T*;W(@8BD@=&AE(')E;6%I;F1EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/'`@F4Z(#AP="<^1F]R(&9I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&9O M;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&9O;G0@&5S(&]F('1H92!P2!T:&]U6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^5V4@87)E(&YO="!A#0IP87)T>2!T;R!A;GD@;&ET:6=A=&EO M;B!A="!T:&ES('1I;64@86YD('=E(&%R92!N;W0@87=A7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&9O;G0@65A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`R,"4[(&)OF4Z(#AP="<^ M4F5C;W)D#0H@("`@1&%T93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,C`E.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`R,"4[(&)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M6QE/3-$)V)O6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W9EF4Z(#AP="<^/&(^5&]T86P\+V(^/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)OF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`@6QE/3-$)W9E'0M86QI9VXZ(&-E;G1EF4Z(#AP="<^1&ES=')I8G5T M:6]N#0H@("`@1&%T93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,C`E.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@6QE/3-$ M)V9O;G0MF4Z M(#AP="<^5&]T86P-"B`@("!!;6]U;G0\+V9O;G0^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9EF4Z(#AP M="<^,3$O,#@O,C`Q,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)W9EF4Z(#AP="<^/&(^5&]T M86P\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)OF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!B92!G2!I=',@=&5R;2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M M'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M2`R,RP-"C(P,#F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/'`@F4Z(#AP="<^/'4^475A;&EF:65D($EN8V5N=&EV92!3=&]C:R!/<'1I M;VYS#0HH475A;&EF:65D($E33RD\+W4^/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^07,@;V8@3F]V96UB97(-"C,P+"`R,#$S M+"!E;7!L;WEE97,@:&]L9"!1=6%L:69I960@4T\@=&\@<'5R8VAA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UEF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X-"B`@("`@("`@/'`@6QE/3-$)V9O;G0MF4Z(#AP="<^3G5M8F5R#0H@("`@;V8@3W!T:6]N'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1EF4Z(#AP="<^5V5I9VAT960M079E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)V)A8VMG'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M&5R8VES960\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E MF4Z(#AP="<^3W5T2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M&5R8VES86)L92P-"B`@("!.;W9E;6)E6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^5&AE(&9A:7(@=F%L=64-"F]F M('1H92!O<'1I;VYS+"!I;F-L=61I;F<@8F]T:"!)4T\@86YD($Y14T\@;W!T M:6]N6EE;&0@ M;V8@,RXQ-"4L('!R92UV97-T(&9O2!O9B`S."XY-24L#0IR:7-K+69R964@:6YT M97)E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z M(#AP="<^/'4^3F]N+5%U86QI9FEE9`T*(%-T;V-K($]P=&EO;G,@*$YO;BU1 M=6%L:69I960@4T\I/"]U/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$ M)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0M M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9EF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/"]T'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)W9E MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)A8VMG'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M&5R8VES960\+V9O;G0^/"]T9#X-"B`@("`\=&0@2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)V)A8VMG2<^/&9O;G0@6QE/3-$)W9E2<^/&9O;G0@6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF4Z M(#AP="<^)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^5&AE('=E:6=H=&5D+6%V97)A9V4-"G)E;6%I;FEN M9R!C;VYT&5R8VES92!PF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@ M6QE/3-$)V9O;G0M M&5R8VES90T*("`@(%!R:6-E/"]F;VYT/CPO=&0^#0H@ M("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V)O'0M M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V9O;G0M&5R8VES M86)L93PO9F]N=#X\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Y)3L@8F]R9&5R.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M,B4[(&)O6QE M/3-$)W=I9'1H.B`Q.24[(&)O6QE/3-$)V9O;G0MF4Z(#AP="<^5V5I9VAT960- M"B`@("!!=F5R86=E(%)E;6%I;FEN9R!#;VYT6QE/3-$)W=I9'1H.B`Q,R4[(&)O&5R8VES92!06QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0M65A6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^,C6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)O M6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M)#,N,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M65A6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)#(N M,S4\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3$L-C`P M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0M65A6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.#@L-3`P/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0M65A6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,3(L,#`P/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M65A6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF4Z(#AP="<^/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^07,@;V8@3F]V96UB97(-"C,P+"`R,#$S+"!I;F-L M=61E9"!I;B!B;VYU'!E;G-E0T*86UO=6YT(&]F(&)O;G5S M('!A>6%B;&4@=&\@=&AE($-OB!A6UE;G0@86=R965M96YT(%1H M92!O=&AEBP@ M;W5R(%!R97-I9&5N="]#:&EE9B!%>&5C=71I=F4@3V9F:6-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#%I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^5V4@;W!E2X@3W5R(&]P97)A=&EN9R!R97-U;'1S(&-O M=6QD(&)E('-I9VYI9FEC86YT;'D-"F%F9F5C=&5D(&)Y(&]UF4Z(#AP="<^/&(^ M)B,Q-C`[/"]B/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@0T*;V8@;W5R(&-UFEN9R!I;B!T:&4@<&AA3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U M8E]F-C'0O:'1M;#L@8VAA M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q-24[(&)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^3F]V96UB97(-"B`@("`S,"P@,C`Q,SPO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)V)O6QE/3-$)V)OF4Z(#AP="<^3F]V96UB97(-"B`@("`S,"P@,C`Q,CPO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO<#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPOF4Z(#AP="<^5V4@;6%I;G1A:6X@ M80T*-#`Q*$LI(%!L86X@9F]R(&%L;"!E;&EG:6)L92!E;7!L;WEE97,L(&%N M9"!W92!M86ME(&UA=&-H:6YG(&-O;G1R:6)U=&EO;G,@97%U86P@=&\@,3`P M)2!O9B!T:&4@96UP;&]Y964F(S$T-CMS(&5L96-T:79E(&1E9F5R3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F M-C'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE65E(%-T;V-K($]P=&EO M;B!0;&%N+B!4:&4@86UE;F1M96YT('=O=6QD(&EN8W)E87-E('1H92!N=6UB M97(@;V8@2`Q+#`P M,"PP,#`N(%1H92!A;65N9&UE;G0@:7,@2!S:&%R96AO;&1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B93`P M9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ M'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M2!A8V-E<'1E9"!I;B!T:&4@56YI M=&5D#0I3=&%T97,@;V8@06UEF5D(&-O;7!U=&5R('-O M9G1W87)E(&1E=F5L;W!M96YT(&-O'0M86QI M9VXZ(&IUF4Z(#AP M="<^/'4^4F5V96YU92!296-O9VYI=&EO;CPO=3X\+V9O;G0^/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4-"G)E=F5N M=65S(')E;&%T960@=&\@2!H87,@8F5E;B!M861E+"`S*2!T:&4-"F%M;W5N="!IF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X- M"@T*/'`@F4Z(#AP="<^07,@82!B>7!R;V1U8W0- M"F]F(&]N9V]I;F<@:6UP'!A;F0@=&AE(&9U;F-T:6]N86QI='D@;V8@=&AE('-O9G1W87)E+B!4:&5S M92!A2X@5V4@8V]N6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&9O M;G0@2P@=V4-"F5N M=&5R(&EN=&\@;VYE+7EE87(@;&EC96YS92!A9W)E96UE;G1S('=I=&@@8W5S M=&]M97)S(&9O'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M65AF5D(&]N92!Y96%R(&%T(&$@=&EM92X\+V9O;G0^/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M2!A;F0-"F5Q=6EP;65N="!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)W=I9'1H.B`W M,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E MF4Z(#AP="<^17%U:7!M96YT/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S-24[('1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-2!Y96%R MF4Z(#AP="<^0V]M<'5T97(@97%U:7!M M96YT/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,R!T;R`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`[/"]F M;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#AP="<^/&(^3&5V96P-"B`@("!)/"]B M/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,34E.R!B M;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#AP="<^/&(^3&5V96P-"B`@ M("!)24D\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q-24[(&)OF4Z(#AP="<^/&(^5&]T86P\+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&-E;G1EF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#AP="<^5&]T86P\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)"8C,38P.R8C,38P.S$P+#4U-"PW,#<\+V9O;G0^/"]T9#X- M"B`@("`\=&0@F4Z(#AP="<^)"8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.RT\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)"8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.RT\+V9O;G0^/"]T9#X-"B`@("`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`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'`@F4Z(#AP="<^/"]F M;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^/'4^26YC M;VUE(%1A>&5S/"]U/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4@1D%30@T*05-#(#&5S)B,Q-#@[/"]I/B!W:&EC:"!R97%U:7)E'!E8W1E9`T*9G5T=7)E('1A>"!C;VYS97%U96YC M97,@;V8@979E;G1S('1H870@:&%V92!B965N(&EN8VQU9&5D(&EN('1H92!F M:6YA;F-I86P@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M"!C;VYS97%U96YC97,@:6X@9G5T=7)E('EE87)S(&]F M(&1I9F9E"!B87-E65A"!R871E2P-"G1O M(')E9'5C92!D969E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!A9W)E96UE;G0@=VET:"!%;G-L M96EN(%)EF5D#0IO=F5R(#$P('EE87)S M('5N9&5R('1H92!S=')A:6=H="UL:6YE(&UE=&AO9"X@06UOF%T:6]N M(&5X<&5N2X@06-C=6UU;&%T960@86UOF%T:6]N(&%S(&]F($YO M=F5M8F5R(#,P+`T*,C`Q,R!W87,@)#$S+#$R-2X\+V9O;G0^/"]P/@T*#0H- M"@T*/'`@'0M86QI9VXZ(&IU MF4Z(#AP="<^/'4^ M16%R;FEN9W,@<&5R#0I3:&%R93PO=3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M2!T M:&4@=V5I9VAT960M879E&-E M<'0@=&AA="!T:&4@9&5N;VUI;F%T;W(@:7,@:6YCF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X- M"@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M M6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^3G5M97)A=&]R/"]F;VYT M/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D/CQF;VYT M('-T>6QE/3-$)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W=I9'1H.B`V-B4[('1E>'0M86QI9VXZ(&IU MF4Z(#AP="<^3F5T(&EN8V]M90T* M("`@(&%T=')I8G5T86)L92!T;R!C;VUM;VX@6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/CQT M9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`R)2<^/&9O;G0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^-3@V+#DX-CPO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^1&5N;VUI;F%T;W(\+V9O;G0^/"]T M9#X\=&0^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O M;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E3L@<&%D9&EN9RUL M969T.B`R,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E'0M:6YD96YT.B`M,3!P="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^,S$W+#`Q,SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M'0M:6YD M96YT.B`M,3!P="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^,38L,S8U+#4U,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ M'0M86QI9VXZ(&IU MF4Z(#AP="<^/'4^ M4W1O8VLM0F%S960-"D-O;7!E;G-A=&EO;CPO=3X\+V9O;G0^/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2P@ M86YD(&ES(&EN8VQU9&5D(&EN('1H92!C;VYD96YS960@'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!)6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&9O;G0@65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-EF4Z(#AP="<^ M26X@2G5L>2`R,#$S+`T*=&AE($9!4T(@:7-S=65D($%352`R,#$S+3$Q+"`\ M:3Y);F-O;64@5&%X97,@*%1O<&EC(#"!L;W-S(&]R(&$@=&%X(&-R961I="!C87)R>69O&%B;&4@:6YC;VUE(&]R('1A>"!P M87EA8FQE('1H870@=V]U;&0@28C M,30V.W,@8F%L86YC92!S:&5E="!A;F0@:7,@969F96-T:79E(&9O65A'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!A;F0@17%U:7!M96YT(&5S=&EM871E9"!U M6QE/3-$)W9E6QE/3-$)V9O;G0M'1U M6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-2!T;R`W M('EE87)S/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^4VAO6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q-24[(&)OF4Z(#AP="<^/&(^3&5V96P-"B`@("!)/"]B/CPO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,34E.R!B;W)D97(M M=&]P.B!";&%C:R`Q<'0@'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#AP="<^/&(^3&5V96P-"B`@("!)24D\ M+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q-24[ M(&)OF4Z(#AP="<^/&(^5&]T86P\+V(^/"]F;VYT/CPO=&0^/"]TF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&-E;G1EF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#AP="<^5&]T86P\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@F4Z(#AP M="<^)"8C,38P.R8C,38P.S$P+#4U-"PW,#<\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@F4Z(#AP="<^)"8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.RT\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)"8C,38P.R8C,38P.S$P+#4U-"PW,#<\+V9O;G0^/"]T M9#X\+W1R/@T*/"]T86)L93X\6QE/3-$)W9EF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^3G5M97)A M=&]R/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W=I9'1H.B`V-B4[('1E>'0M M86QI9VXZ(&IUF4Z(#AP="<^3F5T M(&EN8V]M90T*("`@(&%T=')I8G5T86)L92!T;R!C;VUM;VX@6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N M=#X\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`R)2<^/&9O;G0@'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-3@V+#DX-CPO9F]N=#X\+W1D M/CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^1&5N;VUI;F%T;W(\ M+V9O;G0^/"]T9#X\=&0^/&9O;G0@F4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$ M)W9E3L@ M<&%D9&EN9RUL969T.B`R,'!T.R!T97AT+6EN9&5N=#H@+3$P<'0G/CQF;VYT M('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E'0M:6YD96YT.B`M,3!P="<^ M/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^,S$W+#`Q,SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M M'0M:6YD96YT.B`M,3!P="<^/&9O;G0@F4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,38L,S8U+#4U,CPO9F]N=#X\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B M93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA2P@4&QA;G0@86YD($5Q=6EP M;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@F4Z M(#AP="<^/"]F;VYT/CPO<#X-"@T*/'`@6QE/3-$)V)O M6QE M/3-$)W9EF4Z(#AP="<^17%U:7!M96YT/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$ M)W=I9'1H.B`R)2<^/&9O;G0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,R4[('1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^,3(T+#`T,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,24[ M('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9E M2<^/&9O M;G0@F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^1G5R;FET=7)E(&%N9"!F:7AT=7)EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^3&5AF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,C,L-C0U/"]F;VYT/CPO M=&0^/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[4W5B('1O=&%L/"]F;VYT/CPO=&0^/'1D/CQF;VYT M('-T>6QE/3-$)V9O;G0MF4Z(#AP M="<^3&5S'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V9O;G0M M3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[3F5T($)O;VL-"B`@("!686QU93PO9F]N=#X\+W1D/CQT9"!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M MF4Z(#AP="<^)#PO M9F]N=#X\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R M+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^,3$U+#DR-SPO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[('1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPOF4Z(#AP M="<^5&AE($)O87)D(&]F#0I$:7)E8W1O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`R,"4[(&)OF4Z(#AP="<^3G5M8F5R#0H@("`@;V8@4VAA6QE/3-$)W=I9'1H.B`R,"4[(&)O6QE/3-$)W=I9'1H.B`R,"4[ M(&)O'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W9EF4Z M(#AP="<^-2\W+S(P,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`R M,"4[(&)OF4Z(#AP="<^4F5C;W)D#0H@("`@ M1&%T93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,C`E M.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`R,"4[(&)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V)O6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)OF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O6QE M/3-$)V)O6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^/'4^475A;&EF:65D($EN8V5N=&EV M92!3=&]C:R!/<'1I;VYS#0HH475A;&EF:65D($E33RD\+W4^/"]F;VYT/CPO M<#X-"@T*/'`@F4Z(#AP="<^07,@;V8@3F]V96UB M97(-"C,P+"`R,#$S+"!E;7!L;WEE97,@:&]L9"!1=6%L:69I960@25-/('1O M('!U&5R8VES92!PF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^5')A;G-A8W1I;VYS#0H@("`@("`@(&EN($99,3,\ M+V9O;G0^/"]P/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W9EF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/"]T'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^ M1W)A;G1E9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#AP M="<^17AE6QE/3-$)W9E M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E2<^/&9O;G0@2<^/&9O;G0@ M6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M&5R8VES M86)L92P-"B`@("!.;W9E;6)E6QE/3-$)V9O M;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#AP="<^07,@;V8@3F]V96UB97(-"C,P+"`R,#$S+"!T:&4@ M;W5TF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^5')A M;G-A8W1I;VYS#0H@("`@("`@(&EN($99,3,\+V9O;G0^/"]P/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1EF4Z(#AP="<^5V5I9VAT M960M079E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG2<^/&9O;G0@6QE/3-$)V9O;G0M2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#AP="<^3W5T6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)A8VMG M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M&5R8VES86)L92P-"B`@("!. M;W9E;6)E6QE/3-$)V9O;G0M'0^)SQT86)L M92!C96QL6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^ M17AE6QE/3-$)V9O;G0MF4Z(#AP="<^07=AF4Z(#AP="<^3&]W/"]F;VYT/CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@8F]R9&5R+71O<#H@0FQA M8VL@,7!T('-O;&ED.R!B;W)D97(MF4Z(#AP="<^2&EG:#PO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3(E.R!B;W)D97(M M=&]P.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0M3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,3DE.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0M MF4Z(#AP="<^5V5I9VAT960-"B`@("!!=F5R86=E($5X97)C M:7-E(%!R:6-E/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,B4[(&)O6QE/3-$)W=I9'1H.B`Q-"4[(&)O6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)#$N-3`\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^)#8N-C@\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^/&(^,SDQ+#@P,#PO8CX\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP="<^ M3F]R=&@-"B`@("!!;65R:6-A/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#AP="<^175R M;W!E/"]F;VYT/CPO<#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,34E.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q-24[(&)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B M93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA'1U3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N M(&]F(&EN=&%N9VEB;&4@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ+#@W-3QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R MF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@R,3'0^ M)SQS<&%N/CPO2!A;F0@97%U:7!M96YT+"!G2!A;F0@ M97%U:7!M96YT+"!G'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^3F]V(#@L#0H)"3(P,3(\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`W+`T*"0DR,#$S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^075G(#$R+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M&5R8VES86)L92P@96YD(&]F('!E'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES86)L M92P@96YD(&]F('!E'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)S,@>65A7,\7,\ M&5R8VES92!0'0^)SQS<&%N/CPO7,\&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)S8@>65A7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)S0@>65A&5R8VES92!P&5R8VES92!P'0^)S,@>65A7,\&5R8VES92!P'0^)S8@ M>65A&5R M8VES92!P'0^ M)S8@>65A&5R8VES92!P&5R8VES86)L93PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&5R8VES M92!P'0^)S,@>65A M7,\'0^)SQS<&%N/CPO7,\ M7,\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!4'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8V5T960@=F]L871I M;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]B93`P9F)A,E\S-&4X7S0X-3E?86,U8E]F M-C&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U&UL/@T*+2TM+2TM/5].97AT4&%R=%]B93`P9F)A A,E\S-&4X7S0X-3E?86,U8E]F-C XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) (USD $)
3 Months Ended
Nov. 30, 2013
Awards Outstanding 637,600
Weighted average remaining contractual life - awards outstanding 4 years 3 months 11 days
Weighted average exercise price - awards outstanding $ 2.61
Awards Exercisable 391,800
Weighted average remaining contractual life - awards exercisable 3 years 10 months 24 days
Weighted average exercise price - awards exercisable $ 1.71
Stock Options One
 
Exercise price low $ 1.00
Exercise price high $ 1.50
Awards Outstanding 313,100
Weighted average remaining contractual life - awards outstanding 3 years 10 months 13 days
Weighted average exercise price - awards outstanding $ 1.06
Awards Exercisable 279,700
Weighted average remaining contractual life - awards exercisable 3 years 8 months 12 days
Weighted average exercise price - awards exercisable $ 1.06
Stock Options Two
 
Exercise price low $ 1.51
Exercise price high $ 3.00
Awards Outstanding 31,600
Weighted average remaining contractual life - awards outstanding 6 years 4 months 10 days
Weighted average exercise price - awards outstanding $ 2.35
Awards Exercisable 11,600
Weighted average remaining contractual life - awards exercisable 6 years 3 months 18 days
Weighted average exercise price - awards exercisable $ 2.11
Stock Options Three
 
Exercise price low $ 3.01
Exercise price high $ 4.50
Awards Outstanding 156,900
Weighted average remaining contractual life - awards outstanding 3 years 10 months 24 days
Weighted average exercise price - awards outstanding $ 3.26
Awards Exercisable 88,500
Weighted average remaining contractual life - awards exercisable 4 years
Weighted average exercise price - awards exercisable $ 3.18
Stock Options Four
 
Exercise price low $ 4.51
Exercise price high $ 6.68
Awards Outstanding 136,000
Weighted average remaining contractual life - awards outstanding 5 years 1 month 28 days
Weighted average exercise price - awards outstanding $ 5.49
Awards Exercisable 12,000
Weighted average remaining contractual life - awards exercisable 3 years 8 months 12 days
Weighted average exercise price - awards exercisable $ 5.59
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY (Details-Options Outstanding) (USD $)
3 Months Ended
Nov. 30, 2013
Number of Options  
Awards Outstanding, ending balance 637,600
Exercisable, end of period 391,800
Weighted-Average Exercise Price Per Share  
Outstanding $ 2.61
Exercisable, end of period $ 1.71
Qualified ISO
 
Number of Options  
Awards Outstanding, beginning balance 532,000
Granted 100,000
Exercised (40,000)
Awards Outstanding, ending balance 592,000
Exercisable, end of period 366,600
Weighted-Average Exercise Price Per Share  
Outstanding $ 1.82
Granted $ 5.61
Exercised $ 1.12
Outstanding $ 2.51
Exercisable, end of period $ 1.59
Weighted-Average Remaining Contractual Life  
Outstanding, beginning of period 3 years 11 months 12 days
Outstanding, end of period 4 years 7 days
Exercisable 3 years 7 months 28 days
Non-Qualified SO
 
Number of Options  
Awards Outstanding, beginning balance 48,600
Exercised (3,000)
Awards Outstanding, ending balance 45,600
Exercisable, end of period 25,200
Weighted-Average Exercise Price Per Share  
Outstanding $ 3.47
Exercised $ 1.80
Outstanding $ 3.92
Exercisable, end of period $ 1.89
Weighted-Average Remaining Contractual Life  
Outstanding, beginning of period 7 years 10 months 6 days
Outstanding, end of period 7 years 9 months 11 days
Exercisable 6 years 7 months 13 days
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. RELATED PARTY TRANSACTIONS (Narrative) (USD $)
3 Months Ended
Nov. 30, 2013
Related Party Transactions [Abstract]  
Bonuses paid $ 60,000
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. CONCENTRATIONS AND UNCERTAINTIES (Narrative)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
International Sales
   
Net sales concentration percentage 52.00% 55.00%
Customer 1 | Net Sales
   
Net sales concentration percentage 19.00% 22.00%
Customer 2 | Net Sales
   
Net sales concentration percentage 13.00% 14.00%
Customer 3 | Net Sales
   
Net sales concentration percentage 11.00% 12.00%
Customer 4 | Net Sales
   
Net sales concentration percentage 10.00% 8.00%
Customer A
   
Accounts receivable concentration percentage 18.00% 17.00%
Customer B
   
Accounts receivable concentration percentage 18.00% 16.00%
Customer C
   
Accounts receivable concentration percentage 15.00% 11.00%
Customer D
   
Accounts receivable concentration percentage 7.00% 7.00%
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT
3 Months Ended
Nov. 30, 2013
Property, Plant and Equipment [Abstract]  
Note 3. PROPERTY AND EQUIPMENT

Property and equipment as of November 30, 2013 consisted of the following:

 

Equipment  $124,042 
Computer equipment   134,398 
Furniture and fixtures   51,465 
Leasehold improvements   23,645 
     Sub total   333,550 
Less: Accumulated depreciation and amortization   (217,623)
     Net Book Value  $115,927 

 

XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. GEOGRAPHIC REPORTING (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Revenues $ 2,641 $ 2,290
North America
   
Revenues 1,260 1,033
Europe
   
Revenues 536 598
Asia
   
Revenues 842 659
South America
   
Revenues $ 3 $ 0
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
Nov. 30, 2013
Aug. 31, 2013
Current assets    
Cash and cash equivalents $ 10,554,707 $ 10,179,298
Prepaid income taxes 64,798 301,573
Accounts receivable, net of allowance for doubtful accounts of $0 1,866,445 1,910,615
Contracts receivable 289,040 203,913
Prepaid expenses and other current assets 173,075 192,173
Deferred income taxes 188,126 184,258
Total current assets 13,136,191 12,971,830
Long-term assets    
Capitalized computer software development costs, net of accumulated amortization of $5,993,404 and $5,801,578 3,072,547 2,891,169
Property and equipment, net (note 3) 115,927 117,987
Intellectual property, net of accumulated amortization of $13,125 and $11,250 61,875 63,750
Other assets 18,445 18,445
Total assets 16,404,985 16,063,181
Current liabilities    
Accounts payable 235,422 146,011
Accrued payroll and other expenses 337,603 311,209
Accrued bonuses to officer 30,000 60,000
Other current liabilities 19,859 19,859
Deferred revenue 168,241 89,227
Total current liabilities 791,125 626,306
Long-term liabilities    
Deferred income taxes 1,220,435 1,146,389
Other long-term liabilities 43,028 47,993
Total liabilities 2,054,588 1,820,688
Commitments and contingencies (note 4)      
Shareholders' equity (note 5)    
Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding 0 0
Common stock, $0.001 par value 50,000,000 shares authorized 16,073,894 and 16,030,894 shares issued and outstanding 4,545 4,502
Additional paid-in capital 4,908,456 4,842,794
Retained earnings 9,437,396 9,395,197
Total shareholders' equity 14,350,397 14,242,493
Total liabilities and shareholders' equity $ 16,404,985 $ 16,063,181
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. GENERAL
3 Months Ended
Nov. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Note 1. GENERAL

This report on Form 10-Q for the quarter ended November 30, 2013, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. ("we", "our", "us"), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.

XML 26 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) (USD $)
Nov. 30, 2013
Cash and cash equivalents $ 10,554,707
Total assets 10,554,707
Level I
 
Cash and cash equivalents 10,554,707
Total assets 10,554,707
Level II
 
Cash and cash equivalents 0
Total assets 0
Level III
 
Cash and cash equivalents 0
Total assets $ 0
XML 27 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (USD $)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Aug. 31, 2013
Accumulated amortization of intellectual property $ 13,125   $ 11,250
Stock-based compensation 15,360 38,099  
Software Development Costs
     
Amortization of intangible assets 191,829 182,085  
Intellectual Property
     
Amortization of intangible assets 1,875    
Accumulated amortization of intellectual property $ 13,125    
XML 28 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 29 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Nov. 30, 2013
Accounting Policies [Abstract]  
Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

 

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

  

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

 

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

 

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $191,829 and $182,085 the three months ended November 30, 2013 and 2012, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

 

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at November 30, 2013 for assets and liabilities measured at fair value on a recurring basis:

 

  Level I Level II Level III Total
Cash and cash equivalents $  10,554,707 $           - $           - $  10,554,707
         
Total $  10,554,707 $           - $           - $  10,554,707

 

For certain of our financial instruments, including accounts receivable, accounts payable, accrued payroll and other expenses, accrued bonus to officer, and accrued warranty and service costs, the amounts approximate fair value due to their short maturities.

 

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

 

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

 

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for the fiscal quarter ended November 30, 2013 and 2012 >was $1,875 and $1,875 respectfully. Accumulated amortization as of November 30, 2013 was $13,125.

 

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three months ended November 30, 2013 and 2012 were as follows:

 

   11/30/2013   11/30/2012 
Numerator          
Net income attributable to common shareholders
  $685,155   $586,986 
Denominator          
Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13   16,049,707    15,927,806 
Dilutive effect of stock options   317,013    437,746 
Common stock and common stock equivalents used for diluted earning per share   16,366,720    16,365,552 

 

Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, “Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $15,360 and $38,099 for the three months ended November 30, 2013 and 2012, respectively, and is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

 

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

XML 30 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED BALANCE SHEETS (Parenthetical) (USD $)
Nov. 30, 2013
Aug. 31, 2013
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 0 $ 0
Accumulated amortization of computer software development costs 5,993,404 5,801,578
Accumulated amortization on intellectual property $ 13,125 $ 11,250
Preferred stock par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock par value $ 0.001 $ 0.001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 16,073,894 16,030,894
Common stock shares outstanding 16,073,894 16,030,894
XML 31 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Nov. 30, 2013
Accounting Policies [Abstract]  
Property and Equipment estimated useful lives
Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease
Summary of fair value measurements by level
  Level I Level II Level III Total
Cash and cash equivalents $  10,554,707 $           - $           - $  10,554,707
         
Total $  10,554,707 $           - $           - $  10,554,707
Components of basic and diluted earnings per share
   11/30/2013   11/30/2012 
Numerator          
Net income attributable to common shareholders
  $685,155   $586,986 
Denominator          
Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13   16,049,707    15,927,806 
Dilutive effect of stock options   317,013    437,746 
Common stock and common stock equivalents used for diluted earning per share   16,366,720    16,365,552 
XML 32 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
3 Months Ended
Nov. 30, 2013
Jan. 13, 2014
Document And Entity Information    
Entity Registrant Name SIMULATIONS PLUS INC  
Entity Central Index Key 0001023459  
Document Type 10-Q  
Document Period End Date Nov. 30, 2013  
Amendment Flag false  
Current Fiscal Year End Date --08-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   16,073,894
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2014  
XML 33 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT (Tables)
3 Months Ended
Nov. 30, 2013
Property, Plant and Equipment [Abstract]  
Property and equipment

Equipment  $124,042 
Computer equipment   134,398 
Furniture and fixtures   51,465 
Leasehold improvements   23,645 
     Sub total   333,550 
Less: Accumulated depreciation and amortization   (217,623)
     Net Book Value  $115,927 

 

XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Income Statement [Abstract]    
Net sales $ 2,641,000 $ 2,290,094
Cost of sales 448,420 386,870
Gross profit 2,192,580 1,903,224
Operating expenses    
Selling, general, and administrative 1,071,091 931,060
Research and development 162,116 180,335
Total operating expenses 1,233,207 1,111,395
Income from operations 959,373 791,829
Interest income 9,026 13,728
Miscellaneous income 0 15,404
Gain on currency exchange 23,709 74,654
Total other income (expense) 32,735 103,786
Income from operations before provision for income taxes 992,108 895,615
Provision for income taxes (306,953) (308,629)
Net Income $ 685,155 $ 586,986
Earnings per share - Basic $ 0.04 $ 0.04
Earnings per share - Diluted $ 0.04 $ 0.04
Weighted-average common shares outstanding    
Basic 16,049,707 15,927,806
Diluted 16,366,720 16,365,552
XML 35 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. CONCENTRATIONS AND UNCERTAINTIES
3 Months Ended
Nov. 30, 2013
Concentrations And Uncertainties  
Note 7. CONCENTRATIONS AND UNCERTAINTIES

Revenue concentration shows that International sales accounted for 52% and 55% of net sales for the three months ended November 30, 2013 and 2012, respectively. Four customers accounting for 19%, 13%, 11% (a dealer account in Japan representing various customers), and 10% of net sales during the three months ended November 30, 2013, compared with four customers accounting for 22%, 14% (a dealer account in Japan representing various customers), 12%, and 8% of net sales during the three months ended November 30, 2012.

 

Accounts receivable concentration shows that four customers comprised 18%, 18% (a dealer account in Japan representing various customers), 15%, and 7% of accounts receivable at November 30, 2013, and four customers comprised 17% (a dealer account in Japan representing various customers), 16%, 11%, and 7% of accounts receivable at November 30, 2012.

 

We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.

 

The majority of our customers are in the pharmaceutical industry. During the recent economic downturn, we have seen consolidations in the pharmaceutical industry. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.

XML 36 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. RELATED PARTY TRANSACTIONS
3 Months Ended
Nov. 30, 2013
Related Party Transactions [Abstract]  
Note 6. RELATED PARTY TRANSACTIONS

As of November 30, 2013, included in bonus expenses to officers was $60,000, of which $15,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $15,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee during the quarter ended November 30, 2013.

XML 37 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) (USD $)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Numerator    
Net income attributable to common shareholders $ 685,155 $ 586,986
Denominator    
Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13 16,049,707 15,927,806
Dilutive effect of stock options 317,013 437,746
Common stock and common stock equivalents used for diluted earnings per share 16,366,720 16,365,552
XML 38 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY (Tables)
3 Months Ended
Nov. 30, 2013
Equity [Abstract]  
Details of dividend paid

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/8/2012 11/13/2012 15,927,806 $0.05 $796,390
12/24/2012 12/28/2012 16,021,309 $0.14 $2,242,983
5/7/2013 5/10/2013 16,030,433 $0.03 $480,913
8/12/2013 8/15/2013 16,030,894 $0.03 $480,926
Total       $4,001,212

 

The Board of Directors also declared cash dividend during the first quarter of fiscal year 2014.

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/08/2013 11/15/2013 16,073,894 $0.04 $642,956
         
Total       642,956

  

Summary of the stock option transactions

Qualified Incentive Stock Options (Qualified ISO)

As of November 30, 2013, employees hold Qualified ISO to purchase 592,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to November 30, 2013.

 

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 532,000   $1.82 3.95
Granted 100,000   $5.61  
Exercised (40,000)   $1.12  
Outstanding, November 30,  2013 592,000   $2.51 4.02
Exercisable, November 30, 2013 366,600   $1.59 3.66

 

 

Non-Qualified Stock Options (Non-Qualified SO)

As of November 30, 2013, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to November 30, 2013.

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 48,600   $3.47 7.85
Exercised (3,000)   $1.80  
Outstanding, November 30, 2013 45,600   $3.92 7.78
Exercisable, November 30, 2013 25,200   $1.89 6.62
Exercise prices for the options outstanding
Exercise Price Awards Outstanding Awards Exercisable
Low High Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price
$1.00 $1.50 313,100 3.87 years $1.06 279,700 3.7 years $1.06
$1.51 $3.00 31,600 6.36 years $2.35 11,600 6.3 years $2.11
$3.01 $4.50 156,900 3.90 years $3.26 88,500   4.0 years $3.18
$4.51 $6.68 136,000 5.16 years $5.49 12,000   3.7 years $5.59
    637,600 4.28 years $2.61 391,800 3.9 years $1.71
XML 39 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
10. SUBSEQUENT EVENTS
3 Months Ended
Nov. 30, 2013
Subsequent Events [Abstract]  
10. SUBSEQUENT EVENTS

On December 6, 2013, the Board of Directors voted to amend the Company’s 2007 Employee Stock Option Plan. The amendment would increase the number of shares issuable under the plan by 1,000,000. The amendment is subject to approval by shareholder vote at the next shareholder meeting scheduled for February 25th, 2014.

 

XML 40 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. GEOGRAPHIC REPORTING
3 Months Ended
Nov. 30, 2013
Geographic Reporting  
Note 8. GEOGRAPHIC REPORTING

We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the three months ended November 30, 2013 and 2012 were as follows (in thousands):

 

  North America

Europe

Asia

South America

Total

November 30, 2013 $1,260 $536 $842 $3 $2,641
November 30, 2012 $1,033 $598 $659 $- $2,290

 

XML 41 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. EMPLOYEE BENEFIT PLAN
3 Months Ended
Nov. 30, 2013
Compensation Related Costs [Abstract]  
Note 9. EMPLOYEE BENEFIT PLAN

We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee’s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $26,127 and $20,814 for the three months ended November 30, 2013 and 2012, respectively.

XML 42 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Nov. 30, 2013
Accounting Policies [Abstract]  
Estimates

Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

Revenue Recognition

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

  

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

Cash and Cash Equivalents

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

Accounts Receivable

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

Capitalized Computer Software Development Costs

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $191,829 and $182,085 the three months ended November 30, 2013 and 2012, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at November 30, 2013 for assets and liabilities measured at fair value on a recurring basis:

 

  Level I Level II Level III Total
Cash and cash equivalents $  10,554,707 $           - $           - $  10,554,707
         
Total $  10,554,707 $           - $           - $  10,554,707

 

For certain of our financial instruments, including accounts receivable, accounts payable, accrued payroll and other expenses, accrued bonus to officer, and accrued warranty and service costs, the amounts approximate fair value due to their short maturities.

Research and Development Costs

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

Income Taxes

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

Intellectual property

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for the fiscal quarter ended November 30, 2013 and 2012 was $1,875 and $1,875 respectfully. Accumulated amortization as of November 30, 2013 was $13,125.

Earnings per Share

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three months ended November 30, 2013 and 2012 were as follows:

 

   11/30/2013   11/30/2012 
Numerator          
Net income attributable to common shareholders
  $685,155   $586,986 
Denominator          
Weighted-average number of common shares outstanding during the 3 months of FY14 and FY13   16,049,707    15,927,806 
Dilutive effect of stock options   317,013    437,746 
Common stock and common stock equivalents used for diluted earning per share   16,366,720    16,365,552 

 

Stock-Based Compensation

Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, “Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $15,360 and $38,099 for the three months ended November 30, 2013 and 2012, respectively, and is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

Recently Issued Accounting Standards

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

XML 43 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY (Narrative) (USD $)
3 Months Ended
Nov. 30, 2013
Equity [Abstract]  
Fair value of options granted $ 130,781
Assumptions used  
Pricing model Black-Scholes option-pricing model
Dividend yield 3.14%
Pre-vest forfeiture rate 6.25%
Expeceted volatility 38.95%
Risk-free interest rate 1.36%
Expected life 5 years
XML 44 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment)
3 Months Ended
Nov. 30, 2013
Equipment
 
Estimated useful lives 5 years
Computer equipment
 
Estimated useful lives 3 to 7 years
Furniture and fixtures
 
Estimated useful lives 5 to 7 years
Leasehold improvements
 
Estimated useful lives Shorter of life of asset or lease
XML 45 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. COMMITMENTS AND CONTINGENCIES (Narrative) (USD $)
3 Months Ended
Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Bonus paid $ 30,000
XML 46 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Cash flows from operating activities    
Net income $ 685,155 $ 586,986
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization of property and equipment 11,903 10,690
Amortization of capitalized computer software development costs 191,829 182,085
Amortization of Intellectual property 1,875 1,875
Stock-based compensation 15,360 38,099
Deferred income taxes 70,178 46,339
(Increase) decrease in    
Accounts receivable and Contracts receivable (40,957) (390,434)
Prepaid income taxes 236,775 0
Prepaid expenses and other assets 19,098 (60,930)
Accounts payable 89,408 16,598
Accrued payroll and other expenses 26,394 9,893
Accrued bonus (30,000) (45,000)
Accrued income taxes 0 (733,233)
Other liabilities (4,965) 0
Deferred revenue 79,014 75,446
Net cash provided by operating activities 1,351,067 (261,586)
Cash flows from investing activities    
Purchases of property and equipment (9,843) (1,638)
Capitalized computer software development costs (373,204) (262,083)
Net cash provided by (used in) investing activities (383,047) (263,721)
Cash flows from financing activities    
Payment of dividends (642,956) (796,390)
Proceeds from the exercise of stock options 50,345 0
Net cash (used in) financing activities of continuing operations (592,611) (796,390)
Net increase (decrease) in cash and cash equivalents 375,409 (1,321,697)
Cash and cash equivalents, beginning of year 10,179,298 12,701,075
Cash and cash equivalents, end of period 10,554,707 11,379,378
Supplemental disclosures of cash flow information    
Interest paid 0 0
Income taxes paid $ 0 $ 1,091,545
XML 47 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY
3 Months Ended
Nov. 30, 2013
Equity [Abstract]  
Note 5. SHAREHOLDERS' EQUITY

Dividend

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/8/2012 11/13/2012 15,927,806 $0.05 $796,390
12/24/2012 12/28/2012 16,021,309 $0.14 $2,242,983
5/7/2013 5/10/2013 16,030,433 $0.03 $480,913
8/12/2013 8/15/2013 16,030,894 $0.03 $480,926
Total       $4,001,212

 

The Board of Directors also declared cash dividend during the first quarter of fiscal year 2014.

 

Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount
11/08/2013 11/15/2013 16,073,894 $0.04 $642,956
         
Total       642,956

  

Stock Option Plan

In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the "Option Plan") under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.

 

On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance.

 

Qualified Incentive Stock Options (Qualified ISO)

As of November 30, 2013, employees hold Qualified SO to purchase 592,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to November 30, 2013.

 

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 532,000   $1.82 3.95
Granted 100,000   $5.61  
Exercised (40,000)   $1.12  
Outstanding, November 30, 2013 592,000   $2.51 4.02
Exercisable, November 30, 2013 366,600   $1.59 3.66

 

The fair value of the options, including both ISO and NQSO options, granted during the quarter ended November 30, 2013 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE November 30, 2013: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.

 

Non-Qualified Stock Options (Non-Qualified SO)

As of November 30, 2013, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to November 30, 2013.

 

 

Transactions in FY13

Number of Options  

Weighted-Average Exercise Price

Per Share

Weighted-Average Remaining Contractual Life
         
Outstanding, August 31, 2013 48,600   $3.47 7.85
Exercised (3,000)   $1.80  
Outstanding, November 30, 2013 45,600   $3.92 7.78
Exercisable, November 30, 2013 25,200   $1.89 6.62

  

The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified ISO, was 4.28 years at November 30, 2013. The exercise prices for the options outstanding at November 30, 2012 ranged from $1.00 to $6.68, and the information relating to these options is as follows:

 

Exercise Price Awards Outstanding Awards Exercisable
Low High Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price Quantity Weighted Average Remaining Contractual Life Weighted Average Exercise Price
$1.00 $1.50 313,100 3.87 years $1.06 279,700 3.7 years $1.06
$1.51 $3.00 31,600 6.36 years $2.35 11,600 6.3 years $2.11
$3.01 $4.50 156,900 3.90 years $3.26 88,500   4.0 years $3.18
$4.51 $6.68 136,000 5.16 years $5.49 12,000   3.7 years $5.59
    637,600 4.28 years $2.61 391,800 3.9 years $1.71

 

XML 48 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. SHAREHOLDERS' EQUITY (Details-Dividends) (USD $)
3 Months Ended 12 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Aug. 31, 2013
Total Amount $ 642,956 $ 796,390 $ 4,001,212
Record Date 11/08/2012
     
Record Date     Nov. 08, 2012
Distribution Date     Nov. 13, 2012
Number of Shares Outstanding on Record Date     15,927,806
Dividend per Share     $ 0.05
Total Amount     796,390
Record Date 12/24/2012
     
Record Date     Dec. 24, 2012
Distribution Date     Dec. 28, 2012
Number of Shares Outstanding on Record Date     16,021,309
Dividend per Share     $ 0.14
Total Amount     2,242,983
Record Date 05/07/2013
     
Record Date     May 07, 2013
Distribution Date     May 10, 2013
Number of Shares Outstanding on Record Date     16,030,433
Dividend per Share     $ 0.03
Total Amount     480,913
Record Date 08/12/2013
     
Record Date     Aug. 12, 2013
Distribution Date     Aug. 15, 2013
Number of Shares Outstanding on Record Date     16,030,894
Dividend per Share     $ 0.03
Total Amount     480,926
Record Date 11/08/2013
     
Record Date Nov. 08, 2013    
Distribution Date Nov. 15, 2013    
Number of Shares Outstanding on Record Date 16,073,894    
Dividend per Share $ 0.04    
Total Amount $ 642,956    
XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 68 165 1 false 34 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://simulations.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS Sheet http://simulations.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://simulations.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://simulations.com/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS false false R5.htm 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://simulations.com/role/CondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS false false R6.htm 00000006 - Disclosure - 1. GENERAL Sheet http://simulations.com/role/General 1. GENERAL false false R7.htm 00000007 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://simulations.com/role/SummaryOfSignificantAccountingPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 00000008 - Disclosure - 3. PROPERTY AND EQUIPMENT Sheet http://simulations.com/role/PropertyAndEquipment 3. PROPERTY AND EQUIPMENT false false R9.htm 00000009 - Disclosure - 4. COMMITMENTS AND CONTINGENCIES Sheet http://simulations.com/role/CommitmentsAndContingencies 4. COMMITMENTS AND CONTINGENCIES false false R10.htm 00000010 - Disclosure - 5. SHAREHOLDERS' EQUITY Sheet http://simulations.com/role/ShareholdersEquity 5. SHAREHOLDERS' EQUITY false false R11.htm 00000011 - Disclosure - 6. RELATED PARTY TRANSACTIONS Sheet http://simulations.com/role/RelatedPartyTransactions 6. RELATED PARTY TRANSACTIONS false false R12.htm 00000012 - Disclosure - 7. CONCENTRATIONS AND UNCERTAINTIES Sheet http://simulations.com/role/ConcentrationsAndUncertainties 7. CONCENTRATIONS AND UNCERTAINTIES false false R13.htm 00000013 - Disclosure - 8. GEOGRAPHIC REPORTING Sheet http://simulations.com/role/GeographicReporting 8. GEOGRAPHIC REPORTING false false R14.htm 00000014 - Disclosure - 9. EMPLOYEE BENEFIT PLAN Sheet http://simulations.com/role/EmployeeBenefitPlan 9. EMPLOYEE BENEFIT PLAN false false R15.htm 00000015 - Disclosure - 10. SUBSEQUENT EVENTS Sheet http://simulations.com/role/SubsequentEvents 10. SUBSEQUENT EVENTS false false R16.htm 00000016 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R17.htm 00000017 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R18.htm 00000018 - Disclosure - 3. PROPERTY AND EQUIPMENT (Tables) Sheet http://simulations.com/role/PropertyAndEquipmentTables 3. PROPERTY AND EQUIPMENT (Tables) false false R19.htm 00000019 - Disclosure - 5. SHAREHOLDERS' EQUITY (Tables) Sheet http://simulations.com/role/ShareholdersEquityTables 5. SHAREHOLDERS' EQUITY (Tables) false false R20.htm 00000020 - Disclosure - 8. SEGMENT AND GEOGRAPHIC REPORTING (Tables) Sheet http://simulations.com/role/SegmentAndGeographicReportingTables 8. SEGMENT AND GEOGRAPHIC REPORTING (Tables) false false R21.htm 00000021 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) false false R22.htm 00000022 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) false false R23.htm 00000023 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) false false R24.htm 00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesNarrative 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) false false R25.htm 00000025 - Disclosure - 3. PROPERTY AND EQUIPMENT (Details) Sheet http://simulations.com/role/PropertyAndEquipmentDetails 3. PROPERTY AND EQUIPMENT (Details) false false R26.htm 00000026 - Disclosure - 4. COMMITMENTS AND CONTINGENCIES (Narrative) Sheet http://simulations.com/role/CommitmentsAndContingenciesNarrative 4. COMMITMENTS AND CONTINGENCIES (Narrative) false false R27.htm 00000027 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Dividends) Sheet http://simulations.com/role/ShareholdersEquityDetails-Dividends 5. SHAREHOLDERS' EQUITY (Details-Dividends) false false R28.htm 00000028 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding) Sheet http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstanding 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding) false false R29.htm 00000029 - Disclosure - 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) Sheet http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable 5. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) false false R30.htm 00000030 - Disclosure - 6. RELATED PARTY TRANSACTIONS (Narrative) Sheet http://simulations.com/role/RelatedPartyTransactionsNarrative 6. RELATED PARTY TRANSACTIONS (Narrative) false false R31.htm 00000031 - Disclosure - 7. CONCENTRATIONS AND UNCERTAINTIES (Narrative) Sheet http://simulations.com/role/ConcentrationsAndUncertaintiesNarrative 7. CONCENTRATIONS AND UNCERTAINTIES (Narrative) false false R32.htm 00000032 - Disclosure - 8. GEOGRAPHIC REPORTING (Details) Sheet http://simulations.com/role/GeographicReportingDetails 8. GEOGRAPHIC REPORTING (Details) false false R33.htm 00000033 - Disclosure - 9. EMPLOYEE BENEFIT PLAN (Narrative) Sheet http://simulations.com/role/EmployeeBenefitPlanNarrative 9. EMPLOYEE BENEFIT PLAN (Narrative) false false R34.htm 00000034 - Disclosure - 5. SHAREHOLDERS' EQUITY (Narrative) Sheet http://simulations.com/role/ShareholdersEquityNarrative 5. SHAREHOLDERS' EQUITY (Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONDENSED BALANCE SHEETS Process Flow-Through: Removing column 'Nov. 30, 2012' Process Flow-Through: Removing column 'Aug. 31, 2012' Process Flow-Through: 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Process Flow-Through: 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2013' simu-20131130.xml simu-20131130.xsd simu-20131130_cal.xml simu-20131130_def.xml simu-20131130_lab.xml simu-20131130_pre.xml true true XML 50 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. SEGMENT AND GEOGRAPHIC REPORTING (Tables)
3 Months Ended
Nov. 30, 2013
Geographic Reporting  
Geographical revenues
  North America

Europe

Asia

South America

Total

November 30, 2013 $1,260 $536 $842 $3 $2,641
November 30, 2012 $1,033 $598 $659 $- $2,290